id	sid	tid	token	lemma	pos
bptjm-12	1	1	the	the	DET
bptjm-12	1	2	therapeutic	therapeutic	ADJ
bptjm-12	1	3	potential	potential	NOUN
bptjm-12	1	4	of	of	ADP
bptjm-12	1	5	synthetic	synthetic	ADJ
bptjm-12	1	6	and	and	CCONJ
bptjm-12	1	7	natural	natural	ADJ
bptjm-12	1	8	cannabinoids	cannabinoid	NOUN
bptjm-12	1	9	in	in	ADP
bptjm-12	1	10	treating	treat	VERB
bptjm-12	1	11	alzheimer	alzheimer	PROPN
bptjm-12	1	12	’s	’s	PART
bptjm-12	1	13	disease	disease	NOUN
bptjm-12	1	14	front	front	ADJ
bptjm-12	1	15	page	page	NOUN
bptjm-12	1	16	berkeley	berkeley	PROPN
bptjm-12	1	17	pharma	pharma	PROPN
bptjm-12	1	18	tech	tech	NOUN
bptjm-12	1	19	journal	journal	NOUN
bptjm-12	1	20	of	of	ADP
bptjm-12	1	21	medicine	medicine	NOUN
bptjm-12	1	22	correspondence	correspondence	NOUN
bptjm-12	1	23	nidhirkan@gmail.com	nidhirkan@gmail.com	PUNCT
bptjm-12	2	1	keywords	keyword	VERB
bptjm-12	2	2	alzheimer	alzheimer	PROPN
bptjm-12	2	3	's	's	PART
bptjm-12	2	4	disease	disease	NOUN
bptjm-12	2	5	amyloid	amyloid	NOUN
bptjm-12	2	6	-	-	PUNCT
bptjm-12	2	7	beta	beta	NOUN
bptjm-12	2	8	cannabinoids	cannabinoid	NOUN
bptjm-12	2	9	tau	tau	VERB
bptjm-12	2	10	protein	protein	NOUN
bptjm-12	2	11	hyperphosphorylation	hyperphosphorylation	NOUN
bptjm-12	2	12	∆9	∆9	NOUN
bptjm-12	2	13	-	-	PUNCT
bptjm-12	2	14	tetrahydrocannabinol	tetrahydrocannabinol	NOUN
bptjm-12	2	15	submitted	submit	VERB
bptjm-12	2	16	june	june	PROPN
bptjm-12	2	17	28	28	NUM
bptjm-12	2	18	,	,	PUNCT
bptjm-12	2	19	2021	2021	NUM
bptjm-12	2	20	accepted	accept	VERB
bptjm-12	2	21	july	july	PROPN
bptjm-12	2	22	6	6	NUM
bptjm-12	2	23	,	,	PUNCT
bptjm-12	2	24	2021	2021	NUM
bptjm-12	2	25	published	publish	VERB
bptjm-12	2	26	december	december	PROPN
bptjm-12	2	27	17	17	NUM
bptjm-12	2	28	,	,	PUNCT
bptjm-12	2	29	2021	2021	NUM
bptjm-12	2	30	full	full	ADJ
bptjm-12	2	31	open	open	ADJ
bptjm-12	2	32	access	access	NOUN
bptjm-12	2	33	creative	creative	ADJ
bptjm-12	2	34	commons	common	NOUN
bptjm-12	2	35	attribution	attribution	NOUN
bptjm-12	2	36	license	license	VERB
bptjm-12	2	37	4.0	4.0	NUM
bptjm-12	2	38	abstract	abstract	ADJ
bptjm-12	2	39	alzheimer	alzheimer	X
bptjm-12	2	40	’s	’s	PART
bptjm-12	2	41	disease	disease	NOUN
bptjm-12	2	42	(	(	PUNCT
bptjm-12	2	43	ad	ad	NOUN
bptjm-12	2	44	)	)	PUNCT
bptjm-12	2	45	is	be	AUX
bptjm-12	2	46	one	one	NUM
bptjm-12	2	47	of	of	ADP
bptjm-12	2	48	the	the	DET
bptjm-12	2	49	most	most	ADV
bptjm-12	2	50	prevalent	prevalent	ADJ
bptjm-12	2	51	and	and	CCONJ
bptjm-12	2	52	debilitating	debilitate	VERB
bptjm-12	2	53	neurodegenerative	neurodegenerative	ADJ
bptjm-12	2	54	diseases	disease	NOUN
bptjm-12	2	55	in	in	ADP
bptjm-12	2	56	the	the	DET
bptjm-12	2	57	world	world	NOUN
bptjm-12	2	58	,	,	PUNCT
bptjm-12	2	59	highlighting	highlight	VERB
bptjm-12	2	60	the	the	DET
bptjm-12	2	61	need	need	NOUN
bptjm-12	2	62	for	for	ADP
bptjm-12	2	63	research	research	NOUN
bptjm-12	2	64	on	on	ADP
bptjm-12	2	65	novel	novel	ADJ
bptjm-12	2	66	treatments	treatment	NOUN
bptjm-12	2	67	and	and	CCONJ
bptjm-12	2	68	therapies	therapy	NOUN
bptjm-12	2	69	.	.	PUNCT
bptjm-12	3	1	previous	previous	ADJ
bptjm-12	3	2	studies	study	NOUN
bptjm-12	3	3	have	have	AUX
bptjm-12	3	4	found	find	VERB
bptjm-12	3	5	that	that	SCONJ
bptjm-12	3	6	the	the	DET
bptjm-12	3	7	body	body	NOUN
bptjm-12	3	8	’s	’s	PART
bptjm-12	3	9	endocannabinoid	endocannabinoid	NOUN
bptjm-12	3	10	system	system	NOUN
bptjm-12	3	11	(	(	PUNCT
bptjm-12	3	12	ecs	ec	NOUN
bptjm-12	3	13	)	)	PUNCT
bptjm-12	3	14	interacts	interact	VERB
bptjm-12	3	15	closely	closely	ADV
bptjm-12	3	16	with	with	ADP
bptjm-12	3	17	its	its	PRON
bptjm-12	3	18	neural	neural	ADJ
bptjm-12	3	19	system	system	NOUN
bptjm-12	3	20	,	,	PUNCT
bptjm-12	3	21	making	make	VERB
bptjm-12	3	22	it	it	PRON
bptjm-12	3	23	a	a	DET
bptjm-12	3	24	potential	potential	ADJ
bptjm-12	3	25	avenue	avenue	NOUN
bptjm-12	3	26	for	for	ADP
bptjm-12	3	27	the	the	DET
bptjm-12	3	28	treatment	treatment	NOUN
bptjm-12	3	29	of	of	ADP
bptjm-12	3	30	neurological	neurological	ADJ
bptjm-12	3	31	disorders	disorder	NOUN
bptjm-12	3	32	.	.	PUNCT
bptjm-12	4	1	one	one	NUM
bptjm-12	4	2	hallmark	hallmark	NOUN
bptjm-12	4	3	of	of	ADP
bptjm-12	4	4	ad	ad	NOUN
bptjm-12	4	5	is	be	AUX
bptjm-12	4	6	the	the	DET
bptjm-12	4	7	accumulation	accumulation	NOUN
bptjm-12	4	8	of	of	ADP
bptjm-12	4	9	amyloid	amyloid	NOUN
bptjm-12	4	10	-	-	PUNCT
bptjm-12	4	11	beta	beta	NOUN
bptjm-12	4	12	(	(	PUNCT
bptjm-12	4	13	aβ	aβ	NOUN
bptjm-12	4	14	)	)	PUNCT
bptjm-12	4	15	in	in	ADP
bptjm-12	4	16	the	the	DET
bptjm-12	4	17	brain	brain	NOUN
bptjm-12	4	18	and	and	CCONJ
bptjm-12	4	19	its	its	PRON
bptjm-12	4	20	potentially	potentially	ADV
bptjm-12	4	21	detrimental	detrimental	ADJ
bptjm-12	4	22	effects	effect	NOUN
bptjm-12	4	23	on	on	ADP
bptjm-12	4	24	cognitive	cognitive	ADJ
bptjm-12	4	25	function	function	NOUN
bptjm-12	4	26	.	.	PUNCT
bptjm-12	5	1	cannabis	cannabis	NOUN
bptjm-12	5	2	-	-	PUNCT
bptjm-12	5	3	based	base	VERB
bptjm-12	5	4	drugs	drug	NOUN
bptjm-12	5	5	have	have	AUX
bptjm-12	5	6	been	be	AUX
bptjm-12	5	7	observed	observe	VERB
bptjm-12	5	8	to	to	PART
bptjm-12	5	9	regulate	regulate	VERB
bptjm-12	5	10	aβ	aβ	ADP
bptjm-12	5	11	modifications	modification	NOUN
bptjm-12	5	12	and	and	CCONJ
bptjm-12	5	13	inhibit	inhibit	VERB
bptjm-12	5	14	ad	ad	NOUN
bptjm-12	5	15	progression	progression	NOUN
bptjm-12	5	16	.	.	PUNCT
bptjm-12	6	1	furthermore	furthermore	ADV
bptjm-12	6	2	,	,	PUNCT
bptjm-12	6	3	cannabinoids	cannabinoid	NOUN
bptjm-12	6	4	have	have	AUX
bptjm-12	6	5	been	be	AUX
bptjm-12	6	6	noted	note	VERB
bptjm-12	6	7	to	to	PART
bptjm-12	6	8	reduce	reduce	VERB
bptjm-12	6	9	inflammation	inflammation	NOUN
bptjm-12	6	10	and	and	CCONJ
bptjm-12	6	11	neurotoxicity	neurotoxicity	NOUN
bptjm-12	6	12	.	.	PUNCT
bptjm-12	7	1	synthetic	synthetic	ADJ
bptjm-12	7	2	cannabinoids	cannabinoid	NOUN
bptjm-12	7	3	were	be	AUX
bptjm-12	7	4	able	able	ADJ
bptjm-12	7	5	to	to	PART
bptjm-12	7	6	rescue	rescue	VERB
bptjm-12	7	7	memory	memory	NOUN
bptjm-12	7	8	deficits	deficit	NOUN
bptjm-12	7	9	and	and	CCONJ
bptjm-12	7	10	neurodegeneration	neurodegeneration	NOUN
bptjm-12	7	11	,	,	PUNCT
bptjm-12	7	12	and	and	CCONJ
bptjm-12	7	13	reduce	reduce	VERB
bptjm-12	7	14	immunoreactivity	immunoreactivity	NOUN
bptjm-12	7	15	.	.	PUNCT
bptjm-12	8	1	similarly	similarly	ADV
bptjm-12	8	2	,	,	PUNCT
bptjm-12	8	3	natural	natural	ADJ
bptjm-12	8	4	cannabinoids	cannabinoid	NOUN
bptjm-12	8	5	like	like	ADP
bptjm-12	8	6	∆9	∆9	NOUN
bptjm-12	8	7	-	-	PUNCT
bptjm-12	8	8	tetrahydrocannabinol	tetrahydrocannabinol	NOUN
bptjm-12	8	9	(	(	PUNCT
bptjm-12	8	10	thc	thc	NOUN
bptjm-12	8	11	)	)	PUNCT
bptjm-12	8	12	and	and	CCONJ
bptjm-12	8	13	cannabidiol	cannabidiol	PROPN
bptjm-12	8	14	(	(	PUNCT
bptjm-12	8	15	cbd	cbd	NOUN
bptjm-12	8	16	)	)	PUNCT
bptjm-12	8	17	demonstrate	demonstrate	VERB
bptjm-12	8	18	therapeutic	therapeutic	ADJ
bptjm-12	8	19	potential	potential	NOUN
bptjm-12	8	20	by	by	ADP
bptjm-12	8	21	interacting	interact	VERB
bptjm-12	8	22	with	with	ADP
bptjm-12	8	23	the	the	DET
bptjm-12	8	24	cholinergic	cholinergic	ADJ
bptjm-12	8	25	system	system	NOUN
bptjm-12	8	26	,	,	PUNCT
bptjm-12	8	27	and	and	CCONJ
bptjm-12	8	28	reversing	reverse	VERB
bptjm-12	8	29	the	the	DET
bptjm-12	8	30	symptoms	symptom	NOUN
bptjm-12	8	31	of	of	ADP
bptjm-12	8	32	ad	ad	NOUN
bptjm-12	8	33	.	.	PUNCT
bptjm-12	9	1	although	although	SCONJ
bptjm-12	9	2	further	further	ADJ
bptjm-12	9	3	research	research	NOUN
bptjm-12	9	4	and	and	CCONJ
bptjm-12	9	5	testing	testing	NOUN
bptjm-12	9	6	are	be	AUX
bptjm-12	9	7	needed	need	VERB
bptjm-12	9	8	,	,	PUNCT
bptjm-12	9	9	it	it	PRON
bptjm-12	9	10	is	be	AUX
bptjm-12	9	11	evident	evident	ADJ
bptjm-12	9	12	that	that	SCONJ
bptjm-12	9	13	the	the	DET
bptjm-12	9	14	use	use	NOUN
bptjm-12	9	15	of	of	ADP
bptjm-12	9	16	cannabinoids	cannabinoid	NOUN
bptjm-12	9	17	shows	show	VERB
bptjm-12	9	18	promise	promise	NOUN
bptjm-12	9	19	for	for	ADP
bptjm-12	9	20	future	future	ADJ
bptjm-12	9	21	treatment	treatment	NOUN
bptjm-12	9	22	in	in	ADP
bptjm-12	9	23	ad	ad	NOUN
bptjm-12	9	24	patients	patient	NOUN
bptjm-12	9	25	.	.	PUNCT
bptjm-12	10	1	the	the	DET
bptjm-12	10	2	therapeutic	therapeutic	ADJ
bptjm-12	10	3	potential	potential	NOUN
bptjm-12	10	4	of	of	ADP
bptjm-12	10	5	synthetic	synthetic	ADJ
bptjm-12	10	6	and	and	CCONJ
bptjm-12	10	7	natural	natural	ADJ
bptjm-12	10	8	cannabinoids	cannabinoid	NOUN
bptjm-12	10	9	in	in	ADP
bptjm-12	10	10	treating	treat	VERB
bptjm-12	10	11	alzheimer	alzheimer	PROPN
bptjm-12	10	12	’s	’s	PART
bptjm-12	10	13	disease	disease	NOUN
bptjm-12	10	14	by	by	ADP
bptjm-12	10	15	:	:	PUNCT
bptjm-12	10	16	nidhi	nidhi	PROPN
bptjm-12	10	17	kanchumarthi	kanchumarthi	PROPN
bptjm-12	10	18	,	,	PUNCT
bptjm-12	10	19	avigail	avigail	PROPN
bptjm-12	10	20	rockland	rockland	NOUN
bptjm-12	10	21	,	,	PUNCT
bptjm-12	10	22	thejaswini	thejaswini	PROPN
bptjm-12	10	23	vembar	vembar	NOUN
bptjm-12	10	24	,	,	PUNCT
bptjm-12	10	25	elaine	elaine	PROPN
bptjm-12	10	26	liu	liu	PROPN
bptjm-12	10	27	,	,	PUNCT
bptjm-12	10	28	rithvik	rithvik	PROPN
bptjm-12	10	29	kanaad	kanaad	PROPN
bptjm-12	10	30	,	,	PUNCT
bptjm-12	10	31	erick	erick	PROPN
bptjm-12	10	32	torres	torre	VERB
bptjm-12	10	33	hinojosa	hinojosa	PROPN
bptjm-12	10	34	,	,	PUNCT
bptjm-12	10	35	kira	kira	PROPN
bptjm-12	10	36	tiv	tiv	PROPN
bptjm-12	10	37	,	,	PUNCT
bptjm-12	10	38	benjamin	benjamin	PROPN
bptjm-12	10	39	chen	chen	PROPN
bptjm-12	10	40	,	,	PUNCT
bptjm-12	10	41	shira	shira	PROPN
bptjm-12	10	42	hao	hao	PROPN
bptjm-12	10	43	,	,	PUNCT
bptjm-12	10	44	sri	sri	PROPN
bptjm-12	10	45	guttikonda	guttikonda	NOUN
bptjm-12	10	46	,	,	PUNCT
bptjm-12	10	47	and	and	CCONJ
bptjm-12	10	48	ramiro	ramiro	PROPN
bptjm-12	10	49	garza	garza	PROPN
bptjm-12	10	50	i.	i.	PROPN
bptjm-12	10	51	introduction	introduction	PROPN
bptjm-12	10	52	previous	previous	ADJ
bptjm-12	10	53	studies	study	NOUN
bptjm-12	10	54	have	have	AUX
bptjm-12	10	55	concluded	conclude	VERB
bptjm-12	10	56	that	that	SCONJ
bptjm-12	10	57	the	the	DET
bptjm-12	10	58	endocannabinoid	endocannabinoid	NOUN
bptjm-12	10	59	system	system	NOUN
bptjm-12	10	60	(	(	PUNCT
bptjm-12	10	61	ecs	ec	NOUN
bptjm-12	10	62	)	)	PUNCT
bptjm-12	10	63	is	be	AUX
bptjm-12	10	64	disrupted	disrupt	VERB
bptjm-12	10	65	by	by	ADP
bptjm-12	10	66	many	many	ADJ
bptjm-12	10	67	neurodegenerative	neurodegenerative	ADJ
bptjm-12	10	68	disorders	disorder	NOUN
bptjm-12	10	69	(	(	PUNCT
bptjm-12	10	70	di	di	NOUN
bptjm-12	10	71	marzo	marzo	NOUN
bptjm-12	10	72	et	et	PROPN
bptjm-12	10	73	al	al	PROPN
bptjm-12	10	74	.	.	PROPN
bptjm-12	10	75	,	,	PUNCT
bptjm-12	10	76	2015	2015	NUM
bptjm-12	10	77	;	;	PUNCT
bptjm-12	10	78	fagan	fagan	PROPN
bptjm-12	10	79	,	,	PUNCT
bptjm-12	10	80	2014	2014	NUM
bptjm-12	10	81	;	;	PUNCT
bptjm-12	10	82	paloczi	paloczi	NOUN
bptjm-12	10	83	et	et	PROPN
bptjm-12	10	84	al	al	PROPN
bptjm-12	10	85	.	.	PROPN
bptjm-12	10	86	,	,	PUNCT
bptjm-12	10	87	2018	2018	NUM
bptjm-12	10	88	)	)	PUNCT
bptjm-12	10	89	.	.	PUNCT
bptjm-12	11	1	the	the	DET
bptjm-12	11	2	goal	goal	NOUN
bptjm-12	11	3	of	of	ADP
bptjm-12	11	4	this	this	DET
bptjm-12	11	5	paper	paper	NOUN
bptjm-12	11	6	is	be	AUX
bptjm-12	11	7	to	to	PART
bptjm-12	11	8	comprehensively	comprehensively	ADV
bptjm-12	11	9	review	review	VERB
bptjm-12	11	10	and	and	CCONJ
bptjm-12	11	11	outline	outline	VERB
bptjm-12	11	12	the	the	DET
bptjm-12	11	13	most	most	ADV
bptjm-12	11	14	recent	recent	ADJ
bptjm-12	11	15	data	datum	NOUN
bptjm-12	11	16	around	around	ADP
bptjm-12	11	17	the	the	DET
bptjm-12	11	18	pathophysiology	pathophysiology	NOUN
bptjm-12	11	19	of	of	ADP
bptjm-12	11	20	the	the	DET
bptjm-12	11	21	ecs	ecs	PROPN
bptjm-12	11	22	as	as	SCONJ
bptjm-12	11	23	it	it	PRON
bptjm-12	11	24	relates	relate	VERB
bptjm-12	11	25	to	to	ADP
bptjm-12	11	26	alzheimer	alzheimer	PROPN
bptjm-12	11	27	’s	’s	PART
bptjm-12	11	28	disease	disease	NOUN
bptjm-12	11	29	(	(	PUNCT
bptjm-12	11	30	ad	ad	NOUN
bptjm-12	11	31	)	)	PUNCT
bptjm-12	11	32	,	,	PUNCT
bptjm-12	11	33	as	as	ADV
bptjm-12	11	34	well	well	ADV
bptjm-12	11	35	as	as	ADP
bptjm-12	11	36	to	to	PART
bptjm-12	11	37	investigate	investigate	VERB
bptjm-12	11	38	the	the	DET
bptjm-12	11	39	e	e	PROPN
bptjm-12	11	40	�	�	NOUN
bptjm-12	11	41	cacy	cacy	NOUN
bptjm-12	11	42	of	of	ADP
bptjm-12	11	43	natural	natural	ADJ
bptjm-12	11	44	and	and	CCONJ
bptjm-12	11	45	synthetic	synthetic	ADJ
bptjm-12	11	46	cannabinoids	cannabinoid	NOUN
bptjm-12	11	47	as	as	ADP
bptjm-12	11	48	a	a	DET
bptjm-12	11	49	therapeutic	therapeutic	ADJ
bptjm-12	11	50	option	option	NOUN
bptjm-12	11	51	.	.	PUNCT
bptjm-12	12	1	even	even	ADV
bptjm-12	12	2	as	as	SCONJ
bptjm-12	12	3	medicine	medicine	NOUN
bptjm-12	12	4	advances	advance	NOUN
bptjm-12	12	5	and	and	CCONJ
bptjm-12	12	6	life	life	NOUN
bptjm-12	12	7	expectancy	expectancy	NOUN
bptjm-12	12	8	increases	increase	NOUN
bptjm-12	12	9	,	,	PUNCT
bptjm-12	12	10	ad	ad	NOUN
bptjm-12	12	11	is	be	AUX
bptjm-12	12	12	still	still	ADV
bptjm-12	12	13	a	a	DET
bptjm-12	12	14	prevalent	prevalent	ADJ
bptjm-12	12	15	issue	issue	NOUN
bptjm-12	12	16	.	.	PUNCT
bptjm-12	13	1	with	with	ADP
bptjm-12	13	2	increased	increase	VERB
bptjm-12	13	3	prevalence	prevalence	NOUN
bptjm-12	13	4	comes	come	VERB
bptjm-12	13	5	the	the	DET
bptjm-12	13	6	need	need	NOUN
bptjm-12	13	7	for	for	ADP
bptjm-12	13	8	new	new	ADJ
bptjm-12	13	9	and	and	CCONJ
bptjm-12	13	10	e	e	NOUN
bptjm-12	13	11	�	�	NOUN
bptjm-12	13	12	ective	ective	ADJ
bptjm-12	13	13	therapies	therapy	NOUN
bptjm-12	13	14	.	.	PUNCT
bptjm-12	14	1	the	the	DET
bptjm-12	14	2	endocannabinoid	endocannabinoid	NOUN
bptjm-12	14	3	system	system	NOUN
bptjm-12	14	4	shows	show	VERB
bptjm-12	14	5	promise	promise	NOUN
bptjm-12	14	6	,	,	PUNCT
bptjm-12	14	7	serving	serve	VERB
bptjm-12	14	8	as	as	ADP
bptjm-12	14	9	both	both	CCONJ
bptjm-12	14	10	a	a	DET
bptjm-12	14	11	neuromodulator	neuromodulator	NOUN
bptjm-12	14	12	and	and	CCONJ
bptjm-12	14	13	immunomodulator	immunomodulator	NOUN
bptjm-12	14	14	.	.	PUNCT
bptjm-12	15	1	cannabis	cannabis	NOUN
bptjm-12	15	2	sativa	sativa	NOUN
bptjm-12	15	3	has	have	AUX
bptjm-12	15	4	been	be	AUX
bptjm-12	15	5	studied	study	VERB
bptjm-12	15	6	for	for	ADP
bptjm-12	15	7	its	its	PRON
bptjm-12	15	8	potential	potential	ADJ
bptjm-12	15	9	neuroprotective	neuroprotective	ADJ
bptjm-12	15	10	qualities	quality	NOUN
bptjm-12	15	11	and	and	CCONJ
bptjm-12	15	12	its	its	PRON
bptjm-12	15	13	role	role	NOUN
bptjm-12	15	14	in	in	ADP
bptjm-12	15	15	attenuating	attenuate	VERB
bptjm-12	15	16	nociception	nociception	NOUN
bptjm-12	15	17	in	in	ADP
bptjm-12	15	18	several	several	ADJ
bptjm-12	15	19	medical	medical	ADJ
bptjm-12	15	20	contexts	contexts	NOUN
bptjm-12	15	21	,	,	PUNCT
bptjm-12	15	22	including	include	VERB
bptjm-12	15	23	cancer	cancer	NOUN
bptjm-12	15	24	,	,	PUNCT
bptjm-12	15	25	psychiatric	psychiatric	ADJ
bptjm-12	15	26	disorders	disorder	NOUN
bptjm-12	15	27	,	,	PUNCT
bptjm-12	15	28	and	and	CCONJ
bptjm-12	15	29	epilepsy	epilepsy	NOUN
bptjm-12	15	30	.	.	PUNCT
bptjm-12	16	1	its	its	PRON
bptjm-12	16	2	primary	primary	ADJ
bptjm-12	16	3	active	active	ADJ
bptjm-12	16	4	components	component	NOUN
bptjm-12	16	5	,	,	PUNCT
bptjm-12	16	6	∆9	∆9	NOUN
bptjm-12	16	7	-	-	PUNCT
bptjm-12	16	8	tetrahydrocannabinol	tetrahydrocannabinol	NOUN
bptjm-12	16	9	(	(	PUNCT
bptjm-12	16	10	thc	thc	NOUN
bptjm-12	16	11	)	)	PUNCT
bptjm-12	16	12	and	and	CCONJ
bptjm-12	16	13	cannabidiol	cannabidiol	PROPN
bptjm-12	16	14	(	(	PUNCT
bptjm-12	16	15	cbd	cbd	NOUN
bptjm-12	16	16	)	)	PUNCT
bptjm-12	16	17	,	,	PUNCT
bptjm-12	16	18	interact	interact	VERB
bptjm-12	16	19	with	with	ADP
bptjm-12	16	20	the	the	DET
bptjm-12	16	21	endocannabinoid	endocannabinoid	NOUN
bptjm-12	16	22	signaling	signal	VERB
bptjm-12	16	23	system	system	NOUN
bptjm-12	16	24	through	through	ADP
bptjm-12	16	25	the	the	DET
bptjm-12	16	26	endocannabinoid	endocannabinoid	NOUN
bptjm-12	16	27	cb1	cb1	NOUN
bptjm-12	16	28	and	and	CCONJ
bptjm-12	16	29	cb2	cb2	PROPN
bptjm-12	16	30	receptors	receptor	NOUN
bptjm-12	16	31	.	.	PUNCT
bptjm-12	17	1	stimulation	stimulation	NOUN
bptjm-12	17	2	of	of	ADP
bptjm-12	17	3	these	these	DET
bptjm-12	17	4	receptors	receptor	NOUN
bptjm-12	17	5	by	by	ADP
bptjm-12	17	6	various	various	ADJ
bptjm-12	17	7	agonists	agonist	NOUN
bptjm-12	17	8	has	have	AUX
bptjm-12	17	9	also	also	ADV
bptjm-12	17	10	successfully	successfully	ADV
bptjm-12	17	11	reduced	reduce	VERB
bptjm-12	17	12	the	the	DET
bptjm-12	17	13	chronic	chronic	ADJ
bptjm-12	17	14	neuroin	neuroin	NOUN
bptjm-12	17	15	�	�	PROPN
bptjm-12	17	16	ammation	ammation	NOUN
bptjm-12	17	17	associated	associate	VERB
bptjm-12	17	18	with	with	ADP
bptjm-12	17	19	ad	ad	NOUN
bptjm-12	17	20	by	by	ADP
bptjm-12	17	21	interfering	interfere	VERB
bptjm-12	17	22	with	with	ADP
bptjm-12	17	23	the	the	DET
bptjm-12	17	24	di	di	PROPN
bptjm-12	17	25	�	�	PROPN
bptjm-12	17	26	erent	erent	NOUN
bptjm-12	17	27	neural	neural	ADJ
bptjm-12	17	28	pathways	pathway	NOUN
bptjm-12	17	29	.	.	PUNCT
bptjm-12	18	1	our	our	PRON
bptjm-12	18	2	goal	goal	NOUN
bptjm-12	18	3	has	have	AUX
bptjm-12	18	4	been	be	AUX
bptjm-12	18	5	to	to	PART
bptjm-12	18	6	identify	identify	VERB
bptjm-12	18	7	the	the	DET
bptjm-12	18	8	mechanisms	mechanism	NOUN
bptjm-12	18	9	by	by	ADP
bptjm-12	18	10	which	which	PRON
bptjm-12	18	11	the	the	DET
bptjm-12	18	12	reduction	reduction	NOUN
bptjm-12	18	13	in	in	ADP
bptjm-12	18	14	neuroin	neuroin	NOUN
bptjm-12	18	15	�	�	PROPN
bptjm-12	18	16	ammation	ammation	NOUN
bptjm-12	18	17	is	be	AUX
bptjm-12	18	18	accomplished	accomplish	VERB
bptjm-12	18	19	.	.	PUNCT
bptjm-12	19	1	accumulation	accumulation	NOUN
bptjm-12	19	2	of	of	ADP
bptjm-12	19	3	aβ	aβ	PRON
bptjm-12	19	4	peptide	peptide	NOUN
bptjm-12	19	5	and	and	CCONJ
bptjm-12	19	6	hyperphosphorylated	hyperphosphorylate	VERB
bptjm-12	19	7	tau	tau	PROPN
bptjm-12	19	8	protein	protein	NOUN
bptjm-12	19	9	in	in	ADP
bptjm-12	19	10	the	the	DET
bptjm-12	19	11	brain	brain	NOUN
bptjm-12	19	12	play	play	VERB
bptjm-12	19	13	an	an	DET
bptjm-12	19	14	important	important	ADJ
bptjm-12	19	15	role	role	NOUN
bptjm-12	19	16	in	in	ADP
bptjm-12	19	17	the	the	DET
bptjm-12	19	18	onset	onset	NOUN
bptjm-12	19	19	and	and	CCONJ
bptjm-12	19	20	progression	progression	NOUN
bptjm-12	19	21	of	of	ADP
bptjm-12	19	22	alzheimer	alzheimer	PROPN
bptjm-12	19	23	's	's	PART
bptjm-12	19	24	disease	disease	NOUN
bptjm-12	19	25	(	(	PUNCT
bptjm-12	19	26	ad	ad	NOUN
bptjm-12	19	27	)	)	PUNCT
bptjm-12	19	28	(	(	PUNCT
bptjm-12	19	29	farkhondeh	farkhondeh	VERB
bptjm-12	19	30	et	et	PROPN
bptjm-12	19	31	al	al	PROPN
bptjm-12	19	32	.	.	PROPN
bptjm-12	19	33	,	,	PUNCT
bptjm-12	19	34	2020	2020	NUM
bptjm-12	19	35	)	)	PUNCT
bptjm-12	19	36	.	.	PUNCT
bptjm-12	20	1	however	however	ADV
bptjm-12	20	2	,	,	PUNCT
bptjm-12	20	3	recent	recent	ADJ
bptjm-12	20	4	research	research	NOUN
bptjm-12	20	5	has	have	AUX
bptjm-12	20	6	suggested	suggest	VERB
bptjm-12	20	7	that	that	SCONJ
bptjm-12	20	8	aβ	aβ	NOUN
bptjm-12	20	9	is	be	AUX
bptjm-12	20	10	no	no	ADV
bptjm-12	20	11	longer	long	ADV
bptjm-12	20	12	considered	consider	VERB
bptjm-12	20	13	the	the	DET
bptjm-12	20	14	primary	primary	ADJ
bptjm-12	20	15	cause	cause	NOUN
bptjm-12	20	16	,	,	PUNCT
bptjm-12	20	17	which	which	PRON
bptjm-12	20	18	was	be	AUX
bptjm-12	20	19	the	the	DET
bptjm-12	20	20	accepted	accepted	ADJ
bptjm-12	20	21	belief	belief	NOUN
bptjm-12	20	22	for	for	ADP
bptjm-12	20	23	many	many	ADJ
bptjm-12	20	24	years	year	NOUN
bptjm-12	20	25	(	(	PUNCT
bptjm-12	20	26	cubinkova	cubinkova	X
bptjm-12	20	27	et	et	PROPN
bptjm-12	20	28	al	al	PROPN
bptjm-12	20	29	.	.	PROPN
bptjm-12	20	30	,	,	PUNCT
bptjm-12	20	31	2018	2018	NUM
bptjm-12	20	32	)	)	PUNCT
bptjm-12	20	33	.	.	PUNCT
bptjm-12	21	1	nevertheless	nevertheless	ADV
bptjm-12	21	2	,	,	PUNCT
bptjm-12	21	3	the	the	DET
bptjm-12	21	4	ecs	ecs	PROPN
bptjm-12	21	5	o	o	NOUN
bptjm-12	21	6	�	�	PROPN
bptjm-12	21	7	ers	er	VERB
bptjm-12	21	8	many	many	ADJ
bptjm-12	21	9	therapeutic	therapeutic	ADJ
bptjm-12	21	10	possibilities	possibility	NOUN
bptjm-12	21	11	for	for	ADP
bptjm-12	21	12	targeting	target	VERB
bptjm-12	21	13	these	these	DET
bptjm-12	21	14	aβ	aβ	PRON
bptjm-12	21	15	deposits	deposit	NOUN
bptjm-12	21	16	.	.	PUNCT
bptjm-12	22	1	many	many	ADJ
bptjm-12	22	2	studies	study	NOUN
bptjm-12	22	3	support	support	VERB
bptjm-12	22	4	the	the	DET
bptjm-12	22	5	�	�	NOUN
bptjm-12	22	6	nding	nde	VERB
bptjm-12	22	7	that	that	DET
bptjm-12	22	8	elevated	elevated	ADJ
bptjm-12	22	9	levels	level	NOUN
bptjm-12	22	10	of	of	ADP
bptjm-12	22	11	the	the	DET
bptjm-12	22	12	endocannabinoid	endocannabinoid	NOUN
bptjm-12	22	13	2ag	2ag	NOUN
bptjm-12	22	14	,	,	PUNCT
bptjm-12	22	15	coupled	couple	VERB
bptjm-12	22	16	with	with	ADP
bptjm-12	22	17	the	the	DET
bptjm-12	22	18	modulation	modulation	NOUN
bptjm-12	22	19	of	of	ADP
bptjm-12	22	20	the	the	DET
bptjm-12	22	21	common	common	ADJ
bptjm-12	22	22	cannabinoid	cannabinoid	NOUN
bptjm-12	22	23	receptor	receptor	NOUN
bptjm-12	22	24	cb2	cb2	PROPN
bptjm-12	22	25	,	,	PUNCT
bptjm-12	22	26	could	could	AUX
bptjm-12	22	27	reduce	reduce	VERB
bptjm-12	22	28	aβ	aβ	PRON
bptjm-12	22	29	plaque	plaque	NOUN
bptjm-12	22	30	accumulation	accumulation	NOUN
bptjm-12	22	31	(	(	PUNCT
bptjm-12	22	32	paloczi	paloczi	NOUN
bptjm-12	22	33	,	,	PUNCT
bptjm-12	22	34	2018	2018	NUM
bptjm-12	22	35	)	)	PUNCT
bptjm-12	22	36	.	.	PUNCT
bptjm-12	23	1	while	while	SCONJ
bptjm-12	23	2	aβ	aβ	PRON
bptjm-12	23	3	may	may	AUX
bptjm-12	23	4	not	not	PART
bptjm-12	23	5	be	be	AUX
bptjm-12	23	6	the	the	DET
bptjm-12	23	7	primary	primary	ADJ
bptjm-12	23	8	cause	cause	NOUN
bptjm-12	23	9	of	of	ADP
bptjm-12	23	10	ad	ad	NOUN
bptjm-12	23	11	,	,	PUNCT
bptjm-12	23	12	studies	study	NOUN
bptjm-12	23	13	have	have	AUX
bptjm-12	23	14	shown	show	VERB
bptjm-12	23	15	that	that	SCONJ
bptjm-12	23	16	these	these	DET
bptjm-12	23	17	deposits	deposit	NOUN
bptjm-12	23	18	are	be	AUX
bptjm-12	23	19	detrimental	detrimental	ADJ
bptjm-12	23	20	to	to	ADP
bptjm-12	23	21	healthy	healthy	ADJ
bptjm-12	23	22	synapses	synapsis	NOUN
bptjm-12	23	23	(	(	PUNCT
bptjm-12	23	24	shankar	shankar	PROPN
bptjm-12	23	25	et	et	PROPN
bptjm-12	23	26	al	al	PROPN
bptjm-12	23	27	.	.	PROPN
bptjm-12	23	28	,	,	PUNCT
bptjm-12	23	29	2008	2008	NUM
bptjm-12	23	30	)	)	PUNCT
bptjm-12	23	31	,	,	PUNCT
bptjm-12	23	32	decreasing	decrease	VERB
bptjm-12	23	33	long	long	ADJ
bptjm-12	23	34	-	-	PUNCT
bptjm-12	23	35	term	term	NOUN
bptjm-12	23	36	potentiation	potentiation	NOUN
bptjm-12	23	37	and	and	CCONJ
bptjm-12	23	38	increasing	increase	VERB
bptjm-12	23	39	long	long	ADJ
bptjm-12	23	40	-	-	PUNCT
bptjm-12	23	41	term	term	NOUN
bptjm-12	23	42	depression	depression	NOUN
bptjm-12	23	43	.	.	PUNCT
bptjm-12	24	1	sometimes	sometimes	ADV
bptjm-12	24	2	,	,	PUNCT
bptjm-12	24	3	this	this	DET
bptjm-12	24	4	neural	neural	ADJ
bptjm-12	24	5	damage	damage	NOUN
bptjm-12	24	6	is	be	AUX
bptjm-12	24	7	permanent	permanent	ADJ
bptjm-12	24	8	,	,	PUNCT
bptjm-12	24	9	but	but	CCONJ
bptjm-12	24	10	the	the	DET
bptjm-12	24	11	use	use	NOUN
bptjm-12	24	12	of	of	ADP
bptjm-12	24	13	cannabinoids	cannabinoid	NOUN
bptjm-12	24	14	to	to	PART
bptjm-12	24	15	stimulate	stimulate	VERB
bptjm-12	24	16	the	the	DET
bptjm-12	24	17	ecs	ecs	PROPN
bptjm-12	24	18	has	have	AUX
bptjm-12	24	19	shown	show	VERB
bptjm-12	24	20	some	some	DET
bptjm-12	24	21	success	success	NOUN
bptjm-12	24	22	in	in	ADP
bptjm-12	24	23	preventing	prevent	VERB
bptjm-12	24	24	this	this	DET
bptjm-12	24	25	kind	kind	NOUN
bptjm-12	24	26	of	of	ADP
bptjm-12	24	27	damage	damage	NOUN
bptjm-12	24	28	.	.	PUNCT
bptjm-12	25	1	berkeley	berkeley	PROPN
bptjm-12	25	2	pharma	pharma	PROPN
bptjm-12	25	3	tech	tech	PROPN
bptjm-12	25	4	journal	journal	NOUN
bptjm-12	25	5	of	of	ADP
bptjm-12	25	6	medicine	medicine	NOUN
bptjm-12	25	7	|	|	ADV
bptjm-12	25	8	2	2	NUM
bptjm-12	25	9	pathology	pathology	NOUN
bptjm-12	25	10	of	of	ADP
bptjm-12	25	11	the	the	DET
bptjm-12	25	12	cholinergic	cholinergic	ADJ
bptjm-12	25	13	system	system	NOUN
bptjm-12	25	14	is	be	AUX
bptjm-12	25	15	also	also	ADV
bptjm-12	25	16	associated	associate	VERB
bptjm-12	25	17	with	with	ADP
bptjm-12	25	18	ad	ad	NOUN
bptjm-12	25	19	and	and	CCONJ
bptjm-12	25	20	thus	thus	ADV
bptjm-12	25	21	has	have	AUX
bptjm-12	25	22	been	be	AUX
bptjm-12	25	23	further	far	ADV
bptjm-12	25	24	investigated	investigate	VERB
bptjm-12	25	25	as	as	ADP
bptjm-12	25	26	a	a	DET
bptjm-12	25	27	therapeutic	therapeutic	ADJ
bptjm-12	25	28	target	target	NOUN
bptjm-12	25	29	.	.	PUNCT
bptjm-12	26	1	many	many	ADJ
bptjm-12	26	2	cholinergic	cholinergic	ADJ
bptjm-12	26	3	pathways	pathway	NOUN
bptjm-12	26	4	function	function	NOUN
bptjm-12	26	5	in	in	ADP
bptjm-12	26	6	conscious	conscious	ADJ
bptjm-12	26	7	awareness	awareness	NOUN
bptjm-12	26	8	,	,	PUNCT
bptjm-12	26	9	attention	attention	NOUN
bptjm-12	26	10	,	,	PUNCT
bptjm-12	26	11	and	and	CCONJ
bptjm-12	26	12	working	working	NOUN
bptjm-12	26	13	memory	memory	NOUN
bptjm-12	26	14	,	,	PUNCT
bptjm-12	26	15	which	which	PRON
bptjm-12	26	16	are	be	AUX
bptjm-12	26	17	areas	area	NOUN
bptjm-12	26	18	commonly	commonly	ADV
bptjm-12	26	19	found	find	VERB
bptjm-12	26	20	to	to	PART
bptjm-12	26	21	be	be	AUX
bptjm-12	26	22	damaged	damage	VERB
bptjm-12	26	23	or	or	CCONJ
bptjm-12	26	24	dysfunctional	dysfunctional	ADJ
bptjm-12	26	25	in	in	ADP
bptjm-12	26	26	those	those	PRON
bptjm-12	26	27	who	who	PRON
bptjm-12	26	28	su	su	PROPN
bptjm-12	26	29	�	�	PROPN
bptjm-12	26	30	er	er	NOUN
bptjm-12	26	31	from	from	ADP
bptjm-12	26	32	ad	ad	NOUN
bptjm-12	26	33	.	.	PUNCT
bptjm-12	27	1	research	research	NOUN
bptjm-12	27	2	by	by	ADP
bptjm-12	27	3	k.j	k.j	PROPN
bptjm-12	27	4	.	.	PROPN
bptjm-12	27	5	thompson	thompson	PROPN
bptjm-12	27	6	suggests	suggest	VERB
bptjm-12	27	7	that	that	SCONJ
bptjm-12	27	8	interacting	interact	VERB
bptjm-12	27	9	signals	signal	NOUN
bptjm-12	27	10	between	between	ADP
bptjm-12	27	11	the	the	DET
bptjm-12	27	12	endocannabinoid	endocannabinoid	NOUN
bptjm-12	27	13	and	and	CCONJ
bptjm-12	27	14	cholinergic	cholinergic	ADJ
bptjm-12	27	15	systems	system	NOUN
bptjm-12	27	16	may	may	AUX
bptjm-12	27	17	be	be	AUX
bptjm-12	27	18	a	a	DET
bptjm-12	27	19	way	way	NOUN
bptjm-12	27	20	to	to	PART
bptjm-12	27	21	improve	improve	VERB
bptjm-12	27	22	cholinergic	cholinergic	ADJ
bptjm-12	27	23	signaling	signal	VERB
bptjm-12	27	24	and	and	CCONJ
bptjm-12	27	25	repair	repair	VERB
bptjm-12	27	26	synaptic	synaptic	ADJ
bptjm-12	27	27	plasticity	plasticity	NOUN
bptjm-12	27	28	that	that	PRON
bptjm-12	27	29	is	be	AUX
bptjm-12	27	30	damaged	damage	VERB
bptjm-12	27	31	as	as	ADP
bptjm-12	27	32	a	a	DET
bptjm-12	27	33	result	result	NOUN
bptjm-12	27	34	of	of	ADP
bptjm-12	27	35	ad	ad	NOUN
bptjm-12	27	36	(	(	PUNCT
bptjm-12	27	37	thompson	thompson	PROPN
bptjm-12	27	38	et	et	PROPN
bptjm-12	27	39	al	al	PROPN
bptjm-12	27	40	.	.	PROPN
bptjm-12	27	41	,	,	PUNCT
bptjm-12	27	42	2020	2020	NUM
bptjm-12	27	43	)	)	PUNCT
bptjm-12	27	44	.	.	PUNCT
bptjm-12	28	1	we	we	PRON
bptjm-12	28	2	then	then	ADV
bptjm-12	28	3	investigate	investigate	VERB
bptjm-12	28	4	the	the	DET
bptjm-12	28	5	inhibitory	inhibitory	ADJ
bptjm-12	28	6	activity	activity	NOUN
bptjm-12	28	7	of	of	ADP
bptjm-12	28	8	various	various	ADJ
bptjm-12	28	9	receptor	receptor	NOUN
bptjm-12	28	10	agonists	agonist	NOUN
bptjm-12	28	11	of	of	ADP
bptjm-12	28	12	the	the	DET
bptjm-12	28	13	ecs	ec	NOUN
bptjm-12	28	14	,	,	PUNCT
bptjm-12	28	15	both	both	PRON
bptjm-12	28	16	natural	natural	ADJ
bptjm-12	28	17	and	and	CCONJ
bptjm-12	28	18	synthetic	synthetic	NOUN
bptjm-12	28	19	.	.	PUNCT
bptjm-12	29	1	this	this	DET
bptjm-12	29	2	section	section	NOUN
bptjm-12	29	3	looks	look	VERB
bptjm-12	29	4	at	at	ADP
bptjm-12	29	5	cbd	cbd	NOUN
bptjm-12	29	6	and	and	CCONJ
bptjm-12	29	7	thc	thc	NOUN
bptjm-12	29	8	as	as	ADP
bptjm-12	29	9	receptor	receptor	NOUN
bptjm-12	29	10	agonists	agonist	NOUN
bptjm-12	29	11	and	and	CCONJ
bptjm-12	29	12	concludes	conclude	VERB
bptjm-12	29	13	that	that	SCONJ
bptjm-12	29	14	cbd	cbd	NOUN
bptjm-12	29	15	plays	play	VERB
bptjm-12	29	16	a	a	DET
bptjm-12	29	17	role	role	NOUN
bptjm-12	29	18	in	in	ADP
bptjm-12	29	19	the	the	DET
bptjm-12	29	20	inhibition	inhibition	NOUN
bptjm-12	29	21	of	of	ADP
bptjm-12	29	22	neural	neural	ADJ
bptjm-12	29	23	apoptosis	apoptosis	NOUN
bptjm-12	29	24	while	while	SCONJ
bptjm-12	29	25	thc	thc	PROPN
bptjm-12	29	26	is	be	AUX
bptjm-12	29	27	active	active	ADJ
bptjm-12	29	28	in	in	ADP
bptjm-12	29	29	the	the	DET
bptjm-12	29	30	inhibition	inhibition	NOUN
bptjm-12	29	31	of	of	ADP
bptjm-12	29	32	acetylcholinesterase	acetylcholinesterase	NOUN
bptjm-12	29	33	(	(	PUNCT
bptjm-12	29	34	ache	ache	ADV
bptjm-12	29	35	)	)	PUNCT
bptjm-12	29	36	,	,	PUNCT
bptjm-12	29	37	which	which	PRON
bptjm-12	29	38	serves	serve	VERB
bptjm-12	29	39	to	to	PART
bptjm-12	29	40	improve	improve	VERB
bptjm-12	29	41	the	the	DET
bptjm-12	29	42	reduced	reduced	ADJ
bptjm-12	29	43	cholinergic	cholinergic	NOUN
bptjm-12	29	44	signalling	signal	VERB
bptjm-12	29	45	associated	associate	VERB
bptjm-12	29	46	with	with	ADP
bptjm-12	29	47	ad	ad	NOUN
bptjm-12	29	48	.	.	PUNCT
bptjm-12	30	1	both	both	DET
bptjm-12	30	2	agonists	agonist	NOUN
bptjm-12	30	3	seem	seem	VERB
bptjm-12	30	4	to	to	PART
bptjm-12	30	5	play	play	VERB
bptjm-12	30	6	a	a	DET
bptjm-12	30	7	part	part	NOUN
bptjm-12	30	8	in	in	ADP
bptjm-12	30	9	the	the	DET
bptjm-12	30	10	reduction	reduction	NOUN
bptjm-12	30	11	of	of	ADP
bptjm-12	30	12	aβ	aβ	DET
bptjm-12	30	13	build	build	NOUN
bptjm-12	30	14	-	-	PUNCT
bptjm-12	30	15	up	up	NOUN
bptjm-12	30	16	,	,	PUNCT
bptjm-12	30	17	but	but	CCONJ
bptjm-12	30	18	the	the	DET
bptjm-12	30	19	exact	exact	ADJ
bptjm-12	30	20	pathways	pathway	NOUN
bptjm-12	30	21	still	still	ADV
bptjm-12	30	22	need	need	VERB
bptjm-12	30	23	to	to	PART
bptjm-12	30	24	be	be	AUX
bptjm-12	30	25	elucidated	elucidate	VERB
bptjm-12	30	26	.	.	PUNCT
bptjm-12	31	1	some	some	PRON
bptjm-12	31	2	of	of	ADP
bptjm-12	31	3	the	the	DET
bptjm-12	31	4	most	most	ADV
bptjm-12	31	5	e	e	NOUN
bptjm-12	31	6	�	�	NOUN
bptjm-12	31	7	ective	ective	ADJ
bptjm-12	31	8	and	and	CCONJ
bptjm-12	31	9	well	well	ADV
bptjm-12	31	10	-	-	PUNCT
bptjm-12	31	11	researched	research	VERB
bptjm-12	31	12	synthetic	synthetic	ADJ
bptjm-12	31	13	agonists	agonist	NOUN
bptjm-12	31	14	of	of	ADP
bptjm-12	31	15	the	the	DET
bptjm-12	31	16	ecs	ecs	PROPN
bptjm-12	31	17	include	include	VERB
bptjm-12	31	18	dronabinol	dronabinol	NOUN
bptjm-12	31	19	,	,	PUNCT
bptjm-12	31	20	nabilone	nabilone	PROPN
bptjm-12	31	21	,	,	PUNCT
bptjm-12	31	22	win55,212	win55,212	PROPN
bptjm-12	31	23	-	-	PUNCT
bptjm-12	31	24	2	2	NUM
bptjm-12	31	25	,	,	PUNCT
bptjm-12	31	26	and	and	CCONJ
bptjm-12	31	27	jwh-015	jwh-015	PROPN
bptjm-12	31	28	.	.	PUNCT
bptjm-12	32	1	dronabinol	dronabinol	PROPN
bptjm-12	32	2	and	and	CCONJ
bptjm-12	32	3	nabilone	nabilone	PROPN
bptjm-12	32	4	were	be	AUX
bptjm-12	32	5	found	find	VERB
bptjm-12	32	6	to	to	PART
bptjm-12	32	7	be	be	AUX
bptjm-12	32	8	particularly	particularly	ADV
bptjm-12	32	9	e	e	X
bptjm-12	32	10	�	�	NOUN
bptjm-12	32	11	ective	ective	ADJ
bptjm-12	32	12	in	in	ADP
bptjm-12	32	13	treating	treat	VERB
bptjm-12	32	14	the	the	DET
bptjm-12	32	15	neuropsychiatric	neuropsychiatric	ADJ
bptjm-12	32	16	symptoms	symptom	NOUN
bptjm-12	32	17	(	(	PUNCT
bptjm-12	32	18	nps	nps	PROPN
bptjm-12	32	19	)	)	PUNCT
bptjm-12	32	20	associated	associate	VERB
bptjm-12	32	21	with	with	ADP
bptjm-12	32	22	ad	ad	NOUN
bptjm-12	32	23	,	,	PUNCT
bptjm-12	32	24	while	while	SCONJ
bptjm-12	32	25	the	the	DET
bptjm-12	32	26	others	other	NOUN
bptjm-12	32	27	primarily	primarily	ADV
bptjm-12	32	28	function	function	VERB
bptjm-12	32	29	in	in	ADP
bptjm-12	32	30	reducing	reduce	VERB
bptjm-12	32	31	aβ	aβ	PRON
bptjm-12	32	32	plaques	plaque	NOUN
bptjm-12	32	33	and	and	CCONJ
bptjm-12	32	34	neuroin	neuroin	NOUN
bptjm-12	32	35	�	�	PROPN
bptjm-12	32	36	ammation	ammation	NOUN
bptjm-12	32	37	.	.	PUNCT
bptjm-12	33	1	our	our	PRON
bptjm-12	33	2	review	review	NOUN
bptjm-12	33	3	presents	present	VERB
bptjm-12	33	4	published	publish	VERB
bptjm-12	33	5	research	research	NOUN
bptjm-12	33	6	that	that	PRON
bptjm-12	33	7	supports	support	VERB
bptjm-12	33	8	the	the	DET
bptjm-12	33	9	e	e	PROPN
bptjm-12	33	10	�	�	NOUN
bptjm-12	33	11	cacy	cacy	NOUN
bptjm-12	33	12	of	of	ADP
bptjm-12	33	13	both	both	CCONJ
bptjm-12	33	14	natural	natural	ADJ
bptjm-12	33	15	and	and	CCONJ
bptjm-12	33	16	synthetic	synthetic	ADJ
bptjm-12	33	17	cannabinoids	cannabinoid	NOUN
bptjm-12	33	18	as	as	ADP
bptjm-12	33	19	a	a	DET
bptjm-12	33	20	potential	potential	ADJ
bptjm-12	33	21	treatment	treatment	NOUN
bptjm-12	33	22	for	for	ADP
bptjm-12	33	23	ad	ad	NOUN
bptjm-12	33	24	.	.	PUNCT
bptjm-12	34	1	this	this	PRON
bptjm-12	34	2	introduces	introduce	VERB
bptjm-12	34	3	a	a	DET
bptjm-12	34	4	potential	potential	ADJ
bptjm-12	34	5	bias	bias	NOUN
bptjm-12	34	6	,	,	PUNCT
bptjm-12	34	7	as	as	SCONJ
bptjm-12	34	8	studies	study	NOUN
bptjm-12	34	9	which	which	PRON
bptjm-12	34	10	conclude	conclude	VERB
bptjm-12	34	11	positive	positive	ADJ
bptjm-12	34	12	results	result	NOUN
bptjm-12	34	13	and	and	CCONJ
bptjm-12	34	14	relationships	relationship	NOUN
bptjm-12	34	15	are	be	AUX
bptjm-12	34	16	more	more	ADV
bptjm-12	34	17	likely	likely	ADJ
bptjm-12	34	18	to	to	PART
bptjm-12	34	19	be	be	AUX
bptjm-12	34	20	published	publish	VERB
bptjm-12	34	21	than	than	ADP
bptjm-12	34	22	those	those	PRON
bptjm-12	34	23	with	with	ADP
bptjm-12	34	24	negative	negative	ADJ
bptjm-12	34	25	results	result	NOUN
bptjm-12	34	26	.	.	PUNCT
bptjm-12	35	1	nevertheless	nevertheless	ADV
bptjm-12	35	2	,	,	PUNCT
bptjm-12	35	3	this	this	DET
bptjm-12	35	4	research	research	NOUN
bptjm-12	35	5	highlights	highlight	VERB
bptjm-12	35	6	the	the	DET
bptjm-12	35	7	potential	potential	ADJ
bptjm-12	35	8	bene	bene	PROPN
bptjm-12	35	9	�	�	PROPN
bptjm-12	35	10	ts	ts	ADP
bptjm-12	35	11	that	that	PRON
bptjm-12	35	12	cannabinoid	cannabinoid	NOUN
bptjm-12	35	13	therapy	therapy	NOUN
bptjm-12	35	14	could	could	AUX
bptjm-12	35	15	provide	provide	VERB
bptjm-12	35	16	and	and	CCONJ
bptjm-12	35	17	recommends	recommend	VERB
bptjm-12	35	18	that	that	SCONJ
bptjm-12	35	19	it	it	PRON
bptjm-12	35	20	be	be	AUX
bptjm-12	35	21	studied	study	VERB
bptjm-12	35	22	further	far	ADV
bptjm-12	35	23	.	.	PUNCT
bptjm-12	36	1	ii	ii	X
bptjm-12	36	2	.	.	PUNCT
bptjm-12	36	3	neural	neural	ADJ
bptjm-12	36	4	pathway	pathway	PROPN
bptjm-12	36	5	a.	a.	PROPN
bptjm-12	36	6	amyloidogenic	amyloidogenic	PROPN
bptjm-12	36	7	pathway	pathway	NOUN
bptjm-12	36	8	accumulation	accumulation	NOUN
bptjm-12	36	9	of	of	ADP
bptjm-12	36	10	aβ	aβ	PRON
bptjm-12	36	11	peptide	peptide	NOUN
bptjm-12	36	12	and	and	CCONJ
bptjm-12	36	13	hyperphosphorylated	hyperphosphorylate	VERB
bptjm-12	36	14	tau	tau	PROPN
bptjm-12	36	15	protein	protein	NOUN
bptjm-12	36	16	in	in	ADP
bptjm-12	36	17	the	the	DET
bptjm-12	36	18	brain	brain	NOUN
bptjm-12	36	19	are	be	AUX
bptjm-12	36	20	the	the	DET
bptjm-12	36	21	leading	lead	VERB
bptjm-12	36	22	sources	source	NOUN
bptjm-12	36	23	of	of	ADP
bptjm-12	36	24	the	the	DET
bptjm-12	36	25	onset	onset	NOUN
bptjm-12	36	26	and	and	CCONJ
bptjm-12	36	27	progression	progression	NOUN
bptjm-12	36	28	of	of	ADP
bptjm-12	36	29	ad	ad	NOUN
bptjm-12	36	30	(	(	PUNCT
bptjm-12	36	31	farkhondeh	farkhondeh	NOUN
bptjm-12	36	32	et	et	PROPN
bptjm-12	36	33	al	al	PROPN
bptjm-12	36	34	.	.	PROPN
bptjm-12	36	35	,	,	PUNCT
bptjm-12	36	36	2020	2020	NUM
bptjm-12	36	37	)	)	PUNCT
bptjm-12	36	38	.	.	PUNCT
bptjm-12	37	1	when	when	SCONJ
bptjm-12	37	2	amyloid	amyloid	NOUN
bptjm-12	37	3	precursor	precursor	NOUN
bptjm-12	37	4	protein	protein	NOUN
bptjm-12	37	5	(	(	PUNCT
bptjm-12	37	6	app	app	X
bptjm-12	37	7	)	)	PUNCT
bptjm-12	37	8	is	be	AUX
bptjm-12	37	9	activated	activate	VERB
bptjm-12	37	10	,	,	PUNCT
bptjm-12	37	11	it	it	PRON
bptjm-12	37	12	is	be	AUX
bptjm-12	37	13	cleaved	cleave	VERB
bptjm-12	37	14	by	by	ADP
bptjm-12	37	15	other	other	ADJ
bptjm-12	37	16	proteins	protein	NOUN
bptjm-12	37	17	,	,	PUNCT
bptjm-12	37	18	which	which	PRON
bptjm-12	37	19	leads	lead	VERB
bptjm-12	37	20	to	to	ADP
bptjm-12	37	21	the	the	DET
bptjm-12	37	22	production	production	NOUN
bptjm-12	37	23	of	of	ADP
bptjm-12	37	24	small	small	ADJ
bptjm-12	37	25	aβ	aβ	NOUN
bptjm-12	37	26	fragments	fragment	NOUN
bptjm-12	37	27	.	.	PUNCT
bptjm-12	38	1	this	this	PRON
bptjm-12	38	2	induces	induce	VERB
bptjm-12	38	3	an	an	DET
bptjm-12	38	4	increased	increase	VERB
bptjm-12	38	5	production	production	NOUN
bptjm-12	38	6	and	and	CCONJ
bptjm-12	38	7	aggregation	aggregation	NOUN
bptjm-12	38	8	of	of	ADP
bptjm-12	38	9	aβ	aβ	PRON
bptjm-12	38	10	peptide	peptide	NOUN
bptjm-12	38	11	in	in	ADP
bptjm-12	38	12	limbic	limbic	ADJ
bptjm-12	38	13	and	and	CCONJ
bptjm-12	38	14	association	association	NOUN
bptjm-12	38	15	cortices	cortex	NOUN
bptjm-12	38	16	.	.	PUNCT
bptjm-12	39	1	as	as	ADP
bptjm-12	39	2	a	a	DET
bptjm-12	39	3	result	result	NOUN
bptjm-12	39	4	,	,	PUNCT
bptjm-12	39	5	the	the	DET
bptjm-12	39	6	altered	altered	ADJ
bptjm-12	39	7	neuronal	neuronal	ADJ
bptjm-12	39	8	homeostasis	homeostasis	NOUN
bptjm-12	39	9	and	and	CCONJ
bptjm-12	39	10	oxidative	oxidative	ADJ
bptjm-12	39	11	injury	injury	NOUN
bptjm-12	39	12	provoke	provoke	VERB
bptjm-12	39	13	neuro	neuro	PROPN
bptjm-12	39	14	�	�	PROPN
bptjm-12	39	15	brillary	brillary	ADJ
bptjm-12	39	16	tangle	tangle	NOUN
bptjm-12	39	17	formation	formation	NOUN
bptjm-12	39	18	.	.	PUNCT
bptjm-12	40	1	these	these	DET
bptjm-12	40	2	tangles	tangle	NOUN
bptjm-12	40	3	are	be	AUX
bptjm-12	40	4	a	a	DET
bptjm-12	40	5	characteristic	characteristic	ADJ
bptjm-12	40	6	trait	trait	NOUN
bptjm-12	40	7	of	of	ADP
bptjm-12	40	8	ad	ad	NOUN
bptjm-12	40	9	brains	brain	NOUN
bptjm-12	40	10	and	and	CCONJ
bptjm-12	40	11	lead	lead	VERB
bptjm-12	40	12	to	to	ADP
bptjm-12	40	13	berkeley	berkeley	PROPN
bptjm-12	40	14	pharma	pharma	PROPN
bptjm-12	40	15	tech	tech	NOUN
bptjm-12	40	16	journal	journal	NOUN
bptjm-12	40	17	of	of	ADP
bptjm-12	40	18	medicine	medicine	NOUN
bptjm-12	40	19	|	|	ADV
bptjm-12	40	20	3	3	NUM
bptjm-12	40	21	neuronal	neuronal	ADJ
bptjm-12	40	22	loss	loss	NOUN
bptjm-12	40	23	and	and	CCONJ
bptjm-12	40	24	cognitive	cognitive	ADJ
bptjm-12	40	25	impairment	impairment	NOUN
bptjm-12	40	26	(	(	PUNCT
bptjm-12	40	27	hall	hall	NOUN
bptjm-12	40	28	et	et	PROPN
bptjm-12	40	29	al	al	PROPN
bptjm-12	40	30	.	.	PROPN
bptjm-12	40	31	,	,	PUNCT
bptjm-12	40	32	2001	2001	NUM
bptjm-12	40	33	;	;	PUNCT
bptjm-12	40	34	nelson	nelson	PROPN
bptjm-12	40	35	et	et	PROPN
bptjm-12	40	36	al	al	PROPN
bptjm-12	40	37	.	.	PROPN
bptjm-12	40	38	,	,	PUNCT
bptjm-12	40	39	2012	2012	NUM
bptjm-12	40	40	)	)	PUNCT
bptjm-12	40	41	.	.	PUNCT
bptjm-12	41	1	fig	fig	NOUN
bptjm-12	41	2	.	.	PUNCT
bptjm-12	42	1	1	1	NUM
bptjm-12	42	2	:	:	PUNCT
bptjm-12	42	3	the	the	DET
bptjm-12	42	4	process	process	NOUN
bptjm-12	42	5	of	of	ADP
bptjm-12	42	6	neuro	neuro	PROPN
bptjm-12	42	7	�	�	PROPN
bptjm-12	42	8	brillary	brillary	ADJ
bptjm-12	42	9	tangle	tangle	NOUN
bptjm-12	42	10	formation	formation	NOUN
bptjm-12	42	11	induced	induce	VERB
bptjm-12	42	12	by	by	ADP
bptjm-12	42	13	amyloid	amyloid	NOUN
bptjm-12	42	14	plaque	plaque	NOUN
bptjm-12	42	15	buildup	buildup	NOUN
bptjm-12	42	16	.	.	PUNCT
bptjm-12	43	1	as	as	SCONJ
bptjm-12	43	2	the	the	DET
bptjm-12	43	3	amyloid	amyloid	NOUN
bptjm-12	43	4	precursor	precursor	NOUN
bptjm-12	43	5	protein	protein	NOUN
bptjm-12	43	6	(	(	PUNCT
bptjm-12	43	7	app	app	X
bptjm-12	43	8	)	)	PUNCT
bptjm-12	43	9	is	be	AUX
bptjm-12	43	10	activated	activate	VERB
bptjm-12	43	11	,	,	PUNCT
bptjm-12	43	12	amounts	amount	NOUN
bptjm-12	43	13	of	of	ADP
bptjm-12	43	14	aβ	aβ	NOUN
bptjm-12	43	15	are	be	AUX
bptjm-12	43	16	produced	produce	VERB
bptjm-12	43	17	.	.	PUNCT
bptjm-12	44	1	this	this	DET
bptjm-12	44	2	excess	excess	NOUN
bptjm-12	44	3	aβ	aβ	NOUN
bptjm-12	44	4	leads	lead	VERB
bptjm-12	44	5	the	the	DET
bptjm-12	44	6	neuro	neuro	PROPN
bptjm-12	44	7	�	�	PROPN
bptjm-12	44	8	brillary	brillary	ADJ
bptjm-12	44	9	tangle	tangle	NOUN
bptjm-12	44	10	formation	formation	NOUN
bptjm-12	44	11	,	,	PUNCT
bptjm-12	44	12	as	as	SCONJ
bptjm-12	44	13	seen	see	VERB
bptjm-12	44	14	in	in	ADP
bptjm-12	44	15	ad	ad	NOUN
bptjm-12	44	16	a	a	DET
bptjm-12	44	17	�	�	NOUN
bptjm-12	44	18	ected	ecte	VERB
bptjm-12	44	19	patients	patient	NOUN
bptjm-12	44	20	.	.	PUNCT
bptjm-12	45	1	cbd	cbd	PROPN
bptjm-12	45	2	,	,	PUNCT
bptjm-12	45	3	a	a	DET
bptjm-12	45	4	cannabis	cannabis	NOUN
bptjm-12	45	5	derivative	derivative	NOUN
bptjm-12	45	6	devoid	devoid	ADJ
bptjm-12	45	7	of	of	ADP
bptjm-12	45	8	psychotropic	psychotropic	ADJ
bptjm-12	45	9	e	e	NOUN
bptjm-12	45	10	�	�	NOUN
bptjm-12	45	11	ects	ect	NOUN
bptjm-12	45	12	,	,	PUNCT
bptjm-12	45	13	has	have	AUX
bptjm-12	45	14	been	be	AUX
bptjm-12	45	15	shown	show	VERB
bptjm-12	45	16	to	to	PART
bptjm-12	45	17	interfere	interfere	VERB
bptjm-12	45	18	with	with	ADP
bptjm-12	45	19	several	several	ADJ
bptjm-12	45	20	aβ	aβ	NOUN
bptjm-12	45	21	-	-	PUNCT
bptjm-12	45	22	triggered	trigger	VERB
bptjm-12	45	23	neurodegenerative	neurodegenerative	ADJ
bptjm-12	45	24	pathways	pathway	NOUN
bptjm-12	45	25	(	(	PUNCT
bptjm-12	45	26	scuderi	scuderi	PROPN
bptjm-12	45	27	et	et	PROPN
bptjm-12	45	28	al	al	PROPN
bptjm-12	45	29	.	.	PROPN
bptjm-12	45	30	,	,	PUNCT
bptjm-12	45	31	2014	2014	NUM
bptjm-12	45	32	)	)	PUNCT
bptjm-12	45	33	.	.	PUNCT
bptjm-12	46	1	studies	study	NOUN
bptjm-12	46	2	found	find	VERB
bptjm-12	46	3	that	that	SCONJ
bptjm-12	46	4	cbd	cbd	NOUN
bptjm-12	46	5	led	lead	VERB
bptjm-12	46	6	to	to	ADP
bptjm-12	46	7	the	the	DET
bptjm-12	46	8	downregulation	downregulation	NOUN
bptjm-12	46	9	of	of	ADP
bptjm-12	46	10	genes	gene	NOUN
bptjm-12	46	11	linked	link	VERB
bptjm-12	46	12	to	to	ADP
bptjm-12	46	13	ad	ad	NOUN
bptjm-12	46	14	,	,	PUNCT
bptjm-12	46	15	including	include	VERB
bptjm-12	46	16	genes	gene	NOUN
bptjm-12	46	17	coding	code	VERB
bptjm-12	46	18	for	for	ADP
bptjm-12	46	19	the	the	DET
bptjm-12	46	20	kinases	kinase	NOUN
bptjm-12	46	21	responsible	responsible	ADJ
bptjm-12	46	22	for	for	ADP
bptjm-12	46	23	tau	tau	PROPN
bptjm-12	46	24	phosphorylation	phosphorylation	NOUN
bptjm-12	46	25	and	and	CCONJ
bptjm-12	46	26	for	for	ADP
bptjm-12	46	27	the	the	DET
bptjm-12	46	28	secretases	secretase	NOUN
bptjm-12	46	29	involved	involve	VERB
bptjm-12	46	30	in	in	ADP
bptjm-12	46	31	aβ	aβ	DET
bptjm-12	46	32	generation	generation	NOUN
bptjm-12	46	33	.	.	PUNCT
bptjm-12	47	1	pre	pre	ADJ
bptjm-12	47	2	-	-	NOUN
bptjm-12	47	3	treatment	treatment	NOUN
bptjm-12	47	4	with	with	ADP
bptjm-12	47	5	cbd	cbd	NOUN
bptjm-12	47	6	prevented	prevent	VERB
bptjm-12	47	7	the	the	DET
bptjm-12	47	8	expression	expression	NOUN
bptjm-12	47	9	of	of	ADP
bptjm-12	47	10	proteins	protein	NOUN
bptjm-12	47	11	potentially	potentially	ADV
bptjm-12	47	12	involved	involve	VERB
bptjm-12	47	13	in	in	ADP
bptjm-12	47	14	tau	tau	PROPN
bptjm-12	47	15	phosphorylation	phosphorylation	NOUN
bptjm-12	47	16	and	and	CCONJ
bptjm-12	47	17	aβ	aβ	DET
bptjm-12	47	18	production	production	NOUN
bptjm-12	47	19	in	in	ADP
bptjm-12	47	20	gingiva	gingiva	NOUN
bptjm-12	47	21	-	-	PUNCT
bptjm-12	47	22	derived	derive	VERB
bptjm-12	47	23	berkeley	berkeley	PROPN
bptjm-12	47	24	pharma	pharma	PROPN
bptjm-12	47	25	tech	tech	NOUN
bptjm-12	47	26	journal	journal	NOUN
bptjm-12	47	27	of	of	ADP
bptjm-12	47	28	medicine	medicine	NOUN
bptjm-12	47	29	|	|	ADV
bptjm-12	47	30	4	4	NUM
bptjm-12	47	31	mesenchymal	mesenchymal	ADJ
bptjm-12	47	32	stem	stem	NOUN
bptjm-12	47	33	cells	cell	NOUN
bptjm-12	47	34	(	(	PUNCT
bptjm-12	47	35	gmscs	gmscs	PROPN
bptjm-12	47	36	)	)	PUNCT
bptjm-12	47	37	(	(	PUNCT
bptjm-12	47	38	libroet	libroet	VERB
bptjm-12	47	39	al	al	PROPN
bptjm-12	47	40	.	.	PROPN
bptjm-12	47	41	,	,	PUNCT
bptjm-12	47	42	2016	2016	NUM
bptjm-12	47	43	)	)	PUNCT
bptjm-12	47	44	.	.	PUNCT
bptjm-12	48	1	in	in	ADP
bptjm-12	48	2	one	one	NUM
bptjm-12	48	3	study	study	NOUN
bptjm-12	48	4	,	,	PUNCT
bptjm-12	48	5	the	the	DET
bptjm-12	48	6	role	role	NOUN
bptjm-12	48	7	of	of	ADP
bptjm-12	48	8	cbd	cbd	NOUN
bptjm-12	48	9	was	be	AUX
bptjm-12	48	10	investigated	investigate	VERB
bptjm-12	48	11	as	as	ADP
bptjm-12	48	12	a	a	DET
bptjm-12	48	13	modulating	modulating	ADJ
bptjm-12	48	14	compound	compound	NOUN
bptjm-12	48	15	of	of	ADP
bptjm-12	48	16	app	app	NOUN
bptjm-12	48	17	processing	processing	NOUN
bptjm-12	48	18	in	in	ADP
bptjm-12	48	19	shsy5y(app+	shsy5y(app+	NOUN
bptjm-12	48	20	)	)	PUNCT
bptjm-12	48	21	neurons	neuron	NOUN
bptjm-12	48	22	.	.	PUNCT
bptjm-12	49	1	in	in	ADP
bptjm-12	49	2	addition	addition	NOUN
bptjm-12	49	3	,	,	PUNCT
bptjm-12	49	4	the	the	DET
bptjm-12	49	5	putative	putative	ADJ
bptjm-12	49	6	involvement	involvement	NOUN
bptjm-12	49	7	of	of	ADP
bptjm-12	49	8	pparγ	pparγ	NOUN
bptjm-12	49	9	was	be	AUX
bptjm-12	49	10	explored	explore	VERB
bptjm-12	49	11	as	as	ADP
bptjm-12	49	12	a	a	DET
bptjm-12	49	13	candidate	candidate	NOUN
bptjm-12	49	14	molecular	molecular	ADJ
bptjm-12	49	15	site	site	NOUN
bptjm-12	49	16	responsible	responsible	ADJ
bptjm-12	49	17	for	for	ADP
bptjm-12	49	18	cbd	cbd	NOUN
bptjm-12	49	19	actions	action	NOUN
bptjm-12	49	20	.	.	PUNCT
bptjm-12	50	1	the	the	DET
bptjm-12	50	2	results	result	NOUN
bptjm-12	50	3	indicated	indicate	VERB
bptjm-12	50	4	that	that	SCONJ
bptjm-12	50	5	cbd	cbd	NOUN
bptjm-12	50	6	is	be	AUX
bptjm-12	50	7	capable	capable	ADJ
bptjm-12	50	8	of	of	ADP
bptjm-12	50	9	inducing	induce	VERB
bptjm-12	50	10	the	the	DET
bptjm-12	50	11	ubiquitination	ubiquitination	NOUN
bptjm-12	50	12	—	—	PUNCT
bptjm-12	50	13	the	the	DET
bptjm-12	50	14	degradation	degradation	NOUN
bptjm-12	50	15	—	—	PUNCT
bptjm-12	50	16	of	of	ADP
bptjm-12	50	17	app	app	NOUN
bptjm-12	50	18	protein	protein	NOUN
bptjm-12	50	19	,	,	PUNCT
bptjm-12	50	20	leading	lead	VERB
bptjm-12	50	21	to	to	ADP
bptjm-12	50	22	a	a	DET
bptjm-12	50	23	decrease	decrease	NOUN
bptjm-12	50	24	in	in	ADP
bptjm-12	50	25	app	app	PROPN
bptjm-12	50	26	full	full	ADJ
bptjm-12	50	27	length	length	NOUN
bptjm-12	50	28	protein	protein	NOUN
bptjm-12	50	29	levels	level	NOUN
bptjm-12	50	30	in	in	ADP
bptjm-12	50	31	shsy5y(app+	shsy5y(app+	PROPN
bptjm-12	50	32	)	)	PUNCT
bptjm-12	50	33	and	and	CCONJ
bptjm-12	50	34	a	a	DET
bptjm-12	50	35	consequent	consequent	ADJ
bptjm-12	50	36	decrease	decrease	NOUN
bptjm-12	50	37	in	in	ADP
bptjm-12	50	38	aβ	aβ	DET
bptjm-12	50	39	production	production	NOUN
bptjm-12	50	40	.	.	PUNCT
bptjm-12	51	1	cbd	cbd	PROPN
bptjm-12	51	2	also	also	ADV
bptjm-12	51	3	promoted	promote	VERB
bptjm-12	51	4	an	an	DET
bptjm-12	51	5	increased	increased	ADJ
bptjm-12	51	6	survival	survival	NOUN
bptjm-12	51	7	of	of	ADP
bptjm-12	51	8	shsy5y(app+	shsy5y(app+	NOUN
bptjm-12	51	9	)	)	PUNCT
bptjm-12	51	10	neurons	neuron	NOUN
bptjm-12	51	11	by	by	ADP
bptjm-12	51	12	reducing	reduce	VERB
bptjm-12	51	13	their	their	PRON
bptjm-12	51	14	long	long	ADJ
bptjm-12	51	15	-	-	PUNCT
bptjm-12	51	16	term	term	NOUN
bptjm-12	51	17	apoptotic	apoptotic	ADJ
bptjm-12	51	18	rate	rate	NOUN
bptjm-12	51	19	(	(	PUNCT
bptjm-12	51	20	scuderi	scuderi	PROPN
bptjm-12	51	21	et	et	PROPN
bptjm-12	51	22	al	al	PROPN
bptjm-12	51	23	.	.	PROPN
bptjm-12	51	24	,	,	PUNCT
bptjm-12	51	25	2014	2014	NUM
bptjm-12	51	26	)	)	PUNCT
bptjm-12	51	27	.	.	PUNCT
bptjm-12	52	1	in	in	ADP
bptjm-12	52	2	conclusion	conclusion	NOUN
bptjm-12	52	3	,	,	PUNCT
bptjm-12	52	4	research	research	NOUN
bptjm-12	52	5	indicates	indicate	VERB
bptjm-12	52	6	that	that	SCONJ
bptjm-12	52	7	cannabis	cannabis	NOUN
bptjm-12	52	8	-	-	PUNCT
bptjm-12	52	9	based	base	VERB
bptjm-12	52	10	drugs	drug	NOUN
bptjm-12	52	11	inhibited	inhibit	VERB
bptjm-12	52	12	the	the	DET
bptjm-12	52	13	progression	progression	NOUN
bptjm-12	52	14	of	of	ADP
bptjm-12	52	15	ad	ad	NOUN
bptjm-12	52	16	by	by	ADP
bptjm-12	52	17	regulating	regulate	VERB
bptjm-12	52	18	aβ	aβ	PRON
bptjm-12	52	19	modi	modi	PROPN
bptjm-12	52	20	�	�	PROPN
bptjm-12	52	21	cations	cation	NOUN
bptjm-12	52	22	(	(	PUNCT
bptjm-12	52	23	farkhondeh	farkhondeh	VERB
bptjm-12	52	24	et	et	PROPN
bptjm-12	52	25	al	al	PROPN
bptjm-12	52	26	.	.	PROPN
bptjm-12	52	27	,	,	PUNCT
bptjm-12	52	28	2020	2020	NUM
bptjm-12	52	29	)	)	PUNCT
bptjm-12	52	30	.	.	PUNCT
bptjm-12	53	1	while	while	SCONJ
bptjm-12	53	2	the	the	DET
bptjm-12	53	3	aggregation	aggregation	NOUN
bptjm-12	53	4	of	of	ADP
bptjm-12	53	5	aβ	aβ	PRON
bptjm-12	53	6	plaques	plaque	NOUN
bptjm-12	53	7	has	have	AUX
bptjm-12	53	8	been	be	AUX
bptjm-12	53	9	the	the	DET
bptjm-12	53	10	leading	lead	VERB
bptjm-12	53	11	hypothesis	hypothesis	NOUN
bptjm-12	53	12	in	in	ADP
bptjm-12	53	13	the	the	DET
bptjm-12	53	14	onset	onset	NOUN
bptjm-12	53	15	ofad	ofad	NOUN
bptjm-12	53	16	for	for	ADP
bptjm-12	53	17	several	several	ADJ
bptjm-12	53	18	years	year	NOUN
bptjm-12	53	19	,	,	PUNCT
bptjm-12	53	20	recent	recent	ADJ
bptjm-12	53	21	research	research	NOUN
bptjm-12	53	22	has	have	AUX
bptjm-12	53	23	suggested	suggest	VERB
bptjm-12	53	24	alternative	alternative	ADJ
bptjm-12	53	25	hypotheses	hypothesis	NOUN
bptjm-12	53	26	.	.	PUNCT
bptjm-12	54	1	a	a	DET
bptjm-12	54	2	number	number	NOUN
bptjm-12	54	3	of	of	ADP
bptjm-12	54	4	drugs	drug	NOUN
bptjm-12	54	5	targeting	target	VERB
bptjm-12	54	6	aβ	aβ	NOUN
bptjm-12	54	7	,	,	PUNCT
bptjm-12	54	8	such	such	ADJ
bptjm-12	54	9	as	as	ADP
bptjm-12	54	10	aducanumab	aducanumab	NOUN
bptjm-12	54	11	—	—	PUNCT
bptjm-12	54	12	an	an	DET
bptjm-12	54	13	antibody	antibody	NOUN
bptjm-12	54	14	drug	drug	NOUN
bptjm-12	54	15	that	that	PRON
bptjm-12	54	16	binds	bind	VERB
bptjm-12	54	17	to	to	ADP
bptjm-12	54	18	insoluble	insoluble	ADJ
bptjm-12	54	19	and	and	CCONJ
bptjm-12	54	20	soluble	soluble	ADJ
bptjm-12	54	21	aβ	aβ	NOUN
bptjm-12	54	22	plaques	plaque	NOUN
bptjm-12	54	23	to	to	PART
bptjm-12	54	24	reduce	reduce	VERB
bptjm-12	54	25	its	its	PRON
bptjm-12	54	26	levels	level	NOUN
bptjm-12	54	27	in	in	ADP
bptjm-12	54	28	the	the	DET
bptjm-12	54	29	brain	brain	NOUN
bptjm-12	54	30	—	—	PUNCT
bptjm-12	54	31	were	be	AUX
bptjm-12	54	32	successful	successful	ADJ
bptjm-12	54	33	in	in	ADP
bptjm-12	54	34	slowing	slow	VERB
bptjm-12	54	35	the	the	DET
bptjm-12	54	36	rate	rate	NOUN
bptjm-12	54	37	of	of	ADP
bptjm-12	54	38	cognitive	cognitive	ADJ
bptjm-12	54	39	function	function	NOUN
bptjm-12	54	40	decline	decline	NOUN
bptjm-12	54	41	in	in	ADP
bptjm-12	54	42	patients	patient	NOUN
bptjm-12	54	43	with	with	ADP
bptjm-12	54	44	mild	mild	ADJ
bptjm-12	54	45	ad	ad	NOUN
bptjm-12	54	46	,	,	PUNCT
bptjm-12	54	47	but	but	CCONJ
bptjm-12	54	48	not	not	PART
bptjm-12	54	49	in	in	ADP
bptjm-12	54	50	treating	treat	VERB
bptjm-12	54	51	the	the	DET
bptjm-12	54	52	root	root	NOUN
bptjm-12	54	53	cause	cause	NOUN
bptjm-12	54	54	.	.	PUNCT
bptjm-12	55	1	one	one	NUM
bptjm-12	55	2	hypothesis	hypothesis	NOUN
bptjm-12	55	3	suggests	suggest	VERB
bptjm-12	55	4	that	that	SCONJ
bptjm-12	55	5	ad	ad	NOUN
bptjm-12	55	6	is	be	AUX
bptjm-12	55	7	a	a	DET
bptjm-12	55	8	synaptic	synaptic	ADJ
bptjm-12	55	9	disease	disease	NOUN
bptjm-12	55	10	.	.	PUNCT
bptjm-12	56	1	it	it	PRON
bptjm-12	56	2	has	have	AUX
bptjm-12	56	3	been	be	AUX
bptjm-12	56	4	argued	argue	VERB
bptjm-12	56	5	that	that	SCONJ
bptjm-12	56	6	synaptic	synaptic	ADJ
bptjm-12	56	7	impairment	impairment	NOUN
bptjm-12	56	8	is	be	AUX
bptjm-12	56	9	an	an	DET
bptjm-12	56	10	early	early	ADJ
bptjm-12	56	11	event	event	NOUN
bptjm-12	56	12	in	in	ADP
bptjm-12	56	13	neurodegenerative	neurodegenerative	ADJ
bptjm-12	56	14	processes	process	NOUN
bptjm-12	56	15	during	during	ADP
bptjm-12	56	16	ad	ad	NOUN
bptjm-12	56	17	and	and	CCONJ
bptjm-12	56	18	that	that	SCONJ
bptjm-12	56	19	synaptic	synaptic	ADJ
bptjm-12	56	20	loss	loss	NOUN
bptjm-12	56	21	and	and	CCONJ
bptjm-12	56	22	failure	failure	NOUN
bptjm-12	56	23	corresponds	correspond	VERB
bptjm-12	56	24	with	with	ADP
bptjm-12	56	25	cognitive	cognitive	ADJ
bptjm-12	56	26	decline	decline	NOUN
bptjm-12	56	27	in	in	ADP
bptjm-12	56	28	ad	ad	NOUN
bptjm-12	56	29	as	as	ADV
bptjm-12	56	30	well	well	ADV
bptjm-12	56	31	(	(	PUNCT
bptjm-12	56	32	cubinkova	cubinkova	X
bptjm-12	56	33	et	et	PROPN
bptjm-12	56	34	al	al	PROPN
bptjm-12	56	35	.	.	PROPN
bptjm-12	56	36	,	,	PUNCT
bptjm-12	56	37	2018	2018	NUM
bptjm-12	56	38	)	)	PUNCT
bptjm-12	56	39	.	.	PUNCT
bptjm-12	57	1	recently	recently	ADV
bptjm-12	57	2	,	,	PUNCT
bptjm-12	57	3	it	it	PRON
bptjm-12	57	4	was	be	AUX
bptjm-12	57	5	shown	show	VERB
bptjm-12	57	6	that	that	SCONJ
bptjm-12	57	7	impaired	impaired	ADJ
bptjm-12	57	8	synapses	synapsis	NOUN
bptjm-12	57	9	in	in	ADP
bptjm-12	57	10	ad	ad	NOUN
bptjm-12	57	11	brains	brain	NOUN
bptjm-12	57	12	released	release	VERB
bptjm-12	57	13	tau	tau	PROPN
bptjm-12	57	14	protein	protein	NOUN
bptjm-12	57	15	in	in	ADP
bptjm-12	57	16	response	response	NOUN
bptjm-12	57	17	to	to	PART
bptjm-12	57	18	potassium	potassium	NOUN
bptjm-12	57	19	chloride	chloride	NOUN
bptjm-12	57	20	(	(	PUNCT
bptjm-12	57	21	kcl	kcl	NOUN
bptjm-12	57	22	)	)	PUNCT
bptjm-12	57	23	stimulation	stimulation	NOUN
bptjm-12	57	24	,	,	PUNCT
bptjm-12	57	25	suggesting	suggest	VERB
bptjm-12	57	26	that	that	SCONJ
bptjm-12	57	27	it	it	PRON
bptjm-12	57	28	may	may	AUX
bptjm-12	57	29	be	be	AUX
bptjm-12	57	30	involved	involve	VERB
bptjm-12	57	31	in	in	ADP
bptjm-12	57	32	the	the	DET
bptjm-12	57	33	progression	progression	NOUN
bptjm-12	57	34	of	of	ADP
bptjm-12	57	35	tau	tau	PROPN
bptjm-12	57	36	in	in	ADP
bptjm-12	57	37	the	the	DET
bptjm-12	57	38	brain	brain	NOUN
bptjm-12	57	39	(	(	PUNCT
bptjm-12	57	40	cubinkovaet	cubinkovaet	PROPN
bptjm-12	57	41	al	al	PROPN
bptjm-12	57	42	.	.	PROPN
bptjm-12	57	43	,	,	PUNCT
bptjm-12	57	44	2018	2018	NUM
bptjm-12	57	45	)	)	PUNCT
bptjm-12	57	46	.	.	PUNCT
bptjm-12	58	1	in	in	ADP
bptjm-12	58	2	addition	addition	NOUN
bptjm-12	58	3	to	to	ADP
bptjm-12	58	4	the	the	DET
bptjm-12	58	5	synaptic	synaptic	ADJ
bptjm-12	58	6	hypothesis	hypothesis	NOUN
bptjm-12	58	7	,	,	PUNCT
bptjm-12	58	8	some	some	DET
bptjm-12	58	9	researchers	researcher	NOUN
bptjm-12	58	10	believe	believe	VERB
bptjm-12	58	11	that	that	SCONJ
bptjm-12	58	12	alpha	alpha	NOUN
bptjm-12	58	13	-	-	PUNCT
bptjm-12	58	14	synuclein	synuclein	NOUN
bptjm-12	58	15	acts	act	VERB
bptjm-12	58	16	as	as	ADP
bptjm-12	58	17	a	a	DET
bptjm-12	58	18	pathogenic	pathogenic	ADJ
bptjm-12	58	19	modulator	modulator	NOUN
bptjm-12	58	20	in	in	ADP
bptjm-12	58	21	ad	ad	NOUN
bptjm-12	58	22	.	.	PUNCT
bptjm-12	59	1	alpha	alpha	PROPN
bptjm-12	59	2	-	-	PUNCT
bptjm-12	59	3	synuclein	synuclein	NOUN
bptjm-12	59	4	is	be	AUX
bptjm-12	59	5	a	a	DET
bptjm-12	59	6	protein	protein	NOUN
bptjm-12	59	7	that	that	PRON
bptjm-12	59	8	localizes	localize	VERB
bptjm-12	59	9	to	to	ADP
bptjm-12	59	10	the	the	DET
bptjm-12	59	11	nerve	nerve	NOUN
bptjm-12	59	12	terminal	terminal	NOUN
bptjm-12	59	13	and	and	CCONJ
bptjm-12	59	14	regulates	regulate	VERB
bptjm-12	59	15	neurotransmitter	neurotransmitter	NOUN
bptjm-12	59	16	release	release	NOUN
bptjm-12	59	17	in	in	ADP
bptjm-12	59	18	the	the	DET
bptjm-12	59	19	presynaptic	presynaptic	ADJ
bptjm-12	59	20	neuron	neuron	NOUN
bptjm-12	59	21	.	.	PUNCT
bptjm-12	60	1	it	it	PRON
bptjm-12	60	2	was	be	AUX
bptjm-12	60	3	found	find	VERB
bptjm-12	60	4	that	that	SCONJ
bptjm-12	60	5	levels	level	NOUN
bptjm-12	60	6	of	of	ADP
bptjm-12	60	7	soluble	soluble	ADJ
bptjm-12	60	8	alpha	alpha	NOUN
bptjm-12	60	9	-	-	PUNCT
bptjm-12	60	10	synuclein	synuclein	NOUN
bptjm-12	60	11	are	be	AUX
bptjm-12	60	12	about	about	ADV
bptjm-12	60	13	two	two	NUM
bptjm-12	60	14	-	-	PUNCT
bptjm-12	60	15	fold	fold	VERB
bptjm-12	60	16	higher	higher	ADV
bptjm-12	60	17	in	in	ADP
bptjm-12	60	18	the	the	DET
bptjm-12	60	19	brains	brain	NOUN
bptjm-12	60	20	of	of	ADP
bptjm-12	60	21	ad	ad	NOUN
bptjm-12	60	22	patients	patient	NOUN
bptjm-12	60	23	than	than	ADP
bptjm-12	60	24	in	in	ADP
bptjm-12	60	25	control	control	NOUN
bptjm-12	60	26	brains	brain	NOUN
bptjm-12	60	27	and	and	CCONJ
bptjm-12	60	28	correlate	correlate	VERB
bptjm-12	60	29	better	well	ADV
bptjm-12	60	30	with	with	ADP
bptjm-12	60	31	cognitive	cognitive	ADJ
bptjm-12	60	32	impairment	impairment	NOUN
bptjm-12	60	33	(	(	PUNCT
bptjm-12	60	34	cubinkova	cubinkova	X
bptjm-12	60	35	et	et	PROPN
bptjm-12	60	36	al	al	PROPN
bptjm-12	60	37	.	.	PROPN
bptjm-12	60	38	,2018	,2018	PROPN
bptjm-12	60	39	)	)	PUNCT
bptjm-12	60	40	,	,	PUNCT
bptjm-12	60	41	suggesting	suggest	VERB
bptjm-12	60	42	that	that	SCONJ
bptjm-12	60	43	overexpression	overexpression	NOUN
bptjm-12	60	44	of	of	ADP
bptjm-12	60	45	the	the	DET
bptjm-12	60	46	alpha	alpha	NOUN
bptjm-12	60	47	-	-	PUNCT
bptjm-12	60	48	synuclein	synuclein	NOUN
bptjm-12	60	49	protein	protein	NOUN
bptjm-12	60	50	may	may	AUX
bptjm-12	60	51	play	play	VERB
bptjm-12	60	52	a	a	DET
bptjm-12	60	53	role	role	NOUN
bptjm-12	60	54	in	in	ADP
bptjm-12	60	55	the	the	DET
bptjm-12	60	56	onset	onset	NOUN
bptjm-12	60	57	of	of	ADP
bptjm-12	60	58	ad	ad	NOUN
bptjm-12	60	59	.	.	PUNCT
bptjm-12	61	1	even	even	ADV
bptjm-12	61	2	in	in	ADP
bptjm-12	61	3	light	light	NOUN
bptjm-12	61	4	of	of	ADP
bptjm-12	61	5	these	these	DET
bptjm-12	61	6	alternative	alternative	ADJ
bptjm-12	61	7	hypotheses	hypothesis	NOUN
bptjm-12	61	8	,	,	PUNCT
bptjm-12	61	9	most	most	ADJ
bptjm-12	61	10	research	research	NOUN
bptjm-12	61	11	focuses	focus	VERB
bptjm-12	61	12	on	on	ADP
bptjm-12	61	13	the	the	DET
bptjm-12	61	14	e	e	NOUN
bptjm-12	61	15	�	�	NOUN
bptjm-12	61	16	ects	ect	VERB
bptjm-12	61	17	that	that	SCONJ
bptjm-12	61	18	cannabinoids	cannabinoid	NOUN
bptjm-12	61	19	have	have	VERB
bptjm-12	61	20	on	on	ADP
bptjm-12	61	21	the	the	DET
bptjm-12	61	22	production	production	NOUN
bptjm-12	61	23	of	of	ADP
bptjm-12	61	24	aβ	aβ	DET
bptjm-12	61	25	plaques	plaque	NOUN
bptjm-12	61	26	as	as	ADP
bptjm-12	61	27	a	a	DET
bptjm-12	61	28	measure	measure	NOUN
bptjm-12	61	29	of	of	ADP
bptjm-12	61	30	treating	treat	VERB
bptjm-12	61	31	ad	ad	NOUN
bptjm-12	61	32	.	.	PUNCT
bptjm-12	62	1	berkeley	berkeley	PROPN
bptjm-12	62	2	pharma	pharma	PROPN
bptjm-12	62	3	tech	tech	PROPN
bptjm-12	62	4	journal	journal	NOUN
bptjm-12	62	5	of	of	ADP
bptjm-12	62	6	medicine	medicine	NOUN
bptjm-12	62	7	|	|	ADV
bptjm-12	62	8	5	5	NUM
bptjm-12	62	9	b.	b.	PROPN
bptjm-12	62	10	endocannabinoid	endocannabinoid	NOUN
bptjm-12	62	11	signaling	signal	VERB
bptjm-12	62	12	the	the	DET
bptjm-12	62	13	endocannabinoid	endocannabinoid	NOUN
bptjm-12	62	14	system	system	NOUN
bptjm-12	62	15	regulates	regulate	VERB
bptjm-12	62	16	brain	brain	NOUN
bptjm-12	62	17	function	function	NOUN
bptjm-12	62	18	as	as	ADV
bptjm-12	62	19	well	well	ADV
bptjm-12	62	20	as	as	ADP
bptjm-12	62	21	immune	immune	ADJ
bptjm-12	62	22	system	system	NOUN
bptjm-12	62	23	activity	activity	NOUN
bptjm-12	62	24	,	,	PUNCT
bptjm-12	62	25	thus	thus	ADV
bptjm-12	62	26	allowing	allow	VERB
bptjm-12	62	27	it	it	PRON
bptjm-12	62	28	to	to	PART
bptjm-12	62	29	serve	serve	VERB
bptjm-12	62	30	as	as	ADP
bptjm-12	62	31	a	a	DET
bptjm-12	62	32	therapeutic	therapeutic	ADJ
bptjm-12	62	33	strategy	strategy	NOUN
bptjm-12	62	34	for	for	ADP
bptjm-12	62	35	ad	ad	NOUN
bptjm-12	62	36	.	.	PUNCT
bptjm-12	63	1	its	its	PRON
bptjm-12	63	2	dual	dual	ADJ
bptjm-12	63	3	ability	ability	NOUN
bptjm-12	63	4	as	as	ADP
bptjm-12	63	5	a	a	DET
bptjm-12	63	6	neuromodulator	neuromodulator	NOUN
bptjm-12	63	7	and	and	CCONJ
bptjm-12	63	8	immunomodulator	immunomodulator	NOUN
bptjm-12	63	9	is	be	AUX
bptjm-12	63	10	due	due	ADJ
bptjm-12	63	11	to	to	ADP
bptjm-12	63	12	the	the	DET
bptjm-12	63	13	speci	speci	PROPN
bptjm-12	63	14	�	�	PROPN
bptjm-12	63	15	c	c	NOUN
bptjm-12	63	16	locations	location	NOUN
bptjm-12	63	17	in	in	ADP
bptjm-12	63	18	which	which	PRON
bptjm-12	63	19	cannabinoid	cannabinoid	NOUN
bptjm-12	63	20	receptors	receptor	NOUN
bptjm-12	63	21	type	type	VERB
bptjm-12	63	22	1	1	NUM
bptjm-12	63	23	(	(	PUNCT
bptjm-12	63	24	cb1	cb1	PROPN
bptjm-12	63	25	)	)	PUNCT
bptjm-12	63	26	and	and	CCONJ
bptjm-12	63	27	type	type	NOUN
bptjm-12	63	28	2	2	NUM
bptjm-12	63	29	(	(	PUNCT
bptjm-12	63	30	cb2	cb2	NOUN
bptjm-12	63	31	)	)	PUNCT
bptjm-12	63	32	gather	gather	NOUN
bptjm-12	63	33	(	(	PUNCT
bptjm-12	63	34	bonnet	bonnet	NOUN
bptjm-12	63	35	&	&	CCONJ
bptjm-12	63	36	marchant	marchant	NOUN
bptjm-12	63	37	,	,	PUNCT
bptjm-12	63	38	2015	2015	NUM
bptjm-12	63	39	)	)	PUNCT
bptjm-12	63	40	.	.	PUNCT
bptjm-12	64	1	the	the	DET
bptjm-12	64	2	components	component	NOUN
bptjm-12	64	3	of	of	ADP
bptjm-12	64	4	the	the	DET
bptjm-12	64	5	endocannabinoid	endocannabinoid	NOUN
bptjm-12	64	6	system	system	NOUN
bptjm-12	64	7	primarily	primarily	ADV
bptjm-12	64	8	include	include	VERB
bptjm-12	64	9	two	two	NUM
bptjm-12	64	10	endocannabinoid	endocannabinoid	NOUN
bptjm-12	64	11	signaling	signal	VERB
bptjm-12	64	12	molecules	molecule	NOUN
bptjm-12	64	13	,	,	PUNCT
bptjm-12	64	14	2	2	NUM
bptjm-12	64	15	-	-	PUNCT
bptjm-12	64	16	arachidonoyl	arachidonoyl	ADJ
bptjm-12	64	17	glycerol	glycerol	NOUN
bptjm-12	64	18	(	(	PUNCT
bptjm-12	64	19	2ag	2ag	ADJ
bptjm-12	64	20	)	)	PUNCT
bptjm-12	64	21	and	and	CCONJ
bptjm-12	64	22	anandamide	anandamide	PROPN
bptjm-12	64	23	(	(	PUNCT
bptjm-12	64	24	aea	aea	PROPN
bptjm-12	64	25	)	)	PUNCT
bptjm-12	64	26	,	,	PUNCT
bptjm-12	64	27	and	and	CCONJ
bptjm-12	64	28	their	their	PRON
bptjm-12	64	29	g	g	NOUN
bptjm-12	64	30	-	-	PUNCT
bptjm-12	64	31	protein	protein	NOUN
bptjm-12	64	32	coupled	couple	VERB
bptjm-12	64	33	receptors	receptor	NOUN
bptjm-12	64	34	,	,	PUNCT
bptjm-12	64	35	cannabinoid	cannabinoid	X
bptjm-12	64	36	receptor	receptor	NOUN
bptjm-12	64	37	type	type	NOUN
bptjm-12	64	38	1	1	NUM
bptjm-12	64	39	and	and	CCONJ
bptjm-12	64	40	cannabinoid	cannabinoid	VERB
bptjm-12	64	41	receptor	receptor	NOUN
bptjm-12	64	42	type	type	NOUN
bptjm-12	64	43	2	2	NUM
bptjm-12	64	44	(	(	PUNCT
bptjm-12	64	45	fagan	fagan	PROPN
bptjm-12	64	46	&	&	CCONJ
bptjm-12	64	47	campbell	campbell	PROPN
bptjm-12	64	48	,	,	PUNCT
bptjm-12	64	49	2014	2014	NUM
bptjm-12	64	50	)	)	PUNCT
bptjm-12	64	51	.	.	PUNCT
bptjm-12	65	1	the	the	DET
bptjm-12	65	2	endocannabinoid	endocannabinoid	NOUN
bptjm-12	65	3	system	system	NOUN
bptjm-12	65	4	works	work	VERB
bptjm-12	65	5	speci	speci	NOUN
bptjm-12	65	6	�	�	PROPN
bptjm-12	65	7	cally	cally	ADV
bptjm-12	65	8	in	in	ADP
bptjm-12	65	9	both	both	CCONJ
bptjm-12	65	10	the	the	DET
bptjm-12	65	11	regulation	regulation	NOUN
bptjm-12	65	12	of	of	ADP
bptjm-12	65	13	neuroin	neuroin	NOUN
bptjm-12	65	14	�	�	PROPN
bptjm-12	65	15	ammation	ammation	NOUN
bptjm-12	65	16	as	as	ADV
bptjm-12	65	17	well	well	ADV
bptjm-12	65	18	as	as	ADP
bptjm-12	65	19	neurogenesis.studies	neurogenesis.studies	PRON
bptjm-12	65	20	show	show	VERB
bptjm-12	65	21	that	that	SCONJ
bptjm-12	65	22	the	the	DET
bptjm-12	65	23	endocannabinoid	endocannabinoid	NOUN
bptjm-12	65	24	system	system	NOUN
bptjm-12	65	25	is	be	AUX
bptjm-12	65	26	able	able	ADJ
bptjm-12	65	27	to	to	PART
bptjm-12	65	28	reduce	reduce	VERB
bptjm-12	65	29	chronic	chronic	ADJ
bptjm-12	65	30	neuroin	neuroin	NOUN
bptjm-12	65	31	�	�	PROPN
bptjm-12	65	32	ammation	ammation	NOUN
bptjm-12	65	33	,	,	PUNCT
bptjm-12	65	34	a	a	DET
bptjm-12	65	35	major	major	ADJ
bptjm-12	65	36	mediator	mediator	NOUN
bptjm-12	65	37	in	in	ADP
bptjm-12	65	38	neurodegeneration	neurodegeneration	NOUN
bptjm-12	65	39	in	in	ADP
bptjm-12	65	40	alzheimer	alzheimer	PROPN
bptjm-12	65	41	’s	’s	PART
bptjm-12	65	42	patients	patient	NOUN
bptjm-12	65	43	.	.	PUNCT
bptjm-12	66	1	ppar𝛾	ppar𝛾	PROPN
bptjm-12	66	2	is	be	AUX
bptjm-12	66	3	a	a	DET
bptjm-12	66	4	key	key	ADJ
bptjm-12	66	5	component	component	NOUN
bptjm-12	66	6	involved	involve	VERB
bptjm-12	66	7	in	in	ADP
bptjm-12	66	8	the	the	DET
bptjm-12	66	9	cannabinoid	cannabinoid	NOUN
bptjm-12	66	10	anti	anti	ADJ
bptjm-12	66	11	-	-	ADJ
bptjm-12	66	12	in	in	ADP
bptjm-12	66	13	�	�	NOUN
bptjm-12	66	14	ammatory	ammatory	NOUN
bptjm-12	66	15	e	e	NOUN
bptjm-12	66	16	�	�	NOUN
bptjm-12	66	17	ect	ect	VERB
bptjm-12	66	18	.	.	PUNCT
bptjm-12	67	1	this	this	DET
bptjm-12	67	2	protein	protein	NOUN
bptjm-12	67	3	consists	consist	VERB
bptjm-12	67	4	of	of	ADP
bptjm-12	67	5	a	a	DET
bptjm-12	67	6	group	group	NOUN
bptjm-12	67	7	of	of	ADP
bptjm-12	67	8	hormone	hormone	NOUN
bptjm-12	67	9	receptors	receptor	NOUN
bptjm-12	67	10	involved	involve	VERB
bptjm-12	67	11	in	in	ADP
bptjm-12	67	12	gene	gene	NOUN
bptjm-12	67	13	expression	expression	NOUN
bptjm-12	67	14	and	and	CCONJ
bptjm-12	67	15	in	in	ADP
bptjm-12	67	16	�	�	PROPN
bptjm-12	67	17	ammation	ammation	NOUN
bptjm-12	67	18	.	.	PUNCT
bptjm-12	68	1	the	the	DET
bptjm-12	68	2	use	use	NOUN
bptjm-12	68	3	of	of	ADP
bptjm-12	68	4	cannabinoids	cannabinoid	NOUN
bptjm-12	68	5	increases	increase	VERB
bptjm-12	68	6	ppar𝛾transcriptional	ppar𝛾transcriptional	ADJ
bptjm-12	68	7	activity	activity	NOUN
bptjm-12	68	8	in	in	ADP
bptjm-12	68	9	adult	adult	NOUN
bptjm-12	68	10	rats	rat	NOUN
bptjm-12	68	11	,	,	PUNCT
bptjm-12	68	12	thus	thus	ADV
bptjm-12	68	13	decreasing	decrease	VERB
bptjm-12	68	14	neuroin	neuroin	NOUN
bptjm-12	68	15	�	�	PROPN
bptjm-12	68	16	ammation	ammation	NOUN
bptjm-12	68	17	(	(	PUNCT
bptjm-12	68	18	fagan	fagan	PROPN
bptjm-12	68	19	&	&	CCONJ
bptjm-12	68	20	campbell	campbell	PROPN
bptjm-12	68	21	,	,	PUNCT
bptjm-12	68	22	2014	2014	NUM
bptjm-12	68	23	)	)	PUNCT
bptjm-12	68	24	.	.	PUNCT
bptjm-12	69	1	fig	fig	NOUN
bptjm-12	69	2	.	.	PUNCT
bptjm-12	70	1	2	2	NUM
bptjm-12	70	2	:	:	PUNCT
bptjm-12	70	3	illustration	illustration	NOUN
bptjm-12	70	4	and	and	CCONJ
bptjm-12	70	5	description	description	NOUN
bptjm-12	70	6	of	of	ADP
bptjm-12	70	7	cb1	cb1	PROPN
bptjm-12	70	8	&	&	CCONJ
bptjm-12	70	9	cb2	cb2	PROPN
bptjm-12	70	10	receptors	receptor	NOUN
bptjm-12	70	11	,	,	PUNCT
bptjm-12	70	12	and	and	CCONJ
bptjm-12	70	13	the	the	DET
bptjm-12	70	14	endocannabinoid	endocannabinoid	NOUN
bptjm-12	70	15	signaling	signal	VERB
bptjm-12	70	16	molecules	molecule	NOUN
bptjm-12	70	17	,	,	PUNCT
bptjm-12	70	18	anandamide	anandamide	NOUN
bptjm-12	70	19	(	(	PUNCT
bptjm-12	70	20	aea	aea	PROPN
bptjm-12	70	21	)	)	PUNCT
bptjm-12	70	22	and	and	CCONJ
bptjm-12	70	23	2	2	NUM
bptjm-12	70	24	-	-	PUNCT
bptjm-12	70	25	arachidonoyl	arachidonoyl	ADJ
bptjm-12	70	26	glycerol	glycerol	NOUN
bptjm-12	70	27	(	(	PUNCT
bptjm-12	70	28	2ag	2ag	NOUN
bptjm-12	70	29	)	)	PUNCT
bptjm-12	70	30	.	.	PUNCT
bptjm-12	71	1	an	an	DET
bptjm-12	71	2	elevation	elevation	NOUN
bptjm-12	71	3	of	of	ADP
bptjm-12	71	4	the	the	DET
bptjm-12	71	5	2ag	2ag	ADJ
bptjm-12	71	6	endocannabinoid	endocannabinoid	NOUN
bptjm-12	71	7	signaling	signal	VERB
bptjm-12	71	8	molecule	molecule	NOUN
bptjm-12	71	9	,	,	PUNCT
bptjm-12	71	10	coupled	couple	VERB
bptjm-12	71	11	with	with	ADP
bptjm-12	71	12	a	a	DET
bptjm-12	71	13	modulation	modulation	NOUN
bptjm-12	71	14	of	of	ADP
bptjm-12	71	15	the	the	DET
bptjm-12	71	16	cb2	cb2	PROPN
bptjm-12	71	17	speci	speci	PROPN
bptjm-12	71	18	�	�	PROPN
bptjm-12	71	19	c	c	PROPN
bptjm-12	71	20	cannabinoid	cannabinoid	NOUN
bptjm-12	71	21	receptor	receptor	NOUN
bptjm-12	71	22	,	,	PUNCT
bptjm-12	71	23	could	could	AUX
bptjm-12	71	24	combat	combat	VERB
bptjm-12	71	25	aggregated	aggregate	VERB
bptjm-12	71	26	aβ	aβ	ADP
bptjm-12	71	27	neuritic	neuritic	ADJ
bptjm-12	71	28	plaques	plaque	NOUN
bptjm-12	71	29	(	(	PUNCT
bptjm-12	71	30	palocziet	palocziet	PROPN
bptjm-12	71	31	al	al	PROPN
bptjm-12	71	32	.	.	PROPN
bptjm-12	71	33	,	,	PUNCT
bptjm-12	71	34	2018	2018	NUM
bptjm-12	71	35	)	)	PUNCT
bptjm-12	71	36	.	.	PUNCT
bptjm-12	72	1	the	the	DET
bptjm-12	72	2	cannabinoid	cannabinoid	NOUN
bptjm-12	72	3	receptors	receptor	NOUN
bptjm-12	72	4	play	play	VERB
bptjm-12	72	5	a	a	DET
bptjm-12	72	6	vital	vital	ADJ
bptjm-12	72	7	role	role	NOUN
bptjm-12	72	8	in	in	ADP
bptjm-12	72	9	allowing	allow	VERB
bptjm-12	72	10	the	the	DET
bptjm-12	72	11	formation	formation	NOUN
bptjm-12	72	12	of	of	ADP
bptjm-12	72	13	new	new	ADJ
bptjm-12	72	14	neurons	neuron	NOUN
bptjm-12	72	15	and	and	CCONJ
bptjm-12	72	16	neuronal	neuronal	ADJ
bptjm-12	72	17	connections	connection	NOUN
bptjm-12	72	18	to	to	PART
bptjm-12	72	19	sustain	sustain	VERB
bptjm-12	72	20	neuronal	neuronal	ADJ
bptjm-12	72	21	function	function	NOUN
bptjm-12	72	22	.	.	PUNCT
bptjm-12	73	1	the	the	DET
bptjm-12	73	2	proliferation	proliferation	NOUN
bptjm-12	73	3	of	of	ADP
bptjm-12	73	4	neural	neural	ADJ
bptjm-12	73	5	precursor	precursor	NOUN
bptjm-12	73	6	cells	cell	NOUN
bptjm-12	73	7	,	,	PUNCT
bptjm-12	73	8	both	both	DET
bptjm-12	73	9	neural	neural	ADJ
bptjm-12	73	10	stem	stem	NOUN
bptjm-12	73	11	cells	cell	NOUN
bptjm-12	73	12	and	and	CCONJ
bptjm-12	73	13	neural	neural	ADJ
bptjm-12	73	14	progenitor	progenitor	NOUN
bptjm-12	73	15	cells	cell	NOUN
bptjm-12	73	16	,	,	PUNCT
bptjm-12	73	17	has	have	AUX
bptjm-12	73	18	been	be	AUX
bptjm-12	73	19	proven	prove	VERB
bptjm-12	73	20	to	to	PART
bptjm-12	73	21	activate	activate	VERB
bptjm-12	73	22	cb1	cb1	NOUN
bptjm-12	73	23	receptors	receptor	NOUN
bptjm-12	73	24	;	;	PUNCT
bptjm-12	73	25	the	the	DET
bptjm-12	73	26	proliferation	proliferation	NOUN
bptjm-12	73	27	of	of	ADP
bptjm-12	73	28	neural	neural	ADJ
bptjm-12	73	29	berkeley	berkeley	PROPN
bptjm-12	73	30	pharma	pharma	PROPN
bptjm-12	73	31	tech	tech	NOUN
bptjm-12	73	32	journal	journal	NOUN
bptjm-12	73	33	of	of	ADP
bptjm-12	73	34	medicine	medicine	NOUN
bptjm-12	73	35	|	|	ADV
bptjm-12	73	36	6	6	NUM
bptjm-12	73	37	progenitor	progenitor	NOUN
bptjm-12	73	38	cells	cell	NOUN
bptjm-12	73	39	has	have	AUX
bptjm-12	73	40	been	be	AUX
bptjm-12	73	41	seen	see	VERB
bptjm-12	73	42	to	to	PART
bptjm-12	73	43	activate	activate	VERB
bptjm-12	73	44	both	both	PRON
bptjm-12	73	45	cb1	cb1	PROPN
bptjm-12	73	46	and	and	CCONJ
bptjm-12	73	47	cb2	cb2	PROPN
bptjm-12	73	48	receptors	receptor	NOUN
bptjm-12	73	49	,	,	PUNCT
bptjm-12	73	50	allowing	allow	VERB
bptjm-12	73	51	the	the	DET
bptjm-12	73	52	production	production	NOUN
bptjm-12	73	53	and	and	CCONJ
bptjm-12	73	54	survival	survival	NOUN
bptjm-12	73	55	of	of	ADP
bptjm-12	73	56	new	new	ADJ
bptjm-12	73	57	neurons	neuron	NOUN
bptjm-12	73	58	(	(	PUNCT
bptjm-12	73	59	fagan	fagan	PROPN
bptjm-12	73	60	&	&	CCONJ
bptjm-12	73	61	campbell	campbell	PROPN
bptjm-12	73	62	,	,	PUNCT
bptjm-12	73	63	2014	2014	NUM
bptjm-12	73	64	)	)	PUNCT
bptjm-12	73	65	.	.	PUNCT
bptjm-12	74	1	this	this	DET
bptjm-12	74	2	activation	activation	NOUN
bptjm-12	74	3	of	of	ADP
bptjm-12	74	4	neurogenesis	neurogenesis	NOUN
bptjm-12	74	5	o	o	NOUN
bptjm-12	74	6	�	�	NOUN
bptjm-12	74	7	ers	er	NOUN
bptjm-12	74	8	promising	promise	VERB
bptjm-12	74	9	potential	potential	NOUN
bptjm-12	74	10	within	within	ADP
bptjm-12	74	11	the	the	DET
bptjm-12	74	12	endocannabinoid	endocannabinoid	NOUN
bptjm-12	74	13	system	system	NOUN
bptjm-12	74	14	in	in	ADP
bptjm-12	74	15	reducing	reduce	VERB
bptjm-12	74	16	brain	brain	NOUN
bptjm-12	74	17	atrophy	atrophy	NOUN
bptjm-12	74	18	in	in	ADP
bptjm-12	74	19	alzheimer	alzheimer	PROPN
bptjm-12	74	20	patients	patient	NOUN
bptjm-12	74	21	(	(	PUNCT
bptjm-12	74	22	fagan	fagan	PROPN
bptjm-12	74	23	&	&	CCONJ
bptjm-12	74	24	campbell	campbell	PROPN
bptjm-12	74	25	,	,	PUNCT
bptjm-12	74	26	2014	2014	NUM
bptjm-12	74	27	)	)	PUNCT
bptjm-12	74	28	.	.	PUNCT
bptjm-12	75	1	a	a	DET
bptjm-12	75	2	potential	potential	ADJ
bptjm-12	75	3	therapeutic	therapeutic	ADJ
bptjm-12	75	4	component	component	NOUN
bptjm-12	75	5	of	of	ADP
bptjm-12	75	6	the	the	DET
bptjm-12	75	7	endocannabinoid	endocannabinoid	NOUN
bptjm-12	75	8	system	system	NOUN
bptjm-12	75	9	involves	involve	VERB
bptjm-12	75	10	the	the	DET
bptjm-12	75	11	cannabinoid	cannabinoid	NOUN
bptjm-12	75	12	receptors	receptor	NOUN
bptjm-12	75	13	cb1	cb1	NOUN
bptjm-12	75	14	and	and	CCONJ
bptjm-12	75	15	cb2	cb2	PROPN
bptjm-12	75	16	.	.	PUNCT
bptjm-12	76	1	cb1	cb1	PROPN
bptjm-12	76	2	receptors	receptor	NOUN
bptjm-12	76	3	,	,	PUNCT
bptjm-12	76	4	the	the	DET
bptjm-12	76	5	most	most	ADV
bptjm-12	76	6	abundant	abundant	ADJ
bptjm-12	76	7	cannabinoid	cannabinoid	NOUN
bptjm-12	76	8	receptors	receptor	NOUN
bptjm-12	76	9	,	,	PUNCT
bptjm-12	76	10	are	be	AUX
bptjm-12	76	11	mainly	mainly	ADV
bptjm-12	76	12	located	locate	VERB
bptjm-12	76	13	in	in	ADP
bptjm-12	76	14	the	the	DET
bptjm-12	76	15	neurons	neuron	NOUN
bptjm-12	76	16	of	of	ADP
bptjm-12	76	17	the	the	DET
bptjm-12	76	18	central	central	ADJ
bptjm-12	76	19	nervous	nervous	ADJ
bptjm-12	76	20	system	system	NOUN
bptjm-12	76	21	and	and	CCONJ
bptjm-12	76	22	work	work	NOUN
bptjm-12	76	23	to	to	PART
bptjm-12	76	24	regulate	regulate	VERB
bptjm-12	76	25	cognition	cognition	NOUN
bptjm-12	76	26	and	and	CCONJ
bptjm-12	76	27	memory	memory	NOUN
bptjm-12	76	28	,	,	PUNCT
bptjm-12	76	29	motor	motor	NOUN
bptjm-12	76	30	control	control	NOUN
bptjm-12	76	31	,	,	PUNCT
bptjm-12	76	32	feeding	feeding	NOUN
bptjm-12	76	33	,	,	PUNCT
bptjm-12	76	34	and	and	CCONJ
bptjm-12	76	35	pain	pain	NOUN
bptjm-12	76	36	perception	perception	NOUN
bptjm-12	76	37	—	—	PUNCT
bptjm-12	76	38	allowing	allow	VERB
bptjm-12	76	39	the	the	DET
bptjm-12	76	40	endocannabinoid	endocannabinoid	NOUN
bptjm-12	76	41	system	system	NOUN
bptjm-12	76	42	to	to	PART
bptjm-12	76	43	serve	serve	VERB
bptjm-12	76	44	as	as	ADP
bptjm-12	76	45	a	a	DET
bptjm-12	76	46	neuromodulator	neuromodulator	NOUN
bptjm-12	76	47	.	.	PUNCT
bptjm-12	77	1	studies	study	NOUN
bptjm-12	77	2	on	on	ADP
bptjm-12	77	3	cb1	cb1	PROPN
bptjm-12	77	4	receptors	receptor	NOUN
bptjm-12	77	5	have	have	AUX
bptjm-12	77	6	yielded	yield	VERB
bptjm-12	77	7	inconsistent	inconsistent	ADJ
bptjm-12	77	8	results	result	NOUN
bptjm-12	77	9	,	,	PUNCT
bptjm-12	77	10	preventing	prevent	VERB
bptjm-12	77	11	a	a	DET
bptjm-12	77	12	correlation	correlation	NOUN
bptjm-12	77	13	between	between	ADP
bptjm-12	77	14	cb1	cb1	PROPN
bptjm-12	77	15	presence	presence	NOUN
bptjm-12	77	16	in	in	ADP
bptjm-12	77	17	ad	ad	NOUN
bptjm-12	77	18	patients	patient	NOUN
bptjm-12	77	19	and	and	CCONJ
bptjm-12	77	20	in	in	ADP
bptjm-12	77	21	control	control	NOUN
bptjm-12	77	22	patients	patient	NOUN
bptjm-12	77	23	from	from	ADP
bptjm-12	77	24	being	be	AUX
bptjm-12	77	25	observed	observe	VERB
bptjm-12	77	26	(	(	PUNCT
bptjm-12	77	27	ahmad	ahmad	PROPN
bptjm-12	77	28	et	et	PROPN
bptjm-12	77	29	al	al	PROPN
bptjm-12	77	30	.	.	PROPN
bptjm-12	77	31	,	,	PUNCT
bptjm-12	77	32	2014	2014	NUM
bptjm-12	77	33	)	)	PUNCT
bptjm-12	77	34	.	.	PUNCT
bptjm-12	78	1	a	a	DET
bptjm-12	78	2	more	more	ADV
bptjm-12	78	3	recent	recent	ADJ
bptjm-12	78	4	study	study	NOUN
bptjm-12	78	5	has	have	AUX
bptjm-12	78	6	indicated	indicate	VERB
bptjm-12	78	7	a	a	DET
bptjm-12	78	8	reduction	reduction	NOUN
bptjm-12	78	9	in	in	ADP
bptjm-12	78	10	the	the	DET
bptjm-12	78	11	number	number	NOUN
bptjm-12	78	12	of	of	ADP
bptjm-12	78	13	cb1	cb1	NOUN
bptjm-12	78	14	receptors	receptor	NOUN
bptjm-12	78	15	in	in	ADP
bptjm-12	78	16	the	the	DET
bptjm-12	78	17	frontal	frontal	ADJ
bptjm-12	78	18	cortex	cortex	NOUN
bptjm-12	78	19	while	while	SCONJ
bptjm-12	78	20	no	no	DET
bptjm-12	78	21	change	change	NOUN
bptjm-12	78	22	was	be	AUX
bptjm-12	78	23	observed	observe	VERB
bptjm-12	78	24	in	in	ADP
bptjm-12	78	25	the	the	DET
bptjm-12	78	26	hippocampus	hippocampus	NOUN
bptjm-12	78	27	.	.	PUNCT
bptjm-12	79	1	cb2	cb2	NOUN
bptjm-12	79	2	receptors	receptor	NOUN
bptjm-12	79	3	,	,	PUNCT
bptjm-12	79	4	on	on	ADP
bptjm-12	79	5	the	the	DET
bptjm-12	79	6	other	other	ADJ
bptjm-12	79	7	hand	hand	NOUN
bptjm-12	79	8	,	,	PUNCT
bptjm-12	79	9	are	be	AUX
bptjm-12	79	10	expressed	express	VERB
bptjm-12	79	11	mostly	mostly	ADV
bptjm-12	79	12	in	in	ADP
bptjm-12	79	13	immune	immune	ADJ
bptjm-12	79	14	cells	cell	NOUN
bptjm-12	79	15	and	and	CCONJ
bptjm-12	79	16	to	to	ADP
bptjm-12	79	17	some	some	DET
bptjm-12	79	18	extent	extent	NOUN
bptjm-12	79	19	,	,	PUNCT
bptjm-12	79	20	in	in	ADP
bptjm-12	79	21	the	the	DET
bptjm-12	79	22	peripheral	peripheral	ADJ
bptjm-12	79	23	system	system	NOUN
bptjm-12	79	24	of	of	ADP
bptjm-12	79	25	the	the	DET
bptjm-12	79	26	brain	brain	NOUN
bptjm-12	79	27	—	—	PUNCT
bptjm-12	79	28	allowing	allow	VERB
bptjm-12	79	29	the	the	DET
bptjm-12	79	30	endocannabinoid	endocannabinoid	NOUN
bptjm-12	79	31	system	system	NOUN
bptjm-12	79	32	to	to	PART
bptjm-12	79	33	serve	serve	VERB
bptjm-12	79	34	as	as	ADP
bptjm-12	79	35	an	an	DET
bptjm-12	79	36	immunomodulator	immunomodulator	NOUN
bptjm-12	79	37	.	.	PUNCT
bptjm-12	80	1	as	as	ADP
bptjm-12	80	2	such	such	ADJ
bptjm-12	80	3	,	,	PUNCT
bptjm-12	80	4	cb2	cb2	PROPN
bptjm-12	80	5	is	be	AUX
bptjm-12	80	6	highly	highly	ADV
bptjm-12	80	7	involved	involve	VERB
bptjm-12	80	8	in	in	ADP
bptjm-12	80	9	the	the	DET
bptjm-12	80	10	research	research	NOUN
bptjm-12	80	11	regarding	regard	VERB
bptjm-12	80	12	the	the	DET
bptjm-12	80	13	neuroin	neuroin	NOUN
bptjm-12	80	14	�	�	PROPN
bptjm-12	80	15	ammatory	ammatory	ADJ
bptjm-12	80	16	response	response	NOUN
bptjm-12	80	17	associated	associate	VERB
bptjm-12	80	18	with	with	ADP
bptjm-12	80	19	ad	ad	NOUN
bptjm-12	80	20	(	(	PUNCT
bptjm-12	80	21	atakan	atakan	ADJ
bptjm-12	80	22	,	,	PUNCT
bptjm-12	80	23	2012	2012	NUM
bptjm-12	80	24	)	)	PUNCT
bptjm-12	80	25	.	.	PUNCT
bptjm-12	81	1	within	within	ADP
bptjm-12	81	2	the	the	DET
bptjm-12	81	3	endocannabinoid	endocannabinoid	NOUN
bptjm-12	81	4	system	system	NOUN
bptjm-12	81	5	in	in	ADP
bptjm-12	81	6	an	an	DET
bptjm-12	81	7	alzheimer	alzheimer	X
bptjm-12	81	8	’s	’s	PART
bptjm-12	81	9	patient	patient	NOUN
bptjm-12	81	10	’s	’s	PART
bptjm-12	81	11	brain	brain	NOUN
bptjm-12	81	12	,	,	PUNCT
bptjm-12	81	13	studies	study	NOUN
bptjm-12	81	14	found	find	VERB
bptjm-12	81	15	an	an	DET
bptjm-12	81	16	increase	increase	NOUN
bptjm-12	81	17	in	in	ADP
bptjm-12	81	18	cb2	cb2	NOUN
bptjm-12	81	19	receptor	receptor	NOUN
bptjm-12	81	20	expression	expression	NOUN
bptjm-12	81	21	in	in	ADP
bptjm-12	81	22	microglia	microglia	ADJ
bptjm-12	81	23	,	,	PUNCT
bptjm-12	81	24	phagocytic	phagocytic	ADJ
bptjm-12	81	25	cells	cell	NOUN
bptjm-12	81	26	in	in	ADP
bptjm-12	81	27	the	the	DET
bptjm-12	81	28	brain	brain	NOUN
bptjm-12	81	29	and	and	CCONJ
bptjm-12	81	30	spinal	spinal	ADJ
bptjm-12	81	31	cord	cord	NOUN
bptjm-12	81	32	.	.	PUNCT
bptjm-12	82	1	this	this	DET
bptjm-12	82	2	increase	increase	NOUN
bptjm-12	82	3	correlates	correlate	VERB
bptjm-12	82	4	with	with	ADP
bptjm-12	82	5	aβ	aβ	NOUN
bptjm-12	82	6	levels	level	NOUN
bptjm-12	82	7	and	and	CCONJ
bptjm-12	82	8	plaque	plaque	NOUN
bptjm-12	82	9	accumulation	accumulation	NOUN
bptjm-12	82	10	,	,	PUNCT
bptjm-12	82	11	suggesting	suggest	VERB
bptjm-12	82	12	that	that	SCONJ
bptjm-12	82	13	the	the	DET
bptjm-12	82	14	activation	activation	NOUN
bptjm-12	82	15	of	of	ADP
bptjm-12	82	16	cb2	cb2	PROPN
bptjm-12	82	17	receptors	receptor	NOUN
bptjm-12	82	18	plays	play	VERB
bptjm-12	82	19	a	a	DET
bptjm-12	82	20	role	role	NOUN
bptjm-12	82	21	in	in	ADP
bptjm-12	82	22	stimulating	stimulate	VERB
bptjm-12	82	23	aβ	aβ	DET
bptjm-12	82	24	removal	removal	NOUN
bptjm-12	82	25	(	(	PUNCT
bptjm-12	82	26	talarico	talarico	NOUN
bptjm-12	82	27	et	et	NOUN
bptjm-12	82	28	al	al	PROPN
bptjm-12	82	29	.	.	PROPN
bptjm-12	82	30	,	,	PUNCT
bptjm-12	82	31	2019	2019	NUM
bptjm-12	82	32	)	)	PUNCT
bptjm-12	82	33	.	.	PUNCT
bptjm-12	83	1	the	the	DET
bptjm-12	83	2	use	use	NOUN
bptjm-12	83	3	of	of	ADP
bptjm-12	83	4	cb2	cb2	NOUN
bptjm-12	83	5	receptors	receptor	NOUN
bptjm-12	83	6	has	have	AUX
bptjm-12	83	7	shown	show	VERB
bptjm-12	83	8	to	to	PART
bptjm-12	83	9	be	be	AUX
bptjm-12	83	10	a	a	DET
bptjm-12	83	11	promising	promising	ADJ
bptjm-12	83	12	medium	medium	NOUN
bptjm-12	83	13	for	for	ADP
bptjm-12	83	14	both	both	CCONJ
bptjm-12	83	15	a	a	DET
bptjm-12	83	16	therapeutic	therapeutic	ADJ
bptjm-12	83	17	treatment	treatment	NOUN
bptjm-12	83	18	and	and	CCONJ
bptjm-12	83	19	as	as	ADP
bptjm-12	83	20	a	a	DET
bptjm-12	83	21	marker	marker	NOUN
bptjm-12	83	22	for	for	ADP
bptjm-12	83	23	the	the	DET
bptjm-12	83	24	advancement	advancement	NOUN
bptjm-12	83	25	of	of	ADP
bptjm-12	83	26	alzheimer	alzheimer	PROPN
bptjm-12	83	27	’s	’s	PART
bptjm-12	83	28	disease	disease	NOUN
bptjm-12	83	29	.	.	PUNCT
bptjm-12	84	1	in	in	ADP
bptjm-12	84	2	addition	addition	NOUN
bptjm-12	84	3	,	,	PUNCT
bptjm-12	84	4	cb2	cb2	PROPN
bptjm-12	84	5	receptors	receptor	NOUN
bptjm-12	84	6	have	have	AUX
bptjm-12	84	7	continuously	continuously	ADV
bptjm-12	84	8	been	be	AUX
bptjm-12	84	9	co	co	VERB
bptjm-12	84	10	-	-	VERB
bptjm-12	84	11	localized	localize	VERB
bptjm-12	84	12	with	with	ADP
bptjm-12	84	13	aβ	aβ	PRON
bptjm-12	84	14	plaque	plaque	NOUN
bptjm-12	84	15	buildup	buildup	NOUN
bptjm-12	84	16	(	(	PUNCT
bptjm-12	84	17	ahmad	ahmad	PROPN
bptjm-12	84	18	et	et	PROPN
bptjm-12	84	19	al	al	PROPN
bptjm-12	84	20	.	.	PROPN
bptjm-12	84	21	,	,	PUNCT
bptjm-12	84	22	2016	2016	NUM
bptjm-12	84	23	)	)	PUNCT
bptjm-12	84	24	.	.	PUNCT
bptjm-12	85	1	despite	despite	SCONJ
bptjm-12	85	2	this	this	PRON
bptjm-12	85	3	,	,	PUNCT
bptjm-12	85	4	there	there	PRON
bptjm-12	85	5	have	have	AUX
bptjm-12	85	6	been	be	AUX
bptjm-12	85	7	�	�	NOUN
bptjm-12	85	8	ndings	nding	NOUN
bptjm-12	85	9	that	that	PRON
bptjm-12	85	10	demonstrated	demonstrate	VERB
bptjm-12	85	11	cb2	cb2	PROPN
bptjm-12	85	12	receptor	receptor	NOUN
bptjm-12	85	13	concentration	concentration	NOUN
bptjm-12	85	14	is	be	AUX
bptjm-12	85	15	highly	highly	ADV
bptjm-12	85	16	expressed	express	VERB
bptjm-12	85	17	within	within	ADP
bptjm-12	85	18	microglia	microglia	ADJ
bptjm-12	85	19	cells	cell	NOUN
bptjm-12	85	20	surrounding	surround	VERB
bptjm-12	85	21	senile	senile	ADJ
bptjm-12	85	22	plaques	plaque	NOUN
bptjm-12	85	23	—	—	PUNCT
bptjm-12	85	24	extracellular	extracellular	ADJ
bptjm-12	85	25	deposits	deposit	NOUN
bptjm-12	85	26	of	of	ADP
bptjm-12	85	27	aβ	aβ	NOUN
bptjm-12	85	28	—	—	PUNCT
bptjm-12	85	29	within	within	ADP
bptjm-12	85	30	post	post	ADJ
bptjm-12	85	31	-	-	ADJ
bptjm-12	85	32	mortem	mortem	NOUN
bptjm-12	85	33	brainsdiagnosed	brainsdiagnose	VERB
bptjm-12	85	34	with	with	ADP
bptjm-12	85	35	ad	ad	NOUN
bptjm-12	85	36	(	(	PUNCT
bptjm-12	85	37	aso	aso	PROPN
bptjm-12	85	38	&	&	CCONJ
bptjm-12	85	39	ferrer	ferrer	PROPN
bptjm-12	85	40	,	,	PUNCT
bptjm-12	85	41	2016	2016	NUM
bptjm-12	85	42	)	)	PUNCT
bptjm-12	85	43	.	.	PUNCT
bptjm-12	86	1	conversely	conversely	ADV
bptjm-12	86	2	,	,	PUNCT
bptjm-12	86	3	studies	study	NOUN
bptjm-12	86	4	demonstrated	demonstrate	VERB
bptjm-12	86	5	that	that	SCONJ
bptjm-12	86	6	cb2	cb2	PROPN
bptjm-12	86	7	receptors	receptor	NOUN
bptjm-12	86	8	may	may	AUX
bptjm-12	86	9	not	not	PART
bptjm-12	86	10	be	be	AUX
bptjm-12	86	11	the	the	DET
bptjm-12	86	12	most	most	ADV
bptjm-12	86	13	accurate	accurate	ADJ
bptjm-12	86	14	biomarker	biomarker	NOUN
bptjm-12	86	15	for	for	ADP
bptjm-12	86	16	tracking	track	VERB
bptjm-12	86	17	ad	ad	NOUN
bptjm-12	86	18	advancement	advancement	NOUN
bptjm-12	86	19	,	,	PUNCT
bptjm-12	86	20	as	as	SCONJ
bptjm-12	86	21	they	they	PRON
bptjm-12	86	22	are	be	AUX
bptjm-12	86	23	also	also	ADV
bptjm-12	86	24	found	find	VERB
bptjm-12	86	25	on	on	ADP
bptjm-12	86	26	neuronal	neuronal	ADJ
bptjm-12	86	27	cells	cell	NOUN
bptjm-12	86	28	.	.	PUNCT
bptjm-12	87	1	however	however	ADV
bptjm-12	87	2	,	,	PUNCT
bptjm-12	87	3	this	this	PRON
bptjm-12	87	4	does	do	AUX
bptjm-12	87	5	not	not	PART
bptjm-12	87	6	necessarily	necessarily	ADV
bptjm-12	87	7	eliminate	eliminate	VERB
bptjm-12	87	8	them	they	PRON
bptjm-12	87	9	as	as	ADP
bptjm-12	87	10	targets	target	NOUN
bptjm-12	87	11	for	for	ADP
bptjm-12	87	12	treatment	treatment	NOUN
bptjm-12	87	13	as	as	SCONJ
bptjm-12	87	14	they	they	PRON
bptjm-12	87	15	remain	remain	AUX
bptjm-12	87	16	largely	largely	ADV
bptjm-12	87	17	expressed	express	VERB
bptjm-12	87	18	within	within	ADP
bptjm-12	87	19	immune	immune	ADJ
bptjm-12	87	20	cells	cell	NOUN
bptjm-12	87	21	(	(	PUNCT
bptjm-12	87	22	ahmad	ahmad	PROPN
bptjm-12	87	23	et	et	PROPN
bptjm-12	87	24	al	al	PROPN
bptjm-12	87	25	.	.	PROPN
bptjm-12	87	26	,	,	PUNCT
bptjm-12	87	27	2016	2016	NUM
bptjm-12	87	28	)	)	PUNCT
bptjm-12	87	29	.	.	PUNCT
bptjm-12	88	1	as	as	ADP
bptjm-12	88	2	such	such	ADJ
bptjm-12	88	3	,	,	PUNCT
bptjm-12	88	4	the	the	DET
bptjm-12	88	5	signi	signi	PROPN
bptjm-12	88	6	�	�	NOUN
bptjm-12	88	7	cant	cant	VERB
bptjm-12	88	8	presence	presence	NOUN
bptjm-12	88	9	of	of	ADP
bptjm-12	88	10	cb2	cb2	NOUN
bptjm-12	88	11	receptors	receptor	NOUN
bptjm-12	88	12	in	in	ADP
bptjm-12	88	13	microglia	microglia	ADJ
bptjm-12	88	14	cells	cell	NOUN
bptjm-12	88	15	in	in	ADP
bptjm-12	88	16	brains	brain	NOUN
bptjm-12	88	17	of	of	ADP
bptjm-12	88	18	ad	ad	NOUN
bptjm-12	88	19	patients	patient	NOUN
bptjm-12	88	20	allows	allow	VERB
bptjm-12	88	21	for	for	ADP
bptjm-12	88	22	selective	selective	ADJ
bptjm-12	88	23	activation(stimulating	activation(stimulate	VERB
bptjm-12	88	24	certain	certain	ADJ
bptjm-12	88	25	cb2	cb2	NOUN
bptjm-12	88	26	receptors	receptor	NOUN
bptjm-12	88	27	to	to	PART
bptjm-12	88	28	decrease	decrease	VERB
bptjm-12	88	29	in	in	ADP
bptjm-12	88	30	�	�	NOUN
bptjm-12	88	31	ammatory	ammatory	NOUN
bptjm-12	88	32	cell	cell	NOUN
bptjm-12	88	33	generation	generation	NOUN
bptjm-12	88	34	)	)	PUNCT
bptjm-12	88	35	in	in	ADP
bptjm-12	88	36	a	a	DET
bptjm-12	88	37	�	�	PROPN
bptjm-12	88	38	ected	ecte	VERB
bptjm-12	88	39	berkeley	berkeley	PROPN
bptjm-12	88	40	pharma	pharma	PROPN
bptjm-12	88	41	tech	tech	NOUN
bptjm-12	88	42	journal	journal	NOUN
bptjm-12	88	43	of	of	ADP
bptjm-12	88	44	medicine	medicine	NOUN
bptjm-12	88	45	|	|	ADV
bptjm-12	88	46	7	7	NUM
bptjm-12	88	47	tissues	tissue	NOUN
bptjm-12	88	48	,	,	PUNCT
bptjm-12	88	49	therefore	therefore	ADV
bptjm-12	88	50	decreasing	decrease	VERB
bptjm-12	88	51	the	the	DET
bptjm-12	88	52	risk	risk	NOUN
bptjm-12	88	53	of	of	ADP
bptjm-12	88	54	harmful	harmful	ADJ
bptjm-12	88	55	e	e	NOUN
bptjm-12	88	56	�	�	NOUN
bptjm-12	88	57	ects	ect	NOUN
bptjm-12	88	58	(	(	PUNCT
bptjm-12	88	59	ramírez	ramírez	NOUN
bptjm-12	88	60	et	et	PROPN
bptjm-12	88	61	al	al	PROPN
bptjm-12	88	62	.	.	PROPN
bptjm-12	88	63	,	,	PUNCT
bptjm-12	88	64	2005	2005	NUM
bptjm-12	88	65	)	)	PUNCT
bptjm-12	88	66	.	.	PUNCT
bptjm-12	89	1	fig	fig	NOUN
bptjm-12	89	2	.	.	PUNCT
bptjm-12	90	1	3	3	NUM
bptjm-12	90	2	:	:	PUNCT
bptjm-12	90	3	illustration	illustration	NOUN
bptjm-12	90	4	of	of	ADP
bptjm-12	90	5	the	the	DET
bptjm-12	90	6	interaction	interaction	NOUN
bptjm-12	90	7	between	between	ADP
bptjm-12	90	8	endocannabinoids	endocannabinoid	NOUN
bptjm-12	90	9	and	and	CCONJ
bptjm-12	90	10	the	the	DET
bptjm-12	90	11	cannabinoid	cannabinoid	NOUN
bptjm-12	90	12	receptors	receptor	NOUN
bptjm-12	90	13	,	,	PUNCT
bptjm-12	90	14	cb1	cb1	PROPN
bptjm-12	90	15	and	and	CCONJ
bptjm-12	90	16	cb2	cb2	PROPN
bptjm-12	90	17	.	.	PUNCT
bptjm-12	90	18	endocannabinoids	endocannabinoid	NOUN
bptjm-12	90	19	from	from	ADP
bptjm-12	90	20	the	the	DET
bptjm-12	90	21	postsynaptic	postsynaptic	ADJ
bptjm-12	90	22	neuron	neuron	NOUN
bptjm-12	90	23	travel	travel	VERB
bptjm-12	90	24	through	through	ADP
bptjm-12	90	25	the	the	DET
bptjm-12	90	26	synaptic	synaptic	ADJ
bptjm-12	90	27	cleft	cleft	NOUN
bptjm-12	90	28	to	to	ADP
bptjm-12	90	29	the	the	DET
bptjm-12	90	30	presynaptic	presynaptic	ADJ
bptjm-12	90	31	neuron	neuron	NOUN
bptjm-12	90	32	,	,	PUNCT
bptjm-12	90	33	thus	thus	ADV
bptjm-12	90	34	attaching	attach	VERB
bptjm-12	90	35	to	to	ADP
bptjm-12	90	36	the	the	DET
bptjm-12	90	37	cannabinoid	cannabinoid	NOUN
bptjm-12	90	38	type	type	NOUN
bptjm-12	90	39	1	1	NUM
bptjm-12	90	40	receptor	receptor	NOUN
bptjm-12	90	41	.	.	PUNCT
bptjm-12	91	1	the	the	DET
bptjm-12	91	2	binding	binding	NOUN
bptjm-12	91	3	of	of	ADP
bptjm-12	91	4	these	these	DET
bptjm-12	91	5	two	two	NUM
bptjm-12	91	6	molecules	molecule	NOUN
bptjm-12	91	7	results	result	NOUN
bptjm-12	91	8	in	in	ADP
bptjm-12	91	9	a	a	DET
bptjm-12	91	10	suppression	suppression	NOUN
bptjm-12	91	11	of	of	ADP
bptjm-12	91	12	neurotransmitters	neurotransmitter	NOUN
bptjm-12	91	13	altering	alter	VERB
bptjm-12	91	14	the	the	DET
bptjm-12	91	15	neuronal	neuronal	ADJ
bptjm-12	91	16	�	�	NOUN
bptjm-12	91	17	ring	ring	NOUN
bptjm-12	91	18	in	in	ADP
bptjm-12	91	19	the	the	DET
bptjm-12	91	20	postsynaptic	postsynaptic	ADJ
bptjm-12	91	21	cell	cell	NOUN
bptjm-12	91	22	,	,	PUNCT
bptjm-12	91	23	thus	thus	ADV
bptjm-12	91	24	allowing	allow	VERB
bptjm-12	91	25	it	it	PRON
bptjm-12	91	26	to	to	PART
bptjm-12	91	27	work	work	VERB
bptjm-12	91	28	as	as	ADP
bptjm-12	91	29	a	a	DET
bptjm-12	91	30	regulator	regulator	NOUN
bptjm-12	91	31	.	.	PUNCT
bptjm-12	92	1	one	one	NUM
bptjm-12	92	2	avenue	avenue	NOUN
bptjm-12	92	3	of	of	ADP
bptjm-12	92	4	therapeutic	therapeutic	ADJ
bptjm-12	92	5	treatment	treatment	NOUN
bptjm-12	92	6	is	be	AUX
bptjm-12	92	7	the	the	DET
bptjm-12	92	8	usage	usage	NOUN
bptjm-12	92	9	of	of	ADP
bptjm-12	92	10	cb2	cb2	NOUN
bptjm-12	92	11	activity	activity	NOUN
bptjm-12	92	12	against	against	ADP
bptjm-12	92	13	in	in	ADP
bptjm-12	92	14	�	�	PROPN
bptjm-12	92	15	ammation	ammation	NOUN
bptjm-12	92	16	.	.	PUNCT
bptjm-12	93	1	within	within	ADP
bptjm-12	93	2	microglia	microglia	ADJ
bptjm-12	93	3	cells	cell	NOUN
bptjm-12	93	4	,	,	PUNCT
bptjm-12	93	5	cb2	cb2	PROPN
bptjm-12	93	6	receptors	receptor	NOUN
bptjm-12	93	7	inhibit	inhibit	VERB
bptjm-12	93	8	neurotoxicity	neurotoxicity	NOUN
bptjm-12	93	9	caused	cause	VERB
bptjm-12	93	10	by	by	ADP
bptjm-12	93	11	microglia	microglia	NOUN
bptjm-12	93	12	by	by	ADP
bptjm-12	93	13	substantially	substantially	ADV
bptjm-12	93	14	reducing	reduce	VERB
bptjm-12	93	15	the	the	DET
bptjm-12	93	16	production	production	NOUN
bptjm-12	93	17	of	of	ADP
bptjm-12	93	18	pro	pro	ADJ
bptjm-12	93	19	-	-	ADJ
bptjm-12	93	20	in	in	ADP
bptjm-12	93	21	�	�	NOUN
bptjm-12	93	22	ammatory	ammatory	NOUN
bptjm-12	93	23	molecules	molecule	NOUN
bptjm-12	93	24	and	and	CCONJ
bptjm-12	93	25	by	by	ADP
bptjm-12	93	26	manipulating	manipulate	VERB
bptjm-12	93	27	macrophage	macrophage	ADJ
bptjm-12	93	28	migration(aso	migration(aso	PROPN
bptjm-12	93	29	&	&	CCONJ
bptjm-12	93	30	ferrer	ferrer	PROPN
bptjm-12	93	31	,	,	PUNCT
bptjm-12	93	32	2016	2016	NUM
bptjm-12	93	33	)	)	PUNCT
bptjm-12	93	34	.	.	PUNCT
bptjm-12	94	1	"	"	PUNCT
bptjm-12	94	2	this	this	PRON
bptjm-12	94	3	was	be	AUX
bptjm-12	94	4	supported	support	VERB
bptjm-12	94	5	by	by	ADP
bptjm-12	94	6	experiments	experiment	NOUN
bptjm-12	94	7	utilizing	utilize	VERB
bptjm-12	94	8	receptor	receptor	NOUN
bptjm-12	94	9	agonists	agonist	NOUN
bptjm-12	94	10	within	within	ADP
bptjm-12	94	11	in	in	ADP
bptjm-12	94	12	vitro	vitro	X
bptjm-12	94	13	experiments	experiment	NOUN
bptjm-12	94	14	containing	contain	VERB
bptjm-12	94	15	di	di	NOUN
bptjm-12	94	16	�	�	PROPN
bptjm-12	94	17	erent	erent	NOUN
bptjm-12	94	18	species	specie	NOUN
bptjm-12	94	19	of	of	ADP
bptjm-12	94	20	toxic	toxic	ADJ
bptjm-12	94	21	aβs	aβs	PROPN
bptjm-12	94	22	,	,	PUNCT
bptjm-12	94	23	such	such	ADJ
bptjm-12	94	24	as	as	ADP
bptjm-12	94	25	jwh-015	jwh-015	NOUN
bptjm-12	94	26	,	,	PUNCT
bptjm-12	94	27	jwh-133	jwh-133	PROPN
bptjm-12	94	28	,	,	PUNCT
bptjm-12	94	29	hu-308	hu-308	PROPN
bptjm-12	94	30	,	,	PUNCT
bptjm-12	94	31	win55,212	win55,212	PROPN
bptjm-12	94	32	-	-	PUNCT
bptjm-12	94	33	2	2	NUM
bptjm-12	94	34	,	,	PUNCT
bptjm-12	94	35	and	and	CCONJ
bptjm-12	94	36	hu-210	hu-210	PROPN
bptjm-12	94	37	,	,	PUNCT
bptjm-12	94	38	which	which	PRON
bptjm-12	94	39	observed	observe	VERB
bptjm-12	94	40	a	a	DET
bptjm-12	94	41	reduction	reduction	NOUN
bptjm-12	94	42	of	of	ADP
bptjm-12	94	43	in	in	ADP
bptjm-12	94	44	�	�	NOUN
bptjm-12	94	45	ammatory	ammatory	NOUN
bptjm-12	94	46	molecules	molecule	NOUN
bptjm-12	94	47	”	"	PUNCT
bptjm-12	94	48	(	(	PUNCT
bptjm-12	94	49	aso	aso	PROPN
bptjm-12	94	50	&	&	CCONJ
bptjm-12	94	51	ferrer	ferrer	PROPN
bptjm-12	94	52	,	,	PUNCT
bptjm-12	94	53	2016	2016	NUM
bptjm-12	94	54	)	)	PUNCT
bptjm-12	94	55	.	.	PUNCT
bptjm-12	95	1	it	it	PRON
bptjm-12	95	2	has	have	AUX
bptjm-12	95	3	been	be	AUX
bptjm-12	95	4	postulated	postulate	VERB
bptjm-12	95	5	that	that	SCONJ
bptjm-12	95	6	these	these	DET
bptjm-12	95	7	cb2	cb2	PROPN
bptjm-12	95	8	receptor	receptor	NOUN
bptjm-12	95	9	agonists	agonist	NOUN
bptjm-12	95	10	aid	aid	VERB
bptjm-12	95	11	in	in	ADP
bptjm-12	95	12	inhibiting	inhibit	VERB
bptjm-12	95	13	microglial	microglial	ADJ
bptjm-12	95	14	activation	activation	NOUN
bptjm-12	95	15	through	through	ADP
bptjm-12	95	16	decreasing	decrease	VERB
bptjm-12	95	17	intracellular	intracellular	ADJ
bptjm-12	95	18	calcium	calcium	NOUN
bptjm-12	95	19	concentration	concentration	NOUN
bptjm-12	95	20	(	(	PUNCT
bptjm-12	95	21	martín	martín	NOUN
bptjm-12	95	22	-	-	PUNCT
bptjm-12	95	23	moreno	moreno	PROPN
bptjm-12	95	24	et	et	PROPN
bptjm-12	95	25	al	al	PROPN
bptjm-12	95	26	.	.	PROPN
bptjm-12	95	27	,	,	PUNCT
bptjm-12	95	28	2011	2011	NUM
bptjm-12	95	29	)	)	PUNCT
bptjm-12	95	30	.	.	PUNCT
bptjm-12	96	1	in	in	ADP
bptjm-12	96	2	essence	essence	NOUN
bptjm-12	96	3	,	,	PUNCT
bptjm-12	96	4	the	the	DET
bptjm-12	96	5	utilization	utilization	NOUN
bptjm-12	96	6	and	and	CCONJ
bptjm-12	96	7	subsequent	subsequent	ADJ
bptjm-12	96	8	exploitation	exploitation	NOUN
bptjm-12	96	9	of	of	ADP
bptjm-12	96	10	the	the	DET
bptjm-12	96	11	endocannabinoid	endocannabinoid	NOUN
bptjm-12	96	12	system	system	NOUN
bptjm-12	96	13	provides	provide	VERB
bptjm-12	96	14	an	an	DET
bptjm-12	96	15	essential	essential	ADJ
bptjm-12	96	16	medium	medium	NOUN
bptjm-12	96	17	for	for	ADP
bptjm-12	96	18	the	the	DET
bptjm-12	96	19	therapeutic	therapeutic	ADJ
bptjm-12	96	20	treatment	treatment	NOUN
bptjm-12	96	21	of	of	ADP
bptjm-12	96	22	alzheimer	alzheimer	PROPN
bptjm-12	96	23	’s	’s	PART
bptjm-12	96	24	disease	disease	NOUN
bptjm-12	96	25	.	.	PUNCT
bptjm-12	97	1	berkeley	berkeley	PROPN
bptjm-12	97	2	pharma	pharma	PROPN
bptjm-12	97	3	tech	tech	PROPN
bptjm-12	97	4	journal	journal	NOUN
bptjm-12	97	5	of	of	ADP
bptjm-12	97	6	medicine	medicine	NOUN
bptjm-12	97	7	|	|	ADV
bptjm-12	97	8	8	8	NUM
bptjm-12	97	9	the	the	DET
bptjm-12	97	10	endocannabinoid	endocannabinoid	NOUN
bptjm-12	97	11	system	system	NOUN
bptjm-12	97	12	has	have	AUX
bptjm-12	97	13	shown	show	VERB
bptjm-12	97	14	to	to	PART
bptjm-12	97	15	reduce	reduce	VERB
bptjm-12	97	16	in	in	ADP
bptjm-12	97	17	�	�	NOUN
bptjm-12	97	18	ammatory	ammatory	ADJ
bptjm-12	97	19	response	response	NOUN
bptjm-12	97	20	through	through	ADP
bptjm-12	97	21	thepparγ	thepparγ	ADJ
bptjm-12	97	22	protein	protein	NOUN
bptjm-12	97	23	as	as	ADV
bptjm-12	97	24	well	well	ADV
bptjm-12	97	25	as	as	ADP
bptjm-12	97	26	facilitate	facilitate	ADJ
bptjm-12	97	27	neurogenesis	neurogenesis	NOUN
bptjm-12	97	28	through	through	ADP
bptjm-12	97	29	the	the	DET
bptjm-12	97	30	activation	activation	NOUN
bptjm-12	97	31	of	of	ADP
bptjm-12	97	32	both	both	CCONJ
bptjm-12	97	33	the	the	DET
bptjm-12	97	34	cannabinoid	cannabinoid	NOUN
bptjm-12	97	35	receptors	receptor	NOUN
bptjm-12	97	36	,	,	PUNCT
bptjm-12	97	37	when	when	SCONJ
bptjm-12	97	38	neural	neural	ADJ
bptjm-12	97	39	stem	stem	NOUN
bptjm-12	97	40	cells	cell	NOUN
bptjm-12	97	41	and	and	CCONJ
bptjm-12	97	42	neural	neural	ADJ
bptjm-12	97	43	progenitor	progenitor	NOUN
bptjm-12	97	44	cells	cell	NOUN
bptjm-12	97	45	are	be	AUX
bptjm-12	97	46	proliferated	proliferate	VERB
bptjm-12	97	47	.	.	PUNCT
bptjm-12	98	1	the	the	DET
bptjm-12	98	2	self	self	NOUN
bptjm-12	98	3	-	-	PUNCT
bptjm-12	98	4	renewal	renewal	NOUN
bptjm-12	98	5	capability	capability	NOUN
bptjm-12	98	6	and	and	CCONJ
bptjm-12	98	7	multipotency	multipotency	NOUN
bptjm-12	98	8	of	of	ADP
bptjm-12	98	9	stem	stem	NOUN
bptjm-12	98	10	cells	cell	NOUN
bptjm-12	98	11	is	be	AUX
bptjm-12	98	12	supported	support	VERB
bptjm-12	98	13	through	through	ADP
bptjm-12	98	14	the	the	DET
bptjm-12	98	15	complex	complex	ADJ
bptjm-12	98	16	microenvironment	microenvironment	NOUN
bptjm-12	98	17	provided	provide	VERB
bptjm-12	98	18	through	through	ADP
bptjm-12	98	19	the	the	DET
bptjm-12	98	20	action	action	NOUN
bptjm-12	98	21	of	of	ADP
bptjm-12	98	22	the	the	DET
bptjm-12	98	23	endocannabinoid	endocannabinoid	NOUN
bptjm-12	98	24	system	system	NOUN
bptjm-12	98	25	,	,	PUNCT
bptjm-12	98	26	speci	speci	PROPN
bptjm-12	98	27	�	�	PROPN
bptjm-12	98	28	cally	cally	ADV
bptjm-12	98	29	cannabinoid	cannabinoid	NOUN
bptjm-12	98	30	receptors	receptor	NOUN
bptjm-12	98	31	cb1	cb1	NOUN
bptjm-12	98	32	and	and	CCONJ
bptjm-12	98	33	cb2	cb2	PROPN
bptjm-12	99	1	(	(	PUNCT
bptjm-12	99	2	rodrigues	rodrigues	PROPN
bptjm-12	99	3	et	et	PROPN
bptjm-12	99	4	al	al	PROPN
bptjm-12	99	5	.	.	PROPN
bptjm-12	99	6	,	,	PUNCT
bptjm-12	99	7	2019	2019	NUM
bptjm-12	99	8	)	)	PUNCT
bptjm-12	99	9	.	.	PUNCT
bptjm-12	100	1	the	the	DET
bptjm-12	100	2	prospect	prospect	NOUN
bptjm-12	100	3	of	of	ADP
bptjm-12	100	4	neural	neural	ADJ
bptjm-12	100	5	stem	stem	NOUN
bptjm-12	100	6	cells	cell	NOUN
bptjm-12	100	7	as	as	ADP
bptjm-12	100	8	regenerative	regenerative	ADJ
bptjm-12	100	9	therapies	therapy	NOUN
bptjm-12	100	10	is	be	AUX
bptjm-12	100	11	very	very	ADV
bptjm-12	100	12	promising	promising	ADJ
bptjm-12	100	13	,	,	PUNCT
bptjm-12	100	14	leading	lead	VERB
bptjm-12	100	15	to	to	ADP
bptjm-12	100	16	a	a	DET
bptjm-12	100	17	possible	possible	ADJ
bptjm-12	100	18	personalized	personalized	ADJ
bptjm-12	100	19	and	and	CCONJ
bptjm-12	100	20	e	e	NOUN
bptjm-12	100	21	�	�	NOUN
bptjm-12	100	22	ective	ective	ADJ
bptjm-12	100	23	approach	approach	NOUN
bptjm-12	100	24	(	(	PUNCT
bptjm-12	100	25	rodrigueset	rodrigueset	PROPN
bptjm-12	100	26	al	al	PROPN
bptjm-12	100	27	.	.	PROPN
bptjm-12	100	28	,	,	PUNCT
bptjm-12	100	29	2019	2019	NUM
bptjm-12	100	30	)	)	PUNCT
bptjm-12	100	31	.	.	PUNCT
bptjm-12	101	1	moreover	moreover	ADV
bptjm-12	101	2	,	,	PUNCT
bptjm-12	101	3	the	the	DET
bptjm-12	101	4	various	various	ADJ
bptjm-12	101	5	cannabinoid	cannabinoid	NOUN
bptjm-12	101	6	actions	action	NOUN
bptjm-12	101	7	on	on	ADP
bptjm-12	101	8	neural	neural	ADJ
bptjm-12	101	9	stem	stem	NOUN
bptjm-12	101	10	cells	cell	NOUN
bptjm-12	101	11	open	open	ADJ
bptjm-12	101	12	paths	path	NOUN
bptjm-12	101	13	of	of	ADP
bptjm-12	101	14	research	research	NOUN
bptjm-12	101	15	to	to	PART
bptjm-12	101	16	uncover	uncover	VERB
bptjm-12	101	17	the	the	DET
bptjm-12	101	18	mechanisms	mechanism	NOUN
bptjm-12	101	19	responsible	responsible	ADJ
bptjm-12	101	20	behind	behind	ADP
bptjm-12	101	21	cannabinoid	cannabinoid	PROPN
bptjm-12	101	22	e	e	NOUN
bptjm-12	101	23	�	�	NOUN
bptjm-12	101	24	ects	ect	NOUN
bptjm-12	101	25	.	.	PUNCT
bptjm-12	102	1	new	new	ADJ
bptjm-12	102	2	avenues	avenue	NOUN
bptjm-12	102	3	of	of	ADP
bptjm-12	102	4	research	research	NOUN
bptjm-12	102	5	could	could	AUX
bptjm-12	102	6	provide	provide	VERB
bptjm-12	102	7	new	new	ADJ
bptjm-12	102	8	knowledge	knowledge	NOUN
bptjm-12	102	9	,	,	PUNCT
bptjm-12	102	10	leading	lead	VERB
bptjm-12	102	11	to	to	ADP
bptjm-12	102	12	the	the	DET
bptjm-12	102	13	development	development	NOUN
bptjm-12	102	14	of	of	ADP
bptjm-12	102	15	re	re	PROPN
bptjm-12	102	16	�	�	NOUN
bptjm-12	102	17	ned	ne	VERB
bptjm-12	102	18	therapeutic	therapeutic	ADJ
bptjm-12	102	19	strategies	strategy	NOUN
bptjm-12	102	20	to	to	PART
bptjm-12	102	21	alleviate	alleviate	VERB
bptjm-12	102	22	alzheimer	alzheimer	PROPN
bptjm-12	102	23	’s	’s	PART
bptjm-12	102	24	e	e	NOUN
bptjm-12	102	25	�	�	NOUN
bptjm-12	102	26	ects	ect	NOUN
bptjm-12	102	27	.	.	PUNCT
bptjm-12	103	1	c.	c.	PROPN
bptjm-12	103	2	synaptic	synaptic	ADJ
bptjm-12	103	3	plasticity	plasticity	NOUN
bptjm-12	103	4	among	among	ADP
bptjm-12	103	5	the	the	DET
bptjm-12	103	6	neural	neural	ADJ
bptjm-12	103	7	pathways	pathway	NOUN
bptjm-12	103	8	negatively	negatively	ADV
bptjm-12	103	9	impacted	impact	VERB
bptjm-12	103	10	by	by	ADP
bptjm-12	103	11	ad	ad	NOUN
bptjm-12	103	12	are	be	AUX
bptjm-12	103	13	those	those	PRON
bptjm-12	103	14	involved	involve	VERB
bptjm-12	103	15	in	in	ADP
bptjm-12	103	16	synaptic	synaptic	ADJ
bptjm-12	103	17	plasticity	plasticity	NOUN
bptjm-12	103	18	.	.	PUNCT
bptjm-12	104	1	the	the	DET
bptjm-12	104	2	brain	brain	NOUN
bptjm-12	104	3	’s	’s	PART
bptjm-12	104	4	circuitry	circuitry	NOUN
bptjm-12	104	5	is	be	AUX
bptjm-12	104	6	heavily	heavily	ADV
bptjm-12	104	7	a	a	DET
bptjm-12	104	8	�	�	NOUN
bptjm-12	104	9	ected	ecte	VERB
bptjm-12	104	10	by	by	ADP
bptjm-12	104	11	numerous	numerous	ADJ
bptjm-12	104	12	daily	daily	ADJ
bptjm-12	104	13	activities	activity	NOUN
bptjm-12	104	14	ranging	range	VERB
bptjm-12	104	15	from	from	ADP
bptjm-12	104	16	learning	learn	VERB
bptjm-12	104	17	new	new	ADJ
bptjm-12	104	18	information	information	NOUN
bptjm-12	104	19	to	to	ADP
bptjm-12	104	20	engaging	engage	VERB
bptjm-12	104	21	in	in	ADP
bptjm-12	104	22	social	social	ADJ
bptjm-12	104	23	interactions	interaction	NOUN
bptjm-12	104	24	.	.	PUNCT
bptjm-12	105	1	these	these	DET
bptjm-12	105	2	exposures	exposure	NOUN
bptjm-12	105	3	to	to	ADP
bptjm-12	105	4	the	the	DET
bptjm-12	105	5	environment	environment	NOUN
bptjm-12	105	6	have	have	VERB
bptjm-12	105	7	the	the	DET
bptjm-12	105	8	potential	potential	NOUN
bptjm-12	105	9	to	to	PART
bptjm-12	105	10	modify	modify	VERB
bptjm-12	105	11	the	the	DET
bptjm-12	105	12	brain	brain	NOUN
bptjm-12	105	13	’s	’s	PART
bptjm-12	105	14	neural	neural	ADJ
bptjm-12	105	15	organization	organization	NOUN
bptjm-12	105	16	and	and	CCONJ
bptjm-12	105	17	in	in	ADP
bptjm-12	105	18	�	�	NOUN
bptjm-12	105	19	uence	uence	NOUN
bptjm-12	105	20	its	its	PRON
bptjm-12	105	21	activity	activity	NOUN
bptjm-12	105	22	.	.	PUNCT
bptjm-12	106	1	synaptic	synaptic	ADJ
bptjm-12	106	2	plasticity	plasticity	NOUN
bptjm-12	106	3	is	be	AUX
bptjm-12	106	4	the	the	DET
bptjm-12	106	5	phenomenon	phenomenon	NOUN
bptjm-12	106	6	that	that	PRON
bptjm-12	106	7	describes	describe	VERB
bptjm-12	106	8	these	these	DET
bptjm-12	106	9	changes	change	NOUN
bptjm-12	106	10	in	in	ADP
bptjm-12	106	11	the	the	DET
bptjm-12	106	12	neural	neural	ADJ
bptjm-12	106	13	circuits	circuit	NOUN
bptjm-12	106	14	’	'	PUNCT
bptjm-12	106	15	structure	structure	NOUN
bptjm-12	106	16	and	and	CCONJ
bptjm-12	106	17	function	function	NOUN
bptjm-12	106	18	,	,	PUNCT
bptjm-12	106	19	which	which	PRON
bptjm-12	106	20	result	result	VERB
bptjm-12	106	21	from	from	ADP
bptjm-12	106	22	modi	modi	PROPN
bptjm-12	106	23	�	�	PROPN
bptjm-12	106	24	cations	cation	NOUN
bptjm-12	106	25	to	to	ADP
bptjm-12	106	26	synaptic	synaptic	ADJ
bptjm-12	106	27	transmission	transmission	NOUN
bptjm-12	106	28	.	.	PUNCT
bptjm-12	107	1	although	although	SCONJ
bptjm-12	107	2	synaptic	synaptic	ADJ
bptjm-12	107	3	plasticity	plasticity	NOUN
bptjm-12	107	4	may	may	AUX
bptjm-12	107	5	allow	allow	VERB
bptjm-12	107	6	a	a	DET
bptjm-12	107	7	damaged	damage	VERB
bptjm-12	107	8	brain	brain	NOUN
bptjm-12	107	9	to	to	PART
bptjm-12	107	10	restrengthen	restrengthen	VERB
bptjm-12	107	11	synaptic	synaptic	ADJ
bptjm-12	107	12	connections	connection	NOUN
bptjm-12	107	13	and	and	CCONJ
bptjm-12	107	14	reverse	reverse	ADJ
bptjm-12	107	15	damage	damage	NOUN
bptjm-12	107	16	,	,	PUNCT
bptjm-12	107	17	ad	ad	NOUN
bptjm-12	107	18	is	be	AUX
bptjm-12	107	19	known	know	VERB
bptjm-12	107	20	to	to	PART
bptjm-12	107	21	impair	impair	VERB
bptjm-12	107	22	this	this	DET
bptjm-12	107	23	plasticity	plasticity	NOUN
bptjm-12	107	24	and	and	CCONJ
bptjm-12	107	25	leave	leave	VERB
bptjm-12	107	26	permanent	permanent	ADJ
bptjm-12	107	27	damage	damage	NOUN
bptjm-12	107	28	.	.	PUNCT
bptjm-12	108	1	research	research	NOUN
bptjm-12	108	2	has	have	AUX
bptjm-12	108	3	demonstrated	demonstrate	VERB
bptjm-12	108	4	that	that	DET
bptjm-12	108	5	aβdeposition	aβdeposition	NOUN
bptjm-12	108	6	,	,	PUNCT
bptjm-12	108	7	a	a	DET
bptjm-12	108	8	widely	widely	ADV
bptjm-12	108	9	recognized	recognize	VERB
bptjm-12	108	10	hallmark	hallmark	NOUN
bptjm-12	108	11	of	of	ADP
bptjm-12	108	12	ad	ad	NOUN
bptjm-12	108	13	pathophysiology	pathophysiology	NOUN
bptjm-12	108	14	,	,	PUNCT
bptjm-12	108	15	is	be	AUX
bptjm-12	108	16	detrimental	detrimental	ADJ
bptjm-12	108	17	to	to	ADP
bptjm-12	108	18	healthy	healthy	ADJ
bptjm-12	108	19	synapses	synapsis	NOUN
bptjm-12	108	20	(	(	PUNCT
bptjm-12	108	21	shankar	shankar	PROPN
bptjm-12	108	22	et	et	PROPN
bptjm-12	108	23	al	al	PROPN
bptjm-12	108	24	.	.	PROPN
bptjm-12	108	25	,	,	PUNCT
bptjm-12	108	26	2008	2008	NUM
bptjm-12	108	27	)	)	PUNCT
bptjm-12	108	28	.	.	PUNCT
bptjm-12	109	1	soluble	soluble	ADJ
bptjm-12	109	2	dimeric	dimeric	ADJ
bptjm-12	109	3	aβ	aβ	NOUN
bptjm-12	109	4	assemblies	assembly	NOUN
bptjm-12	109	5	were	be	AUX
bptjm-12	109	6	found	find	VERB
bptjm-12	109	7	to	to	PART
bptjm-12	109	8	be	be	AUX
bptjm-12	109	9	strong	strong	ADJ
bptjm-12	109	10	inhibitors	inhibitor	NOUN
bptjm-12	109	11	of	of	ADP
bptjm-12	109	12	long	long	ADJ
bptjm-12	109	13	-	-	PUNCT
bptjm-12	109	14	term	term	NOUN
bptjm-12	109	15	potentiation	potentiation	NOUN
bptjm-12	109	16	—	—	PUNCT
bptjm-12	109	17	the	the	DET
bptjm-12	109	18	strengthening	strengthening	NOUN
bptjm-12	109	19	of	of	ADP
bptjm-12	109	20	synaptic	synaptic	ADJ
bptjm-12	109	21	communication	communication	NOUN
bptjm-12	109	22	by	by	ADP
bptjm-12	109	23	repeated	repeat	VERB
bptjm-12	109	24	stimulation	stimulation	NOUN
bptjm-12	109	25	(	(	PUNCT
bptjm-12	109	26	shankar	shankar	PROPN
bptjm-12	109	27	et	et	PROPN
bptjm-12	109	28	al	al	PROPN
bptjm-12	109	29	.	.	PROPN
bptjm-12	109	30	,	,	PUNCT
bptjm-12	109	31	2008	2008	NUM
bptjm-12	109	32	)	)	PUNCT
bptjm-12	109	33	.	.	PUNCT
bptjm-12	110	1	the	the	DET
bptjm-12	110	2	soluble	soluble	ADJ
bptjm-12	110	3	aβ	aβ	NOUN
bptjm-12	110	4	assemblies	assembly	NOUN
bptjm-12	110	5	were	be	AUX
bptjm-12	110	6	also	also	ADV
bptjm-12	110	7	found	find	VERB
bptjm-12	110	8	to	to	PART
bptjm-12	110	9	augment	augment	VERB
bptjm-12	110	10	long	long	ADJ
bptjm-12	110	11	-	-	PUNCT
bptjm-12	110	12	term	term	NOUN
bptjm-12	110	13	depression	depression	NOUN
bptjm-12	110	14	causing	cause	VERB
bptjm-12	110	15	a	a	DET
bptjm-12	110	16	decrease	decrease	NOUN
bptjm-12	110	17	in	in	ADP
bptjm-12	110	18	dendritic	dendritic	ADJ
bptjm-12	110	19	spine	spine	ADJ
bptjm-12	110	20	density	density	NOUN
bptjm-12	110	21	.	.	PUNCT
bptjm-12	111	1	dendritic	dendritic	ADJ
bptjm-12	111	2	spine	spine	ADJ
bptjm-12	111	3	density	density	NOUN
bptjm-12	111	4	has	have	AUX
bptjm-12	111	5	been	be	AUX
bptjm-12	111	6	found	find	VERB
bptjm-12	111	7	to	to	PART
bptjm-12	111	8	strongly	strongly	ADV
bptjm-12	111	9	correlate	correlate	VERB
bptjm-12	111	10	to	to	ADP
bptjm-12	111	11	the	the	DET
bptjm-12	111	12	degree	degree	NOUN
bptjm-12	111	13	of	of	ADP
bptjm-12	111	14	dementia	dementia	NOUN
bptjm-12	111	15	for	for	ADP
bptjm-12	111	16	patients	patient	NOUN
bptjm-12	111	17	with	with	ADP
bptjm-12	111	18	ad	ad	NOUN
bptjm-12	111	19	.	.	PUNCT
bptjm-12	112	1	speci	speci	PROPN
bptjm-12	112	2	�	�	PROPN
bptjm-12	112	3	cally	cally	ADV
bptjm-12	112	4	,	,	PUNCT
bptjm-12	112	5	the	the	DET
bptjm-12	112	6	research	research	NOUN
bptjm-12	112	7	showed	show	VERB
bptjm-12	112	8	that	that	SCONJ
bptjm-12	112	9	ad	ad	NOUN
bptjm-12	112	10	brain	brain	NOUN
bptjm-12	112	11	samples	sample	NOUN
bptjm-12	112	12	had	have	VERB
bptjm-12	112	13	a	a	DET
bptjm-12	112	14	47	47	NUM
bptjm-12	112	15	%	%	NOUN
bptjm-12	112	16	decrease	decrease	NOUN
bptjm-12	112	17	in	in	ADP
bptjm-12	112	18	spine	spine	ADJ
bptjm-12	112	19	density	density	NOUN
bptjm-12	112	20	when	when	SCONJ
bptjm-12	112	21	compared	compare	VERB
bptjm-12	112	22	to	to	ADP
bptjm-12	112	23	a	a	DET
bptjm-12	112	24	control	control	NOUN
bptjm-12	112	25	(	(	PUNCT
bptjm-12	112	26	shankar	shankar	PROPN
bptjm-12	112	27	et	et	PROPN
bptjm-12	112	28	al	al	PROPN
bptjm-12	112	29	.	.	PROPN
bptjm-12	112	30	,	,	PUNCT
bptjm-12	112	31	2008	2008	NUM
bptjm-12	112	32	)	)	PUNCT
bptjm-12	112	33	.	.	PUNCT
bptjm-12	113	1	the	the	DET
bptjm-12	113	2	researchers	researcher	NOUN
bptjm-12	113	3	localized	localize	VERB
bptjm-12	113	4	various	various	ADJ
bptjm-12	113	5	receptors	receptor	NOUN
bptjm-12	113	6	,	,	PUNCT
bptjm-12	113	7	includingn	includingn	NOUN
bptjm-12	113	8	-	-	PUNCT
bptjm-12	113	9	methyl	methyl	NOUN
bptjm-12	113	10	-	-	PUNCT
bptjm-12	113	11	d	d	NOUN
bptjm-12	113	12	-	-	PUNCT
bptjm-12	113	13	aspartate	aspartate	ADJ
bptjm-12	113	14	receptors	receptor	NOUN
bptjm-12	113	15	(	(	PUNCT
bptjm-12	113	16	nmdar	nmdar	ADV
bptjm-12	113	17	)	)	PUNCT
bptjm-12	113	18	,	,	PUNCT
bptjm-12	113	19	metabotropic	metabotropic	NOUN
bptjm-12	113	20	glutamate	glutamate	NOUN
bptjm-12	113	21	receptors	receptor	NOUN
bptjm-12	113	22	(	(	PUNCT
bptjm-12	113	23	mglur	mglur	PROPN
bptjm-12	113	24	)	)	PUNCT
bptjm-12	113	25	,	,	PUNCT
bptjm-12	113	26	and	and	CCONJ
bptjm-12	113	27	nicotinic	nicotinic	ADJ
bptjm-12	113	28	acetylcholine	acetylcholine	NOUN
bptjm-12	113	29	receptors(nachr	receptors(nachr	PROPN
bptjm-12	113	30	)	)	PUNCT
bptjm-12	113	31	as	as	ADP
bptjm-12	113	32	among	among	ADP
bptjm-12	113	33	those	those	PRON
bptjm-12	113	34	impacted	impact	VERB
bptjm-12	113	35	by	by	ADP
bptjm-12	113	36	aβ	aβ	ADP
bptjm-12	113	37	and	and	CCONJ
bptjm-12	113	38	negatively	negatively	ADV
bptjm-12	113	39	a	a	DET
bptjm-12	113	40	�	�	NOUN
bptjm-12	113	41	ecting	ecte	VERB
bptjm-12	113	42	berkeley	berkeley	PROPN
bptjm-12	113	43	pharma	pharma	PROPN
bptjm-12	113	44	tech	tech	NOUN
bptjm-12	113	45	journal	journal	NOUN
bptjm-12	113	46	of	of	ADP
bptjm-12	113	47	medicine	medicine	NOUN
bptjm-12	113	48	|	|	ADV
bptjm-12	113	49	9	9	NUM
bptjm-12	113	50	synaptic	synaptic	ADJ
bptjm-12	113	51	plasticity	plasticity	NOUN
bptjm-12	113	52	in	in	ADP
bptjm-12	113	53	diseased	diseased	ADJ
bptjm-12	113	54	brains	brain	NOUN
bptjm-12	113	55	.	.	PUNCT
bptjm-12	114	1	studies	study	NOUN
bptjm-12	114	2	con	con	PROPN
bptjm-12	114	3	�	�	PROPN
bptjm-12	114	4	rmed	rme	VERB
bptjm-12	114	5	that	that	SCONJ
bptjm-12	114	6	the	the	DET
bptjm-12	114	7	introduction	introduction	NOUN
bptjm-12	114	8	of	of	ADP
bptjm-12	114	9	soluble	soluble	ADJ
bptjm-12	114	10	aβ	aβ	NOUN
bptjm-12	114	11	dimers	dimer	NOUN
bptjm-12	114	12	into	into	ADP
bptjm-12	114	13	rats	rat	NOUN
bptjm-12	114	14	interrupted	interrupt	VERB
bptjm-12	114	15	their	their	PRON
bptjm-12	114	16	ability	ability	NOUN
bptjm-12	114	17	to	to	PART
bptjm-12	114	18	recall	recall	VERB
bptjm-12	114	19	learned	learn	VERB
bptjm-12	114	20	behaviors	behavior	NOUN
bptjm-12	114	21	,	,	PUNCT
bptjm-12	114	22	further	far	ADV
bptjm-12	114	23	implicating	implicate	VERB
bptjm-12	114	24	aβ	aβ	PRON
bptjm-12	114	25	as	as	ADP
bptjm-12	114	26	the	the	DET
bptjm-12	114	27	primary	primary	ADJ
bptjm-12	114	28	culprit	culprit	NOUN
bptjm-12	114	29	responsible	responsible	ADJ
bptjm-12	114	30	for	for	ADP
bptjm-12	114	31	impaired	impaired	ADJ
bptjm-12	114	32	synapse	synapse	NOUN
bptjm-12	114	33	remodeling	remodeling	NOUN
bptjm-12	114	34	and	and	CCONJ
bptjm-12	114	35	plasticity	plasticity	NOUN
bptjm-12	114	36	(	(	PUNCT
bptjm-12	114	37	shankar	shankar	PROPN
bptjm-12	114	38	et	et	PROPN
bptjm-12	114	39	al	al	PROPN
bptjm-12	114	40	.	.	PROPN
bptjm-12	114	41	,	,	PUNCT
bptjm-12	114	42	2008	2008	NUM
bptjm-12	114	43	)	)	PUNCT
bptjm-12	114	44	.	.	PUNCT
bptjm-12	115	1	fig	fig	NOUN
bptjm-12	115	2	.	.	PUNCT
bptjm-12	116	1	4	4	NUM
bptjm-12	116	2	:	:	PUNCT
bptjm-12	116	3	in	in	ADP
bptjm-12	116	4	a	a	DET
bptjm-12	116	5	research	research	NOUN
bptjm-12	116	6	study	study	NOUN
bptjm-12	116	7	conducted	conduct	VERB
bptjm-12	116	8	by	by	ADP
bptjm-12	116	9	hughes	hughe	NOUN
bptjm-12	116	10	and	and	CCONJ
bptjm-12	116	11	herron	herron	PROPN
bptjm-12	116	12	,	,	PUNCT
bptjm-12	116	13	e	e	NOUN
bptjm-12	116	14	�	�	NOUN
bptjm-12	116	15	ects	ect	NOUN
bptjm-12	116	16	of	of	ADP
bptjm-12	116	17	long	long	ADJ
bptjm-12	116	18	-	-	PUNCT
bptjm-12	116	19	term	term	NOUN
bptjm-12	116	20	potentiation	potentiation	NOUN
bptjm-12	116	21	(	(	PUNCT
bptjm-12	116	22	ltp	ltp	NOUN
bptjm-12	116	23	)	)	PUNCT
bptjm-12	116	24	of	of	ADP
bptjm-12	116	25	cbd	cbd	NOUN
bptjm-12	116	26	was	be	AUX
bptjm-12	116	27	investigated	investigate	VERB
bptjm-12	116	28	in	in	ADP
bptjm-12	116	29	the	the	DET
bptjm-12	116	30	hippocampus	hippocampus	NOUN
bptjm-12	116	31	.	.	PUNCT
bptjm-12	117	1	treatment	treatment	NOUN
bptjm-12	117	2	of	of	ADP
bptjm-12	117	3	slices	slice	NOUN
bptjm-12	117	4	with	with	ADP
bptjm-12	117	5	cbd	cbd	NOUN
bptjm-12	117	6	attenuated	attenuate	VERB
bptjm-12	117	7	the	the	DET
bptjm-12	117	8	aβ	aβ	NOUN
bptjm-12	117	9	-	-	PUNCT
bptjm-12	117	10	mediated	mediate	VERB
bptjm-12	117	11	de	de	NOUN
bptjm-12	117	12	�	�	NOUN
bptjm-12	117	13	cit	cit	PROPN
bptjm-12	117	14	in	in	ADP
bptjm-12	117	15	ltp	ltp	PROPN
bptjm-12	117	16	.	.	PUNCT
bptjm-12	118	1	ltp	ltp	PROPN
bptjm-12	118	2	was	be	AUX
bptjm-12	118	3	signi	signi	ADJ
bptjm-12	118	4	�	�	PROPN
bptjm-12	118	5	cantly	cantly	ADV
bptjm-12	118	6	attenuated	attenuate	VERB
bptjm-12	118	7	in	in	ADP
bptjm-12	118	8	the	the	DET
bptjm-12	118	9	presence	presence	NOUN
bptjm-12	118	10	of	of	ADP
bptjm-12	118	11	aβ1–42	aβ1–42	PROPN
bptjm-12	118	12	(	(	PUNCT
bptjm-12	118	13	500	500	NUM
bptjm-12	118	14	nm	nm	NOUN
bptjm-12	118	15	)	)	PUNCT
bptjm-12	118	16	(	(	PUNCT
bptjm-12	118	17	112.6±2.9%;n=23	112.6±2.9%;n=23	NUM
bptjm-12	118	18	)	)	PUNCT
bptjm-12	118	19	compared	compare	VERB
bptjm-12	118	20	to	to	ADP
bptjm-12	118	21	control	control	NOUN
bptjm-12	118	22	(	(	PUNCT
bptjm-12	118	23	148.6±2.4	148.6±2.4	NUM
bptjm-12	118	24	%	%	NOUN
bptjm-12	118	25	;	;	PUNCT
bptjm-12	118	26	n=59	n=59	X
bptjm-12	118	27	;	;	PUNCT
bptjm-12	118	28	aandc	aandc	NOUN
bptjm-12	118	29	)	)	PUNCT
bptjm-12	118	30	.	.	PUNCT
bptjm-12	119	1	b	b	X
bptjm-12	119	2	application	application	NOUN
bptjm-12	119	3	of	of	ADP
bptjm-12	119	4	cbd	cbd	NOUN
bptjm-12	119	5	to	to	ADP
bptjm-12	119	6	slices	slice	NOUN
bptjm-12	119	7	30	30	NUM
bptjm-12	119	8	minutes	minute	NOUN
bptjm-12	119	9	prior	prior	ADV
bptjm-12	119	10	to	to	ADP
bptjm-12	119	11	addition	addition	NOUN
bptjm-12	119	12	of	of	ADP
bptjm-12	119	13	aβ	aβ	PRON
bptjm-12	119	14	attenuated	attenuate	VERB
bptjm-12	119	15	theaβ	theaβ	ADV
bptjm-12	119	16	-	-	PUNCT
bptjm-12	119	17	mediated	mediate	VERB
bptjm-12	119	18	de	de	NOUN
bptjm-12	119	19	�	�	NOUN
bptjm-12	119	20	cit	cit	PROPN
bptjm-12	119	21	in	in	ADP
bptjm-12	119	22	ltp	ltp	PROPN
bptjm-12	119	23	(	(	PUNCT
bptjm-12	119	24	136.9±5.9	136.9±5.9	NUM
bptjm-12	119	25	%	%	NOUN
bptjm-12	119	26	;	;	PUNCT
bptjm-12	119	27	n=15	n=15	NUM
bptjm-12	119	28	,	,	PUNCT
bptjm-12	119	29	p≤0.001	p≤0.001	VERB
bptjm-12	119	30	)	)	PUNCT
bptjm-12	119	31	compared	compare	VERB
bptjm-12	119	32	to	to	ADP
bptjm-12	119	33	aβ	aβ	PRON
bptjm-12	119	34	alone	alone	ADV
bptjm-12	119	35	.	.	PUNCT
bptjm-12	120	1	ltp	ltp	PROPN
bptjm-12	120	2	in	in	ADP
bptjm-12	120	3	the	the	DET
bptjm-12	120	4	presence	presence	NOUN
bptjm-12	120	5	of	of	ADP
bptjm-12	120	6	cbd	cbd	NOUN
bptjm-12	120	7	and	and	CCONJ
bptjm-12	120	8	aβ	aβ	NOUN
bptjm-12	120	9	was	be	AUX
bptjm-12	120	10	similar	similar	ADJ
bptjm-12	120	11	to	to	ADP
bptjm-12	120	12	control	control	NOUN
bptjm-12	120	13	(	(	PUNCT
bptjm-12	120	14	p>0.05	p>0.05	PROPN
bptjm-12	120	15	)	)	PUNCT
bptjm-12	120	16	.	.	PUNCT
bptjm-12	121	1	citation	citation	NOUN
bptjm-12	121	2	:	:	PUNCT
bptjm-12	122	1	cannabidiol	cannabidiol	PROPN
bptjm-12	122	2	reverses	reverse	VERB
bptjm-12	122	3	de	de	PROPN
bptjm-12	122	4	�	�	PROPN
bptjm-12	122	5	cits	cit	NOUN
bptjm-12	122	6	in	in	ADP
bptjm-12	122	7	hippocampal	hippocampal	ADJ
bptjm-12	122	8	ltp	ltp	PROPN
bptjm-12	122	9	in	in	ADP
bptjm-12	122	10	a	a	DET
bptjm-12	122	11	model	model	NOUN
bptjm-12	122	12	of	of	ADP
bptjm-12	122	13	alzheimer	alzheimer	PROPN
bptjm-12	122	14	’s	’s	PART
bptjm-12	122	15	disease	disease	NOUN
bptjm-12	122	16	.	.	PUNCT
bptjm-12	123	1	(	(	PUNCT
bptjm-12	123	2	n.d	n.d	PROPN
bptjm-12	123	3	.	.	PROPN
bptjm-12	123	4	)	)	PUNCT
bptjm-12	123	5	.	.	PUNCT
bptjm-12	124	1	neurochemicalresearch	neurochemicalresearch	PROPN
bptjm-12	124	2	.	.	PUNCT
bptjm-12	125	1	https://link.springer.com/article/10.1007/s11064-018-2513-z	https://link.springer.com/article/10.1007/s11064-018-2513-z	PROPN
bptjm-12	125	2	synaptic	synaptic	ADJ
bptjm-12	125	3	plasticity	plasticity	NOUN
bptjm-12	125	4	can	can	AUX
bptjm-12	125	5	be	be	AUX
bptjm-12	125	6	modulated	modulate	VERB
bptjm-12	125	7	through	through	ADP
bptjm-12	125	8	the	the	DET
bptjm-12	125	9	interaction	interaction	NOUN
bptjm-12	125	10	between	between	ADP
bptjm-12	125	11	cbd	cbd	NOUN
bptjm-12	125	12	and	and	CCONJ
bptjm-12	125	13	the	the	DET
bptjm-12	125	14	endocannabinoid	endocannabinoid	NOUN
bptjm-12	125	15	system	system	NOUN
bptjm-12	125	16	.	.	PUNCT
bptjm-12	126	1	while	while	SCONJ
bptjm-12	126	2	the	the	DET
bptjm-12	126	3	exact	exact	ADJ
bptjm-12	126	4	mechanism	mechanism	NOUN
bptjm-12	126	5	must	must	AUX
bptjm-12	126	6	still	still	ADV
bptjm-12	126	7	be	be	AUX
bptjm-12	126	8	elucidated	elucidate	VERB
bptjm-12	126	9	,	,	PUNCT
bptjm-12	126	10	it	it	PRON
bptjm-12	126	11	is	be	AUX
bptjm-12	126	12	clear	clear	ADJ
bptjm-12	126	13	that	that	SCONJ
bptjm-12	126	14	cbd	cbd	NOUN
bptjm-12	126	15	in	in	ADP
bptjm-12	126	16	�	�	NOUN
bptjm-12	126	17	uences	uence	NOUN
bptjm-12	126	18	and	and	CCONJ
bptjm-12	126	19	interacts	interact	VERB
bptjm-12	126	20	with	with	ADP
bptjm-12	126	21	endocannabinoid	endocannabinoid	ADJ
bptjm-12	126	22	receptors	receptor	NOUN
bptjm-12	126	23	.	.	PUNCT
bptjm-12	127	1	various	various	ADJ
bptjm-12	127	2	studies	study	NOUN
bptjm-12	127	3	have	have	AUX
bptjm-12	127	4	arrived	arrive	VERB
bptjm-12	127	5	at	at	ADP
bptjm-12	127	6	di	di	PROPN
bptjm-12	127	7	�	�	PROPN
bptjm-12	127	8	erent	erent	NOUN
bptjm-12	127	9	conclusions	conclusion	NOUN
bptjm-12	127	10	on	on	ADP
bptjm-12	127	11	the	the	DET
bptjm-12	127	12	actions	action	NOUN
bptjm-12	127	13	of	of	ADP
bptjm-12	127	14	cbd	cbd	NOUN
bptjm-12	127	15	,	,	PUNCT
bptjm-12	127	16	some	some	PRON
bptjm-12	127	17	stating	state	VERB
bptjm-12	127	18	that	that	SCONJ
bptjm-12	127	19	there	there	PRON
bptjm-12	127	20	is	be	VERB
bptjm-12	127	21	no	no	DET
bptjm-12	127	22	a	a	DET
bptjm-12	127	23	�	�	NOUN
bptjm-12	127	24	nity	nity	NOUN
bptjm-12	127	25	between	between	ADP
bptjm-12	127	26	cbd	cbd	NOUN
bptjm-12	127	27	and	and	CCONJ
bptjm-12	127	28	the	the	DET
bptjm-12	127	29	cb1	cb1	PROPN
bptjm-12	127	30	/	/	SYM
bptjm-12	127	31	cb2	cb2	NOUN
bptjm-12	127	32	receptors	receptor	NOUN
bptjm-12	127	33	(	(	PUNCT
bptjm-12	127	34	mcpartland	mcpartland	NOUN
bptjm-12	127	35	,	,	PUNCT
bptjm-12	127	36	2007	2007	NUM
bptjm-12	127	37	)	)	PUNCT
bptjm-12	127	38	.	.	PUNCT
bptjm-12	128	1	others	other	NOUN
bptjm-12	128	2	state	state	PROPN
bptjm-12	128	3	cbd	cbd	PROPN
bptjm-12	128	4	binds	bind	VERB
bptjm-12	128	5	as	as	ADP
bptjm-12	128	6	a	a	DET
bptjm-12	128	7	weak	weak	ADJ
bptjm-12	128	8	antagonist	antagonist	NOUN
bptjm-12	128	9	(	(	PUNCT
bptjm-12	128	10	thomas	thomas	PROPN
bptjm-12	128	11	,	,	PUNCT
bptjm-12	128	12	2007	2007	NUM
bptjm-12	128	13	)	)	PUNCT
bptjm-12	128	14	,	,	PUNCT
bptjm-12	128	15	and	and	CCONJ
bptjm-12	128	16	yet	yet	ADV
bptjm-12	128	17	more	more	ADV
bptjm-12	128	18	that	that	PRON
bptjm-12	128	19	claim	claim	VERB
bptjm-12	128	20	cbd	cbd	NOUN
bptjm-12	128	21	functions	function	NOUN
bptjm-12	128	22	as	as	ADP
bptjm-12	128	23	a	a	DET
bptjm-12	128	24	negative	negative	ADJ
bptjm-12	128	25	allosteric	allosteric	ADJ
bptjm-12	128	26	modulator	modulator	NOUN
bptjm-12	128	27	for	for	ADP
bptjm-12	128	28	the	the	DET
bptjm-12	128	29	endocannabinoids	endocannabinoid	NOUN
bptjm-12	128	30	2	2	NUM
bptjm-12	128	31	-	-	PUNCT
bptjm-12	128	32	ag	ag	PROPN
bptjm-12	128	33	and	and	CCONJ
bptjm-12	128	34	delta-9	delta-9	PROPN
bptjm-12	128	35	-	-	PUNCT
bptjm-12	128	36	thc	thc	NOUN
bptjm-12	128	37	(	(	PUNCT
bptjm-12	128	38	hughes	hughe	NOUN
bptjm-12	128	39	et	et	PROPN
bptjm-12	128	40	al	al	PROPN
bptjm-12	128	41	.	.	PROPN
bptjm-12	128	42	,	,	PUNCT
bptjm-12	128	43	2019	2019	NUM
bptjm-12	128	44	)	)	PUNCT
bptjm-12	128	45	.	.	PUNCT
bptjm-12	129	1	cbd	cbd	NOUN
bptjm-12	129	2	enhances	enhance	VERB
bptjm-12	129	3	neuroprotection	neuroprotection	NOUN
bptjm-12	129	4	by	by	ADP
bptjm-12	129	5	di	di	NOUN
bptjm-12	129	6	�	�	PROPN
bptjm-12	129	7	erent	erent	NOUN
bptjm-12	129	8	signal	signal	NOUN
bptjm-12	129	9	transduction	transduction	NOUN
bptjm-12	129	10	pathways	pathway	NOUN
bptjm-12	129	11	that	that	PRON
bptjm-12	129	12	are	be	AUX
bptjm-12	129	13	controlled	control	VERB
bptjm-12	129	14	indirectly	indirectly	ADV
bptjm-12	129	15	by	by	ADP
bptjm-12	129	16	cannabinoid	cannabinoid	NOUN
bptjm-12	129	17	receptors	receptor	NOUN
bptjm-12	129	18	(	(	PUNCT
bptjm-12	129	19	li	li	PROPN
bptjm-12	129	20	et	et	PROPN
bptjm-12	129	21	al	al	PROPN
bptjm-12	129	22	.	.	PROPN
bptjm-12	129	23	,	,	PUNCT
bptjm-12	129	24	2020	2020	NUM
bptjm-12	129	25	)	)	PUNCT
bptjm-12	129	26	.	.	PUNCT
bptjm-12	130	1	similarly	similarly	ADV
bptjm-12	130	2	,	,	PUNCT
bptjm-12	130	3	cbd	cbd	NOUN
bptjm-12	130	4	treatment	treatment	NOUN
bptjm-12	130	5	enhanced	enhance	VERB
bptjm-12	130	6	synaptic	synaptic	ADJ
bptjm-12	130	7	transmission	transmission	NOUN
bptjm-12	130	8	in	in	ADP
bptjm-12	130	9	mouse	mouse	NOUN
bptjm-12	130	10	models	model	NOUN
bptjm-12	130	11	,	,	PUNCT
bptjm-12	130	12	most	most	ADV
bptjm-12	130	13	likely	likely	ADV
bptjm-12	130	14	acting	act	VERB
bptjm-12	130	15	in	in	ADP
bptjm-12	130	16	conjunction	conjunction	NOUN
bptjm-12	130	17	with	with	ADP
bptjm-12	130	18	cb1	cb1	PROPN
bptjm-12	130	19	and	and	CCONJ
bptjm-12	130	20	cb2	cb2	PROPN
bptjm-12	130	21	receptors	receptor	NOUN
bptjm-12	130	22	to	to	PART
bptjm-12	130	23	decrease	decrease	VERB
bptjm-12	130	24	neurotoxicity	neurotoxicity	NOUN
bptjm-12	130	25	and	and	CCONJ
bptjm-12	130	26	cell	cell	NOUN
bptjm-12	130	27	death	death	NOUN
bptjm-12	130	28	that	that	PRON
bptjm-12	130	29	was	be	AUX
bptjm-12	130	30	the	the	DET
bptjm-12	130	31	result	result	NOUN
bptjm-12	130	32	of	of	ADP
bptjm-12	130	33	aβ	aβ	DET
bptjm-12	130	34	deposits	deposit	NOUN
bptjm-12	130	35	.	.	PUNCT
bptjm-12	131	1	cbd	cbd	PROPN
bptjm-12	131	2	has	have	AUX
bptjm-12	131	3	shown	show	VERB
bptjm-12	131	4	its	its	PRON
bptjm-12	131	5	capability	capability	NOUN
bptjm-12	131	6	in	in	ADP
bptjm-12	131	7	reversing	reverse	VERB
bptjm-12	131	8	and	and	CCONJ
bptjm-12	131	9	preventing	prevent	VERB
bptjm-12	131	10	cognitive	cognitive	ADJ
bptjm-12	131	11	damage	damage	NOUN
bptjm-12	131	12	due	due	ADP
bptjm-12	131	13	to	to	ADP
bptjm-12	131	14	ad	ad	NOUN
bptjm-12	131	15	(	(	PUNCT
bptjm-12	131	16	watt	watt	NOUN
bptjm-12	131	17	et	et	PROPN
bptjm-12	131	18	al	al	PROPN
bptjm-12	131	19	.	.	PROPN
bptjm-12	131	20	,	,	PUNCT
bptjm-12	131	21	2017	2017	NUM
bptjm-12	131	22	)	)	PUNCT
bptjm-12	131	23	and	and	CCONJ
bptjm-12	131	24	precluding	preclude	VERB
bptjm-12	131	25	the	the	DET
bptjm-12	131	26	suppression	suppression	NOUN
bptjm-12	131	27	of	of	ADP
bptjm-12	131	28	long	long	ADJ
bptjm-12	131	29	-	-	PUNCT
bptjm-12	131	30	term	term	NOUN
bptjm-12	131	31	berkeley	berkeley	PROPN
bptjm-12	131	32	pharma	pharma	PROPN
bptjm-12	131	33	tech	tech	NOUN
bptjm-12	131	34	journal	journal	NOUN
bptjm-12	131	35	of	of	ADP
bptjm-12	131	36	medicine	medicine	NOUN
bptjm-12	131	37	|	|	ADV
bptjm-12	131	38	10	10	NUM
bptjm-12	131	39	https://link.springer.com/article/10.1007/s11064-018-2513-z	https://link.springer.com/article/10.1007/s11064-018-2513-z	NOUN
bptjm-12	131	40	potentiation	potentiation	NOUN
bptjm-12	131	41	(	(	PUNCT
bptjm-12	131	42	hughes	hughe	NOUN
bptjm-12	131	43	et	et	PROPN
bptjm-12	131	44	al	al	PROPN
bptjm-12	131	45	.	.	PROPN
bptjm-12	131	46	,	,	PUNCT
bptjm-12	131	47	2019	2019	NUM
bptjm-12	131	48	)	)	PUNCT
bptjm-12	131	49	.	.	PUNCT
bptjm-12	132	1	therefore	therefore	ADV
bptjm-12	132	2	,	,	PUNCT
bptjm-12	132	3	modulation	modulation	NOUN
bptjm-12	132	4	of	of	ADP
bptjm-12	132	5	the	the	DET
bptjm-12	132	6	agonists	agonist	NOUN
bptjm-12	132	7	and	and	CCONJ
bptjm-12	132	8	antagonists	antagonist	NOUN
bptjm-12	132	9	which	which	PRON
bptjm-12	132	10	bind	bind	VERB
bptjm-12	132	11	to	to	ADP
bptjm-12	132	12	cb1	cb1	PROPN
bptjm-12	132	13	and	and	CCONJ
bptjm-12	132	14	cb2	cb2	PROPN
bptjm-12	132	15	receptors	receptor	NOUN
bptjm-12	132	16	,	,	PUNCT
bptjm-12	132	17	such	such	ADJ
bptjm-12	132	18	as	as	ADP
bptjm-12	132	19	cbd	cbd	NOUN
bptjm-12	132	20	,	,	PUNCT
bptjm-12	132	21	has	have	VERB
bptjm-12	132	22	an	an	DET
bptjm-12	132	23	e	e	NOUN
bptjm-12	132	24	�	�	NOUN
bptjm-12	132	25	ect	ect	X
bptjm-12	132	26	on	on	ADP
bptjm-12	132	27	synaptic	synaptic	ADJ
bptjm-12	132	28	plasticity	plasticity	NOUN
bptjm-12	132	29	in	in	ADP
bptjm-12	132	30	the	the	DET
bptjm-12	132	31	brain	brain	NOUN
bptjm-12	132	32	.	.	PUNCT
bptjm-12	133	1	ad	ad	NOUN
bptjm-12	133	2	-	-	PUNCT
bptjm-12	133	3	induced	induce	VERB
bptjm-12	133	4	dysfunction	dysfunction	NOUN
bptjm-12	133	5	of	of	ADP
bptjm-12	133	6	the	the	DET
bptjm-12	133	7	endocannabinoid	endocannabinoid	NOUN
bptjm-12	133	8	receptors	receptor	NOUN
bptjm-12	133	9	negatively	negatively	ADV
bptjm-12	133	10	in	in	ADP
bptjm-12	133	11	�	�	NOUN
bptjm-12	133	12	uences	uence	NOUN
bptjm-12	133	13	synaptic	synaptic	ADJ
bptjm-12	133	14	plasticity	plasticity	NOUN
bptjm-12	133	15	.	.	PUNCT
bptjm-12	134	1	fig	fig	NOUN
bptjm-12	134	2	.	.	PUNCT
bptjm-12	135	1	5	5	NUM
bptjm-12	135	2	:	:	PUNCT
bptjm-12	135	3	illustration	illustration	NOUN
bptjm-12	135	4	of	of	ADP
bptjm-12	135	5	synaptic	synaptic	ADJ
bptjm-12	135	6	plasticity	plasticity	NOUN
bptjm-12	135	7	and	and	CCONJ
bptjm-12	135	8	long	long	ADJ
bptjm-12	135	9	-	-	PUNCT
bptjm-12	135	10	term	term	NOUN
bptjm-12	135	11	potentiation	potentiation	NOUN
bptjm-12	135	12	.	.	PUNCT
bptjm-12	136	1	after	after	ADP
bptjm-12	136	2	repeated	repeat	VERB
bptjm-12	136	3	simulation	simulation	NOUN
bptjm-12	136	4	and	and	CCONJ
bptjm-12	136	5	long	long	ADJ
bptjm-12	136	6	-	-	PUNCT
bptjm-12	136	7	term	term	NOUN
bptjm-12	136	8	potentiation	potentiation	NOUN
bptjm-12	136	9	,	,	PUNCT
bptjm-12	136	10	there	there	PRON
bptjm-12	136	11	is	be	VERB
bptjm-12	136	12	an	an	DET
bptjm-12	136	13	increase	increase	NOUN
bptjm-12	136	14	in	in	ADP
bptjm-12	136	15	the	the	DET
bptjm-12	136	16	number	number	NOUN
bptjm-12	136	17	of	of	ADP
bptjm-12	136	18	neurotransmitters	neurotransmitter	NOUN
bptjm-12	136	19	in	in	ADP
bptjm-12	136	20	the	the	DET
bptjm-12	136	21	presynaptic	presynaptic	ADJ
bptjm-12	136	22	neuron	neuron	NOUN
bptjm-12	136	23	and	and	CCONJ
bptjm-12	136	24	an	an	DET
bptjm-12	136	25	increase	increase	NOUN
bptjm-12	136	26	in	in	ADP
bptjm-12	136	27	the	the	DET
bptjm-12	136	28	number	number	NOUN
bptjm-12	136	29	of	of	ADP
bptjm-12	136	30	receptors	receptor	NOUN
bptjm-12	136	31	in	in	ADP
bptjm-12	136	32	the	the	DET
bptjm-12	136	33	postsynaptic	postsynaptic	ADJ
bptjm-12	136	34	neuron	neuron	NOUN
bptjm-12	136	35	.	.	PUNCT
bptjm-12	137	1	this	this	PRON
bptjm-12	137	2	results	result	VERB
bptjm-12	137	3	in	in	ADP
bptjm-12	137	4	a	a	DET
bptjm-12	137	5	stronger	strong	ADJ
bptjm-12	137	6	response	response	NOUN
bptjm-12	137	7	.	.	PUNCT
bptjm-12	138	1	pathology	pathology	NOUN
bptjm-12	138	2	of	of	ADP
bptjm-12	138	3	the	the	DET
bptjm-12	138	4	cholinergic	cholinergic	ADJ
bptjm-12	138	5	system	system	NOUN
bptjm-12	138	6	is	be	AUX
bptjm-12	138	7	also	also	ADV
bptjm-12	138	8	associated	associate	VERB
bptjm-12	138	9	with	with	ADP
bptjm-12	138	10	ad	ad	NOUN
bptjm-12	138	11	.	.	PUNCT
bptjm-12	139	1	many	many	ADJ
bptjm-12	139	2	cholinergic	cholinergic	ADJ
bptjm-12	139	3	pathways	pathway	NOUN
bptjm-12	139	4	are	be	AUX
bptjm-12	139	5	commonly	commonly	ADV
bptjm-12	139	6	found	find	VERB
bptjm-12	139	7	to	to	PART
bptjm-12	139	8	be	be	AUX
bptjm-12	139	9	damaged	damage	VERB
bptjm-12	139	10	or	or	CCONJ
bptjm-12	139	11	dysfunctional	dysfunctional	ADJ
bptjm-12	139	12	in	in	ADP
bptjm-12	139	13	those	those	PRON
bptjm-12	139	14	who	who	PRON
bptjm-12	139	15	su	su	PROPN
bptjm-12	139	16	�	�	PROPN
bptjm-12	139	17	er	er	NOUN
bptjm-12	139	18	from	from	ADP
bptjm-12	139	19	ad	ad	NOUN
bptjm-12	139	20	,	,	PUNCT
bptjm-12	139	21	impairing	impair	VERB
bptjm-12	139	22	synaptic	synaptic	ADJ
bptjm-12	139	23	plasticity	plasticity	NOUN
bptjm-12	139	24	.	.	PUNCT
bptjm-12	140	1	ad	ad	NOUN
bptjm-12	140	2	has	have	AUX
bptjm-12	140	3	been	be	AUX
bptjm-12	140	4	correlated	correlate	VERB
bptjm-12	140	5	with	with	ADP
bptjm-12	140	6	decreased	decrease	VERB
bptjm-12	140	7	cholinergic	cholinergic	ADJ
bptjm-12	140	8	transmission	transmission	NOUN
bptjm-12	140	9	,	,	PUNCT
bptjm-12	140	10	especially	especially	ADV
bptjm-12	140	11	in	in	ADP
bptjm-12	140	12	the	the	DET
bptjm-12	140	13	hippocampus	hippocampus	NOUN
bptjm-12	140	14	where	where	SCONJ
bptjm-12	140	15	new	new	ADJ
bptjm-12	140	16	memories	memory	NOUN
bptjm-12	140	17	are	be	AUX
bptjm-12	140	18	formed	form	VERB
bptjm-12	140	19	.	.	PUNCT
bptjm-12	141	1	studies	study	NOUN
bptjm-12	141	2	have	have	AUX
bptjm-12	141	3	found	find	VERB
bptjm-12	141	4	‘	'	PUNCT
bptjm-12	141	5	crosstalk	crosstalk	NOUN
bptjm-12	141	6	’	'	PUNCT
bptjm-12	141	7	—	—	PUNCT
bptjm-12	141	8	signals	signal	NOUN
bptjm-12	141	9	within	within	ADP
bptjm-12	141	10	one	one	NUM
bptjm-12	141	11	system	system	NOUN
bptjm-12	141	12	that	that	PRON
bptjm-12	141	13	produce	produce	VERB
bptjm-12	141	14	changes	change	NOUN
bptjm-12	141	15	in	in	ADP
bptjm-12	141	16	another	another	DET
bptjm-12	141	17	system	system	NOUN
bptjm-12	141	18	—	—	PUNCT
bptjm-12	141	19	between	between	ADP
bptjm-12	141	20	the	the	DET
bptjm-12	141	21	cholinergic	cholinergic	NOUN
bptjm-12	141	22	signaling	signaling	NOUN
bptjm-12	141	23	and	and	CCONJ
bptjm-12	141	24	the	the	DET
bptjm-12	141	25	endocannabinoid	endocannabinoid	NOUN
bptjm-12	141	26	signaling	signal	VERB
bptjm-12	141	27	systems	system	NOUN
bptjm-12	141	28	(	(	PUNCT
bptjm-12	141	29	thompson	thompson	PROPN
bptjm-12	141	30	et	et	PROPN
bptjm-12	141	31	al	al	PROPN
bptjm-12	141	32	.	.	PROPN
bptjm-12	141	33	,	,	PUNCT
bptjm-12	141	34	2020	2020	NUM
bptjm-12	141	35	)	)	PUNCT
bptjm-12	141	36	.	.	PUNCT
bptjm-12	142	1	past	past	ADP
bptjm-12	142	2	studies	study	NOUN
bptjm-12	142	3	speci	speci	PROPN
bptjm-12	142	4	�	�	PROPN
bptjm-12	142	5	cally	cally	ADV
bptjm-12	142	6	investigated	investigate	VERB
bptjm-12	142	7	this	this	DET
bptjm-12	142	8	communication	communication	NOUN
bptjm-12	142	9	between	between	ADP
bptjm-12	142	10	the	the	DET
bptjm-12	142	11	systems	system	NOUN
bptjm-12	142	12	in	in	ADP
bptjm-12	142	13	ad	ad	NOUN
bptjm-12	142	14	.	.	PUNCT
bptjm-12	143	1	this	this	DET
bptjm-12	143	2	research	research	NOUN
bptjm-12	143	3	found	find	VERB
bptjm-12	143	4	that	that	SCONJ
bptjm-12	143	5	α-7	α-7	NOUN
bptjm-12	143	6	nachr	nachr	PROPN
bptjm-12	143	7	are	be	AUX
bptjm-12	143	8	of	of	ADP
bptjm-12	143	9	particular	particular	ADJ
bptjm-12	143	10	concern	concern	NOUN
bptjm-12	143	11	because	because	SCONJ
bptjm-12	143	12	they	they	PRON
bptjm-12	143	13	are	be	AUX
bptjm-12	143	14	highly	highly	ADV
bptjm-12	143	15	expressed	express	VERB
bptjm-12	143	16	in	in	ADP
bptjm-12	143	17	the	the	DET
bptjm-12	143	18	hippocampus	hippocampus	NOUN
bptjm-12	143	19	and	and	CCONJ
bptjm-12	143	20	play	play	VERB
bptjm-12	143	21	a	a	DET
bptjm-12	143	22	signi	signi	ADJ
bptjm-12	143	23	�	�	NOUN
bptjm-12	143	24	cant	cant	NOUN
bptjm-12	143	25	role	role	NOUN
bptjm-12	143	26	in	in	ADP
bptjm-12	143	27	the	the	DET
bptjm-12	143	28	development	development	NOUN
bptjm-12	143	29	of	of	ADP
bptjm-12	143	30	memory	memory	NOUN
bptjm-12	143	31	and	and	CCONJ
bptjm-12	143	32	learning	learn	VERB
bptjm-12	143	33	abilities	ability	NOUN
bptjm-12	143	34	(	(	PUNCT
bptjm-12	143	35	thompson	thompson	PROPN
bptjm-12	143	36	et	et	PROPN
bptjm-12	143	37	al	al	PROPN
bptjm-12	143	38	.	.	PROPN
bptjm-12	143	39	,	,	PUNCT
bptjm-12	143	40	2020	2020	NUM
bptjm-12	143	41	)	)	PUNCT
bptjm-12	143	42	.	.	PUNCT
bptjm-12	144	1	elevated	elevated	ADJ
bptjm-12	144	2	levels	level	NOUN
bptjm-12	144	3	of	of	ADP
bptjm-12	144	4	α-7	α-7	NOUN
bptjm-12	144	5	nachr	nachr	PROPN
bptjm-12	144	6	have	have	AUX
bptjm-12	144	7	been	be	AUX
bptjm-12	144	8	found	find	VERB
bptjm-12	144	9	to	to	PART
bptjm-12	144	10	disrupt	disrupt	VERB
bptjm-12	144	11	normal	normal	ADJ
bptjm-12	144	12	signaling	signaling	ADJ
bptjm-12	144	13	and	and	CCONJ
bptjm-12	144	14	negatively	negatively	ADV
bptjm-12	144	15	impact	impact	VERB
bptjm-12	144	16	synaptic	synaptic	ADJ
bptjm-12	144	17	plasticity	plasticity	NOUN
bptjm-12	144	18	(	(	PUNCT
bptjm-12	144	19	thompson	thompson	PROPN
bptjm-12	144	20	et	et	PROPN
bptjm-12	144	21	al	al	PROPN
bptjm-12	144	22	.	.	PROPN
bptjm-12	144	23	,	,	PUNCT
bptjm-12	144	24	2020	2020	NUM
bptjm-12	144	25	)	)	PUNCT
bptjm-12	144	26	.	.	PUNCT
bptjm-12	145	1	interestingly	interestingly	ADV
bptjm-12	145	2	,	,	PUNCT
bptjm-12	145	3	aβ	aβ	DET
bptjm-12	145	4	deposition	deposition	NOUN
bptjm-12	145	5	also	also	ADV
bptjm-12	145	6	seems	seem	VERB
bptjm-12	145	7	to	to	PART
bptjm-12	145	8	increase	increase	VERB
bptjm-12	145	9	in	in	ADP
bptjm-12	145	10	α-7	α-7	NOUN
bptjm-12	145	11	nachr	nachr	PROPN
bptjm-12	145	12	rich	rich	ADJ
bptjm-12	145	13	regions	region	NOUN
bptjm-12	145	14	(	(	PUNCT
bptjm-12	145	15	thompson	thompson	PROPN
bptjm-12	145	16	et	et	PROPN
bptjm-12	145	17	al	al	PROPN
bptjm-12	145	18	.	.	PROPN
bptjm-12	145	19	,	,	PUNCT
bptjm-12	145	20	2020	2020	NUM
bptjm-12	145	21	)	)	PUNCT
bptjm-12	145	22	.	.	PUNCT
bptjm-12	146	1	while	while	SCONJ
bptjm-12	146	2	their	their	PRON
bptjm-12	146	3	research	research	NOUN
bptjm-12	146	4	did	do	AUX
bptjm-12	146	5	not	not	PART
bptjm-12	146	6	corroborate	corroborate	VERB
bptjm-12	146	7	a	a	DET
bptjm-12	146	8	de	de	X
bptjm-12	146	9	�	�	NOUN
bptjm-12	146	10	nite	nite	ADJ
bptjm-12	146	11	‘	'	PUNCT
bptjm-12	146	12	cross	cross	NOUN
bptjm-12	146	13	-	-	ADJ
bptjm-12	146	14	talk	talk	NOUN
bptjm-12	146	15	’	'	PUNCT
bptjm-12	146	16	between	between	ADP
bptjm-12	146	17	the	the	DET
bptjm-12	146	18	ecs	ecs	PROPN
bptjm-12	146	19	and	and	CCONJ
bptjm-12	146	20	α-7	α-7	PROPN
bptjm-12	146	21	nachr	nachr	PROPN
bptjm-12	146	22	speci	speci	PROPN
bptjm-12	146	23	�	�	PROPN
bptjm-12	146	24	cally	cally	ADV
bptjm-12	146	25	,	,	PUNCT
bptjm-12	146	26	they	they	PRON
bptjm-12	146	27	did	do	VERB
bptjm-12	146	28	�	�	PROPN
bptjm-12	146	29	nd	nd	PROPN
bptjm-12	146	30	that	that	SCONJ
bptjm-12	146	31	α-5	α-5	PROPN
bptjm-12	146	32	nachr	nachr	PROPN
bptjm-12	146	33	and	and	CCONJ
bptjm-12	146	34	α-6	α-6	PROPN
bptjm-12	146	35	nachr	nachr	PROPN
bptjm-12	146	36	correlated	correlate	VERB
bptjm-12	146	37	to	to	ADP
bptjm-12	146	38	thc	thc	NOUN
bptjm-12	146	39	addiction	addiction	NOUN
bptjm-12	146	40	and	and	CCONJ
bptjm-12	146	41	withdrawal	withdrawal	NOUN
bptjm-12	146	42	(	(	PUNCT
bptjm-12	146	43	thompson	thompson	PROPN
bptjm-12	146	44	et	et	PROPN
bptjm-12	146	45	al	al	PROPN
bptjm-12	146	46	.	.	PROPN
bptjm-12	146	47	,	,	PUNCT
bptjm-12	146	48	2020	2020	NUM
bptjm-12	146	49	)	)	PUNCT
bptjm-12	146	50	,	,	PUNCT
bptjm-12	146	51	which	which	PRON
bptjm-12	146	52	are	be	AUX
bptjm-12	146	53	known	know	VERB
bptjm-12	146	54	to	to	PART
bptjm-12	146	55	involve	involve	VERB
bptjm-12	146	56	the	the	DET
bptjm-12	146	57	pathways	pathway	NOUN
bptjm-12	146	58	of	of	ADP
bptjm-12	146	59	the	the	DET
bptjm-12	146	60	berkeley	berkeley	PROPN
bptjm-12	146	61	pharma	pharma	PROPN
bptjm-12	146	62	tech	tech	NOUN
bptjm-12	146	63	journal	journal	NOUN
bptjm-12	146	64	of	of	ADP
bptjm-12	146	65	medicine	medicine	NOUN
bptjm-12	146	66	|	|	ADV
bptjm-12	146	67	11	11	NUM
bptjm-12	146	68	ecs	ec	NOUN
bptjm-12	146	69	.	.	PUNCT
bptjm-12	147	1	the	the	DET
bptjm-12	147	2	researchers	researcher	NOUN
bptjm-12	147	3	concluded	conclude	VERB
bptjm-12	147	4	that	that	SCONJ
bptjm-12	147	5	the	the	DET
bptjm-12	147	6	ecs	ecs	PROPN
bptjm-12	147	7	seemingly	seemingly	ADV
bptjm-12	147	8	plays	play	VERB
bptjm-12	147	9	a	a	DET
bptjm-12	147	10	role	role	NOUN
bptjm-12	147	11	in	in	ADP
bptjm-12	147	12	cholinergic	cholinergic	ADJ
bptjm-12	147	13	signaling	signaling	NOUN
bptjm-12	147	14	,	,	PUNCT
bptjm-12	147	15	although	although	SCONJ
bptjm-12	147	16	not	not	PART
bptjm-12	147	17	speci	speci	VERB
bptjm-12	147	18	�	�	PROPN
bptjm-12	147	19	c	c	NOUN
bptjm-12	147	20	to	to	ADP
bptjm-12	147	21	the	the	DET
bptjm-12	147	22	α-7	α-7	NOUN
bptjm-12	147	23	nachr.this	nachr.this	PRON
bptjm-12	147	24	research	research	NOUN
bptjm-12	147	25	suggests	suggest	VERB
bptjm-12	147	26	that	that	SCONJ
bptjm-12	147	27	indirect	indirect	ADJ
bptjm-12	147	28	crosstalk	crosstalk	NOUN
bptjm-12	147	29	between	between	ADP
bptjm-12	147	30	the	the	DET
bptjm-12	147	31	endocannabinoid	endocannabinoid	NOUN
bptjm-12	147	32	and	and	CCONJ
bptjm-12	147	33	cholinergic	cholinergic	ADJ
bptjm-12	147	34	systems	system	NOUN
bptjm-12	147	35	and	and	CCONJ
bptjm-12	147	36	its	its	PRON
bptjm-12	147	37	modulation	modulation	NOUN
bptjm-12	147	38	may	may	AUX
bptjm-12	147	39	be	be	AUX
bptjm-12	147	40	a	a	DET
bptjm-12	147	41	way	way	NOUN
bptjm-12	147	42	to	to	PART
bptjm-12	147	43	improve	improve	VERB
bptjm-12	147	44	cholinergic	cholinergic	ADJ
bptjm-12	147	45	signaling	signal	VERB
bptjm-12	147	46	and	and	CCONJ
bptjm-12	147	47	repair	repair	VERB
bptjm-12	147	48	synaptic	synaptic	ADJ
bptjm-12	147	49	plasticity	plasticity	NOUN
bptjm-12	147	50	that	that	PRON
bptjm-12	147	51	is	be	AUX
bptjm-12	147	52	damaged	damage	VERB
bptjm-12	147	53	as	as	ADP
bptjm-12	147	54	a	a	DET
bptjm-12	147	55	result	result	NOUN
bptjm-12	147	56	of	of	ADP
bptjm-12	147	57	ad	ad	NOUN
bptjm-12	147	58	(	(	PUNCT
bptjm-12	147	59	thompson	thompson	PROPN
bptjm-12	147	60	et	et	PROPN
bptjm-12	147	61	al	al	PROPN
bptjm-12	147	62	.	.	PROPN
bptjm-12	147	63	,	,	PUNCT
bptjm-12	147	64	2020	2020	NUM
bptjm-12	147	65	)	)	PUNCT
bptjm-12	147	66	.	.	PUNCT
bptjm-12	148	1	iii	iii	X
bptjm-12	148	2	.	.	PUNCT
bptjm-12	149	1	receptor	receptor	NOUN
bptjm-12	149	2	agonists	agonist	NOUN
bptjm-12	149	3	a.	a.	NOUN
bptjm-12	149	4	inhibitory	inhibitory	ADJ
bptjm-12	149	5	activity	activity	NOUN
bptjm-12	149	6	by	by	ADP
bptjm-12	149	7	receptor	receptor	NOUN
bptjm-12	149	8	agonists	agonist	NOUN
bptjm-12	149	9	many	many	ADJ
bptjm-12	149	10	studies	study	NOUN
bptjm-12	149	11	have	have	AUX
bptjm-12	149	12	investigated	investigate	VERB
bptjm-12	149	13	the	the	DET
bptjm-12	149	14	variety	variety	NOUN
bptjm-12	149	15	of	of	ADP
bptjm-12	149	16	proposed	propose	VERB
bptjm-12	149	17	therapeutic	therapeutic	ADJ
bptjm-12	149	18	treatments	treatment	NOUN
bptjm-12	149	19	mediated	mediate	VERB
bptjm-12	149	20	by	by	ADP
bptjm-12	149	21	endocannabinoid	endocannabinoid	ADJ
bptjm-12	149	22	receptor	receptor	NOUN
bptjm-12	149	23	agonists	agonist	NOUN
bptjm-12	149	24	,	,	PUNCT
bptjm-12	149	25	speci	speci	PROPN
bptjm-12	149	26	�	�	VERB
bptjm-12	149	27	cally	cally	ADV
bptjm-12	149	28	the	the	DET
bptjm-12	149	29	inhibitory	inhibitory	ADJ
bptjm-12	149	30	activity	activity	NOUN
bptjm-12	149	31	of	of	ADP
bptjm-12	149	32	receptor	receptor	NOUN
bptjm-12	149	33	agonists	agonist	NOUN
bptjm-12	149	34	in	in	ADP
bptjm-12	149	35	alzheimer	alzheimer	PROPN
bptjm-12	149	36	’s	’s	PART
bptjm-12	149	37	disease	disease	NOUN
bptjm-12	149	38	.	.	PUNCT
bptjm-12	150	1	one	one	NUM
bptjm-12	150	2	of	of	ADP
bptjm-12	150	3	the	the	DET
bptjm-12	150	4	primary	primary	ADJ
bptjm-12	150	5	focuses	focus	NOUN
bptjm-12	150	6	of	of	ADP
bptjm-12	150	7	cannabinoid	cannabinoid	NOUN
bptjm-12	150	8	receptor	receptor	NOUN
bptjm-12	150	9	agonists	agonist	NOUN
bptjm-12	150	10	is	be	AUX
bptjm-12	150	11	their	their	PRON
bptjm-12	150	12	ability	ability	NOUN
bptjm-12	150	13	to	to	PART
bptjm-12	150	14	inhibit	inhibit	VERB
bptjm-12	150	15	neuroin	neuroin	PROPN
bptjm-12	150	16	�	�	PROPN
bptjm-12	150	17	ammation	ammation	NOUN
bptjm-12	150	18	,	,	PUNCT
bptjm-12	150	19	a	a	DET
bptjm-12	150	20	speci	speci	ADJ
bptjm-12	150	21	�	�	PROPN
bptjm-12	150	22	c	c	NOUN
bptjm-12	150	23	characteristic	characteristic	NOUN
bptjm-12	150	24	signaled	signal	VERB
bptjm-12	150	25	by	by	ADP
bptjm-12	150	26	the	the	DET
bptjm-12	150	27	dysfunction	dysfunction	NOUN
bptjm-12	150	28	of	of	ADP
bptjm-12	150	29	microglia	microglia	NOUN
bptjm-12	150	30	.	.	PUNCT
bptjm-12	151	1	cannabinoid	cannabinoid	PROPN
bptjm-12	151	2	agonists	agonist	NOUN
bptjm-12	151	3	increase	increase	VERB
bptjm-12	151	4	endocannabinoid	endocannabinoid	ADJ
bptjm-12	151	5	availability	availability	NOUN
bptjm-12	151	6	,	,	PUNCT
bptjm-12	151	7	which	which	PRON
bptjm-12	151	8	allows	allow	VERB
bptjm-12	151	9	activation	activation	NOUN
bptjm-12	151	10	of	of	ADP
bptjm-12	151	11	receptor	receptor	NOUN
bptjm-12	151	12	agonists	agonist	NOUN
bptjm-12	151	13	to	to	PART
bptjm-12	151	14	prevent	prevent	VERB
bptjm-12	151	15	aβ	aβ	NOUN
bptjm-12	151	16	-	-	PUNCT
bptjm-12	151	17	induced	induce	VERB
bptjm-12	151	18	cognitive	cognitive	ADJ
bptjm-12	151	19	de	de	PROPN
bptjm-12	151	20	�	�	PROPN
bptjm-12	151	21	cits	cit	NOUN
bptjm-12	151	22	(	(	PUNCT
bptjm-12	151	23	martín	martín	NOUN
bptjm-12	151	24	-	-	PUNCT
bptjm-12	151	25	moreno	moreno	PROPN
bptjm-12	151	26	et	et	PROPN
bptjm-12	151	27	al	al	PROPN
bptjm-12	151	28	.	.	PROPN
bptjm-12	151	29	,	,	PUNCT
bptjm-12	151	30	2011	2011	NUM
bptjm-12	151	31	)	)	PUNCT
bptjm-12	151	32	.	.	PUNCT
bptjm-12	152	1	the	the	DET
bptjm-12	152	2	synthetic	synthetic	ADJ
bptjm-12	152	3	cannabinoid	cannabinoid	NOUN
bptjm-12	152	4	,	,	PUNCT
bptjm-12	152	5	win	win	VERB
bptjm-12	152	6	5512	5512	NUM
bptjm-12	152	7	-	-	SYM
bptjm-12	152	8	2	2	NUM
bptjm-12	152	9	,	,	PUNCT
bptjm-12	152	10	inhibits	inhibit	VERB
bptjm-12	152	11	neuroin	neuroin	NOUN
bptjm-12	152	12	�	�	PROPN
bptjm-12	152	13	ammation	ammation	NOUN
bptjm-12	152	14	induced	induce	VERB
bptjm-12	152	15	by	by	ADP
bptjm-12	152	16	aβ	aβ	NOUN
bptjm-12	152	17	through	through	ADP
bptjm-12	152	18	the	the	DET
bptjm-12	152	19	cb1	cb1	NOUN
bptjm-12	152	20	and	and	CCONJ
bptjm-12	152	21	cb2	cb2	PROPN
bptjm-12	152	22	receptors	receptor	NOUN
bptjm-12	152	23	.	.	PUNCT
bptjm-12	153	1	in	in	ADP
bptjm-12	153	2	primary	primary	ADJ
bptjm-12	153	3	cultures	culture	NOUN
bptjm-12	153	4	,	,	PUNCT
bptjm-12	153	5	a	a	DET
bptjm-12	153	6	laboratory	laboratory	NOUN
bptjm-12	153	7	procedure	procedure	NOUN
bptjm-12	153	8	in	in	ADP
bptjm-12	153	9	which	which	PRON
bptjm-12	153	10	cell	cell	NOUN
bptjm-12	153	11	extracts	extract	NOUN
bptjm-12	153	12	are	be	AUX
bptjm-12	153	13	grown	grow	VERB
bptjm-12	153	14	under	under	ADP
bptjm-12	153	15	controlled	control	VERB
bptjm-12	153	16	conditions	condition	NOUN
bptjm-12	153	17	,	,	PUNCT
bptjm-12	153	18	win5512	win5512	NOUN
bptjm-12	153	19	-	-	SYM
bptjm-12	153	20	2	2	NUM
bptjm-12	153	21	’s	’s	NOUN
bptjm-12	153	22	in	in	ADP
bptjm-12	153	23	�	�	PROPN
bptjm-12	153	24	ammatory	ammatory	NOUN
bptjm-12	153	25	response	response	NOUN
bptjm-12	153	26	speci	speci	PROPN
bptjm-12	153	27	�	�	PROPN
bptjm-12	153	28	cally	cally	ADV
bptjm-12	153	29	prevented	prevent	VERB
bptjm-12	153	30	cell	cell	NOUN
bptjm-12	153	31	death	death	NOUN
bptjm-12	153	32	in	in	ADP
bptjm-12	153	33	astrocytes	astrocyte	NOUN
bptjm-12	153	34	—	—	PUNCT
bptjm-12	153	35	specialized	specialized	ADJ
bptjm-12	153	36	glial	glial	ADJ
bptjm-12	153	37	cells	cell	NOUN
bptjm-12	153	38	that	that	PRON
bptjm-12	153	39	aid	aid	VERB
bptjm-12	153	40	in	in	ADP
bptjm-12	153	41	a	a	DET
bptjm-12	153	42	variety	variety	NOUN
bptjm-12	153	43	of	of	ADP
bptjm-12	153	44	neurological	neurological	ADJ
bptjm-12	153	45	functions	function	NOUN
bptjm-12	153	46	such	such	ADJ
bptjm-12	153	47	as	as	ADP
bptjm-12	153	48	water	water	NOUN
bptjm-12	153	49	homeostasis	homeostasis	NOUN
bptjm-12	153	50	and	and	CCONJ
bptjm-12	153	51	oxidative	oxidative	ADJ
bptjm-12	153	52	stress	stress	NOUN
bptjm-12	153	53	defense	defense	NOUN
bptjm-12	153	54	(	(	PUNCT
bptjm-12	153	55	sofroniew	sofroniew	NOUN
bptjm-12	153	56	,	,	PUNCT
bptjm-12	153	57	2010	2010	NUM
bptjm-12	153	58	)	)	PUNCT
bptjm-12	153	59	.	.	PUNCT
bptjm-12	154	1	mice	mouse	NOUN
bptjm-12	154	2	studies	study	NOUN
bptjm-12	154	3	have	have	VERB
bptjm-12	154	4	e	e	AUX
bptjm-12	154	5	�	�	NOUN
bptjm-12	154	6	ectively	ectively	ADV
bptjm-12	154	7	demonstrated	demonstrate	VERB
bptjm-12	154	8	this	this	PRON
bptjm-12	154	9	by	by	ADP
bptjm-12	154	10	reducing	reduce	VERB
bptjm-12	154	11	the	the	DET
bptjm-12	154	12	levels	level	NOUN
bptjm-12	154	13	of	of	ADP
bptjm-12	154	14	the	the	DET
bptjm-12	154	15	proin	proin	NOUN
bptjm-12	154	16	�	�	NOUN
bptjm-12	154	17	ammatory	ammatory	NOUN
bptjm-12	154	18	molecules	molecule	NOUN
bptjm-12	154	19	interleukin-1	interleukin-1	NOUN
bptjm-12	154	20	beta	beta	NOUN
bptjm-12	154	21	(	(	PUNCT
bptjm-12	154	22	il-1beta	il-1beta	NOUN
bptjm-12	154	23	)	)	PUNCT
bptjm-12	154	24	,	,	PUNCT
bptjm-12	154	25	tnf	tnf	PROPN
bptjm-12	154	26	-	-	PUNCT
bptjm-12	154	27	alpha	alpha	NOUN
bptjm-12	154	28	,	,	PUNCT
bptjm-12	154	29	cox-2	cox-2	NOUN
bptjm-12	154	30	,	,	PUNCT
bptjm-12	154	31	and	and	CCONJ
bptjm-12	154	32	inducible	inducible	ADJ
bptjm-12	154	33	nitric	nitric	ADJ
bptjm-12	154	34	oxide	oxide	NOUN
bptjm-12	154	35	synthase	synthase	NOUN
bptjm-12	154	36	(	(	PUNCT
bptjm-12	154	37	inos	inos	PROPN
bptjm-12	154	38	)	)	PUNCT
bptjm-12	154	39	(	(	PUNCT
bptjm-12	154	40	aguirre	aguirre	PROPN
bptjm-12	154	41	-	-	PUNCT
bptjm-12	154	42	rueda	rueda	PROPN
bptjm-12	154	43	,	,	PUNCT
bptjm-12	154	44	2015	2015	NUM
bptjm-12	154	45	)	)	PUNCT
bptjm-12	154	46	within	within	ADP
bptjm-12	154	47	their	their	PRON
bptjm-12	154	48	system	system	NOUN
bptjm-12	154	49	.	.	PUNCT
bptjm-12	155	1	additionally	additionally	ADV
bptjm-12	155	2	,	,	PUNCT
bptjm-12	155	3	two	two	NUM
bptjm-12	155	4	proin	proin	NOUN
bptjm-12	155	5	�	�	NOUN
bptjm-12	155	6	ammatory	ammatory	NOUN
bptjm-12	155	7	cytokines	cytokine	NOUN
bptjm-12	155	8	,	,	PUNCT
bptjm-12	155	9	tnf	tnf	PROPN
bptjm-12	155	10	-	-	PUNCT
bptjm-12	155	11	alpha	alpha	NOUN
bptjm-12	155	12	and	and	CCONJ
bptjm-12	155	13	il-6	il-6	NOUN
bptjm-12	155	14	,	,	PUNCT
bptjm-12	155	15	were	be	AUX
bptjm-12	155	16	measured	measure	VERB
bptjm-12	155	17	in	in	ADP
bptjm-12	155	18	the	the	DET
bptjm-12	155	19	cerebral	cerebral	ADJ
bptjm-12	155	20	cortex	cortex	NOUN
bptjm-12	155	21	of	of	ADP
bptjm-12	155	22	mice	mouse	NOUN
bptjm-12	155	23	treated	treat	VERB
bptjm-12	155	24	with	with	ADP
bptjm-12	155	25	cbd	cbd	NOUN
bptjm-12	155	26	and	and	CCONJ
bptjm-12	155	27	win5512	win5512	NOUN
bptjm-12	155	28	-	-	SYM
bptjm-12	155	29	2	2	NUM
bptjm-12	155	30	(	(	PUNCT
bptjm-12	155	31	martín	martín	NOUN
bptjm-12	155	32	-	-	PUNCT
bptjm-12	155	33	moreno	moreno	PROPN
bptjm-12	155	34	et	et	PROPN
bptjm-12	155	35	al	al	PROPN
bptjm-12	155	36	.	.	PROPN
bptjm-12	155	37	,	,	PUNCT
bptjm-12	155	38	2011	2011	NUM
bptjm-12	155	39	)	)	PUNCT
bptjm-12	155	40	.	.	PUNCT
bptjm-12	156	1	the	the	DET
bptjm-12	156	2	initial	initial	ADJ
bptjm-12	156	3	6	6	NUM
bptjm-12	156	4	-	-	ADJ
bptjm-12	156	5	fold	fold	ADJ
bptjm-12	156	6	increase	increase	NOUN
bptjm-12	156	7	of	of	ADP
bptjm-12	156	8	il-6	il-6	NOUN
bptjm-12	156	9	from	from	ADP
bptjm-12	156	10	the	the	DET
bptjm-12	156	11	aβ	aβ	NOUN
bptjm-12	156	12	was	be	AUX
bptjm-12	156	13	decreased	decrease	VERB
bptjm-12	156	14	by	by	ADP
bptjm-12	156	15	both	both	DET
bptjm-12	156	16	cannabinoid	cannabinoid	NOUN
bptjm-12	156	17	agonists	agonist	NOUN
bptjm-12	156	18	,	,	PUNCT
bptjm-12	156	19	and	and	CCONJ
bptjm-12	156	20	win5512	win5512	NOUN
bptjm-12	156	21	-	-	SYM
bptjm-12	156	22	2	2	NUM
bptjm-12	156	23	partially	partially	ADV
bptjm-12	156	24	reduced	reduce	VERB
bptjm-12	156	25	tnf	tnf	PROPN
bptjm-12	156	26	-	-	PUNCT
bptjm-12	156	27	alpha	alpha	NOUN
bptjm-12	156	28	gene	gene	NOUN
bptjm-12	156	29	expression	expression	NOUN
bptjm-12	156	30	(	(	PUNCT
bptjm-12	156	31	martín	martín	NOUN
bptjm-12	156	32	-	-	PUNCT
bptjm-12	156	33	moreno	moreno	PROPN
bptjm-12	156	34	et	et	PROPN
bptjm-12	156	35	al	al	PROPN
bptjm-12	156	36	.	.	PROPN
bptjm-12	156	37	,	,	PUNCT
bptjm-12	156	38	2011	2011	NUM
bptjm-12	156	39	)	)	PUNCT
bptjm-12	156	40	.	.	PUNCT
bptjm-12	157	1	in	in	ADP
bptjm-12	157	2	a	a	DET
bptjm-12	157	3	similar	similar	ADJ
bptjm-12	157	4	experiment	experiment	NOUN
bptjm-12	157	5	,	,	PUNCT
bptjm-12	157	6	aβ	aβ	DET
bptjm-12	157	7	injected	inject	VERB
bptjm-12	157	8	mice	mouse	NOUN
bptjm-12	157	9	subject	subject	ADJ
bptjm-12	157	10	to	to	ADP
bptjm-12	157	11	subchronic	subchronic	ADJ
bptjm-12	157	12	administration	administration	NOUN
bptjm-12	157	13	of	of	ADP
bptjm-12	157	14	win5512	win5512	NOUN
bptjm-12	157	15	-	-	SYM
bptjm-12	157	16	2	2	NUM
bptjm-12	157	17	or	or	CCONJ
bptjm-12	157	18	cbd	cbd	NOUN
bptjm-12	157	19	showed	show	VERB
bptjm-12	157	20	better	well	ADJ
bptjm-12	157	21	performance	performance	NOUN
bptjm-12	157	22	in	in	ADP
bptjm-12	157	23	the	the	DET
bptjm-12	157	24	morris	morris	PROPN
bptjm-12	157	25	water	water	PROPN
bptjm-12	157	26	maze	maze	PROPN
bptjm-12	157	27	task	task	NOUN
bptjm-12	157	28	,	,	PUNCT
bptjm-12	157	29	an	an	DET
bptjm-12	157	30	experiment	experiment	NOUN
bptjm-12	157	31	in	in	ADP
bptjm-12	157	32	which	which	PRON
bptjm-12	157	33	a	a	DET
bptjm-12	157	34	mouse	mouse	NOUN
bptjm-12	157	35	is	be	AUX
bptjm-12	157	36	placed	place	VERB
bptjm-12	157	37	within	within	ADP
bptjm-12	157	38	a	a	DET
bptjm-12	157	39	circular	circular	ADJ
bptjm-12	157	40	pool	pool	NOUN
bptjm-12	157	41	of	of	ADP
bptjm-12	157	42	water	water	NOUN
bptjm-12	157	43	and	and	CCONJ
bptjm-12	157	44	must	must	AUX
bptjm-12	157	45	escape	escape	VERB
bptjm-12	157	46	from	from	ADP
bptjm-12	157	47	the	the	DET
bptjm-12	157	48	water	water	NOUN
bptjm-12	157	49	onto	onto	ADP
bptjm-12	157	50	a	a	DET
bptjm-12	157	51	hidden	hide	VERB
bptjm-12	157	52	platform	platform	NOUN
bptjm-12	157	53	whose	whose	DET
bptjm-12	157	54	location	location	NOUN
bptjm-12	157	55	is	be	AUX
bptjm-12	157	56	discerned	discern	VERB
bptjm-12	157	57	through	through	ADP
bptjm-12	157	58	the	the	DET
bptjm-12	157	59	use	use	NOUN
bptjm-12	157	60	of	of	ADP
bptjm-12	157	61	spatial	spatial	ADJ
bptjm-12	157	62	memory	memory	NOUN
bptjm-12	157	63	(	(	PUNCT
bptjm-12	157	64	martín	martín	NOUN
bptjm-12	157	65	-	-	PUNCT
bptjm-12	157	66	moreno	moreno	PROPN
bptjm-12	157	67	et	et	PROPN
bptjm-12	157	68	al	al	PROPN
bptjm-12	157	69	.	.	PROPN
bptjm-12	157	70	,	,	PUNCT
bptjm-12	157	71	2011	2011	NUM
bptjm-12	157	72	)	)	PUNCT
bptjm-12	157	73	.	.	PUNCT
bptjm-12	158	1	berkeley	berkeley	PROPN
bptjm-12	158	2	pharma	pharma	PROPN
bptjm-12	158	3	tech	tech	PROPN
bptjm-12	158	4	journal	journal	NOUN
bptjm-12	158	5	of	of	ADP
bptjm-12	158	6	medicine	medicine	NOUN
bptjm-12	158	7	|	|	ADV
bptjm-12	158	8	12	12	NUM
bptjm-12	158	9	cbd	cbd	NOUN
bptjm-12	158	10	is	be	AUX
bptjm-12	158	11	a	a	DET
bptjm-12	158	12	cb2	cb2	NOUN
bptjm-12	158	13	receptor	receptor	NOUN
bptjm-12	158	14	agonist	agonist	NOUN
bptjm-12	158	15	that	that	PRON
bptjm-12	158	16	also	also	ADV
bptjm-12	158	17	prevents	prevent	VERB
bptjm-12	158	18	aβ	aβ	DET
bptjm-12	158	19	neurodegeneration	neurodegeneration	NOUN
bptjm-12	158	20	by	by	ADP
bptjm-12	158	21	reducing	reduce	VERB
bptjm-12	158	22	microglial	microglial	ADJ
bptjm-12	158	23	activation	activation	NOUN
bptjm-12	158	24	responsible	responsible	ADJ
bptjm-12	158	25	for	for	ADP
bptjm-12	158	26	the	the	DET
bptjm-12	158	27	release	release	NOUN
bptjm-12	158	28	of	of	ADP
bptjm-12	158	29	toxic	toxic	ADJ
bptjm-12	158	30	molecules	molecule	NOUN
bptjm-12	158	31	like	like	ADP
bptjm-12	158	32	nitric	nitric	ADJ
bptjm-12	158	33	oxide	oxide	NOUN
bptjm-12	158	34	(	(	PUNCT
bptjm-12	158	35	no	no	NOUN
bptjm-12	158	36	)	)	PUNCT
bptjm-12	158	37	and	and	CCONJ
bptjm-12	158	38	proin	proin	VERB
bptjm-12	158	39	�	�	NOUN
bptjm-12	158	40	ammatory	ammatory	ADJ
bptjm-12	158	41	cytokines	cytokine	NOUN
bptjm-12	158	42	(	(	PUNCT
bptjm-12	158	43	martín	martín	NOUN
bptjm-12	158	44	-	-	PUNCT
bptjm-12	158	45	moreno	moreno	PROPN
bptjm-12	158	46	et	et	PROPN
bptjm-12	158	47	al	al	PROPN
bptjm-12	158	48	.	.	PROPN
bptjm-12	158	49	,	,	PUNCT
bptjm-12	158	50	2011	2011	NUM
bptjm-12	158	51	)	)	PUNCT
bptjm-12	158	52	.	.	PUNCT
bptjm-12	159	1	by	by	ADP
bptjm-12	159	2	inhibiting	inhibit	VERB
bptjm-12	159	3	calcium	calcium	NOUN
bptjm-12	159	4	responses	response	NOUN
bptjm-12	159	5	in	in	ADP
bptjm-12	159	6	glial	glial	ADJ
bptjm-12	159	7	cells	cell	NOUN
bptjm-12	159	8	,	,	PUNCT
bptjm-12	159	9	cannabinoid	cannabinoid	PROPN
bptjm-12	159	10	agonists	agonist	NOUN
bptjm-12	159	11	are	be	AUX
bptjm-12	159	12	similarly	similarly	ADV
bptjm-12	159	13	able	able	ADJ
bptjm-12	159	14	to	to	PART
bptjm-12	159	15	prevent	prevent	VERB
bptjm-12	159	16	microglial	microglial	ADJ
bptjm-12	159	17	activation	activation	NOUN
bptjm-12	159	18	.	.	PUNCT
bptjm-12	160	1	fig	fig	NOUN
bptjm-12	160	2	.	.	PUNCT
bptjm-12	161	1	6	6	NUM
bptjm-12	161	2	:	:	PUNCT
bptjm-12	161	3	illustration	illustration	NOUN
bptjm-12	161	4	of	of	ADP
bptjm-12	161	5	inhibitory	inhibitory	ADJ
bptjm-12	161	6	activity	activity	NOUN
bptjm-12	161	7	by	by	ADP
bptjm-12	161	8	receptor	receptor	NOUN
bptjm-12	161	9	agonists	agonist	NOUN
bptjm-12	161	10	.	.	PUNCT
bptjm-12	162	1	additionally	additionally	ADV
bptjm-12	162	2	,	,	PUNCT
bptjm-12	162	3	cb1	cb1	PROPN
bptjm-12	162	4	receptor	receptor	NOUN
bptjm-12	162	5	activation	activation	NOUN
bptjm-12	162	6	causes	cause	VERB
bptjm-12	162	7	migration	migration	NOUN
bptjm-12	162	8	of	of	ADP
bptjm-12	162	9	the	the	DET
bptjm-12	162	10	n13	n13	PROPN
bptjm-12	162	11	(	(	PUNCT
bptjm-12	162	12	nitrogen-13	nitrogen-13	NOUN
bptjm-12	162	13	)	)	PUNCT
bptjm-12	162	14	microglial	microglial	ADJ
bptjm-12	162	15	cells	cell	NOUN
bptjm-12	162	16	and	and	CCONJ
bptjm-12	162	17	primary	primary	ADJ
bptjm-12	162	18	microglial	microglial	ADJ
bptjm-12	162	19	cells	cell	NOUN
bptjm-12	162	20	(	(	PUNCT
bptjm-12	162	21	martín	martín	NOUN
bptjm-12	162	22	-	-	PUNCT
bptjm-12	162	23	morenoetal	morenoetal	ADJ
bptjm-12	162	24	.	.	PUNCT
bptjm-12	162	25	,	,	PUNCT
bptjm-12	162	26	2011	2011	NUM
bptjm-12	162	27	)	)	PUNCT
bptjm-12	162	28	.	.	PUNCT
bptjm-12	163	1	migration	migration	NOUN
bptjm-12	163	2	is	be	AUX
bptjm-12	163	3	a	a	DET
bptjm-12	163	4	cellular	cellular	ADJ
bptjm-12	163	5	mechanism	mechanism	NOUN
bptjm-12	163	6	that	that	PRON
bptjm-12	163	7	ultimately	ultimately	ADV
bptjm-12	163	8	allows	allow	VERB
bptjm-12	163	9	for	for	ADP
bptjm-12	163	10	the	the	DET
bptjm-12	163	11	removal	removal	NOUN
bptjm-12	163	12	of	of	ADP
bptjm-12	163	13	deposit	deposit	NOUN
bptjm-12	163	14	aβ	aβ	NOUN
bptjm-12	163	15	protein	protein	NOUN
bptjm-12	163	16	.	.	PUNCT
bptjm-12	164	1	in	in	ADP
bptjm-12	164	2	a	a	DET
bptjm-12	164	3	study	study	NOUN
bptjm-12	164	4	conducted	conduct	VERB
bptjm-12	164	5	in	in	ADP
bptjm-12	164	6	aβ	aβ	NUM
bptjm-12	164	7	injected	inject	VERB
bptjm-12	164	8	mice	mouse	NOUN
bptjm-12	164	9	,	,	PUNCT
bptjm-12	164	10	those	those	PRON
bptjm-12	164	11	that	that	PRON
bptjm-12	164	12	did	do	AUX
bptjm-12	164	13	not	not	PART
bptjm-12	164	14	receive	receive	VERB
bptjm-12	164	15	the	the	DET
bptjm-12	164	16	cbd	cbd	NOUN
bptjm-12	164	17	treatment	treatment	NOUN
bptjm-12	164	18	of	of	ADP
bptjm-12	164	19	win5512	win5512	NOUN
bptjm-12	164	20	-	-	SYM
bptjm-12	164	21	2	2	NUM
bptjm-12	164	22	showed	show	VERB
bptjm-12	164	23	signi	signi	ADJ
bptjm-12	164	24	�	�	NOUN
bptjm-12	164	25	cant	cant	NOUN
bptjm-12	164	26	reduction	reduction	NOUN
bptjm-12	164	27	in	in	ADP
bptjm-12	164	28	their	their	PRON
bptjm-12	164	29	ability	ability	NOUN
bptjm-12	164	30	to	to	PART
bptjm-12	164	31	reach	reach	VERB
bptjm-12	164	32	a	a	DET
bptjm-12	164	33	hidden	hide	VERB
bptjm-12	164	34	platform	platform	NOUN
bptjm-12	164	35	(	(	PUNCT
bptjm-12	164	36	martín	martín	NOUN
bptjm-12	164	37	-	-	PUNCT
bptjm-12	164	38	moreno	moreno	PROPN
bptjm-12	164	39	et	et	PROPN
bptjm-12	164	40	al	al	PROPN
bptjm-12	164	41	.	.	PROPN
bptjm-12	164	42	,	,	PUNCT
bptjm-12	164	43	2011	2011	NUM
bptjm-12	164	44	)	)	PUNCT
bptjm-12	164	45	.	.	PUNCT
bptjm-12	165	1	another	another	DET
bptjm-12	165	2	strength	strength	NOUN
bptjm-12	165	3	berkeley	berkeley	PROPN
bptjm-12	165	4	pharma	pharma	PROPN
bptjm-12	165	5	tech	tech	NOUN
bptjm-12	165	6	journal	journal	NOUN
bptjm-12	165	7	of	of	ADP
bptjm-12	165	8	medicine	medicine	NOUN
bptjm-12	165	9	|	|	ADV
bptjm-12	165	10	13	13	NUM
bptjm-12	165	11	pertaining	pertain	VERB
bptjm-12	165	12	to	to	ADP
bptjm-12	165	13	the	the	DET
bptjm-12	165	14	inhibitory	inhibitory	ADJ
bptjm-12	165	15	activity	activity	NOUN
bptjm-12	165	16	of	of	ADP
bptjm-12	165	17	receptor	receptor	NOUN
bptjm-12	165	18	agonists	agonist	NOUN
bptjm-12	165	19	is	be	AUX
bptjm-12	165	20	the	the	DET
bptjm-12	165	21	suppression	suppression	NOUN
bptjm-12	165	22	of	of	ADP
bptjm-12	165	23	aβ	aβ	DET
bptjm-12	165	24	plaque	plaque	ADJ
bptjm-12	165	25	buildup	buildup	NOUN
bptjm-12	165	26	.	.	PUNCT
bptjm-12	166	1	aspreviously	aspreviously	ADV
bptjm-12	166	2	mentioned	mention	VERB
bptjm-12	166	3	,	,	PUNCT
bptjm-12	166	4	ad	ad	NOUN
bptjm-12	166	5	has	have	AUX
bptjm-12	166	6	been	be	AUX
bptjm-12	166	7	largely	largely	ADV
bptjm-12	166	8	characterized	characterize	VERB
bptjm-12	166	9	by	by	ADP
bptjm-12	166	10	its	its	PRON
bptjm-12	166	11	substantial	substantial	ADJ
bptjm-12	166	12	aggregation	aggregation	NOUN
bptjm-12	166	13	of	of	ADP
bptjm-12	166	14	beta	beta	ADJ
bptjm-12	166	15	amyloid	amyloid	NOUN
bptjm-12	166	16	peptide	peptide	NOUN
bptjm-12	166	17	clusters	cluster	NOUN
bptjm-12	166	18	;	;	PUNCT
bptjm-12	166	19	thus	thus	ADV
bptjm-12	166	20	,	,	PUNCT
bptjm-12	166	21	focusing	focus	VERB
bptjm-12	166	22	further	further	ADJ
bptjm-12	166	23	investigation	investigation	NOUN
bptjm-12	166	24	towards	towards	ADP
bptjm-12	166	25	the	the	DET
bptjm-12	166	26	wingless	wingless	NOUN
bptjm-12	166	27	-	-	PUNCT
bptjm-12	166	28	related	relate	VERB
bptjm-12	166	29	integration	integration	NOUN
bptjm-12	166	30	site	site	NOUN
bptjm-12	166	31	(	(	PUNCT
bptjm-12	166	32	wnt	wnt	PROPN
bptjm-12	166	33	)	)	PUNCT
bptjm-12	166	34	pathway	pathway	NOUN
bptjm-12	166	35	as	as	SCONJ
bptjm-12	166	36	it	it	PRON
bptjm-12	166	37	becomes	becomes	AUX
bptjm-12	166	38	largely	largely	ADV
bptjm-12	166	39	impacted	impact	VERB
bptjm-12	166	40	due	due	ADP
bptjm-12	166	41	to	to	ADP
bptjm-12	166	42	aforementioned	aforementioned	ADJ
bptjm-12	166	43	clusters	cluster	NOUN
bptjm-12	166	44	(	(	PUNCT
bptjm-12	166	45	esposito	esposito	PROPN
bptjm-12	166	46	,	,	PUNCT
bptjm-12	166	47	2006	2006	NUM
bptjm-12	166	48	)	)	PUNCT
bptjm-12	166	49	.	.	PUNCT
bptjm-12	167	1	normally	normally	ADV
bptjm-12	167	2	,	,	PUNCT
bptjm-12	167	3	wnt	wnt	PROPN
bptjm-12	167	4	activation	activation	NOUN
bptjm-12	167	5	triggers	trigger	VERB
bptjm-12	167	6	the	the	DET
bptjm-12	167	7	“	"	PUNCT
bptjm-12	167	8	...	...	PUNCT
bptjm-12	167	9	inhibition	inhibition	NOUN
bptjm-12	167	10	of	of	ADP
bptjm-12	167	11	glycogen	glycogen	NOUN
bptjm-12	167	12	synthase	synthase	NOUN
bptjm-12	167	13	kinase-3beta	kinase-3beta	PROPN
bptjm-12	167	14	(	(	PUNCT
bptjm-12	167	15	gsk-3β	gsk-3β	PROPN
bptjm-12	167	16	)	)	PUNCT
bptjm-12	167	17	,	,	PUNCT
bptjm-12	167	18	a	a	DET
bptjm-12	167	19	multifunctional	multifunctional	ADJ
bptjm-12	167	20	phosphorylating	phosphorylating	NOUN
bptjm-12	167	21	serine	serine	NOUN
bptjm-12	167	22	/	/	SYM
bptjm-12	167	23	threonine	threonine	ADJ
bptjm-12	167	24	kinase	kinase	NOUN
bptjm-12	167	25	and	and	CCONJ
bptjm-12	167	26	relative	relative	ADJ
bptjm-12	167	27	accumulation	accumulation	NOUN
bptjm-12	167	28	of	of	ADP
bptjm-12	167	29	[	[	X
bptjm-12	167	30	unphosphorylated	unphosphorylate	VERB
bptjm-12	167	31	]	]	PUNCT
bptjm-12	167	32	β	β	NOUN
bptjm-12	167	33	-	-	NOUN
bptjm-12	167	34	catenin	catenin	NOUN
bptjm-12	167	35	in	in	ADP
bptjm-12	167	36	the	the	DET
bptjm-12	167	37	cytoplasm	cytoplasm	NOUN
bptjm-12	167	38	”	"	PUNCT
bptjm-12	167	39	(	(	PUNCT
bptjm-12	167	40	esposito	esposito	PROPN
bptjm-12	167	41	,	,	PUNCT
bptjm-12	167	42	2006	2006	NUM
bptjm-12	167	43	)	)	PUNCT
bptjm-12	167	44	.	.	PUNCT
bptjm-12	168	1	this	this	DET
bptjm-12	168	2	aggregation	aggregation	NOUN
bptjm-12	168	3	allows	allow	VERB
bptjm-12	168	4	for	for	ADP
bptjm-12	168	5	the	the	DET
bptjm-12	168	6	expression	expression	NOUN
bptjm-12	168	7	of	of	ADP
bptjm-12	168	8	genes	gene	NOUN
bptjm-12	168	9	that	that	PRON
bptjm-12	168	10	code	code	VERB
bptjm-12	168	11	for	for	ADP
bptjm-12	168	12	homeostasis	homeostasis	NOUN
bptjm-12	168	13	and	and	CCONJ
bptjm-12	168	14	neuronal	neuronal	ADJ
bptjm-12	168	15	survival	survival	NOUN
bptjm-12	168	16	(	(	PUNCT
bptjm-12	168	17	esposito	esposito	PROPN
bptjm-12	168	18	,	,	PUNCT
bptjm-12	168	19	2006	2006	NUM
bptjm-12	168	20	)	)	PUNCT
bptjm-12	168	21	.	.	PUNCT
bptjm-12	169	1	within	within	ADP
bptjm-12	169	2	neurons	neuron	NOUN
bptjm-12	169	3	exposed	expose	VERB
bptjm-12	169	4	to	to	ADP
bptjm-12	169	5	aβ	aβ	NOUN
bptjm-12	169	6	peptides	peptide	NOUN
bptjm-12	169	7	,	,	PUNCT
bptjm-12	169	8	however	however	ADV
bptjm-12	169	9	,	,	PUNCT
bptjm-12	169	10	gsk-3ß	gsk-3ß	NOUN
bptjm-12	169	11	is	be	AUX
bptjm-12	169	12	activated	activate	VERB
bptjm-12	169	13	through	through	ADP
bptjm-12	169	14	phosphorylation	phosphorylation	NOUN
bptjm-12	169	15	;	;	PUNCT
bptjm-12	169	16	therefore	therefore	ADV
bptjm-12	169	17	,	,	PUNCT
bptjm-12	169	18	wnt	wnt	PROPN
bptjm-12	169	19	signaling	signal	VERB
bptjm-12	169	20	experienced	experienced	ADJ
bptjm-12	169	21	signi	signi	PROPN
bptjm-12	169	22	�	�	NOUN
bptjm-12	169	23	cant	cant	NOUN
bptjm-12	169	24	reduction	reduction	NOUN
bptjm-12	169	25	(	(	PUNCT
bptjm-12	169	26	esposito	esposito	PROPN
bptjm-12	169	27	,	,	PUNCT
bptjm-12	169	28	2006	2006	NUM
bptjm-12	169	29	)	)	PUNCT
bptjm-12	169	30	.	.	PUNCT
bptjm-12	170	1	furthermore	furthermore	ADV
bptjm-12	170	2	,	,	PUNCT
bptjm-12	170	3	these	these	DET
bptjm-12	170	4	phosphorylated	phosphorylate	VERB
bptjm-12	170	5	gsk-3ß	gsk-3ß	NOUN
bptjm-12	170	6	lead	lead	NOUN
bptjm-12	170	7	to	to	ADP
bptjm-12	170	8	the	the	DET
bptjm-12	170	9	neuro	neuro	PROPN
bptjm-12	170	10	�	�	PROPN
bptjm-12	170	11	brillary	brillary	ADJ
bptjm-12	170	12	tangles	tangle	NOUN
bptjm-12	170	13	and	and	CCONJ
bptjm-12	170	14	signi	signi	PROPN
bptjm-12	170	15	�	�	NOUN
bptjm-12	170	16	cant	cant	VERB
bptjm-12	170	17	tau	tau	PROPN
bptjm-12	170	18	protein	protein	NOUN
bptjm-12	170	19	hyperphosphorylation	hyperphosphorylation	NOUN
bptjm-12	170	20	witnessed	witness	VERB
bptjm-12	170	21	in	in	ADP
bptjm-12	170	22	the	the	DET
bptjm-12	170	23	brains	brain	NOUN
bptjm-12	170	24	of	of	ADP
bptjm-12	170	25	patients	patient	NOUN
bptjm-12	170	26	with	with	ADP
bptjm-12	170	27	ad	ad	NOUN
bptjm-12	170	28	(	(	PUNCT
bptjm-12	170	29	esposito	esposito	PROPN
bptjm-12	170	30	,	,	PUNCT
bptjm-12	170	31	2006	2006	NUM
bptjm-12	170	32	)	)	PUNCT
bptjm-12	170	33	.	.	PUNCT
bptjm-12	171	1	cbd	cbd	PROPN
bptjm-12	171	2	serves	serve	VERB
bptjm-12	171	3	as	as	ADP
bptjm-12	171	4	a	a	DET
bptjm-12	171	5	rescue	rescue	NOUN
bptjm-12	171	6	of	of	ADP
bptjm-12	171	7	the	the	DET
bptjm-12	171	8	wnt	wnt	NOUN
bptjm-12	171	9	signaling	signal	VERB
bptjm-12	171	10	pathway	pathway	NOUN
bptjm-12	171	11	as	as	SCONJ
bptjm-12	171	12	it	it	PRON
bptjm-12	171	13	promptly	promptly	ADV
bptjm-12	171	14	reduces	reduce	VERB
bptjm-12	171	15	the	the	DET
bptjm-12	171	16	accumulation	accumulation	NOUN
bptjm-12	171	17	of	of	ADP
bptjm-12	171	18	phosphorylated	phosphorylate	VERB
bptjm-12	171	19	gsk-3ß	gsk-3ß	NOUN
bptjm-12	171	20	,	,	PUNCT
bptjm-12	171	21	consequently	consequently	ADV
bptjm-12	171	22	inhibiting	inhibit	VERB
bptjm-12	171	23	the	the	DET
bptjm-12	171	24	rise	rise	NOUN
bptjm-12	171	25	of	of	ADP
bptjm-12	171	26	neuro	neuro	PROPN
bptjm-12	171	27	�	�	PROPN
bptjm-12	171	28	brillary	brillary	ADJ
bptjm-12	171	29	tangles	tangle	NOUN
bptjm-12	171	30	and	and	CCONJ
bptjm-12	171	31	tau	tau	PROPN
bptjm-12	171	32	protein	protein	NOUN
bptjm-12	171	33	hyperphosphorylation	hyperphosphorylation	NOUN
bptjm-12	171	34	(	(	PUNCT
bptjm-12	171	35	esposito	esposito	PROPN
bptjm-12	171	36	,	,	PUNCT
bptjm-12	171	37	2006	2006	NUM
bptjm-12	171	38	)	)	PUNCT
bptjm-12	171	39	.	.	PUNCT
bptjm-12	172	1	furthermore	furthermore	ADV
bptjm-12	172	2	,	,	PUNCT
bptjm-12	172	3	cbd	cbd	NOUN
bptjm-12	172	4	indirectly	indirectly	ADV
bptjm-12	172	5	inhibits	inhibit	VERB
bptjm-12	172	6	neural	neural	ADJ
bptjm-12	172	7	apoptosis	apoptosis	NOUN
bptjm-12	172	8	due	due	ADP
bptjm-12	172	9	to	to	ADP
bptjm-12	172	10	its	its	PRON
bptjm-12	172	11	rescue	rescue	NOUN
bptjm-12	172	12	of	of	ADP
bptjm-12	172	13	the	the	DET
bptjm-12	172	14	wnt	wnt	NOUN
bptjm-12	172	15	signaling	signal	VERB
bptjm-12	172	16	pathway	pathway	NOUN
bptjm-12	172	17	(	(	PUNCT
bptjm-12	172	18	esposito	esposito	PROPN
bptjm-12	172	19	,	,	PUNCT
bptjm-12	172	20	2006	2006	NUM
bptjm-12	172	21	)	)	PUNCT
bptjm-12	172	22	.	.	PUNCT
bptjm-12	173	1	∆9	∆9	X
bptjm-12	173	2	-	-	PUNCT
bptjm-12	173	3	tetrahydrocannabinol	tetrahydrocannabinol	NOUN
bptjm-12	173	4	(	(	PUNCT
bptjm-12	173	5	thc	thc	NOUN
bptjm-12	173	6	)	)	PUNCT
bptjm-12	173	7	is	be	AUX
bptjm-12	173	8	another	another	DET
bptjm-12	173	9	viable	viable	ADJ
bptjm-12	173	10	receptor	receptor	NOUN
bptjm-12	173	11	agonist	agonist	NOUN
bptjm-12	173	12	in	in	ADP
bptjm-12	173	13	combating	combat	VERB
bptjm-12	173	14	the	the	DET
bptjm-12	173	15	advancement	advancement	NOUN
bptjm-12	173	16	of	of	ADP
bptjm-12	173	17	alzheimer	alzheimer	PROPN
bptjm-12	173	18	’s	’s	PART
bptjm-12	173	19	disease	disease	NOUN
bptjm-12	173	20	via	via	ADP
bptjm-12	173	21	competitive	competitive	ADJ
bptjm-12	173	22	inhibition	inhibition	NOUN
bptjm-12	173	23	.	.	PUNCT
bptjm-12	174	1	thc	thc	NOUN
bptjm-12	174	2	,	,	PUNCT
bptjm-12	174	3	the	the	DET
bptjm-12	174	4	active	active	ADJ
bptjm-12	174	5	component	component	NOUN
bptjm-12	174	6	of	of	ADP
bptjm-12	174	7	marijuana	marijuana	PROPN
bptjm-12	174	8	,	,	PUNCT
bptjm-12	174	9	competitively	competitively	ADV
bptjm-12	174	10	inhibits	inhibit	VERB
bptjm-12	174	11	acetylcholinesterase	acetylcholinesterase	NOUN
bptjm-12	174	12	(	(	PUNCT
bptjm-12	174	13	ache	ache	ADV
bptjm-12	174	14	)	)	PUNCT
bptjm-12	174	15	in	in	ADP
bptjm-12	174	16	addition	addition	NOUN
bptjm-12	174	17	to	to	ADP
bptjm-12	174	18	preventing	prevent	VERB
bptjm-12	174	19	acetylcholinesterase	acetylcholinesterase	NOUN
bptjm-12	174	20	-	-	PUNCT
bptjm-12	174	21	induced	induce	VERB
bptjm-12	174	22	aβ	aβ	NOUN
bptjm-12	174	23	plaque	plaque	NOUN
bptjm-12	174	24	buildup	buildup	NOUN
bptjm-12	174	25	(	(	PUNCT
bptjm-12	174	26	eubanks	eubank	NOUN
bptjm-12	174	27	,	,	PUNCT
bptjm-12	174	28	2006	2006	NUM
bptjm-12	174	29	)	)	PUNCT
bptjm-12	174	30	.	.	PUNCT
bptjm-12	175	1	one	one	NUM
bptjm-12	175	2	study	study	NOUN
bptjm-12	175	3	,	,	PUNCT
bptjm-12	175	4	conducted	conduct	VERB
bptjm-12	175	5	by	by	ADP
bptjm-12	175	6	eubanks	eubank	NOUN
bptjm-12	175	7	et	et	PROPN
bptjm-12	175	8	al	al	PROPN
bptjm-12	175	9	.	.	PROPN
bptjm-12	175	10	,	,	PUNCT
bptjm-12	175	11	demonstrated	demonstrate	VERB
bptjm-12	175	12	through	through	ADP
bptjm-12	175	13	computational	computational	ADJ
bptjm-12	175	14	modeling	modeling	NOUN
bptjm-12	175	15	of	of	ADP
bptjm-12	175	16	thc	thc	PROPN
bptjm-12	175	17	-	-	PUNCT
bptjm-12	175	18	ache	ache	NOUN
bptjm-12	175	19	interaction	interaction	NOUN
bptjm-12	175	20	that	that	SCONJ
bptjm-12	175	21	thc	thc	PROPN
bptjm-12	175	22	binds	bind	VERB
bptjm-12	175	23	to	to	PART
bptjm-12	175	24	ache	ache	ADV
bptjm-12	175	25	in	in	ADP
bptjm-12	175	26	a	a	DET
bptjm-12	175	27	critical	critical	ADJ
bptjm-12	175	28	region	region	NOUN
bptjm-12	175	29	involved	involve	VERB
bptjm-12	175	30	in	in	ADP
bptjm-12	175	31	amyloid	amyloid	NOUN
bptjm-12	175	32	synthesis	synthesis	NOUN
bptjm-12	175	33	,	,	PUNCT
bptjm-12	175	34	ultimately	ultimately	ADV
bptjm-12	175	35	serving	serve	VERB
bptjm-12	175	36	an	an	DET
bptjm-12	175	37	inhibitory	inhibitory	ADJ
bptjm-12	175	38	function	function	NOUN
bptjm-12	175	39	(	(	PUNCT
bptjm-12	175	40	eubanks	eubank	NOUN
bptjm-12	175	41	,	,	PUNCT
bptjm-12	175	42	2006	2006	NUM
bptjm-12	175	43	)	)	PUNCT
bptjm-12	175	44	.	.	PUNCT
bptjm-12	176	1	thc	thc	NOUN
bptjm-12	176	2	and	and	CCONJ
bptjm-12	176	3	analogous	analogous	ADJ
bptjm-12	176	4	compounds	compound	NOUN
bptjm-12	176	5	were	be	AUX
bptjm-12	176	6	found	find	VERB
bptjm-12	176	7	to	to	PART
bptjm-12	176	8	augment	augment	VERB
bptjm-12	176	9	acetylcholine	acetylcholine	NOUN
bptjm-12	176	10	levels	level	NOUN
bptjm-12	176	11	by	by	ADP
bptjm-12	176	12	inhibiting	inhibit	VERB
bptjm-12	176	13	aβ	aβ	NOUN
bptjm-12	176	14	aggregation	aggregation	NOUN
bptjm-12	176	15	and	and	CCONJ
bptjm-12	176	16	reducing	reduce	VERB
bptjm-12	176	17	neurotransmitter	neurotransmitter	NOUN
bptjm-12	176	18	degradation(eubanks	degradation(eubank	NOUN
bptjm-12	176	19	,	,	PUNCT
bptjm-12	176	20	2006).this	2006).this	PRON
bptjm-12	176	21	study	study	NOUN
bptjm-12	176	22	proposes	propose	VERB
bptjm-12	176	23	a	a	DET
bptjm-12	176	24	possible	possible	ADJ
bptjm-12	176	25	mechanism	mechanism	NOUN
bptjm-12	176	26	by	by	ADP
bptjm-12	176	27	which	which	PRON
bptjm-12	176	28	thc	thc	NOUN
bptjm-12	176	29	molecules	molecule	NOUN
bptjm-12	176	30	directly	directly	ADV
bptjm-12	176	31	impact	impact	VERB
bptjm-12	176	32	the	the	DET
bptjm-12	176	33	pathogenesis	pathogenesis	NOUN
bptjm-12	176	34	of	of	ADP
bptjm-12	176	35	alzheimer	alzheimer	PROPN
bptjm-12	176	36	’s	’s	PART
bptjm-12	176	37	disease	disease	NOUN
bptjm-12	176	38	(	(	PUNCT
bptjm-12	176	39	eubanks	eubank	NOUN
bptjm-12	176	40	,	,	PUNCT
bptjm-12	176	41	2006	2006	NUM
bptjm-12	176	42	)	)	PUNCT
bptjm-12	176	43	.	.	PUNCT
bptjm-12	177	1	through	through	ADP
bptjm-12	177	2	focusing	focus	VERB
bptjm-12	177	3	on	on	ADP
bptjm-12	177	4	the	the	DET
bptjm-12	177	5	cholinergic	cholinergic	ADJ
bptjm-12	177	6	system	system	NOUN
bptjm-12	177	7	,	,	PUNCT
bptjm-12	177	8	thc	thc	PROPN
bptjm-12	177	9	was	be	AUX
bptjm-12	177	10	found	find	VERB
bptjm-12	177	11	to	to	PART
bptjm-12	177	12	be	be	AUX
bptjm-12	177	13	a	a	DET
bptjm-12	177	14	promising	promising	ADJ
bptjm-12	177	15	receptor	receptor	NOUN
bptjm-12	177	16	agonist	agonist	NOUN
bptjm-12	177	17	as	as	SCONJ
bptjm-12	177	18	its	its	PRON
bptjm-12	177	19	potential	potential	NOUN
bptjm-12	177	20	ache	ache	NOUN
bptjm-12	177	21	inhibition	inhibition	NOUN
bptjm-12	177	22	might	might	AUX
bptjm-12	177	23	be	be	AUX
bptjm-12	177	24	implicated	implicate	VERB
bptjm-12	177	25	in	in	ADP
bptjm-12	177	26	ad	ad	NOUN
bptjm-12	177	27	treatment	treatment	NOUN
bptjm-12	177	28	(	(	PUNCT
bptjm-12	177	29	campbell	campbell	PROPN
bptjm-12	177	30	et	et	PROPN
bptjm-12	177	31	al	al	PROPN
bptjm-12	177	32	.	.	PROPN
bptjm-12	177	33	,	,	PUNCT
bptjm-12	177	34	2007	2007	NUM
bptjm-12	177	35	)	)	PUNCT
bptjm-12	177	36	.	.	PUNCT
bptjm-12	178	1	multiple	multiple	ADJ
bptjm-12	178	2	drugs	drug	NOUN
bptjm-12	178	3	—	—	PUNCT
bptjm-12	178	4	donepezil	donepezil	NOUN
bptjm-12	178	5	,	,	PUNCT
bptjm-12	178	6	edrophonium	edrophonium	NOUN
bptjm-12	178	7	,	,	PUNCT
bptjm-12	178	8	galantamine	galantamine	NOUN
bptjm-12	178	9	,	,	PUNCT
bptjm-12	178	10	etc	etc	X
bptjm-12	178	11	.	.	X
bptjm-12	178	12	—	—	PUNCT
bptjm-12	178	13	inhibit	inhibit	VERB
bptjm-12	178	14	ache	ache	ADV
bptjm-12	178	15	for	for	ADP
bptjm-12	178	16	the	the	DET
bptjm-12	178	17	purpose	purpose	NOUN
bptjm-12	178	18	of	of	ADP
bptjm-12	178	19	increasing	increase	VERB
bptjm-12	178	20	acetylcholine	acetylcholine	NOUN
bptjm-12	178	21	(	(	PUNCT
bptjm-12	178	22	ach	ach	NOUN
bptjm-12	178	23	)	)	PUNCT
bptjm-12	178	24	levels	level	NOUN
bptjm-12	178	25	in	in	ADP
bptjm-12	178	26	the	the	DET
bptjm-12	178	27	synapse	synapse	NOUN
bptjm-12	178	28	and	and	CCONJ
bptjm-12	178	29	increasing	increase	VERB
bptjm-12	178	30	cholinergic	cholinergic	ADJ
bptjm-12	178	31	berkeley	berkeley	PROPN
bptjm-12	178	32	pharma	pharma	PROPN
bptjm-12	178	33	tech	tech	NOUN
bptjm-12	178	34	journal	journal	NOUN
bptjm-12	178	35	of	of	ADP
bptjm-12	178	36	medicine	medicine	NOUN
bptjm-12	178	37	|	|	ADV
bptjm-12	178	38	14	14	NUM
bptjm-12	178	39	transmission	transmission	NOUN
bptjm-12	178	40	.	.	PUNCT
bptjm-12	179	1	in	in	ADP
bptjm-12	179	2	an	an	DET
bptjm-12	179	3	investigation	investigation	NOUN
bptjm-12	179	4	of	of	ADP
bptjm-12	179	5	cannabinoids	cannabinoid	NOUN
bptjm-12	179	6	as	as	ADP
bptjm-12	179	7	potential	potential	ADJ
bptjm-12	179	8	inhibitors	inhibitor	NOUN
bptjm-12	179	9	of	of	ADP
bptjm-12	179	10	ache	ache	ADV
bptjm-12	179	11	,	,	PUNCT
bptjm-12	179	12	δ-9	δ-9	NOUN
bptjm-12	179	13	-	-	PUNCT
bptjm-12	179	14	thc	thc	NOUN
bptjm-12	179	15	was	be	AUX
bptjm-12	179	16	found	find	VERB
bptjm-12	179	17	to	to	PART
bptjm-12	179	18	be	be	AUX
bptjm-12	179	19	a	a	DET
bptjm-12	179	20	competitive	competitive	ADJ
bptjm-12	179	21	inhibitor	inhibitor	NOUN
bptjm-12	179	22	for	for	ADP
bptjm-12	179	23	ache	ache	NOUN
bptjm-12	179	24	,	,	PUNCT
bptjm-12	179	25	which	which	PRON
bptjm-12	179	26	has	have	VERB
bptjm-12	179	27	the	the	DET
bptjm-12	179	28	added	add	VERB
bptjm-12	179	29	e	e	NOUN
bptjm-12	179	30	�	�	NOUN
bptjm-12	179	31	ect	ect	VERB
bptjm-12	179	32	of	of	ADP
bptjm-12	179	33	inhibiting	inhibit	VERB
bptjm-12	179	34	aβaggregation	aβaggregation	NOUN
bptjm-12	179	35	(	(	PUNCT
bptjm-12	179	36	ache	ache	ADV
bptjm-12	179	37	has	have	AUX
bptjm-12	179	38	been	be	AUX
bptjm-12	179	39	found	find	VERB
bptjm-12	179	40	to	to	PART
bptjm-12	179	41	accelerate	accelerate	VERB
bptjm-12	179	42	the	the	DET
bptjm-12	179	43	aggregation	aggregation	NOUN
bptjm-12	179	44	of	of	ADP
bptjm-12	179	45	aβpeptides	aβpeptide	NOUN
bptjm-12	179	46	into	into	ADP
bptjm-12	179	47	complexes	complex	NOUN
bptjm-12	179	48	,	,	PUNCT
bptjm-12	179	49	increasing	increase	VERB
bptjm-12	179	50	their	their	PRON
bptjm-12	179	51	neurotoxicity	neurotoxicity	NOUN
bptjm-12	179	52	)	)	PUNCT
bptjm-12	179	53	(	(	PUNCT
bptjm-12	179	54	campbell	campbell	PROPN
bptjm-12	179	55	et	et	PROPN
bptjm-12	179	56	al	al	PROPN
bptjm-12	179	57	.	.	PROPN
bptjm-12	179	58	,	,	PUNCT
bptjm-12	179	59	2007	2007	NUM
bptjm-12	179	60	)	)	PUNCT
bptjm-12	179	61	.	.	PUNCT
bptjm-12	180	1	nonetheless	nonetheless	ADV
bptjm-12	180	2	,	,	PUNCT
bptjm-12	180	3	more	more	ADJ
bptjm-12	180	4	research	research	NOUN
bptjm-12	180	5	is	be	AUX
bptjm-12	180	6	needed	need	VERB
bptjm-12	180	7	in	in	ADP
bptjm-12	180	8	order	order	NOUN
bptjm-12	180	9	to	to	PART
bptjm-12	180	10	understand	understand	VERB
bptjm-12	180	11	the	the	DET
bptjm-12	180	12	e	e	PROPN
bptjm-12	180	13	�	�	NOUN
bptjm-12	180	14	cacies	cacie	NOUN
bptjm-12	180	15	of	of	ADP
bptjm-12	180	16	cbd	cbd	NOUN
bptjm-12	180	17	and	and	CCONJ
bptjm-12	180	18	thc	thc	NOUN
bptjm-12	180	19	in	in	ADP
bptjm-12	180	20	the	the	DET
bptjm-12	180	21	treatment	treatment	NOUN
bptjm-12	180	22	of	of	ADP
bptjm-12	180	23	alzheimer	alzheimer	PROPN
bptjm-12	180	24	’s	’s	PART
bptjm-12	180	25	disease	disease	NOUN
bptjm-12	180	26	.	.	PUNCT
bptjm-12	181	1	as	as	SCONJ
bptjm-12	181	2	therapeutic	therapeutic	ADJ
bptjm-12	181	3	treatments	treatment	NOUN
bptjm-12	181	4	for	for	ADP
bptjm-12	181	5	alzheimer	alzheimer	PROPN
bptjm-12	181	6	’s	’s	PART
bptjm-12	181	7	disease	disease	NOUN
bptjm-12	181	8	continue	continue	VERB
bptjm-12	181	9	to	to	PART
bptjm-12	181	10	be	be	AUX
bptjm-12	181	11	explored	explore	VERB
bptjm-12	181	12	,	,	PUNCT
bptjm-12	181	13	cbd	cbd	NOUN
bptjm-12	181	14	is	be	AUX
bptjm-12	181	15	a	a	DET
bptjm-12	181	16	promising	promising	ADJ
bptjm-12	181	17	candidate	candidate	NOUN
bptjm-12	181	18	.	.	PUNCT
bptjm-12	182	1	a	a	DET
bptjm-12	182	2	handful	handful	NOUN
bptjm-12	182	3	of	of	ADP
bptjm-12	182	4	studies	study	NOUN
bptjm-12	182	5	show	show	VERB
bptjm-12	182	6	that	that	SCONJ
bptjm-12	182	7	thc	thc	PROPN
bptjm-12	182	8	is	be	AUX
bptjm-12	182	9	a	a	DET
bptjm-12	182	10	more	more	ADV
bptjm-12	182	11	e	e	NOUN
bptjm-12	182	12	�	�	NOUN
bptjm-12	182	13	ective	ective	ADJ
bptjm-12	182	14	inhibitor	inhibitor	NOUN
bptjm-12	182	15	than	than	ADP
bptjm-12	182	16	cbd	cbd	NOUN
bptjm-12	182	17	in	in	ADP
bptjm-12	182	18	regards	regard	NOUN
bptjm-12	182	19	to	to	ADP
bptjm-12	182	20	amyloid	amyloid	VERB
bptjm-12	182	21	plaque	plaque	NOUN
bptjm-12	182	22	buildup	buildup	NOUN
bptjm-12	182	23	.	.	PUNCT
bptjm-12	183	1	while	while	SCONJ
bptjm-12	183	2	the	the	DET
bptjm-12	183	3	general	general	ADJ
bptjm-12	183	4	consensus	consensus	NOUN
bptjm-12	183	5	of	of	ADP
bptjm-12	183	6	the	the	DET
bptjm-12	183	7	present	present	ADJ
bptjm-12	183	8	community	community	NOUN
bptjm-12	183	9	is	be	AUX
bptjm-12	183	10	built	build	VERB
bptjm-12	183	11	upon	upon	SCONJ
bptjm-12	183	12	the	the	DET
bptjm-12	183	13	e	e	NOUN
bptjm-12	183	14	�	�	PROPN
bptjm-12	183	15	ects	ect	NOUN
bptjm-12	183	16	of	of	ADP
bptjm-12	183	17	cannabidiol	cannabidiol	NOUN
bptjm-12	183	18	,	,	PUNCT
bptjm-12	183	19	the	the	DET
bptjm-12	183	20	e	e	PROPN
bptjm-12	183	21	�	�	PROPN
bptjm-12	183	22	cacy	cacy	NOUN
bptjm-12	183	23	of	of	ADP
bptjm-12	183	24	∆9	∆9	NOUN
bptjm-12	183	25	-	-	PUNCT
bptjm-12	183	26	tetrahydrocannabinol	tetrahydrocannabinol	NOUN
bptjm-12	183	27	should	should	AUX
bptjm-12	183	28	also	also	ADV
bptjm-12	183	29	be	be	AUX
bptjm-12	183	30	considered	consider	VERB
bptjm-12	183	31	as	as	ADP
bptjm-12	183	32	a	a	DET
bptjm-12	183	33	viable	viable	ADJ
bptjm-12	183	34	method	method	NOUN
bptjm-12	183	35	of	of	ADP
bptjm-12	183	36	treatment	treatment	NOUN
bptjm-12	183	37	for	for	ADP
bptjm-12	183	38	alzheimer	alzheimer	NOUN
bptjm-12	183	39	’s	’s	PART
bptjm-12	183	40	.	.	PUNCT
bptjm-12	184	1	it	it	PRON
bptjm-12	184	2	is	be	AUX
bptjm-12	184	3	nearly	nearly	ADV
bptjm-12	184	4	impossible	impossible	ADJ
bptjm-12	184	5	to	to	PART
bptjm-12	184	6	ignore	ignore	VERB
bptjm-12	184	7	the	the	DET
bptjm-12	184	8	therapeutic	therapeutic	ADJ
bptjm-12	184	9	potential	potential	NOUN
bptjm-12	184	10	of	of	ADP
bptjm-12	184	11	receptor	receptor	NOUN
bptjm-12	184	12	agonists	agonist	NOUN
bptjm-12	184	13	within	within	ADP
bptjm-12	184	14	the	the	DET
bptjm-12	184	15	endocannabinoid	endocannabinoid	NOUN
bptjm-12	184	16	system	system	NOUN
bptjm-12	184	17	against	against	ADP
bptjm-12	184	18	the	the	DET
bptjm-12	184	19	advancement	advancement	NOUN
bptjm-12	184	20	of	of	ADP
bptjm-12	184	21	alzheimer	alzheimer	PROPN
bptjm-12	184	22	's	's	PART
bptjm-12	184	23	disease	disease	NOUN
bptjm-12	184	24	.	.	PUNCT
bptjm-12	185	1	b.	b.	PROPN
bptjm-12	185	2	synthetic	synthetic	PROPN
bptjm-12	185	3	cannabinoid	cannabinoid	VERB
bptjm-12	185	4	receptor	receptor	NOUN
bptjm-12	185	5	agonists	agonist	NOUN
bptjm-12	185	6	synthetic	synthetic	VERB
bptjm-12	185	7	cannabinoid	cannabinoid	VERB
bptjm-12	185	8	receptor	receptor	NOUN
bptjm-12	185	9	agonists	agonist	NOUN
bptjm-12	185	10	target	target	VERB
bptjm-12	185	11	the	the	DET
bptjm-12	185	12	degenerative	degenerative	ADJ
bptjm-12	185	13	e	e	NOUN
bptjm-12	185	14	�	�	PROPN
bptjm-12	185	15	ects	ect	NOUN
bptjm-12	185	16	of	of	ADP
bptjm-12	185	17	alzheimer	alzheimer	PROPN
bptjm-12	185	18	’s	’s	NOUN
bptjm-12	185	19	through	through	ADP
bptjm-12	185	20	the	the	DET
bptjm-12	185	21	cb1	cb1	NOUN
bptjm-12	185	22	and	and	CCONJ
bptjm-12	185	23	cb2	cb2	NOUN
bptjm-12	185	24	receptors	receptor	NOUN
bptjm-12	185	25	of	of	ADP
bptjm-12	185	26	the	the	DET
bptjm-12	185	27	ecs	ecs	PROPN
bptjm-12	185	28	.	.	PUNCT
bptjm-12	186	1	these	these	DET
bptjm-12	186	2	receptor	receptor	NOUN
bptjm-12	186	3	agonists	agonist	NOUN
bptjm-12	186	4	can	can	AUX
bptjm-12	186	5	reduce	reduce	VERB
bptjm-12	186	6	the	the	DET
bptjm-12	186	7	density	density	NOUN
bptjm-12	186	8	of	of	ADP
bptjm-12	186	9	neuritic	neuritic	ADJ
bptjm-12	186	10	plaques	plaque	NOUN
bptjm-12	186	11	by	by	ADP
bptjm-12	186	12	inhibiting	inhibit	VERB
bptjm-12	186	13	acetylcholinesterase	acetylcholinesterase	NOUN
bptjm-12	186	14	activity	activity	NOUN
bptjm-12	186	15	,	,	PUNCT
bptjm-12	186	16	or	or	CCONJ
bptjm-12	186	17	increasing	increase	VERB
bptjm-12	186	18	expression	expression	NOUN
bptjm-12	186	19	of	of	ADP
bptjm-12	186	20	neprilysin	neprilysin	NOUN
bptjm-12	186	21	,	,	PUNCT
bptjm-12	186	22	an	an	DET
bptjm-12	186	23	enzyme	enzyme	NOUN
bptjm-12	186	24	in	in	ADP
bptjm-12	186	25	the	the	DET
bptjm-12	186	26	aβ	aβ	NOUN
bptjm-12	186	27	degradation	degradation	NOUN
bptjm-12	186	28	cascade	cascade	NOUN
bptjm-12	186	29	(	(	PUNCT
bptjm-12	186	30	fernández	fernández	PROPN
bptjm-12	186	31	-	-	PUNCT
bptjm-12	186	32	ruiz	ruiz	NOUN
bptjm-12	186	33	et	et	PROPN
bptjm-12	186	34	al	al	PROPN
bptjm-12	186	35	.	.	PROPN
bptjm-12	186	36	,	,	PUNCT
bptjm-12	186	37	2015	2015	NUM
bptjm-12	186	38	)	)	PUNCT
bptjm-12	186	39	.	.	PUNCT
bptjm-12	187	1	the	the	DET
bptjm-12	187	2	syntheticcannabinoids	syntheticcannabinoid	NOUN
bptjm-12	187	3	also	also	ADV
bptjm-12	187	4	function	function	VERB
bptjm-12	187	5	as	as	ADP
bptjm-12	187	6	a	a	DET
bptjm-12	187	7	treatment	treatment	NOUN
bptjm-12	187	8	that	that	PRON
bptjm-12	187	9	blocks	block	VERB
bptjm-12	187	10	the	the	DET
bptjm-12	187	11	activation	activation	NOUN
bptjm-12	187	12	of	of	ADP
bptjm-12	187	13	the	the	DET
bptjm-12	187	14	microglial	microglial	ADJ
bptjm-12	187	15	clustercaused	clustercause	VERB
bptjm-12	187	16	by	by	ADP
bptjm-12	187	17	the	the	DET
bptjm-12	187	18	deposition	deposition	NOUN
bptjm-12	187	19	of	of	ADP
bptjm-12	187	20	aβ	aβ	PRON
bptjm-12	187	21	at	at	ADP
bptjm-12	187	22	the	the	DET
bptjm-12	187	23	senile	senile	ADJ
bptjm-12	187	24	plaque	plaque	NOUN
bptjm-12	187	25	.	.	PUNCT
bptjm-12	188	1	this	this	DET
bptjm-12	188	2	deposition	deposition	NOUN
bptjm-12	188	3	is	be	AUX
bptjm-12	188	4	typically	typically	ADV
bptjm-12	188	5	responsible	responsible	ADJ
bptjm-12	188	6	for	for	ADP
bptjm-12	188	7	the	the	DET
bptjm-12	188	8	prolonged	prolonged	ADJ
bptjm-12	188	9	damaging	damaging	ADJ
bptjm-12	188	10	e	e	NOUN
bptjm-12	188	11	�	�	NOUN
bptjm-12	188	12	ects	ect	NOUN
bptjm-12	188	13	of	of	ADP
bptjm-12	188	14	the	the	DET
bptjm-12	188	15	disease	disease	NOUN
bptjm-12	188	16	,	,	PUNCT
bptjm-12	188	17	and	and	CCONJ
bptjm-12	188	18	the	the	DET
bptjm-12	188	19	presence	presence	NOUN
bptjm-12	188	20	of	of	ADP
bptjm-12	188	21	cannabinoids	cannabinoid	NOUN
bptjm-12	188	22	alleviates	alleviate	VERB
bptjm-12	188	23	neurodegeneration	neurodegeneration	NOUN
bptjm-12	188	24	(	(	PUNCT
bptjm-12	188	25	ramírez	ramírez	NOUN
bptjm-12	188	26	et	et	PROPN
bptjm-12	188	27	al	al	PROPN
bptjm-12	188	28	.	.	PROPN
bptjm-12	188	29	,	,	PUNCT
bptjm-12	188	30	2005	2005	NUM
bptjm-12	188	31	)	)	PUNCT
bptjm-12	188	32	.	.	PUNCT
bptjm-12	189	1	since	since	SCONJ
bptjm-12	189	2	these	these	DET
bptjm-12	189	3	potential	potential	ADJ
bptjm-12	189	4	neuroprotective	neuroprotective	ADJ
bptjm-12	189	5	e	e	NOUN
bptjm-12	189	6	�	�	NOUN
bptjm-12	189	7	ects	ect	NOUN
bptjm-12	189	8	have	have	AUX
bptjm-12	189	9	been	be	AUX
bptjm-12	189	10	discovered	discover	VERB
bptjm-12	189	11	,	,	PUNCT
bptjm-12	189	12	extensive	extensive	ADJ
bptjm-12	189	13	research	research	NOUN
bptjm-12	189	14	is	be	AUX
bptjm-12	189	15	being	be	AUX
bptjm-12	189	16	dedicated	dedicate	VERB
bptjm-12	189	17	towards	towards	ADP
bptjm-12	189	18	studying	study	VERB
bptjm-12	189	19	the	the	DET
bptjm-12	189	20	endocannabinoid	endocannabinoid	NOUN
bptjm-12	189	21	system	system	NOUN
bptjm-12	189	22	.	.	PUNCT
bptjm-12	190	1	researchers	researcher	NOUN
bptjm-12	190	2	have	have	AUX
bptjm-12	190	3	already	already	ADV
bptjm-12	190	4	found	find	VERB
bptjm-12	190	5	that	that	SCONJ
bptjm-12	190	6	dysfunction	dysfunction	NOUN
bptjm-12	190	7	of	of	ADP
bptjm-12	190	8	cb1	cb1	PROPN
bptjm-12	190	9	and	and	CCONJ
bptjm-12	190	10	cb2	cb2	NOUN
bptjm-12	190	11	receptors	receptor	NOUN
bptjm-12	190	12	and	and	CCONJ
bptjm-12	190	13	in	in	ADP
bptjm-12	190	14	endocannabinoid	endocannabinoid	NOUN
bptjm-12	190	15	signaling	signal	VERB
bptjm-12	190	16	plays	play	VERB
bptjm-12	190	17	a	a	DET
bptjm-12	190	18	speci	speci	ADJ
bptjm-12	190	19	�	�	PROPN
bptjm-12	190	20	c	c	NOUN
bptjm-12	190	21	role	role	NOUN
bptjm-12	190	22	in	in	ADP
bptjm-12	190	23	the	the	DET
bptjm-12	190	24	pathophysiology	pathophysiology	NOUN
bptjm-12	190	25	of	of	ADP
bptjm-12	190	26	ad	ad	NOUN
bptjm-12	190	27	(	(	PUNCT
bptjm-12	190	28	liu	liu	PROPN
bptjm-12	190	29	et	et	PROPN
bptjm-12	190	30	al	al	PROPN
bptjm-12	190	31	.	.	PROPN
bptjm-12	190	32	,	,	PUNCT
bptjm-12	190	33	2015	2015	NUM
bptjm-12	190	34	)	)	PUNCT
bptjm-12	190	35	.	.	PUNCT
bptjm-12	191	1	one	one	NUM
bptjm-12	191	2	study	study	NOUN
bptjm-12	191	3	investigated	investigate	VERB
bptjm-12	191	4	the	the	DET
bptjm-12	191	5	speci	speci	PROPN
bptjm-12	191	6	�	�	PROPN
bptjm-12	191	7	c	c	PROPN
bptjm-12	191	8	bene	bene	PROPN
bptjm-12	191	9	�	�	PROPN
bptjm-12	191	10	ts	ts	ADP
bptjm-12	191	11	that	that	SCONJ
bptjm-12	191	12	synthetic	synthetic	ADJ
bptjm-12	191	13	cannabinoids	cannabinoid	NOUN
bptjm-12	191	14	could	could	AUX
bptjm-12	191	15	have	have	VERB
bptjm-12	191	16	on	on	ADP
bptjm-12	191	17	neuropsychiatric	neuropsychiatric	ADJ
bptjm-12	191	18	symptoms	symptom	NOUN
bptjm-12	191	19	(	(	PUNCT
bptjm-12	191	20	nps	nps	PROPN
bptjm-12	191	21	)	)	PUNCT
bptjm-12	191	22	associated	associate	VERB
bptjm-12	191	23	with	with	ADP
bptjm-12	191	24	ad	ad	NOUN
bptjm-12	191	25	.	.	PUNCT
bptjm-12	192	1	the	the	DET
bptjm-12	192	2	researchers	researcher	NOUN
bptjm-12	192	3	studied	study	VERB
bptjm-12	192	4	two	two	NUM
bptjm-12	192	5	synthetic	synthetic	ADJ
bptjm-12	192	6	analogs	analog	NOUN
bptjm-12	192	7	of	of	ADP
bptjm-12	192	8	δ-9	δ-9	NOUN
bptjm-12	192	9	-	-	PUNCT
bptjm-12	192	10	thc	thc	NOUN
bptjm-12	192	11	,	,	PUNCT
bptjm-12	192	12	dronabinol	dronabinol	NOUN
bptjm-12	192	13	and	and	CCONJ
bptjm-12	192	14	nabilone	nabilone	NOUN
bptjm-12	192	15	,	,	PUNCT
bptjm-12	192	16	and	and	CCONJ
bptjm-12	192	17	their	their	PRON
bptjm-12	192	18	interactions	interaction	NOUN
bptjm-12	192	19	with	with	ADP
bptjm-12	192	20	receptors	receptor	NOUN
bptjm-12	192	21	in	in	ADP
bptjm-12	192	22	the	the	DET
bptjm-12	192	23	ecs	ecs	PROPN
bptjm-12	192	24	.	.	PUNCT
bptjm-12	193	1	nabilone	nabilone	PROPN
bptjm-12	193	2	and	and	CCONJ
bptjm-12	193	3	dronabinol	dronabinol	PROPN
bptjm-12	193	4	were	be	AUX
bptjm-12	193	5	berkeley	berkeley	PROPN
bptjm-12	193	6	pharma	pharma	PROPN
bptjm-12	193	7	tech	tech	NOUN
bptjm-12	193	8	journal	journal	NOUN
bptjm-12	193	9	of	of	ADP
bptjm-12	193	10	medicine	medicine	NOUN
bptjm-12	193	11	|	|	ADV
bptjm-12	193	12	15	15	NUM
bptjm-12	193	13	found	find	VERB
bptjm-12	193	14	to	to	PART
bptjm-12	193	15	be	be	AUX
bptjm-12	193	16	more	more	ADV
bptjm-12	193	17	potent	potent	ADJ
bptjm-12	193	18	analogs	analog	NOUN
bptjm-12	193	19	to	to	ADP
bptjm-12	193	20	thc	thc	PROPN
bptjm-12	193	21	that	that	DET
bptjm-12	193	22	act	act	NOUN
bptjm-12	193	23	on	on	ADP
bptjm-12	193	24	both	both	CCONJ
bptjm-12	193	25	cb1	cb1	NOUN
bptjm-12	193	26	and	and	CCONJ
bptjm-12	193	27	cb2	cb2	NOUN
bptjm-12	193	28	receptors	receptor	NOUN
bptjm-12	193	29	and	and	CCONJ
bptjm-12	193	30	reduced	reduce	VERB
bptjm-12	193	31	overall	overall	ADJ
bptjm-12	193	32	agitation	agitation	NOUN
bptjm-12	193	33	in	in	ADP
bptjm-12	193	34	ad	ad	NOUN
bptjm-12	193	35	patients	patient	NOUN
bptjm-12	193	36	(	(	PUNCT
bptjm-12	193	37	liu	liu	PROPN
bptjm-12	193	38	et	et	PROPN
bptjm-12	193	39	al	al	PROPN
bptjm-12	193	40	.	.	PROPN
bptjm-12	193	41	,	,	PUNCT
bptjm-12	193	42	2015	2015	NUM
bptjm-12	193	43	)	)	PUNCT
bptjm-12	193	44	.	.	PUNCT
bptjm-12	194	1	participants	participant	NOUN
bptjm-12	194	2	receiving	receive	VERB
bptjm-12	194	3	nabilone	nabilone	NOUN
bptjm-12	194	4	experienced	experience	VERB
bptjm-12	194	5	no	no	DET
bptjm-12	194	6	adverse	adverse	ADJ
bptjm-12	194	7	side	side	NOUN
bptjm-12	194	8	e	e	NOUN
bptjm-12	194	9	�	�	NOUN
bptjm-12	194	10	ects	ect	NOUN
bptjm-12	194	11	.	.	PUNCT
bptjm-12	195	1	in	in	ADP
bptjm-12	195	2	the	the	DET
bptjm-12	195	3	dronabinol	dronabinol	PROPN
bptjm-12	195	4	study	study	NOUN
bptjm-12	195	5	,	,	PUNCT
bptjm-12	195	6	the	the	DET
bptjm-12	195	7	researchers	researcher	NOUN
bptjm-12	195	8	measured	measure	VERB
bptjm-12	195	9	disturbed	disturbed	ADJ
bptjm-12	195	10	behavior	behavior	NOUN
bptjm-12	195	11	in	in	ADP
bptjm-12	195	12	study	study	NOUN
bptjm-12	195	13	participants	participant	NOUN
bptjm-12	195	14	using	use	VERB
bptjm-12	195	15	the	the	DET
bptjm-12	195	16	cohen	cohen	NOUN
bptjm-12	195	17	-	-	PUNCT
bptjm-12	195	18	mans	mans	PROPN
bptjm-12	195	19	�	�	PROPN
bptjm-12	195	20	eld	eld	PROPN
bptjm-12	195	21	agitation	agitation	PROPN
bptjm-12	195	22	inventory	inventory	NOUN
bptjm-12	195	23	(	(	PUNCT
bptjm-12	195	24	cmai	cmai	PROPN
bptjm-12	195	25	)	)	PUNCT
bptjm-12	195	26	,	,	PUNCT
bptjm-12	195	27	a	a	DET
bptjm-12	195	28	scale	scale	NOUN
bptjm-12	195	29	which	which	PRON
bptjm-12	195	30	systematically	systematically	ADV
bptjm-12	195	31	assesses	assess	VERB
bptjm-12	195	32	patient	patient	ADJ
bptjm-12	195	33	agitation	agitation	NOUN
bptjm-12	195	34	.	.	PUNCT
bptjm-12	196	1	they	they	PRON
bptjm-12	196	2	found	find	VERB
bptjm-12	196	3	that	that	SCONJ
bptjm-12	196	4	with	with	ADP
bptjm-12	196	5	administration	administration	NOUN
bptjm-12	196	6	of	of	ADP
bptjm-12	196	7	the	the	DET
bptjm-12	196	8	synthetic	synthetic	ADJ
bptjm-12	196	9	cannabinoid	cannabinoid	NOUN
bptjm-12	196	10	,	,	PUNCT
bptjm-12	196	11	disturbed	disturbed	ADJ
bptjm-12	196	12	behavior	behavior	NOUN
bptjm-12	196	13	dropped	drop	VERB
bptjm-12	196	14	among	among	ADP
bptjm-12	196	15	the	the	DET
bptjm-12	196	16	participants	participant	NOUN
bptjm-12	196	17	over	over	ADP
bptjm-12	196	18	the	the	DET
bptjm-12	196	19	course	course	NOUN
bptjm-12	196	20	of	of	ADP
bptjm-12	196	21	the	the	DET
bptjm-12	196	22	6	6	NUM
bptjm-12	196	23	-	-	PUNCT
bptjm-12	196	24	week	week	NOUN
bptjm-12	196	25	test	test	NOUN
bptjm-12	196	26	period	period	NOUN
bptjm-12	196	27	(	(	PUNCT
bptjm-12	196	28	liu	liu	PROPN
bptjm-12	196	29	et	et	PROPN
bptjm-12	196	30	al	al	PROPN
bptjm-12	196	31	.	.	PROPN
bptjm-12	196	32	,	,	PUNCT
bptjm-12	196	33	2015	2015	NUM
bptjm-12	196	34	)	)	PUNCT
bptjm-12	196	35	.	.	PUNCT
bptjm-12	197	1	stimulation	stimulation	NOUN
bptjm-12	197	2	of	of	ADP
bptjm-12	197	3	the	the	DET
bptjm-12	197	4	cb2	cb2	NOUN
bptjm-12	197	5	receptor	receptor	NOUN
bptjm-12	197	6	by	by	ADP
bptjm-12	197	7	these	these	DET
bptjm-12	197	8	synthetic	synthetic	ADJ
bptjm-12	197	9	cannabinoids	cannabinoid	NOUN
bptjm-12	197	10	increases	increase	VERB
bptjm-12	197	11	the	the	DET
bptjm-12	197	12	removal	removal	NOUN
bptjm-12	197	13	of	of	ADP
bptjm-12	197	14	aβ	aβ	DET
bptjm-12	197	15	deposits	deposit	NOUN
bptjm-12	197	16	by	by	ADP
bptjm-12	197	17	enhancing	enhance	VERB
bptjm-12	197	18	macrophage	macrophage	ADJ
bptjm-12	197	19	activity	activity	NOUN
bptjm-12	197	20	,	,	PUNCT
bptjm-12	197	21	thus	thus	ADV
bptjm-12	197	22	explaining	explain	VERB
bptjm-12	197	23	the	the	DET
bptjm-12	197	24	improvements	improvement	NOUN
bptjm-12	197	25	in	in	ADP
bptjm-12	197	26	nps	nps	PROPN
bptjm-12	197	27	seen	see	VERB
bptjm-12	197	28	in	in	ADP
bptjm-12	197	29	study	study	NOUN
bptjm-12	197	30	participants	participant	NOUN
bptjm-12	197	31	.	.	PUNCT
bptjm-12	198	1	another	another	DET
bptjm-12	198	2	studyinvestigating	studyinvestigating	NOUN
bptjm-12	198	3	the	the	DET
bptjm-12	198	4	e	e	PROPN
bptjm-12	198	5	�	�	PROPN
bptjm-12	198	6	cacy	cacy	NOUN
bptjm-12	198	7	of	of	ADP
bptjm-12	198	8	nabilone	nabilone	PROPN
bptjm-12	198	9	as	as	ADP
bptjm-12	198	10	a	a	DET
bptjm-12	198	11	potential	potential	ADJ
bptjm-12	198	12	treatment	treatment	NOUN
bptjm-12	198	13	for	for	ADP
bptjm-12	198	14	the	the	DET
bptjm-12	198	15	nps	nps	PROPN
bptjm-12	198	16	of	of	ADP
bptjm-12	198	17	ad	ad	NOUN
bptjm-12	198	18	similarly	similarly	ADV
bptjm-12	198	19	found	find	VERB
bptjm-12	198	20	an	an	DET
bptjm-12	198	21	overall	overall	ADJ
bptjm-12	198	22	decrease	decrease	NOUN
bptjm-12	198	23	in	in	ADP
bptjm-12	198	24	agitation	agitation	NOUN
bptjm-12	198	25	,	,	PUNCT
bptjm-12	198	26	and	and	CCONJ
bptjm-12	198	27	sometimes	sometimes	ADV
bptjm-12	198	28	aggression	aggression	NOUN
bptjm-12	198	29	as	as	ADV
bptjm-12	198	30	well	well	ADV
bptjm-12	198	31	(	(	PUNCT
bptjm-12	198	32	ruthirakuhan	ruthirakuhan	PROPN
bptjm-12	198	33	et	et	PROPN
bptjm-12	198	34	al	al	PROPN
bptjm-12	198	35	.	.	PROPN
bptjm-12	198	36	,	,	PUNCT
bptjm-12	198	37	2019	2019	NUM
bptjm-12	198	38	)	)	PUNCT
bptjm-12	198	39	.	.	PUNCT
bptjm-12	199	1	the	the	DET
bptjm-12	199	2	synthetic	synthetic	ADJ
bptjm-12	199	3	cannabinoid	cannabinoid	NOUN
bptjm-12	199	4	receptor	receptor	NOUN
bptjm-12	199	5	agonists	agonist	NOUN
bptjm-12	199	6	win55,212	win55,212	PROPN
bptjm-12	199	7	-	-	PUNCT
bptjm-12	199	8	2	2	NUM
bptjm-12	199	9	and	and	CCONJ
bptjm-12	199	10	arachidonyl-2	arachidonyl-2	NOUN
bptjm-12	199	11	-	-	PUNCT
bptjm-12	199	12	chloroethylamide	chloroethylamide	NOUN
bptjm-12	199	13	were	be	AUX
bptjm-12	199	14	also	also	ADV
bptjm-12	199	15	found	find	VERB
bptjm-12	199	16	to	to	PART
bptjm-12	199	17	decrease	decrease	VERB
bptjm-12	199	18	aggressive	aggressive	ADJ
bptjm-12	199	19	behavior	behavior	NOUN
bptjm-12	199	20	associated	associate	VERB
bptjm-12	199	21	with	with	ADP
bptjm-12	199	22	ad	ad	NOUN
bptjm-12	199	23	and	and	CCONJ
bptjm-12	199	24	reduce	reduce	VERB
bptjm-12	199	25	tau	tau	PROPN
bptjm-12	199	26	hyperphosphorylation	hyperphosphorylation	NOUN
bptjm-12	199	27	and	and	CCONJ
bptjm-12	199	28	the	the	DET
bptjm-12	199	29	neuro	neuro	PROPN
bptjm-12	199	30	�	�	PROPN
bptjm-12	199	31	brillary	brillary	ADJ
bptjm-12	199	32	tangles	tangle	NOUN
bptjm-12	199	33	(	(	PUNCT
bptjm-12	199	34	liu	liu	PROPN
bptjm-12	199	35	et	et	PROPN
bptjm-12	199	36	al	al	PROPN
bptjm-12	199	37	.	.	PROPN
bptjm-12	199	38	,	,	PUNCT
bptjm-12	199	39	2015	2015	NUM
bptjm-12	199	40	)	)	PUNCT
bptjm-12	199	41	.	.	PUNCT
bptjm-12	200	1	win55,212	win55,212	PROPN
bptjm-12	200	2	-	-	PUNCT
bptjm-12	200	3	2	2	NUM
bptjm-12	200	4	along	along	ADP
bptjm-12	200	5	with	with	ADP
bptjm-12	200	6	jwh-133	jwh-133	NOUN
bptjm-12	200	7	were	be	AUX
bptjm-12	200	8	also	also	ADV
bptjm-12	200	9	found	find	VERB
bptjm-12	200	10	to	to	PART
bptjm-12	200	11	assist	assist	VERB
bptjm-12	200	12	in	in	ADP
bptjm-12	200	13	the	the	DET
bptjm-12	200	14	removal	removal	NOUN
bptjm-12	200	15	of	of	ADP
bptjm-12	200	16	aβ	aβ	DET
bptjm-12	200	17	deposits	deposit	NOUN
bptjm-12	200	18	,	,	PUNCT
bptjm-12	200	19	one	one	NUM
bptjm-12	200	20	of	of	ADP
bptjm-12	200	21	the	the	DET
bptjm-12	200	22	most	most	ADV
bptjm-12	200	23	common	common	ADJ
bptjm-12	200	24	pathophysiology	pathophysiology	NOUN
bptjm-12	200	25	associated	associate	VERB
bptjm-12	200	26	with	with	ADP
bptjm-12	200	27	alzheimer	alzheimer	PROPN
bptjm-12	200	28	’s	’s	PART
bptjm-12	200	29	.	.	PUNCT
bptjm-12	201	1	win55,212	win55,212	PROPN
bptjm-12	201	2	-	-	PUNCT
bptjm-12	201	3	2	2	PROPN
bptjm-12	201	4	’s	’s	PART
bptjm-12	201	5	ability	ability	NOUN
bptjm-12	201	6	to	to	PART
bptjm-12	201	7	stimulate	stimulate	VERB
bptjm-12	201	8	neurogenesis	neurogenesis	NOUN
bptjm-12	201	9	makes	make	VERB
bptjm-12	201	10	it	it	PRON
bptjm-12	201	11	a	a	DET
bptjm-12	201	12	great	great	ADJ
bptjm-12	201	13	contender	contender	NOUN
bptjm-12	201	14	as	as	ADP
bptjm-12	201	15	a	a	DET
bptjm-12	201	16	therapeutic	therapeutic	ADJ
bptjm-12	201	17	agent	agent	NOUN
bptjm-12	201	18	.	.	PUNCT
bptjm-12	202	1	although	although	SCONJ
bptjm-12	202	2	there	there	PRON
bptjm-12	202	3	are	be	VERB
bptjm-12	202	4	positive	positive	ADJ
bptjm-12	202	5	outcomes	outcome	NOUN
bptjm-12	202	6	of	of	ADP
bptjm-12	202	7	such	such	ADJ
bptjm-12	202	8	drugs	drug	NOUN
bptjm-12	202	9	on	on	ADP
bptjm-12	202	10	reversing	reverse	VERB
bptjm-12	202	11	ad	ad	NOUN
bptjm-12	202	12	-	-	PUNCT
bptjm-12	202	13	related	relate	VERB
bptjm-12	202	14	amnesia	amnesia	NOUN
bptjm-12	202	15	,	,	PUNCT
bptjm-12	202	16	they	they	PRON
bptjm-12	202	17	must	must	AUX
bptjm-12	202	18	be	be	AUX
bptjm-12	202	19	used	use	VERB
bptjm-12	202	20	with	with	ADP
bptjm-12	202	21	caution	caution	NOUN
bptjm-12	202	22	as	as	SCONJ
bptjm-12	202	23	there	there	PRON
bptjm-12	202	24	is	be	VERB
bptjm-12	202	25	a	a	DET
bptjm-12	202	26	risk	risk	NOUN
bptjm-12	202	27	of	of	ADP
bptjm-12	202	28	exacerbating	exacerbate	VERB
bptjm-12	202	29	the	the	DET
bptjm-12	202	30	neurodegeneration	neurodegeneration	NOUN
bptjm-12	202	31	associated	associate	VERB
bptjm-12	202	32	with	with	ADP
bptjm-12	202	33	ad	ad	NOUN
bptjm-12	202	34	(	(	PUNCT
bptjm-12	202	35	liu	liu	PROPN
bptjm-12	202	36	et	et	PROPN
bptjm-12	202	37	al	al	PROPN
bptjm-12	202	38	.	.	PROPN
bptjm-12	202	39	,	,	PUNCT
bptjm-12	202	40	2015	2015	NUM
bptjm-12	202	41	)	)	PUNCT
bptjm-12	202	42	.	.	PUNCT
bptjm-12	203	1	agonists	agonist	NOUN
bptjm-12	203	2	that	that	PRON
bptjm-12	203	3	speci	speci	PROPN
bptjm-12	203	4	�	�	PROPN
bptjm-12	203	5	cally	cally	ADV
bptjm-12	203	6	target	target	VERB
bptjm-12	203	7	cb2	cb2	NOUN
bptjm-12	203	8	activate	activate	VERB
bptjm-12	203	9	responses	response	NOUN
bptjm-12	203	10	that	that	PRON
bptjm-12	203	11	reduce	reduce	VERB
bptjm-12	203	12	both	both	PRON
bptjm-12	203	13	in	in	ADP
bptjm-12	203	14	�	�	NOUN
bptjm-12	203	15	ammatory	ammatory	NOUN
bptjm-12	203	16	and	and	CCONJ
bptjm-12	203	17	aβ	aβ	PRON
bptjm-12	203	18	plaque	plaque	NOUN
bptjm-12	203	19	buildup	buildup	NOUN
bptjm-12	203	20	.	.	PUNCT
bptjm-12	204	1	the	the	DET
bptjm-12	204	2	cb2	cb2	PROPN
bptjm-12	204	3	agonist	agonist	NOUN
bptjm-12	204	4	jwh-015	jwh-015	PROPN
bptjm-12	204	5	was	be	AUX
bptjm-12	204	6	used	use	VERB
bptjm-12	204	7	to	to	PART
bptjm-12	204	8	further	far	ADV
bptjm-12	204	9	investigate	investigate	VERB
bptjm-12	204	10	the	the	DET
bptjm-12	204	11	function	function	NOUN
bptjm-12	204	12	of	of	ADP
bptjm-12	204	13	cb2	cb2	PROPN
bptjm-12	204	14	with	with	ADP
bptjm-12	204	15	tests	test	NOUN
bptjm-12	204	16	done	do	VERB
bptjm-12	204	17	on	on	ADP
bptjm-12	204	18	ad	ad	NOUN
bptjm-12	204	19	human	human	ADJ
bptjm-12	204	20	tissue	tissue	NOUN
bptjm-12	204	21	.	.	PUNCT
bptjm-12	205	1	these	these	DET
bptjm-12	205	2	tests	test	NOUN
bptjm-12	205	3	demonstrated	demonstrate	VERB
bptjm-12	205	4	that	that	SCONJ
bptjm-12	205	5	jwh-015	jwh-015	PROPN
bptjm-12	205	6	was	be	AUX
bptjm-12	205	7	able	able	ADJ
bptjm-12	205	8	to	to	PART
bptjm-12	205	9	reduce	reduce	VERB
bptjm-12	205	10	plaque	plaque	NOUN
bptjm-12	205	11	buildup	buildup	NOUN
bptjm-12	205	12	dramatically	dramatically	ADV
bptjm-12	205	13	in	in	ADP
bptjm-12	205	14	thp-1	thp-1	PUNCT
bptjm-12	205	15	macrophage	macrophage	ADJ
bptjm-12	205	16	cells	cell	NOUN
bptjm-12	205	17	(	(	PUNCT
bptjm-12	205	18	tolón	tolón	NOUN
bptjm-12	205	19	et	et	PROPN
bptjm-12	205	20	al	al	PROPN
bptjm-12	205	21	.	.	PROPN
bptjm-12	205	22	,	,	PUNCT
bptjm-12	205	23	2009	2009	NUM
bptjm-12	205	24	)	)	PUNCT
bptjm-12	205	25	.	.	PUNCT
bptjm-12	206	1	however	however	ADV
bptjm-12	206	2	,	,	PUNCT
bptjm-12	206	3	the	the	DET
bptjm-12	206	4	u373	u373	PROPN
bptjm-12	206	5	astrocytoma	astrocytoma	NOUN
bptjm-12	206	6	cells	cell	NOUN
bptjm-12	206	7	,	,	PUNCT
bptjm-12	206	8	which	which	PRON
bptjm-12	206	9	are	be	AUX
bptjm-12	206	10	from	from	ADP
bptjm-12	206	11	the	the	DET
bptjm-12	206	12	astrocytoma	astrocytoma	NOUN
bptjm-12	206	13	cancer	cancer	NOUN
bptjm-12	206	14	cell	cell	NOUN
bptjm-12	206	15	line	line	NOUN
bptjm-12	206	16	in	in	ADP
bptjm-12	206	17	the	the	DET
bptjm-12	206	18	human	human	ADJ
bptjm-12	206	19	brain	brain	NOUN
bptjm-12	206	20	,	,	PUNCT
bptjm-12	206	21	were	be	AUX
bptjm-12	206	22	immune	immune	ADJ
bptjm-12	206	23	to	to	ADP
bptjm-12	206	24	the	the	DET
bptjm-12	206	25	e	e	NOUN
bptjm-12	206	26	�	�	PROPN
bptjm-12	206	27	ects	ect	NOUN
bptjm-12	206	28	(	(	PUNCT
bptjm-12	206	29	tolónet	tolónet	PROPN
bptjm-12	206	30	al	al	PROPN
bptjm-12	206	31	.	.	PROPN
bptjm-12	206	32	,	,	PUNCT
bptjm-12	206	33	2009	2009	NUM
bptjm-12	206	34	)	)	PUNCT
bptjm-12	206	35	.	.	PUNCT
bptjm-12	207	1	thus	thus	ADV
bptjm-12	207	2	,	,	PUNCT
bptjm-12	207	3	the	the	DET
bptjm-12	207	4	cb2	cb2	PROPN
bptjm-12	207	5	agonist	agonist	NOUN
bptjm-12	207	6	induced	induce	VERB
bptjm-12	207	7	plaque	plaque	NOUN
bptjm-12	207	8	removal	removal	NOUN
bptjm-12	207	9	was	be	AUX
bptjm-12	207	10	only	only	ADV
bptjm-12	207	11	e	e	X
bptjm-12	207	12	�	�	NOUN
bptjm-12	207	13	ective	ective	ADJ
bptjm-12	207	14	in	in	ADP
bptjm-12	207	15	certain	certain	ADJ
bptjm-12	207	16	cells	cell	NOUN
bptjm-12	207	17	(	(	PUNCT
bptjm-12	207	18	the	the	DET
bptjm-12	207	19	human	human	ADJ
bptjm-12	207	20	macrophages	macrophage	NOUN
bptjm-12	207	21	)	)	PUNCT
bptjm-12	207	22	.	.	PUNCT
bptjm-12	208	1	this	this	DET
bptjm-12	208	2	�	�	PROPN
bptjm-12	208	3	nding	nding	NOUN
bptjm-12	208	4	shows	show	VERB
bptjm-12	208	5	some	some	DET
bptjm-12	208	6	limits	limit	NOUN
bptjm-12	208	7	of	of	ADP
bptjm-12	208	8	cb2	cb2	NOUN
bptjm-12	208	9	agonist	agonist	NOUN
bptjm-12	208	10	use	use	NOUN
bptjm-12	208	11	in	in	ADP
bptjm-12	208	12	alleviating	alleviate	VERB
bptjm-12	208	13	symptoms	symptom	NOUN
bptjm-12	208	14	,	,	PUNCT
bptjm-12	208	15	while	while	SCONJ
bptjm-12	208	16	narrowing	narrow	VERB
bptjm-12	208	17	down	down	ADP
bptjm-12	208	18	a	a	DET
bptjm-12	208	19	line	line	NOUN
bptjm-12	208	20	of	of	ADP
bptjm-12	208	21	cells	cell	NOUN
bptjm-12	208	22	to	to	PART
bptjm-12	208	23	focus	focus	VERB
bptjm-12	208	24	on	on	ADP
bptjm-12	208	25	.	.	PUNCT
bptjm-12	209	1	cb2	cb2	PROPN
bptjm-12	209	2	receptors	receptor	NOUN
bptjm-12	209	3	'	'	PART
bptjm-12	209	4	primary	primary	ADJ
bptjm-12	209	5	role	role	NOUN
bptjm-12	209	6	in	in	ADP
bptjm-12	209	7	plaque	plaque	NOUN
bptjm-12	209	8	removal	removal	NOUN
bptjm-12	209	9	,	,	PUNCT
bptjm-12	209	10	with	with	ADP
bptjm-12	209	11	in	in	ADP
bptjm-12	209	12	vitro	vitro	X
bptjm-12	209	13	injection	injection	NOUN
bptjm-12	209	14	of	of	ADP
bptjm-12	209	15	the	the	DET
bptjm-12	209	16	antagonist	antagonist	NOUN
bptjm-12	209	17	sr144528	sr144528	NOUN
bptjm-12	209	18	,	,	PUNCT
bptjm-12	209	19	showed	show	VERB
bptjm-12	209	20	partial	partial	ADJ
bptjm-12	209	21	reversal	reversal	NOUN
bptjm-12	209	22	of	of	ADP
bptjm-12	209	23	the	the	DET
bptjm-12	209	24	jwh-015	jwh-015	NOUN
bptjm-12	209	25	aβ	aβ	NOUN
bptjm-12	209	26	removal	removal	NOUN
bptjm-12	209	27	(	(	PUNCT
bptjm-12	209	28	tolón	tolón	NOUN
bptjm-12	209	29	et	et	PROPN
bptjm-12	209	30	al	al	PROPN
bptjm-12	209	31	.	.	PROPN
bptjm-12	209	32	,	,	PUNCT
bptjm-12	209	33	2009	2009	NUM
bptjm-12	209	34	)	)	PUNCT
bptjm-12	209	35	,	,	PUNCT
bptjm-12	209	36	which	which	PRON
bptjm-12	209	37	highlights	highlight	VERB
bptjm-12	209	38	other	other	ADJ
bptjm-12	209	39	factors	factor	NOUN
bptjm-12	209	40	at	at	ADP
bptjm-12	209	41	play	play	NOUN
bptjm-12	209	42	in	in	ADP
bptjm-12	209	43	plaque	plaque	NOUN
bptjm-12	209	44	reduction	reduction	NOUN
bptjm-12	209	45	.	.	PUNCT
bptjm-12	210	1	these	these	DET
bptjm-12	210	2	results	result	NOUN
bptjm-12	210	3	indicate	indicate	VERB
bptjm-12	210	4	that	that	SCONJ
bptjm-12	210	5	jwh-015	jwh-015	NOUN
bptjm-12	210	6	can	can	AUX
bptjm-12	210	7	be	be	AUX
bptjm-12	210	8	used	use	VERB
bptjm-12	210	9	berkeley	berkeley	PROPN
bptjm-12	210	10	pharma	pharma	PROPN
bptjm-12	210	11	tech	tech	NOUN
bptjm-12	210	12	journal	journal	NOUN
bptjm-12	210	13	of	of	ADP
bptjm-12	210	14	medicine	medicine	NOUN
bptjm-12	210	15	|	|	ADV
bptjm-12	210	16	16	16	NUM
bptjm-12	210	17	as	as	ADP
bptjm-12	210	18	a	a	DET
bptjm-12	210	19	speci	speci	ADJ
bptjm-12	210	20	�	�	PROPN
bptjm-12	210	21	c	c	PROPN
bptjm-12	210	22	target	target	NOUN
bptjm-12	210	23	treatment	treatment	NOUN
bptjm-12	210	24	for	for	ADP
bptjm-12	210	25	ad	ad	NOUN
bptjm-12	210	26	,	,	PUNCT
bptjm-12	210	27	however	however	ADV
bptjm-12	210	28	it	it	PRON
bptjm-12	210	29	is	be	AUX
bptjm-12	210	30	not	not	PART
bptjm-12	210	31	the	the	DET
bptjm-12	210	32	only	only	ADJ
bptjm-12	210	33	option	option	NOUN
bptjm-12	210	34	.	.	PUNCT
bptjm-12	211	1	cb2	cb2	PROPN
bptjm-12	211	2	receptor	receptor	NOUN
bptjm-12	211	3	agonists	agonist	NOUN
bptjm-12	211	4	have	have	VERB
bptjm-12	211	5	a	a	DET
bptjm-12	211	6	preventative	preventative	ADJ
bptjm-12	211	7	function	function	NOUN
bptjm-12	211	8	in	in	ADP
bptjm-12	211	9	suppressing	suppress	VERB
bptjm-12	211	10	neuroin	neuroin	NOUN
bptjm-12	211	11	�	�	PROPN
bptjm-12	211	12	ammation	ammation	NOUN
bptjm-12	211	13	(	(	PUNCT
bptjm-12	211	14	ehrhart	ehrhart	NOUN
bptjm-12	211	15	et	et	PROPN
bptjm-12	211	16	al	al	PROPN
bptjm-12	211	17	.	.	PROPN
bptjm-12	211	18	,	,	PUNCT
bptjm-12	211	19	2005	2005	NUM
bptjm-12	211	20	)	)	PUNCT
bptjm-12	211	21	.	.	PUNCT
bptjm-12	212	1	irregularly	irregularly	ADV
bptjm-12	212	2	stimulated	stimulate	VERB
bptjm-12	212	3	cd40	cd40	PROPN
bptjm-12	212	4	receptor	receptor	NOUN
bptjm-12	212	5	expression	expression	NOUN
bptjm-12	212	6	by	by	ADP
bptjm-12	212	7	the	the	DET
bptjm-12	212	8	signaling	signal	VERB
bptjm-12	212	9	pathway	pathway	NOUN
bptjm-12	212	10	ifn	ifn	PROPN
bptjm-12	212	11	-	-	PUNCT
bptjm-12	212	12	γ	γ	PROPN
bptjm-12	212	13	is	be	AUX
bptjm-12	212	14	prominent	prominent	ADJ
bptjm-12	212	15	in	in	ADP
bptjm-12	212	16	patients	patient	NOUN
bptjm-12	212	17	with	with	ADP
bptjm-12	212	18	ad	ad	NOUN
bptjm-12	212	19	and	and	CCONJ
bptjm-12	212	20	is	be	AUX
bptjm-12	212	21	known	know	VERB
bptjm-12	212	22	to	to	PART
bptjm-12	212	23	increase	increase	VERB
bptjm-12	212	24	in	in	ADP
bptjm-12	212	25	�	�	PROPN
bptjm-12	212	26	ammation	ammation	NOUN
bptjm-12	212	27	(	(	PUNCT
bptjm-12	212	28	ehrhart	ehrhart	NOUN
bptjm-12	212	29	et	et	PROPN
bptjm-12	212	30	al	al	PROPN
bptjm-12	212	31	.	.	PROPN
bptjm-12	212	32	,	,	PUNCT
bptjm-12	212	33	2005	2005	NUM
bptjm-12	212	34	)	)	PUNCT
bptjm-12	212	35	.	.	PUNCT
bptjm-12	213	1	cd40	cd40	ADJ
bptjm-12	213	2	induction	induction	NOUN
bptjm-12	213	3	produces	produce	VERB
bptjm-12	213	4	in	in	ADP
bptjm-12	213	5	�	�	NOUN
bptjm-12	213	6	ammatory	ammatory	ADJ
bptjm-12	213	7	cytokines	cytokine	NOUN
bptjm-12	213	8	and	and	CCONJ
bptjm-12	213	9	is	be	AUX
bptjm-12	213	10	correlated	correlate	VERB
bptjm-12	213	11	with	with	ADP
bptjm-12	213	12	the	the	DET
bptjm-12	213	13	in	in	ADP
bptjm-12	213	14	�	�	PROPN
bptjm-12	213	15	ammation	ammation	NOUN
bptjm-12	213	16	and	and	CCONJ
bptjm-12	213	17	aβ	aβ	DET
bptjm-12	213	18	peptide	peptide	ADJ
bptjm-12	213	19	increase	increase	NOUN
bptjm-12	213	20	in	in	ADP
bptjm-12	213	21	ad	ad	NOUN
bptjm-12	213	22	.	.	PUNCT
bptjm-12	214	1	using	use	VERB
bptjm-12	214	2	the	the	DET
bptjm-12	214	3	jwh-015	jwh-015	NOUN
bptjm-12	214	4	agonists	agonist	NOUN
bptjm-12	214	5	,	,	PUNCT
bptjm-12	214	6	stimulation	stimulation	NOUN
bptjm-12	214	7	of	of	ADP
bptjm-12	214	8	cb2	cb2	PROPN
bptjm-12	214	9	diminishes	diminish	VERB
bptjm-12	214	10	ifn	ifn	PROPN
bptjm-12	214	11	-	-	PUNCT
bptjm-12	214	12	γ	γ	NOUN
bptjm-12	214	13	-	-	ADJ
bptjm-12	214	14	induced	induced	ADJ
bptjm-12	214	15	cd40	cd40	PROPN
bptjm-12	214	16	expression	expression	NOUN
bptjm-12	214	17	in	in	ADP
bptjm-12	214	18	microglial	microglial	ADJ
bptjm-12	214	19	cells	cell	NOUN
bptjm-12	214	20	(	(	PUNCT
bptjm-12	214	21	ehrhart	ehrhart	NOUN
bptjm-12	214	22	et	et	PROPN
bptjm-12	214	23	al	al	PROPN
bptjm-12	214	24	.	.	PROPN
bptjm-12	214	25	,	,	PUNCT
bptjm-12	214	26	2005	2005	NUM
bptjm-12	214	27	)	)	PUNCT
bptjm-12	214	28	.	.	PUNCT
bptjm-12	215	1	this	this	PRON
bptjm-12	215	2	occurs	occur	VERB
bptjm-12	215	3	by	by	ADP
bptjm-12	215	4	the	the	DET
bptjm-12	215	5	intervention	intervention	NOUN
bptjm-12	215	6	of	of	ADP
bptjm-12	215	7	the	the	DET
bptjm-12	215	8	jak	jak	PROPN
bptjm-12	215	9	/	/	SYM
bptjm-12	215	10	stat1pathway	stat1pathway	PROPN
bptjm-12	215	11	(	(	PUNCT
bptjm-12	215	12	ehrhart	ehrhart	NOUN
bptjm-12	215	13	et	et	PROPN
bptjm-12	215	14	al	al	PROPN
bptjm-12	215	15	.	.	PROPN
bptjm-12	215	16	,	,	PUNCT
bptjm-12	215	17	2005	2005	NUM
bptjm-12	215	18	)	)	PUNCT
bptjm-12	215	19	,	,	PUNCT
bptjm-12	215	20	which	which	PRON
bptjm-12	215	21	is	be	AUX
bptjm-12	215	22	a	a	DET
bptjm-12	215	23	pathway	pathway	NOUN
bptjm-12	215	24	that	that	PRON
bptjm-12	215	25	is	be	AUX
bptjm-12	215	26	involved	involve	VERB
bptjm-12	215	27	with	with	ADP
bptjm-12	215	28	immune	immune	ADJ
bptjm-12	215	29	system	system	NOUN
bptjm-12	215	30	response	response	NOUN
bptjm-12	215	31	and	and	CCONJ
bptjm-12	215	32	ultimately	ultimately	ADV
bptjm-12	215	33	decreases	decrease	VERB
bptjm-12	215	34	ifn	ifn	PROPN
bptjm-12	215	35	-	-	PUNCT
bptjm-12	215	36	γ	γ	NOUN
bptjm-12	215	37	-	-	ADJ
bptjm-12	215	38	induced	induced	ADJ
bptjm-12	215	39	cd40	cd40	PROPN
bptjm-12	215	40	expression	expression	NOUN
bptjm-12	215	41	.	.	PUNCT
bptjm-12	216	1	there	there	PRON
bptjm-12	216	2	is	be	VERB
bptjm-12	216	3	further	further	ADJ
bptjm-12	216	4	evidence	evidence	NOUN
bptjm-12	216	5	to	to	PART
bptjm-12	216	6	show	show	VERB
bptjm-12	216	7	thatcb2	thatcb2	NOUN
bptjm-12	216	8	agonists	agonist	NOUN
bptjm-12	216	9	have	have	VERB
bptjm-12	216	10	the	the	DET
bptjm-12	216	11	potential	potential	NOUN
bptjm-12	216	12	to	to	PART
bptjm-12	216	13	inhibit	inhibit	VERB
bptjm-12	216	14	in	in	ADP
bptjm-12	216	15	�	�	PROPN
bptjm-12	216	16	ammation	ammation	NOUN
bptjm-12	216	17	.	.	PUNCT
bptjm-12	217	1	jwh-133	jwh-133	PROPN
bptjm-12	217	2	,	,	PUNCT
bptjm-12	217	3	a	a	DET
bptjm-12	217	4	cb2	cb2	PROPN
bptjm-12	217	5	agonist	agonist	NOUN
bptjm-12	217	6	,	,	PUNCT
bptjm-12	217	7	was	be	AUX
bptjm-12	217	8	found	find	VERB
bptjm-12	217	9	to	to	PART
bptjm-12	217	10	rescue	rescue	VERB
bptjm-12	217	11	spatial	spatial	ADJ
bptjm-12	217	12	memory	memory	NOUN
bptjm-12	217	13	de	de	PROPN
bptjm-12	217	14	�	�	PROPN
bptjm-12	217	15	cits	cit	NOUN
bptjm-12	217	16	in	in	ADP
bptjm-12	217	17	rats	rat	NOUN
bptjm-12	217	18	injected	inject	VERB
bptjm-12	217	19	with	with	ADP
bptjm-12	217	20	okadaic	okadaic	ADJ
bptjm-12	217	21	acid	acid	NOUN
bptjm-12	217	22	(	(	PUNCT
bptjm-12	217	23	oka	oka	NOUN
bptjm-12	217	24	)	)	PUNCT
bptjm-12	217	25	,	,	PUNCT
bptjm-12	217	26	which	which	PRON
bptjm-12	217	27	induces	induce	VERB
bptjm-12	217	28	spatial	spatial	ADJ
bptjm-12	217	29	memory	memory	NOUN
bptjm-12	217	30	impairment	impairment	NOUN
bptjm-12	217	31	and	and	CCONJ
bptjm-12	217	32	neurodegeneration	neurodegeneration	NOUN
bptjm-12	217	33	(	(	PUNCT
bptjm-12	217	34	çakır	çakır	PROPN
bptjm-12	217	35	et	et	PROPN
bptjm-12	217	36	al	al	PROPN
bptjm-12	217	37	.	.	PROPN
bptjm-12	217	38	,	,	PUNCT
bptjm-12	217	39	2019	2019	NUM
bptjm-12	217	40	)	)	PUNCT
bptjm-12	217	41	.	.	PUNCT
bptjm-12	218	1	rats	rat	NOUN
bptjm-12	218	2	injected	inject	VERB
bptjm-12	218	3	with	with	ADP
bptjm-12	218	4	oka	oka	NOUN
bptjm-12	218	5	were	be	AUX
bptjm-12	218	6	found	find	VERB
bptjm-12	218	7	to	to	PART
bptjm-12	218	8	have	have	VERB
bptjm-12	218	9	higher	high	ADJ
bptjm-12	218	10	numbers	number	NOUN
bptjm-12	218	11	of	of	ADP
bptjm-12	218	12	degenerative	degenerative	ADJ
bptjm-12	218	13	neurons	neuron	NOUN
bptjm-12	218	14	in	in	ADP
bptjm-12	218	15	the	the	DET
bptjm-12	218	16	cortex	cortex	NOUN
bptjm-12	218	17	and	and	CCONJ
bptjm-12	218	18	hippocampus	hippocampus	NOUN
bptjm-12	218	19	,	,	PUNCT
bptjm-12	218	20	but	but	CCONJ
bptjm-12	218	21	the	the	DET
bptjm-12	218	22	addition	addition	NOUN
bptjm-12	218	23	of	of	ADP
bptjm-12	218	24	jwh-133	jwh-133	PROPN
bptjm-12	218	25	ameliorated	ameliorate	VERB
bptjm-12	218	26	this	this	DET
bptjm-12	218	27	damage	damage	NOUN
bptjm-12	218	28	(	(	PUNCT
bptjm-12	218	29	çakır	çakır	PROPN
bptjm-12	218	30	et	et	PROPN
bptjm-12	218	31	al	al	PROPN
bptjm-12	218	32	.	.	PROPN
bptjm-12	218	33	,	,	PUNCT
bptjm-12	218	34	2019	2019	NUM
bptjm-12	218	35	)	)	PUNCT
bptjm-12	218	36	.	.	PUNCT
bptjm-12	219	1	jwh-133	jwh-133	PROPN
bptjm-12	219	2	application	application	PROPN
bptjm-12	219	3	was	be	AUX
bptjm-12	219	4	found	find	VERB
bptjm-12	219	5	to	to	PART
bptjm-12	219	6	reduce	reduce	VERB
bptjm-12	219	7	the	the	DET
bptjm-12	219	8	level	level	NOUN
bptjm-12	219	9	of	of	ADP
bptjm-12	219	10	immunoreactivity	immunoreactivity	NOUN
bptjm-12	219	11	caused	cause	VERB
bptjm-12	219	12	by	by	ADP
bptjm-12	219	13	oka	oka	NOUN
bptjm-12	219	14	.	.	PUNCT
bptjm-12	220	1	caspase-3	caspase-3	NUM
bptjm-12	220	2	,	,	PUNCT
bptjm-12	220	3	aβ	aβ	NOUN
bptjm-12	220	4	,	,	PUNCT
bptjm-12	220	5	and	and	CCONJ
bptjm-12	220	6	il-1β	il-1β	PROPN
bptjm-12	220	7	immunoreactivity	immunoreactivity	NOUN
bptjm-12	220	8	were	be	AUX
bptjm-12	220	9	reduced	reduce	VERB
bptjm-12	220	10	in	in	ADP
bptjm-12	220	11	both	both	CCONJ
bptjm-12	220	12	the	the	DET
bptjm-12	220	13	hippocampus	hippocampus	NOUN
bptjm-12	220	14	and	and	CCONJ
bptjm-12	220	15	the	the	DET
bptjm-12	220	16	cortex	cortex	NOUN
bptjm-12	220	17	,	,	PUNCT
bptjm-12	220	18	while	while	SCONJ
bptjm-12	220	19	tnf	tnf	PROPN
bptjm-12	220	20	-	-	PUNCT
bptjm-12	220	21	αimmunoreactivity	αimmunoreactivity	PROPN
bptjm-12	220	22	was	be	AUX
bptjm-12	220	23	reduced	reduce	VERB
bptjm-12	220	24	in	in	ADP
bptjm-12	220	25	only	only	ADV
bptjm-12	220	26	the	the	DET
bptjm-12	220	27	hippocampus	hippocampus	NOUN
bptjm-12	220	28	(	(	PUNCT
bptjm-12	220	29	çakır	çakır	PROPN
bptjm-12	220	30	et	et	PROPN
bptjm-12	220	31	al	al	PROPN
bptjm-12	220	32	.	.	PROPN
bptjm-12	220	33	,	,	PUNCT
bptjm-12	220	34	2019	2019	NUM
bptjm-12	220	35	)	)	PUNCT
bptjm-12	220	36	.	.	PUNCT
bptjm-12	221	1	1-((3	1-((3	NUM
bptjm-12	221	2	-	-	PUNCT
bptjm-12	221	3	benzyl-3	benzyl-3	NUM
bptjm-12	221	4	-	-	PUNCT
bptjm-12	221	5	methyl-2,3	methyl-2,3	NOUN
bptjm-12	221	6	-	-	PUNCT
bptjm-12	221	7	dihydro-1	dihydro-1	NOUN
bptjm-12	221	8	-	-	PUNCT
bptjm-12	221	9	benzofuran-6	benzofuran-6	NOUN
bptjm-12	221	10	-	-	PUNCT
bptjm-12	221	11	yl	yl	NOUN
bptjm-12	221	12	)	)	PUNCT
bptjm-12	221	13	carbonyl	carbonyl	NOUN
bptjm-12	221	14	)	)	PUNCT
bptjm-12	221	15	piperidine	piperidine	NOUN
bptjm-12	221	16	(	(	PUNCT
bptjm-12	221	17	mda7	mda7	PROPN
bptjm-12	221	18	)	)	PUNCT
bptjm-12	221	19	,	,	PUNCT
bptjm-12	221	20	a	a	DET
bptjm-12	221	21	highly	highly	ADV
bptjm-12	221	22	-	-	PUNCT
bptjm-12	221	23	selective	selective	ADJ
bptjm-12	221	24	cb2	cb2	PROPN
bptjm-12	221	25	agonist	agonist	NOUN
bptjm-12	221	26	,	,	PUNCT
bptjm-12	221	27	was	be	AUX
bptjm-12	221	28	found	find	VERB
bptjm-12	221	29	to	to	PART
bptjm-12	221	30	have	have	VERB
bptjm-12	221	31	a	a	DET
bptjm-12	221	32	neuroprotective	neuroprotective	ADJ
bptjm-12	221	33	e	e	NOUN
bptjm-12	221	34	�	�	NOUN
bptjm-12	221	35	ect	ect	VERB
bptjm-12	221	36	in	in	ADP
bptjm-12	221	37	in	in	ADP
bptjm-12	221	38	vivo	vivo	NOUN
bptjm-12	221	39	and	and	CCONJ
bptjm-12	221	40	in	in	ADP
bptjm-12	221	41	vitro	vitro	X
bptjm-12	221	42	models	model	NOUN
bptjm-12	221	43	(	(	PUNCT
bptjm-12	221	44	wu	wu	PROPN
bptjm-12	221	45	et	et	PROPN
bptjm-12	221	46	al	al	PROPN
bptjm-12	221	47	.	.	PROPN
bptjm-12	221	48	,	,	PUNCT
bptjm-12	221	49	2012	2012	NUM
bptjm-12	221	50	)	)	PUNCT
bptjm-12	221	51	.	.	PUNCT
bptjm-12	222	1	mda7	mda7	PROPN
bptjm-12	222	2	administration	administration	PROPN
bptjm-12	222	3	in	in	ADP
bptjm-12	222	4	aβ1–4	aβ1–4	PROPN
bptjm-12	222	5	-	-	PUNCT
bptjm-12	222	6	induced	induce	VERB
bptjm-12	222	7	mice	mouse	NOUN
bptjm-12	222	8	was	be	AUX
bptjm-12	222	9	found	find	VERB
bptjm-12	222	10	to	to	PART
bptjm-12	222	11	lower	lower	VERB
bptjm-12	222	12	immunoreactivity	immunoreactivity	NOUN
bptjm-12	222	13	in	in	ADP
bptjm-12	222	14	the	the	DET
bptjm-12	222	15	hippocampus	hippocampus	NOUN
bptjm-12	222	16	(	(	PUNCT
bptjm-12	222	17	wu	wu	PROPN
bptjm-12	222	18	et	et	PROPN
bptjm-12	222	19	al	al	PROPN
bptjm-12	222	20	.	.	PROPN
bptjm-12	222	21	,	,	PUNCT
bptjm-12	222	22	2012	2012	NUM
bptjm-12	222	23	)	)	PUNCT
bptjm-12	222	24	.	.	PUNCT
bptjm-12	223	1	the	the	DET
bptjm-12	223	2	morris	morris	PROPN
bptjm-12	223	3	water	water	PROPN
bptjm-12	223	4	maze	maze	NOUN
bptjm-12	223	5	test	test	NOUN
bptjm-12	223	6	(	(	PUNCT
bptjm-12	223	7	wu	wu	PROPN
bptjm-12	223	8	et	et	PROPN
bptjm-12	223	9	al	al	PROPN
bptjm-12	223	10	.	.	PROPN
bptjm-12	223	11	,	,	PUNCT
bptjm-12	223	12	2012	2012	NUM
bptjm-12	223	13	)	)	PUNCT
bptjm-12	223	14	showed	show	VERB
bptjm-12	223	15	mda7	mda7	NOUN
bptjm-12	223	16	rescued	rescue	VERB
bptjm-12	223	17	amyloid	amyloid	PROPN
bptjm-12	223	18	�	�	PROPN
bptjm-12	223	19	bril	bril	NOUN
bptjm-12	223	20	-	-	PUNCT
bptjm-12	223	21	impaired	impair	VERB
bptjm-12	223	22	performance	performance	NOUN
bptjm-12	223	23	.	.	PUNCT
bptjm-12	224	1	while	while	SCONJ
bptjm-12	224	2	progress	progress	NOUN
bptjm-12	224	3	has	have	AUX
bptjm-12	224	4	been	be	AUX
bptjm-12	224	5	made	make	VERB
bptjm-12	224	6	in	in	ADP
bptjm-12	224	7	the	the	DET
bptjm-12	224	8	development	development	NOUN
bptjm-12	224	9	of	of	ADP
bptjm-12	224	10	drugs	drug	NOUN
bptjm-12	224	11	targeting	target	VERB
bptjm-12	224	12	these	these	DET
bptjm-12	224	13	receptors	receptor	NOUN
bptjm-12	224	14	,	,	PUNCT
bptjm-12	224	15	the	the	DET
bptjm-12	224	16	ones	one	NOUN
bptjm-12	224	17	currently	currently	ADV
bptjm-12	224	18	available	available	ADJ
bptjm-12	224	19	to	to	ADP
bptjm-12	224	20	patients	patient	NOUN
bptjm-12	224	21	come	come	VERB
bptjm-12	224	22	with	with	ADP
bptjm-12	224	23	many	many	ADJ
bptjm-12	224	24	unwanted	unwanted	ADJ
bptjm-12	224	25	side	side	NOUN
bptjm-12	224	26	e	e	NOUN
bptjm-12	224	27	�	�	NOUN
bptjm-12	224	28	ects	ect	NOUN
bptjm-12	224	29	such	such	ADJ
bptjm-12	224	30	as	as	ADP
bptjm-12	224	31	nausea	nausea	NOUN
bptjm-12	224	32	,	,	PUNCT
bptjm-12	224	33	vomiting	vomiting	NOUN
bptjm-12	224	34	,	,	PUNCT
bptjm-12	224	35	and	and	CCONJ
bptjm-12	224	36	weight	weight	NOUN
bptjm-12	224	37	loss	loss	NOUN
bptjm-12	224	38	(	(	PUNCT
bptjm-12	224	39	wattet	wattet	NOUN
bptjm-12	224	40	al	al	PROPN
bptjm-12	224	41	.	.	PROPN
bptjm-12	224	42	,	,	PUNCT
bptjm-12	224	43	2017	2017	NUM
bptjm-12	224	44	)	)	PUNCT
bptjm-12	224	45	.	.	PUNCT
bptjm-12	225	1	while	while	SCONJ
bptjm-12	225	2	there	there	PRON
bptjm-12	225	3	are	be	VERB
bptjm-12	225	4	bound	bind	VERB
bptjm-12	225	5	to	to	PART
bptjm-12	225	6	be	be	AUX
bptjm-12	225	7	side	side	ADJ
bptjm-12	225	8	e	e	NOUN
bptjm-12	225	9	�	�	NOUN
bptjm-12	225	10	ects	ect	VERB
bptjm-12	225	11	to	to	ADP
bptjm-12	225	12	most	most	ADJ
bptjm-12	225	13	drugs	drug	NOUN
bptjm-12	225	14	,	,	PUNCT
bptjm-12	225	15	synthetic	synthetic	ADJ
bptjm-12	225	16	cannabinoids	cannabinoid	NOUN
bptjm-12	225	17	o	o	NOUN
bptjm-12	225	18	�	�	PROPN
bptjm-12	225	19	er	er	INTJ
bptjm-12	225	20	the	the	DET
bptjm-12	225	21	added	add	VERB
bptjm-12	225	22	bene	bene	PROPN
bptjm-12	225	23	�	�	PROPN
bptjm-12	225	24	t	t	PROPN
bptjm-12	225	25	of	of	ADP
bptjm-12	225	26	producing	produce	VERB
bptjm-12	225	27	e	e	NOUN
bptjm-12	225	28	�	�	NOUN
bptjm-12	225	29	ects	ect	VERB
bptjm-12	225	30	similar	similar	ADJ
bptjm-12	225	31	to	to	ADP
bptjm-12	225	32	that	that	PRON
bptjm-12	225	33	which	which	DET
bptjm-12	225	34	natural	natural	ADJ
bptjm-12	225	35	cannabis	cannabis	NOUN
bptjm-12	225	36	derivatives	derivative	NOUN
bptjm-12	225	37	cause	cause	VERB
bptjm-12	225	38	but	but	CCONJ
bptjm-12	225	39	without	without	ADP
bptjm-12	225	40	the	the	DET
bptjm-12	225	41	psychoactive	psychoactive	ADJ
bptjm-12	225	42	side	side	NOUN
bptjm-12	225	43	e	e	NOUN
bptjm-12	225	44	�	�	NOUN
bptjm-12	225	45	ects	ect	NOUN
bptjm-12	225	46	(	(	PUNCT
bptjm-12	225	47	campbell	campbell	PROPN
bptjm-12	225	48	et	et	PROPN
bptjm-12	225	49	al	al	PROPN
bptjm-12	225	50	.	.	PROPN
bptjm-12	225	51	,	,	PUNCT
bptjm-12	225	52	2007	2007	NUM
bptjm-12	225	53	)	)	PUNCT
bptjm-12	225	54	.	.	PUNCT
bptjm-12	226	1	due	due	ADP
bptjm-12	226	2	to	to	ADP
bptjm-12	226	3	the	the	DET
bptjm-12	226	4	complexity	complexity	NOUN
bptjm-12	226	5	of	of	ADP
bptjm-12	226	6	ad	ad	NOUN
bptjm-12	226	7	and	and	CCONJ
bptjm-12	226	8	the	the	DET
bptjm-12	226	9	pathology	pathology	NOUN
bptjm-12	226	10	of	of	ADP
bptjm-12	226	11	many	many	ADJ
bptjm-12	226	12	di	di	PROPN
bptjm-12	226	13	�	�	PROPN
bptjm-12	226	14	erent	erent	NOUN
bptjm-12	226	15	pathways	pathway	NOUN
bptjm-12	226	16	involved	involve	VERB
bptjm-12	226	17	,	,	PUNCT
bptjm-12	226	18	it	it	PRON
bptjm-12	226	19	is	be	AUX
bptjm-12	226	20	unlikely	unlikely	ADJ
bptjm-12	226	21	that	that	SCONJ
bptjm-12	226	22	just	just	ADV
bptjm-12	226	23	one	one	NUM
bptjm-12	226	24	drug	drug	NOUN
bptjm-12	226	25	will	will	AUX
bptjm-12	226	26	su	su	PROPN
bptjm-12	226	27	�	�	PROPN
bptjm-12	226	28	ce	ce	PROPN
bptjm-12	226	29	to	to	PART
bptjm-12	226	30	treat	treat	VERB
bptjm-12	226	31	the	the	DET
bptjm-12	226	32	progression	progression	NOUN
bptjm-12	226	33	of	of	ADP
bptjm-12	226	34	the	the	DET
bptjm-12	226	35	disease	disease	NOUN
bptjm-12	226	36	.	.	PUNCT
bptjm-12	227	1	rather	rather	ADV
bptjm-12	227	2	,	,	PUNCT
bptjm-12	227	3	berkeley	berkeley	PROPN
bptjm-12	227	4	pharma	pharma	PROPN
bptjm-12	227	5	tech	tech	NOUN
bptjm-12	227	6	journal	journal	NOUN
bptjm-12	227	7	of	of	ADP
bptjm-12	227	8	medicine	medicine	NOUN
bptjm-12	227	9	|	|	ADV
bptjm-12	227	10	17	17	NUM
bptjm-12	228	1	it	it	PRON
bptjm-12	228	2	is	be	AUX
bptjm-12	228	3	more	more	ADV
bptjm-12	228	4	likely	likely	ADJ
bptjm-12	228	5	that	that	SCONJ
bptjm-12	228	6	multiple	multiple	ADJ
bptjm-12	228	7	drugs	drug	NOUN
bptjm-12	228	8	will	will	AUX
bptjm-12	228	9	be	be	AUX
bptjm-12	228	10	needed	need	VERB
bptjm-12	228	11	to	to	PART
bptjm-12	228	12	treat	treat	VERB
bptjm-12	228	13	the	the	DET
bptjm-12	228	14	multifaceted	multifaceted	ADJ
bptjm-12	228	15	symptoms	symptom	NOUN
bptjm-12	228	16	of	of	ADP
bptjm-12	228	17	alzheimer	alzheimer	PROPN
bptjm-12	228	18	’s	’s	PART
bptjm-12	228	19	.	.	PUNCT
bptjm-12	229	1	iv	iv	X
bptjm-12	229	2	.	.	PUNCT
bptjm-12	229	3	potential	potential	NOUN
bptjm-12	229	4	and	and	CCONJ
bptjm-12	229	5	e	e	NOUN
bptjm-12	229	6	�	�	NOUN
bptjm-12	229	7	ective	ective	ADJ
bptjm-12	229	8	therapies	therapy	NOUN
bptjm-12	229	9	a.	a.	NOUN
bptjm-12	229	10	natural	natural	ADJ
bptjm-12	229	11	therapies	therapy	NOUN
bptjm-12	229	12	cannabinoids	cannabinoid	NOUN
bptjm-12	229	13	possess	possess	VERB
bptjm-12	229	14	great	great	ADJ
bptjm-12	229	15	potential	potential	NOUN
bptjm-12	229	16	as	as	ADP
bptjm-12	229	17	e	e	X
bptjm-12	229	18	�	�	NOUN
bptjm-12	229	19	ective	ective	ADJ
bptjm-12	229	20	natural	natural	ADJ
bptjm-12	229	21	therapies	therapy	NOUN
bptjm-12	229	22	for	for	ADP
bptjm-12	229	23	ad	ad	NOUN
bptjm-12	229	24	.	.	PUNCT
bptjm-12	230	1	previous	previous	ADJ
bptjm-12	230	2	studies	study	NOUN
bptjm-12	230	3	indicate	indicate	VERB
bptjm-12	230	4	that	that	SCONJ
bptjm-12	230	5	cannabis	cannabis	NOUN
bptjm-12	230	6	use	use	NOUN
bptjm-12	230	7	diminishes	diminish	VERB
bptjm-12	230	8	symptoms	symptom	NOUN
bptjm-12	230	9	associated	associate	VERB
bptjm-12	230	10	with	with	ADP
bptjm-12	230	11	ad	ad	NOUN
bptjm-12	230	12	(	(	PUNCT
bptjm-12	230	13	suryadevara	suryadevara	NOUN
bptjm-12	230	14	et	et	PROPN
bptjm-12	230	15	al	al	PROPN
bptjm-12	230	16	.	.	PROPN
bptjm-12	230	17	,	,	PUNCT
bptjm-12	230	18	2017	2017	NUM
bptjm-12	230	19	)	)	PUNCT
bptjm-12	230	20	.	.	PUNCT
bptjm-12	231	1	when	when	SCONJ
bptjm-12	231	2	administered	administer	VERB
bptjm-12	231	3	in	in	ADP
bptjm-12	231	4	patients	patient	NOUN
bptjm-12	231	5	with	with	ADP
bptjm-12	231	6	similar	similar	ADJ
bptjm-12	231	7	neurodegenerative	neurodegenerative	ADJ
bptjm-12	231	8	conditions	condition	NOUN
bptjm-12	231	9	,	,	PUNCT
bptjm-12	231	10	cannabis	cannabis	NOUN
bptjm-12	231	11	use	use	NOUN
bptjm-12	231	12	is	be	AUX
bptjm-12	231	13	shown	show	VERB
bptjm-12	231	14	to	to	PART
bptjm-12	231	15	decrease	decrease	VERB
bptjm-12	231	16	pain	pain	NOUN
bptjm-12	231	17	and	and	CCONJ
bptjm-12	231	18	spasticity	spasticity	NOUN
bptjm-12	231	19	in	in	ADP
bptjm-12	231	20	people	people	NOUN
bptjm-12	231	21	with	with	ADP
bptjm-12	231	22	multiple	multiple	ADJ
bptjm-12	231	23	sclerosis	sclerosis	NOUN
bptjm-12	231	24	,	,	PUNCT
bptjm-12	231	25	decrease	decrease	NOUN
bptjm-12	231	26	tremor	tremor	NOUN
bptjm-12	231	27	,	,	PUNCT
bptjm-12	231	28	rigidity	rigidity	NOUN
bptjm-12	231	29	,	,	PUNCT
bptjm-12	231	30	and	and	CCONJ
bptjm-12	231	31	pain	pain	NOUN
bptjm-12	231	32	in	in	ADP
bptjm-12	231	33	people	people	NOUN
bptjm-12	231	34	with	with	ADP
bptjm-12	231	35	parkinson	parkinson	NOUN
bptjm-12	231	36	’s	’s	PART
bptjm-12	231	37	disease	disease	NOUN
bptjm-12	231	38	,	,	PUNCT
bptjm-12	231	39	and	and	CCONJ
bptjm-12	231	40	improve	improve	VERB
bptjm-12	231	41	the	the	DET
bptjm-12	231	42	quality	quality	NOUN
bptjm-12	231	43	of	of	ADP
bptjm-12	231	44	life	life	NOUN
bptjm-12	231	45	of	of	ADP
bptjm-12	231	46	amyotrophic	amyotrophic	ADJ
bptjm-12	231	47	lateral	lateral	ADJ
bptjm-12	231	48	sclerosis	sclerosis	NOUN
bptjm-12	231	49	(	(	PUNCT
bptjm-12	231	50	als	als	NOUN
bptjm-12	231	51	)	)	PUNCT
bptjm-12	231	52	patients	patient	NOUN
bptjm-12	231	53	by	by	ADP
bptjm-12	231	54	improving	improve	VERB
bptjm-12	231	55	appetite	appetite	NOUN
bptjm-12	231	56	and	and	CCONJ
bptjm-12	231	57	decreasing	decrease	VERB
bptjm-12	231	58	pain	pain	NOUN
bptjm-12	231	59	and	and	CCONJ
bptjm-12	231	60	spasticity	spasticity	NOUN
bptjm-12	231	61	(	(	PUNCT
bptjm-12	231	62	suryadevara	suryadevara	NOUN
bptjm-12	231	63	et	et	PROPN
bptjm-12	231	64	al	al	PROPN
bptjm-12	231	65	.	.	PROPN
bptjm-12	231	66	,	,	PUNCT
bptjm-12	231	67	2017	2017	NUM
bptjm-12	231	68	)	)	PUNCT
bptjm-12	231	69	.	.	PUNCT
bptjm-12	232	1	interestingly	interestingly	ADV
bptjm-12	232	2	,	,	PUNCT
bptjm-12	232	3	a	a	DET
bptjm-12	232	4	large	large	ADJ
bptjm-12	232	5	portion	portion	NOUN
bptjm-12	232	6	of	of	ADP
bptjm-12	232	7	the	the	DET
bptjm-12	232	8	negative	negative	ADJ
bptjm-12	232	9	side	side	NOUN
bptjm-12	232	10	e	e	NOUN
bptjm-12	232	11	�	�	NOUN
bptjm-12	232	12	ects	ect	VERB
bptjm-12	232	13	from	from	ADP
bptjm-12	232	14	cannabis	cannabis	NOUN
bptjm-12	232	15	administration	administration	NOUN
bptjm-12	232	16	in	in	ADP
bptjm-12	232	17	these	these	DET
bptjm-12	232	18	diseases	disease	NOUN
bptjm-12	232	19	is	be	AUX
bptjm-12	232	20	absent	absent	ADJ
bptjm-12	232	21	in	in	ADP
bptjm-12	232	22	alzheimer	alzheimer	PROPN
bptjm-12	232	23	’s	’s	PART
bptjm-12	232	24	patients	patient	NOUN
bptjm-12	232	25	(	(	PUNCT
bptjm-12	232	26	suryadevara	suryadevara	VERB
bptjm-12	232	27	et	et	PROPN
bptjm-12	232	28	al	al	PROPN
bptjm-12	232	29	.	.	PROPN
bptjm-12	232	30	,	,	PUNCT
bptjm-12	232	31	2017	2017	NUM
bptjm-12	232	32	)	)	PUNCT
bptjm-12	232	33	.	.	PUNCT
bptjm-12	233	1	cannabis	cannabis	NOUN
bptjm-12	233	2	has	have	AUX
bptjm-12	233	3	been	be	AUX
bptjm-12	233	4	used	use	VERB
bptjm-12	233	5	to	to	PART
bptjm-12	233	6	alleviate	alleviate	VERB
bptjm-12	233	7	pain	pain	NOUN
bptjm-12	233	8	and	and	CCONJ
bptjm-12	233	9	muscular	muscular	ADJ
bptjm-12	233	10	contractions	contraction	NOUN
bptjm-12	233	11	to	to	PART
bptjm-12	233	12	target	target	VERB
bptjm-12	233	13	the	the	DET
bptjm-12	233	14	in	in	ADP
bptjm-12	233	15	�	�	PROPN
bptjm-12	233	16	amed	ame	VERB
bptjm-12	233	17	pathways	pathway	NOUN
bptjm-12	233	18	of	of	ADP
bptjm-12	233	19	the	the	DET
bptjm-12	233	20	brain	brain	NOUN
bptjm-12	233	21	in	in	ADP
bptjm-12	233	22	alzheimer	alzheimer	PROPN
bptjm-12	233	23	’s	’s	PART
bptjm-12	233	24	patients	patient	NOUN
bptjm-12	233	25	.	.	PUNCT
bptjm-12	234	1	the	the	DET
bptjm-12	234	2	perception	perception	NOUN
bptjm-12	234	3	of	of	ADP
bptjm-12	234	4	pain	pain	NOUN
bptjm-12	234	5	is	be	AUX
bptjm-12	234	6	atypical	atypical	ADJ
bptjm-12	234	7	in	in	ADP
bptjm-12	234	8	that	that	DET
bptjm-12	234	9	alzheimer	alzheimer	PROPN
bptjm-12	234	10	’s	’s	PART
bptjm-12	234	11	patients	patient	NOUN
bptjm-12	234	12	are	be	AUX
bptjm-12	234	13	more	more	ADV
bptjm-12	234	14	prone	prone	ADJ
bptjm-12	234	15	to	to	ADP
bptjm-12	234	16	oxidative	oxidative	ADJ
bptjm-12	234	17	stress	stress	NOUN
bptjm-12	234	18	,	,	PUNCT
bptjm-12	234	19	which	which	PRON
bptjm-12	234	20	is	be	AUX
bptjm-12	234	21	an	an	DET
bptjm-12	234	22	imbalance	imbalance	NOUN
bptjm-12	234	23	between	between	ADP
bptjm-12	234	24	free	free	ADJ
bptjm-12	234	25	radicals	radical	NOUN
bptjm-12	234	26	and	and	CCONJ
bptjm-12	234	27	the	the	DET
bptjm-12	234	28	body	body	NOUN
bptjm-12	234	29	’s	’s	PART
bptjm-12	234	30	ability	ability	NOUN
bptjm-12	234	31	to	to	PART
bptjm-12	234	32	detoxify	detoxify	VERB
bptjm-12	234	33	them	they	PRON
bptjm-12	234	34	.	.	PUNCT
bptjm-12	235	1	however	however	ADV
bptjm-12	235	2	,	,	PUNCT
bptjm-12	235	3	studies	study	NOUN
bptjm-12	235	4	demonstrate	demonstrate	VERB
bptjm-12	235	5	a	a	DET
bptjm-12	235	6	positive	positive	ADJ
bptjm-12	235	7	relationship	relationship	NOUN
bptjm-12	235	8	between	between	ADP
bptjm-12	235	9	stress	stress	NOUN
bptjm-12	235	10	reduction	reduction	NOUN
bptjm-12	235	11	in	in	ADP
bptjm-12	235	12	dementia	dementia	NOUN
bptjm-12	235	13	and	and	CCONJ
bptjm-12	235	14	medical	medical	ADJ
bptjm-12	235	15	cannabisuse	cannabisuse	PROPN
bptjm-12	235	16	(	(	PUNCT
bptjm-12	235	17	aso	aso	PROPN
bptjm-12	235	18	et	et	PROPN
bptjm-12	235	19	al	al	PROPN
bptjm-12	235	20	.	.	PROPN
bptjm-12	235	21	,	,	PUNCT
bptjm-12	235	22	2014	2014	NUM
bptjm-12	235	23	)	)	PUNCT
bptjm-12	235	24	.	.	PUNCT
bptjm-12	236	1	the	the	DET
bptjm-12	236	2	anti	anti	ADJ
bptjm-12	236	3	-	-	ADJ
bptjm-12	236	4	in	in	ADP
bptjm-12	236	5	�	�	NOUN
bptjm-12	236	6	ammatory	ammatory	NOUN
bptjm-12	236	7	and	and	CCONJ
bptjm-12	236	8	anti	anti	ADJ
bptjm-12	236	9	-	-	ADJ
bptjm-12	236	10	neurotoxicity	neurotoxicity	ADJ
bptjm-12	236	11	properties	property	NOUN
bptjm-12	236	12	of	of	ADP
bptjm-12	236	13	cannabinoids	cannabinoid	NOUN
bptjm-12	236	14	help	help	VERB
bptjm-12	236	15	mediate	mediate	VERB
bptjm-12	236	16	the	the	DET
bptjm-12	236	17	neuroin	neuroin	NOUN
bptjm-12	236	18	�	�	PROPN
bptjm-12	236	19	ammation	ammation	NOUN
bptjm-12	236	20	caused	cause	VERB
bptjm-12	236	21	by	by	ADP
bptjm-12	236	22	microglia	microglia	ADJ
bptjm-12	236	23	activation	activation	NOUN
bptjm-12	236	24	,	,	PUNCT
bptjm-12	236	25	which	which	PRON
bptjm-12	236	26	is	be	AUX
bptjm-12	236	27	characteristic	characteristic	ADJ
bptjm-12	236	28	of	of	ADP
bptjm-12	236	29	chronic	chronic	ADJ
bptjm-12	236	30	pain	pain	NOUN
bptjm-12	236	31	in	in	ADP
bptjm-12	236	32	alzheimer	alzheimer	PROPN
bptjm-12	236	33	's	's	PART
bptjm-12	236	34	patients	patient	NOUN
bptjm-12	236	35	.	.	PUNCT
bptjm-12	237	1	in	in	ADP
bptjm-12	237	2	addition	addition	NOUN
bptjm-12	237	3	,	,	PUNCT
bptjm-12	237	4	further	further	ADJ
bptjm-12	237	5	studies	study	NOUN
bptjm-12	237	6	have	have	AUX
bptjm-12	237	7	shown	show	VERB
bptjm-12	237	8	that	that	SCONJ
bptjm-12	237	9	with	with	ADP
bptjm-12	237	10	the	the	DET
bptjm-12	237	11	use	use	NOUN
bptjm-12	237	12	of	of	ADP
bptjm-12	237	13	cannabinoids	cannabinoid	NOUN
bptjm-12	237	14	,	,	PUNCT
bptjm-12	237	15	alzheimer	alzheimer	PROPN
bptjm-12	237	16	’s	’s	PART
bptjm-12	237	17	patients	patient	NOUN
bptjm-12	237	18	have	have	AUX
bptjm-12	237	19	experienced	experience	VERB
bptjm-12	237	20	a	a	DET
bptjm-12	237	21	decrease	decrease	NOUN
bptjm-12	237	22	in	in	ADP
bptjm-12	237	23	altered	altered	ADJ
bptjm-12	237	24	cognitive	cognitive	ADJ
bptjm-12	237	25	ability	ability	NOUN
bptjm-12	237	26	(	(	PUNCT
bptjm-12	237	27	aso	aso	PROPN
bptjm-12	237	28	et	et	PROPN
bptjm-12	237	29	al	al	PROPN
bptjm-12	237	30	.	.	PROPN
bptjm-12	237	31	,	,	PUNCT
bptjm-12	237	32	2014	2014	NUM
bptjm-12	237	33	)	)	PUNCT
bptjm-12	237	34	.	.	PUNCT
bptjm-12	238	1	research	research	NOUN
bptjm-12	238	2	indicates	indicate	VERB
bptjm-12	238	3	that	that	SCONJ
bptjm-12	238	4	a	a	DET
bptjm-12	238	5	"	"	PUNCT
bptjm-12	238	6	coadministration	coadministration	NOUN
bptjm-12	238	7	of	of	ADP
bptjm-12	238	8	cbd	cbd	NOUN
bptjm-12	238	9	and	and	CCONJ
bptjm-12	238	10	δ9	δ9	PROPN
bptjm-12	238	11	-	-	PUNCT
bptjm-12	238	12	thc	thc	NOUN
bptjm-12	238	13	”	"	PUNCT
bptjm-12	238	14	is	be	AUX
bptjm-12	238	15	necessary	necessary	ADJ
bptjm-12	238	16	in	in	ADP
bptjm-12	238	17	order	order	NOUN
bptjm-12	238	18	to	to	PART
bptjm-12	238	19	deliver	deliver	VERB
bptjm-12	238	20	the	the	DET
bptjm-12	238	21	bene	bene	PROPN
bptjm-12	238	22	�	�	PROPN
bptjm-12	238	23	cial	cial	ADJ
bptjm-12	238	24	elements	element	NOUN
bptjm-12	238	25	of	of	ADP
bptjm-12	238	26	cannabiswhile	cannabiswhile	NOUN
bptjm-12	238	27	attempting	attempt	VERB
bptjm-12	238	28	to	to	PART
bptjm-12	238	29	reduce	reduce	VERB
bptjm-12	238	30	certain	certain	ADJ
bptjm-12	238	31	side	side	NOUN
bptjm-12	238	32	e	e	NOUN
bptjm-12	238	33	�	�	NOUN
bptjm-12	238	34	ects	ect	NOUN
bptjm-12	238	35	of	of	ADP
bptjm-12	238	36	δ9	δ9	NOUN
bptjm-12	238	37	-	-	PUNCT
bptjm-12	238	38	thc	thc	NOUN
bptjm-12	238	39	in	in	ADP
bptjm-12	238	40	alzheimer’spatients	alzheimer’spatient	NOUN
bptjm-12	238	41	(	(	PUNCT
bptjm-12	238	42	giacoppo	giacoppo	PROPN
bptjm-12	238	43	et	et	PROPN
bptjm-12	238	44	al	al	PROPN
bptjm-12	238	45	.	.	PROPN
bptjm-12	238	46	,	,	PUNCT
bptjm-12	238	47	2014	2014	NUM
bptjm-12	238	48	)	)	PUNCT
bptjm-12	238	49	.	.	PUNCT
bptjm-12	239	1	cbd	cbd	PROPN
bptjm-12	239	2	and	and	CCONJ
bptjm-12	239	3	thc	thc	NOUN
bptjm-12	239	4	,	,	PUNCT
bptjm-12	239	5	natural	natural	ADJ
bptjm-12	239	6	components	component	NOUN
bptjm-12	239	7	in	in	ADP
bptjm-12	239	8	cannabinoids	cannabinoid	NOUN
bptjm-12	239	9	,	,	PUNCT
bptjm-12	239	10	provide	provide	VERB
bptjm-12	239	11	encouraging	encouraging	ADJ
bptjm-12	239	12	results	result	NOUN
bptjm-12	239	13	for	for	ADP
bptjm-12	239	14	possible	possible	ADJ
bptjm-12	239	15	use	use	NOUN
bptjm-12	239	16	in	in	ADP
bptjm-12	239	17	alzheimer	alzheimer	PROPN
bptjm-12	239	18	’s	’s	PART
bptjm-12	239	19	patients	patient	NOUN
bptjm-12	239	20	.	.	PUNCT
bptjm-12	240	1	the	the	DET
bptjm-12	240	2	phytocannabinoid	phytocannabinoid	NOUN
bptjm-12	240	3	component	component	NOUN
bptjm-12	240	4	of	of	ADP
bptjm-12	240	5	cannabis	cannabis	NOUN
bptjm-12	240	6	,	,	PUNCT
bptjm-12	240	7	a	a	DET
bptjm-12	240	8	naturally	naturally	ADV
bptjm-12	240	9	occurring	occur	VERB
bptjm-12	240	10	component	component	NOUN
bptjm-12	240	11	found	find	VERB
bptjm-12	240	12	in	in	ADP
bptjm-12	240	13	the	the	DET
bptjm-12	240	14	trichomes	trichome	NOUN
bptjm-12	240	15	of	of	ADP
bptjm-12	240	16	this	this	DET
bptjm-12	240	17	plant	plant	NOUN
bptjm-12	240	18	,	,	PUNCT
bptjm-12	240	19	is	be	AUX
bptjm-12	240	20	seen	see	VERB
bptjm-12	240	21	to	to	PART
bptjm-12	240	22	be	be	AUX
bptjm-12	240	23	particularly	particularly	ADV
bptjm-12	240	24	bene	bene	NOUN
bptjm-12	240	25	�	�	PROPN
bptjm-12	240	26	cial	cial	NOUN
bptjm-12	240	27	in	in	ADP
bptjm-12	240	28	the	the	DET
bptjm-12	240	29	treatment	treatment	NOUN
bptjm-12	240	30	of	of	ADP
bptjm-12	240	31	alzheimer	alzheimer	PROPN
bptjm-12	240	32	's	's	PART
bptjm-12	240	33	disease	disease	NOUN
bptjm-12	240	34	as	as	SCONJ
bptjm-12	240	35	it	it	PRON
bptjm-12	240	36	lacks	lack	VERB
bptjm-12	240	37	psychoactive	psychoactive	ADJ
bptjm-12	240	38	properties	property	NOUN
bptjm-12	240	39	and	and	CCONJ
bptjm-12	240	40	does	do	AUX
bptjm-12	240	41	not	not	PART
bptjm-12	240	42	risk	risk	VERB
bptjm-12	240	43	further	far	ADV
bptjm-12	240	44	cognitive	cognitive	ADJ
bptjm-12	240	45	impairment	impairment	ADJ
bptjm-12	240	46	damage	damage	NOUN
bptjm-12	240	47	in	in	ADP
bptjm-12	240	48	alzheimer	alzheimer	PROPN
bptjm-12	240	49	’s	’s	PART
bptjm-12	240	50	patients	patient	NOUN
bptjm-12	240	51	(	(	PUNCT
bptjm-12	240	52	karlet	karlet	PROPN
bptjm-12	240	53	al	al	PROPN
bptjm-12	240	54	.	.	PROPN
bptjm-12	240	55	,	,	PUNCT
bptjm-12	240	56	2017	2017	NUM
bptjm-12	240	57	)	)	PUNCT
bptjm-12	240	58	.	.	PUNCT
bptjm-12	241	1	in	in	ADP
bptjm-12	241	2	fact	fact	NOUN
bptjm-12	241	3	,	,	PUNCT
bptjm-12	241	4	cannabis	cannabis	NOUN
bptjm-12	241	5	can	can	AUX
bptjm-12	241	6	can	can	AUX
bptjm-12	241	7	actually	actually	ADV
bptjm-12	241	8	help	help	VERB
bptjm-12	241	9	restore	restore	VERB
bptjm-12	241	10	cognitive	cognitive	ADJ
bptjm-12	241	11	dysfunctions	dysfunction	NOUN
bptjm-12	241	12	characteristic	characteristic	ADJ
bptjm-12	241	13	of	of	ADP
bptjm-12	241	14	alzheimer	alzheimer	PROPN
bptjm-12	241	15	’s	’s	PART
bptjm-12	241	16	disease	disease	NOUN
bptjm-12	241	17	(	(	PUNCT
bptjm-12	241	18	uddin	uddin	NOUN
bptjm-12	241	19	et	et	PROPN
bptjm-12	241	20	al	al	PROPN
bptjm-12	241	21	.	.	PROPN
bptjm-12	241	22	,	,	PUNCT
bptjm-12	241	23	2020	2020	NUM
bptjm-12	241	24	)	)	PUNCT
bptjm-12	241	25	.	.	PUNCT
bptjm-12	242	1	cannabis	cannabis	NOUN
bptjm-12	242	2	is	be	AUX
bptjm-12	242	3	a	a	DET
bptjm-12	242	4	promising	promising	ADJ
bptjm-12	242	5	agent	agent	NOUN
bptjm-12	242	6	with	with	ADP
bptjm-12	242	7	numerous	numerous	ADJ
bptjm-12	242	8	berkeley	berkeley	PROPN
bptjm-12	242	9	pharma	pharma	PROPN
bptjm-12	242	10	tech	tech	NOUN
bptjm-12	242	11	journal	journal	NOUN
bptjm-12	242	12	of	of	ADP
bptjm-12	242	13	medicine	medicine	NOUN
bptjm-12	242	14	|	|	ADV
bptjm-12	242	15	18	18	NUM
bptjm-12	242	16	therapeutic	therapeutic	ADJ
bptjm-12	242	17	properties	property	NOUN
bptjm-12	242	18	that	that	PRON
bptjm-12	242	19	hinder	hinder	VERB
bptjm-12	242	20	the	the	DET
bptjm-12	242	21	progression	progression	NOUN
bptjm-12	242	22	of	of	ADP
bptjm-12	242	23	ad	ad	NOUN
bptjm-12	242	24	,	,	PUNCT
bptjm-12	242	25	leading	lead	VERB
bptjm-12	242	26	to	to	ADP
bptjm-12	242	27	the	the	DET
bptjm-12	242	28	investigation	investigation	NOUN
bptjm-12	242	29	of	of	ADP
bptjm-12	242	30	cannabidiol	cannabidiol	PROPN
bptjm-12	242	31	(	(	PUNCT
bptjm-12	242	32	cbd	cbd	NOUN
bptjm-12	242	33	)	)	PUNCT
bptjm-12	242	34	therapies	therapy	NOUN
bptjm-12	242	35	.	.	PUNCT
bptjm-12	243	1	current	current	ADJ
bptjm-12	243	2	cbd	cbd	NOUN
bptjm-12	243	3	therapies	therapy	NOUN
bptjm-12	243	4	are	be	AUX
bptjm-12	243	5	seen	see	VERB
bptjm-12	243	6	to	to	PART
bptjm-12	243	7	bring	bring	VERB
bptjm-12	243	8	“	"	PUNCT
bptjm-12	243	9	very	very	ADV
bptjm-12	243	10	modest	modest	ADJ
bptjm-12	243	11	symptomatic	symptomatic	ADJ
bptjm-12	243	12	relief	relief	NOUN
bptjm-12	243	13	”	"	PUNCT
bptjm-12	243	14	(	(	PUNCT
bptjm-12	243	15	karl	karl	PROPN
bptjm-12	243	16	et	et	PROPN
bptjm-12	243	17	al	al	PROPN
bptjm-12	243	18	.	.	PROPN
bptjm-12	243	19	,	,	PUNCT
bptjm-12	243	20	2017	2017	NUM
bptjm-12	243	21	)	)	PUNCT
bptjm-12	243	22	.	.	PUNCT
bptjm-12	244	1	cbd	cbd	NOUN
bptjm-12	244	2	treatment	treatment	NOUN
bptjm-12	244	3	is	be	AUX
bptjm-12	244	4	described	describe	VERB
bptjm-12	244	5	as	as	ADP
bptjm-12	244	6	being	be	AUX
bptjm-12	244	7	a	a	DET
bptjm-12	244	8	preventative	preventative	ADJ
bptjm-12	244	9	,	,	PUNCT
bptjm-12	244	10	multimodal	multimodal	ADJ
bptjm-12	244	11	drug	drug	NOUN
bptjm-12	244	12	strategy	strategy	NOUN
bptjm-12	244	13	targeting	target	VERB
bptjm-12	244	14	the	the	DET
bptjm-12	244	15	wide	wide	ADJ
bptjm-12	244	16	variety	variety	NOUN
bptjm-12	244	17	of	of	ADP
bptjm-12	244	18	symptoms	symptom	NOUN
bptjm-12	244	19	,	,	PUNCT
bptjm-12	244	20	making	make	VERB
bptjm-12	244	21	it	it	PRON
bptjm-12	244	22	a	a	DET
bptjm-12	244	23	viable	viable	ADJ
bptjm-12	244	24	candidate	candidate	NOUN
bptjm-12	244	25	for	for	ADP
bptjm-12	244	26	ad	ad	NOUN
bptjm-12	244	27	therapy	therapy	NOUN
bptjm-12	244	28	(	(	PUNCT
bptjm-12	244	29	karl	karl	PROPN
bptjm-12	244	30	et	et	PROPN
bptjm-12	244	31	al	al	PROPN
bptjm-12	244	32	.	.	PROPN
bptjm-12	244	33	,	,	PUNCT
bptjm-12	244	34	2017	2017	NUM
bptjm-12	244	35	)	)	PUNCT
bptjm-12	244	36	.	.	PUNCT
bptjm-12	245	1	v.	v.	ADP
bptjm-12	245	2	conclusion	conclusion	NOUN
bptjm-12	245	3	the	the	DET
bptjm-12	245	4	features	feature	NOUN
bptjm-12	245	5	of	of	ADP
bptjm-12	245	6	ad	ad	NOUN
bptjm-12	245	7	,	,	PUNCT
bptjm-12	245	8	which	which	PRON
bptjm-12	245	9	consist	consist	VERB
bptjm-12	245	10	of	of	ADP
bptjm-12	245	11	in	in	ADP
bptjm-12	245	12	�	�	PROPN
bptjm-12	245	13	ammation	ammation	NOUN
bptjm-12	245	14	(	(	PUNCT
bptjm-12	245	15	atakan	atakan	ADJ
bptjm-12	245	16	,	,	PUNCT
bptjm-12	245	17	2012	2012	NUM
bptjm-12	245	18	)	)	PUNCT
bptjm-12	245	19	,	,	PUNCT
bptjm-12	245	20	amyloid	amyloid	NOUN
bptjm-12	245	21	-	-	PUNCT
bptjm-12	245	22	beta	beta	NOUN
bptjm-12	245	23	plaque	plaque	NOUN
bptjm-12	245	24	buildup	buildup	NOUN
bptjm-12	245	25	(	(	PUNCT
bptjm-12	245	26	farkhondehet	farkhondehet	NOUN
bptjm-12	245	27	al	al	PROPN
bptjm-12	245	28	.	.	PROPN
bptjm-12	245	29	,	,	PUNCT
bptjm-12	245	30	2020	2020	NUM
bptjm-12	245	31	)	)	PUNCT
bptjm-12	245	32	,	,	PUNCT
bptjm-12	245	33	and	and	CCONJ
bptjm-12	245	34	neuro	neuro	PROPN
bptjm-12	245	35	�	�	PROPN
bptjm-12	245	36	brillary	brillary	ADJ
bptjm-12	245	37	tangles	tangle	NOUN
bptjm-12	245	38	(	(	PUNCT
bptjm-12	245	39	hall	hall	NOUN
bptjm-12	245	40	et	et	PROPN
bptjm-12	245	41	al	al	PROPN
bptjm-12	245	42	.	.	PROPN
bptjm-12	245	43	,	,	PUNCT
bptjm-12	245	44	2001	2001	NUM
bptjm-12	245	45	;	;	PUNCT
bptjm-12	245	46	nelson	nelson	PROPN
bptjm-12	245	47	et	et	PROPN
bptjm-12	245	48	al	al	PROPN
bptjm-12	245	49	.	.	PROPN
bptjm-12	245	50	,2012	,2012	PROPN
bptjm-12	245	51	)	)	PUNCT
bptjm-12	245	52	,	,	PUNCT
bptjm-12	245	53	lead	lead	VERB
bptjm-12	245	54	to	to	ADP
bptjm-12	245	55	life	life	NOUN
bptjm-12	245	56	-	-	PUNCT
bptjm-12	245	57	altering	alter	VERB
bptjm-12	245	58	cognitive	cognitive	ADJ
bptjm-12	245	59	de	de	X
bptjm-12	245	60	�	�	PROPN
bptjm-12	245	61	cits	cit	NOUN
bptjm-12	245	62	and	and	CCONJ
bptjm-12	245	63	other	other	ADJ
bptjm-12	245	64	extensive	extensive	ADJ
bptjm-12	245	65	e	e	NOUN
bptjm-12	245	66	�	�	NOUN
bptjm-12	245	67	ects	ect	VERB
bptjm-12	245	68	that	that	PRON
bptjm-12	245	69	impact	impact	VERB
bptjm-12	245	70	a	a	DET
bptjm-12	245	71	signi	signi	ADJ
bptjm-12	245	72	�	�	NOUN
bptjm-12	245	73	cant	cant	VERB
bptjm-12	245	74	population	population	NOUN
bptjm-12	245	75	of	of	ADP
bptjm-12	245	76	individuals	individual	NOUN
bptjm-12	245	77	.	.	PUNCT
bptjm-12	246	1	it	it	PRON
bptjm-12	246	2	is	be	AUX
bptjm-12	246	3	one	one	NUM
bptjm-12	246	4	of	of	ADP
bptjm-12	246	5	the	the	DET
bptjm-12	246	6	most	most	ADV
bptjm-12	246	7	heavily	heavily	ADV
bptjm-12	246	8	researched	research	VERB
bptjm-12	246	9	diseases	disease	NOUN
bptjm-12	246	10	,	,	PUNCT
bptjm-12	246	11	yet	yet	CCONJ
bptjm-12	246	12	there	there	PRON
bptjm-12	246	13	is	be	VERB
bptjm-12	246	14	still	still	ADV
bptjm-12	246	15	no	no	DET
bptjm-12	246	16	method	method	NOUN
bptjm-12	246	17	to	to	PART
bptjm-12	246	18	stop	stop	VERB
bptjm-12	246	19	its	its	PRON
bptjm-12	246	20	progression	progression	NOUN
bptjm-12	246	21	.	.	PUNCT
bptjm-12	247	1	therefore	therefore	ADV
bptjm-12	247	2	,	,	PUNCT
bptjm-12	247	3	the	the	DET
bptjm-12	247	4	injection	injection	NOUN
bptjm-12	247	5	of	of	ADP
bptjm-12	247	6	cannabinoids	cannabinoid	NOUN
bptjm-12	247	7	provides	provide	VERB
bptjm-12	247	8	one	one	NUM
bptjm-12	247	9	promising	promising	ADJ
bptjm-12	247	10	revenue	revenue	NOUN
bptjm-12	247	11	for	for	SCONJ
bptjm-12	247	12	scientists	scientist	NOUN
bptjm-12	247	13	to	to	PART
bptjm-12	247	14	counter	counter	VERB
bptjm-12	247	15	the	the	DET
bptjm-12	247	16	damage	damage	NOUN
bptjm-12	247	17	.	.	PUNCT
bptjm-12	248	1	the	the	DET
bptjm-12	248	2	connection	connection	NOUN
bptjm-12	248	3	between	between	ADP
bptjm-12	248	4	ad	ad	NOUN
bptjm-12	248	5	and	and	CCONJ
bptjm-12	248	6	cannabinoids	cannabinoid	NOUN
bptjm-12	248	7	has	have	AUX
bptjm-12	248	8	been	be	AUX
bptjm-12	248	9	made	make	VERB
bptjm-12	248	10	apparent	apparent	ADJ
bptjm-12	248	11	through	through	ADP
bptjm-12	248	12	many	many	ADJ
bptjm-12	248	13	recent	recent	ADJ
bptjm-12	248	14	studies	study	NOUN
bptjm-12	248	15	.	.	PUNCT
bptjm-12	249	1	investigations	investigation	NOUN
bptjm-12	249	2	into	into	ADP
bptjm-12	249	3	the	the	DET
bptjm-12	249	4	e	e	PROPN
bptjm-12	249	5	�	�	PROPN
bptjm-12	249	6	cacy	cacy	NOUN
bptjm-12	249	7	of	of	ADP
bptjm-12	249	8	the	the	DET
bptjm-12	249	9	ecs	ecs	PROPN
bptjm-12	249	10	as	as	ADV
bptjm-12	249	11	well	well	ADV
bptjm-12	249	12	as	as	ADP
bptjm-12	249	13	natural	natural	ADJ
bptjm-12	249	14	and	and	CCONJ
bptjm-12	249	15	synthetic	synthetic	ADJ
bptjm-12	249	16	cannabinoids	cannabinoid	NOUN
bptjm-12	249	17	have	have	AUX
bptjm-12	249	18	developed	develop	VERB
bptjm-12	249	19	in	in	ADP
bptjm-12	249	20	regards	regard	NOUN
bptjm-12	249	21	to	to	ADP
bptjm-12	249	22	the	the	DET
bptjm-12	249	23	treatment	treatment	NOUN
bptjm-12	249	24	and	and	CCONJ
bptjm-12	249	25	management	management	NOUN
bptjm-12	249	26	of	of	ADP
bptjm-12	249	27	ad	ad	NOUN
bptjm-12	249	28	and	and	CCONJ
bptjm-12	249	29	its	its	PRON
bptjm-12	249	30	varying	vary	VERB
bptjm-12	249	31	pathologies	pathology	NOUN
bptjm-12	249	32	.	.	PUNCT
bptjm-12	250	1	cannabinoid	cannabinoid	PROPN
bptjm-12	250	2	agonists	agonist	NOUN
bptjm-12	250	3	have	have	AUX
bptjm-12	250	4	presented	present	VERB
bptjm-12	250	5	researchers	researcher	NOUN
bptjm-12	250	6	with	with	ADP
bptjm-12	250	7	neuroprotective	neuroprotective	ADJ
bptjm-12	250	8	qualities	quality	NOUN
bptjm-12	250	9	as	as	ADV
bptjm-12	250	10	well	well	ADV
bptjm-12	250	11	as	as	ADP
bptjm-12	250	12	the	the	DET
bptjm-12	250	13	ability	ability	NOUN
bptjm-12	250	14	to	to	PART
bptjm-12	250	15	manage	manage	VERB
bptjm-12	250	16	the	the	DET
bptjm-12	250	17	chronic	chronic	ADJ
bptjm-12	250	18	psychiatric	psychiatric	ADJ
bptjm-12	250	19	pathology	pathology	NOUN
bptjm-12	250	20	associated	associate	VERB
bptjm-12	250	21	with	with	ADP
bptjm-12	250	22	ad	ad	NOUN
bptjm-12	250	23	.	.	PUNCT
bptjm-12	251	1	this	this	PRON
bptjm-12	251	2	is	be	AUX
bptjm-12	251	3	due	due	ADJ
bptjm-12	251	4	to	to	ADP
bptjm-12	251	5	the	the	DET
bptjm-12	251	6	inherent	inherent	ADJ
bptjm-12	251	7	physiology	physiology	NOUN
bptjm-12	251	8	of	of	ADP
bptjm-12	251	9	the	the	DET
bptjm-12	251	10	endocannabinoid	endocannabinoid	NOUN
bptjm-12	251	11	system	system	NOUN
bptjm-12	251	12	.	.	PUNCT
bptjm-12	252	1	ecs	ec	NOUN
bptjm-12	252	2	receptors	receptor	NOUN
bptjm-12	252	3	exist	exist	VERB
bptjm-12	252	4	both	both	CCONJ
bptjm-12	252	5	in	in	ADP
bptjm-12	252	6	the	the	DET
bptjm-12	252	7	brain	brain	NOUN
bptjm-12	252	8	and	and	CCONJ
bptjm-12	252	9	parts	part	NOUN
bptjm-12	252	10	of	of	ADP
bptjm-12	252	11	the	the	DET
bptjm-12	252	12	immune	immune	ADJ
bptjm-12	252	13	system	system	NOUN
bptjm-12	252	14	pathways	pathway	NOUN
bptjm-12	252	15	,	,	PUNCT
bptjm-12	252	16	as	as	ADP
bptjm-12	252	17	a	a	DET
bptjm-12	252	18	result	result	NOUN
bptjm-12	252	19	,	,	PUNCT
bptjm-12	252	20	controlling	control	VERB
bptjm-12	252	21	its	its	PRON
bptjm-12	252	22	function	function	NOUN
bptjm-12	252	23	through	through	ADP
bptjm-12	252	24	cannabinoid	cannabinoid	NOUN
bptjm-12	252	25	agonists	agonist	NOUN
bptjm-12	252	26	and	and	CCONJ
bptjm-12	252	27	ecs	ecs	NOUN
bptjm-12	252	28	ligands	ligand	NOUN
bptjm-12	252	29	can	can	AUX
bptjm-12	252	30	serve	serve	VERB
bptjm-12	252	31	both	both	PRON
bptjm-12	252	32	as	as	ADP
bptjm-12	252	33	a	a	DET
bptjm-12	252	34	neuromodulator	neuromodulator	NOUN
bptjm-12	252	35	and	and	CCONJ
bptjm-12	252	36	an	an	DET
bptjm-12	252	37	immunomodulator	immunomodulator	NOUN
bptjm-12	252	38	.	.	PUNCT
bptjm-12	253	1	therapeutic	therapeutic	ADJ
bptjm-12	253	2	use	use	NOUN
bptjm-12	253	3	of	of	ADP
bptjm-12	253	4	the	the	DET
bptjm-12	253	5	ecs	ecs	PROPN
bptjm-12	253	6	and	and	CCONJ
bptjm-12	253	7	cannabinoids	cannabinoid	NOUN
bptjm-12	253	8	in	in	ADP
bptjm-12	253	9	relation	relation	NOUN
bptjm-12	253	10	to	to	ADP
bptjm-12	253	11	ad	ad	NOUN
bptjm-12	253	12	include	include	VERB
bptjm-12	253	13	elevated	elevated	ADJ
bptjm-12	253	14	activation	activation	NOUN
bptjm-12	253	15	of	of	ADP
bptjm-12	253	16	endocannabinoid	endocannabinoid	NOUN
bptjm-12	253	17	receptors	receptor	NOUN
bptjm-12	253	18	to	to	PART
bptjm-12	253	19	bolster	bolster	VERB
bptjm-12	253	20	neurogenesis	neurogenesis	NOUN
bptjm-12	253	21	and	and	CCONJ
bptjm-12	253	22	thus	thus	ADV
bptjm-12	253	23	reduce	reduce	VERB
bptjm-12	253	24	the	the	DET
bptjm-12	253	25	neurodegenerative	neurodegenerative	ADJ
bptjm-12	253	26	e	e	NOUN
bptjm-12	253	27	�	�	NOUN
bptjm-12	253	28	ects	ect	NOUN
bptjm-12	253	29	of	of	ADP
bptjm-12	253	30	ad	ad	NOUN
bptjm-12	253	31	(	(	PUNCT
bptjm-12	253	32	fagan	fagan	PROPN
bptjm-12	253	33	&	&	CCONJ
bptjm-12	253	34	campbell	campbell	PROPN
bptjm-12	253	35	,	,	PUNCT
bptjm-12	253	36	2014	2014	NUM
bptjm-12	253	37	)	)	PUNCT
bptjm-12	253	38	.	.	PUNCT
bptjm-12	254	1	this	this	DET
bptjm-12	254	2	process	process	NOUN
bptjm-12	254	3	occurs	occur	VERB
bptjm-12	254	4	through	through	ADP
bptjm-12	254	5	the	the	DET
bptjm-12	254	6	stimulation	stimulation	NOUN
bptjm-12	254	7	of	of	ADP
bptjm-12	254	8	cb1	cb1	NOUN
bptjm-12	254	9	receptors	receptor	NOUN
bptjm-12	254	10	by	by	ADP
bptjm-12	254	11	the	the	DET
bptjm-12	254	12	endocannabinoid	endocannabinoid	NOUN
bptjm-12	254	13	signaling	signal	VERB
bptjm-12	254	14	molecules	molecule	NOUN
bptjm-12	254	15	and	and	CCONJ
bptjm-12	254	16	external	external	ADJ
bptjm-12	254	17	agonists	agonist	NOUN
bptjm-12	254	18	.	.	PUNCT
bptjm-12	255	1	cb2	cb2	NOUN
bptjm-12	255	2	receptors	receptor	NOUN
bptjm-12	255	3	are	be	AUX
bptjm-12	255	4	mainly	mainly	ADV
bptjm-12	255	5	targeted	target	VERB
bptjm-12	255	6	for	for	ADP
bptjm-12	255	7	their	their	PRON
bptjm-12	255	8	anti	anti	ADJ
bptjm-12	255	9	-	-	ADJ
bptjm-12	255	10	in	in	ADJ
bptjm-12	255	11	�	�	NOUN
bptjm-12	255	12	ammation	ammation	NOUN
bptjm-12	255	13	properties	property	NOUN
bptjm-12	255	14	(	(	PUNCT
bptjm-12	255	15	tolón	tolón	NOUN
bptjm-12	255	16	et	et	PROPN
bptjm-12	255	17	al	al	PROPN
bptjm-12	255	18	.	.	PROPN
bptjm-12	255	19	,	,	PUNCT
bptjm-12	255	20	2009	2009	NUM
bptjm-12	255	21	)	)	PUNCT
bptjm-12	255	22	;	;	PUNCT
bptjm-12	255	23	their	their	PRON
bptjm-12	255	24	modulation	modulation	NOUN
bptjm-12	255	25	using	use	VERB
bptjm-12	255	26	receptor	receptor	NOUN
bptjm-12	255	27	agonists	agonist	NOUN
bptjm-12	255	28	—	—	PUNCT
bptjm-12	255	29	such	such	ADJ
bptjm-12	255	30	as	as	ADP
bptjm-12	255	31	jwh-015	jwh-015	NOUN
bptjm-12	255	32	(	(	PUNCT
bptjm-12	255	33	tolón	tolón	NOUN
bptjm-12	255	34	et	et	PROPN
bptjm-12	255	35	al	al	PROPN
bptjm-12	255	36	.	.	PROPN
bptjm-12	255	37	,	,	PUNCT
bptjm-12	255	38	2009	2009	NUM
bptjm-12	255	39	)	)	PUNCT
bptjm-12	255	40	and	and	CCONJ
bptjm-12	255	41	jwh-133	jwh-133	PROPN
bptjm-12	255	42	(	(	PUNCT
bptjm-12	255	43	çakır	çakır	PROPN
bptjm-12	255	44	et	et	PROPN
bptjm-12	255	45	al	al	PROPN
bptjm-12	255	46	.	.	PROPN
bptjm-12	255	47	,	,	PUNCT
bptjm-12	255	48	2019	2019	NUM
bptjm-12	255	49	)	)	PUNCT
bptjm-12	255	50	—	—	PUNCT
bptjm-12	255	51	indicates	indicate	VERB
bptjm-12	255	52	a	a	DET
bptjm-12	255	53	reduction	reduction	NOUN
bptjm-12	255	54	of	of	ADP
bptjm-12	255	55	proin	proin	NOUN
bptjm-12	255	56	�	�	NOUN
bptjm-12	255	57	ammatory	ammatory	NOUN
bptjm-12	255	58	molecules	molecule	NOUN
bptjm-12	255	59	,	,	PUNCT
bptjm-12	255	60	which	which	PRON
bptjm-12	255	61	block	block	VERB
bptjm-12	255	62	proper	proper	ADJ
bptjm-12	255	63	neurofunction	neurofunction	NOUN
bptjm-12	255	64	,	,	PUNCT
bptjm-12	255	65	that	that	PRON
bptjm-12	255	66	are	be	AUX
bptjm-12	255	67	normally	normally	ADV
bptjm-12	255	68	present	present	ADJ
bptjm-12	255	69	in	in	ADP
bptjm-12	255	70	ad	ad	NOUN
bptjm-12	255	71	.	.	PUNCT
bptjm-12	256	1	endocannabinoid	endocannabinoid	NOUN
bptjm-12	256	2	-	-	PUNCT
bptjm-12	256	3	speci	speci	X
bptjm-12	256	4	�	�	PROPN
bptjm-12	256	5	c	c	NOUN
bptjm-12	256	6	agonists	agonist	NOUN
bptjm-12	256	7	also	also	ADV
bptjm-12	256	8	inhibit	inhibit	VERB
bptjm-12	256	9	the	the	DET
bptjm-12	256	10	e	e	NOUN
bptjm-12	256	11	�	�	PROPN
bptjm-12	256	12	ects	ect	NOUN
bptjm-12	256	13	of	of	ADP
bptjm-12	256	14	ad	ad	NOUN
bptjm-12	256	15	by	by	ADP
bptjm-12	256	16	blocking	block	VERB
bptjm-12	256	17	harmful	harmful	ADJ
bptjm-12	256	18	processes	process	NOUN
bptjm-12	256	19	in	in	ADP
bptjm-12	256	20	the	the	DET
bptjm-12	256	21	brain	brain	NOUN
bptjm-12	256	22	;	;	PUNCT
bptjm-12	256	23	these	these	DET
bptjm-12	256	24	processes	process	NOUN
bptjm-12	256	25	are	be	AUX
bptjm-12	256	26	microglia	microglia	ADJ
bptjm-12	256	27	activation	activation	NOUN
bptjm-12	256	28	(	(	PUNCT
bptjm-12	256	29	martín	martín	NOUN
bptjm-12	256	30	-	-	PUNCT
bptjm-12	256	31	moreno	moreno	PROPN
bptjm-12	256	32	et	et	PROPN
bptjm-12	256	33	al	al	PROPN
bptjm-12	256	34	.	.	PROPN
bptjm-12	256	35	,	,	PUNCT
bptjm-12	256	36	2011	2011	NUM
bptjm-12	256	37	)	)	PUNCT
bptjm-12	256	38	,	,	PUNCT
bptjm-12	256	39	neuro	neuro	PROPN
bptjm-12	256	40	�	�	PROPN
bptjm-12	256	41	brillary	brillary	ADJ
bptjm-12	256	42	tangles	tangle	NOUN
bptjm-12	256	43	,	,	PUNCT
bptjm-12	256	44	and	and	CCONJ
bptjm-12	256	45	tau	tau	PROPN
bptjm-12	256	46	protein	protein	NOUN
bptjm-12	256	47	phosphorylation	phosphorylation	NOUN
bptjm-12	256	48	(	(	PUNCT
bptjm-12	256	49	esposito	esposito	PROPN
bptjm-12	256	50	,	,	PUNCT
bptjm-12	256	51	2006	2006	NUM
bptjm-12	256	52	)	)	PUNCT
bptjm-12	256	53	.	.	PUNCT
bptjm-12	257	1	experimentation	experimentation	NOUN
bptjm-12	257	2	with	with	ADP
bptjm-12	257	3	the	the	DET
bptjm-12	257	4	berkeley	berkeley	PROPN
bptjm-12	257	5	pharma	pharma	PROPN
bptjm-12	257	6	tech	tech	NOUN
bptjm-12	257	7	journal	journal	NOUN
bptjm-12	257	8	of	of	ADP
bptjm-12	257	9	medicine	medicine	NOUN
bptjm-12	257	10	|	|	ADV
bptjm-12	257	11	19	19	NUM
bptjm-12	257	12	synthetic	synthetic	ADJ
bptjm-12	257	13	agonist	agonist	NOUN
bptjm-12	257	14	has	have	AUX
bptjm-12	257	15	been	be	AUX
bptjm-12	257	16	seen	see	VERB
bptjm-12	257	17	to	to	PART
bptjm-12	257	18	further	far	ADV
bptjm-12	257	19	suppress	suppress	VERB
bptjm-12	257	20	symptoms	symptom	NOUN
bptjm-12	257	21	due	due	ADP
bptjm-12	257	22	to	to	ADP
bptjm-12	257	23	their	their	PRON
bptjm-12	257	24	structural	structural	ADJ
bptjm-12	257	25	similarity	similarity	NOUN
bptjm-12	257	26	to	to	ADP
bptjm-12	257	27	the	the	DET
bptjm-12	257	28	natural	natural	ADJ
bptjm-12	257	29	cannabinoids	cannabinoid	NOUN
bptjm-12	257	30	and	and	CCONJ
bptjm-12	257	31	have	have	VERB
bptjm-12	257	32	even	even	ADV
bptjm-12	257	33	stronger	strong	ADJ
bptjm-12	257	34	receptor	receptor	NOUN
bptjm-12	257	35	activation	activation	NOUN
bptjm-12	257	36	.	.	PUNCT
bptjm-12	258	1	mice	mouse	NOUN
bptjm-12	258	2	study	study	NOUN
bptjm-12	258	3	results	result	NOUN
bptjm-12	258	4	identify	identify	VERB
bptjm-12	258	5	the	the	DET
bptjm-12	258	6	synthetic	synthetic	ADJ
bptjm-12	258	7	agonists	agonist	NOUN
bptjm-12	258	8	according	accord	VERB
bptjm-12	258	9	to	to	ADP
bptjm-12	258	10	what	what	PRON
bptjm-12	258	11	they	they	PRON
bptjm-12	258	12	prevent	prevent	VERB
bptjm-12	258	13	in	in	ADP
bptjm-12	258	14	the	the	DET
bptjm-12	258	15	ad	ad	NOUN
bptjm-12	258	16	injured	injure	VERB
bptjm-12	258	17	brain	brain	NOUN
bptjm-12	258	18	:	:	PUNCT
bptjm-12	258	19	win55,212	win55,212	PROPN
bptjm-12	258	20	-	-	PUNCT
bptjm-12	258	21	2	2	NUM
bptjm-12	258	22	is	be	AUX
bptjm-12	258	23	correlated	correlate	VERB
bptjm-12	258	24	to	to	PART
bptjm-12	258	25	nerve	nerve	NOUN
bptjm-12	258	26	development	development	NOUN
bptjm-12	258	27	(	(	PUNCT
bptjm-12	258	28	liu	liu	PROPN
bptjm-12	258	29	et	et	PROPN
bptjm-12	258	30	al	al	PROPN
bptjm-12	258	31	.	.	PROPN
bptjm-12	258	32	,	,	PUNCT
bptjm-12	258	33	2015	2015	NUM
bptjm-12	258	34	)	)	PUNCT
bptjm-12	258	35	,	,	PUNCT
bptjm-12	258	36	jwh-133	jwh-133	PROPN
bptjm-12	258	37	binds	bind	VERB
bptjm-12	258	38	to	to	PART
bptjm-12	258	39	cb2	cb2	VERB
bptjm-12	258	40	to	to	PART
bptjm-12	258	41	reduce	reduce	VERB
bptjm-12	258	42	rapid	rapid	ADJ
bptjm-12	258	43	in	in	ADP
bptjm-12	258	44	�	�	PROPN
bptjm-12	258	45	ammation	ammation	NOUN
bptjm-12	258	46	(	(	PUNCT
bptjm-12	258	47	çakır	çakır	PROPN
bptjm-12	258	48	et	et	PROPN
bptjm-12	258	49	al	al	PROPN
bptjm-12	258	50	.	.	PROPN
bptjm-12	258	51	,	,	PUNCT
bptjm-12	258	52	2019	2019	NUM
bptjm-12	258	53	)	)	PUNCT
bptjm-12	258	54	,	,	PUNCT
bptjm-12	258	55	and	and	CCONJ
bptjm-12	258	56	dronabinol	dronabinol	NOUN
bptjm-12	258	57	and	and	CCONJ
bptjm-12	258	58	nabilone	nabilone	PROPN
bptjm-12	258	59	treat	treat	NOUN
bptjm-12	258	60	mostly	mostly	ADV
bptjm-12	258	61	neuropsychiatric	neuropsychiatric	ADJ
bptjm-12	258	62	symptoms	symptom	NOUN
bptjm-12	258	63	(	(	PUNCT
bptjm-12	258	64	liu	liu	PROPN
bptjm-12	258	65	et	et	PROPN
bptjm-12	258	66	al	al	PROPN
bptjm-12	258	67	.	.	PROPN
bptjm-12	258	68	,2015	,2015	PROPN
bptjm-12	258	69	)	)	PUNCT
bptjm-12	258	70	.	.	PUNCT
bptjm-12	259	1	in	in	ADP
bptjm-12	259	2	dealing	deal	VERB
bptjm-12	259	3	with	with	ADP
bptjm-12	259	4	the	the	DET
bptjm-12	259	5	synapse	synapse	NOUN
bptjm-12	259	6	,	,	PUNCT
bptjm-12	259	7	long	long	ADJ
bptjm-12	259	8	term	term	NOUN
bptjm-12	259	9	potentiation	potentiation	NOUN
bptjm-12	259	10	was	be	AUX
bptjm-12	259	11	regained	regain	VERB
bptjm-12	259	12	in	in	ADP
bptjm-12	259	13	tests	test	NOUN
bptjm-12	259	14	with	with	ADP
bptjm-12	259	15	mice	mouse	NOUN
bptjm-12	259	16	who	who	PRON
bptjm-12	259	17	had	have	VERB
bptjm-12	259	18	amyloid	amyloid	NOUN
bptjm-12	259	19	-	-	PUNCT
bptjm-12	259	20	beta	beta	NOUN
bptjm-12	259	21	plaque	plaque	NOUN
bptjm-12	259	22	buildup	buildup	NOUN
bptjm-12	259	23	in	in	ADP
bptjm-12	259	24	combination	combination	NOUN
bptjm-12	259	25	with	with	ADP
bptjm-12	259	26	cbd	cbd	NOUN
bptjm-12	259	27	dosages	dosage	NOUN
bptjm-12	259	28	(	(	PUNCT
bptjm-12	259	29	hughes	hughe	NOUN
bptjm-12	259	30	et	et	PROPN
bptjm-12	259	31	al	al	PROPN
bptjm-12	259	32	.	.	PROPN
bptjm-12	259	33	,	,	PUNCT
bptjm-12	259	34	2019	2019	NUM
bptjm-12	259	35	)	)	PUNCT
bptjm-12	259	36	.	.	PUNCT
bptjm-12	260	1	as	as	SCONJ
bptjm-12	260	2	the	the	DET
bptjm-12	260	3	major	major	ADJ
bptjm-12	260	4	�	�	PROPN
bptjm-12	260	5	nding	nding	NOUN
bptjm-12	260	6	is	be	AUX
bptjm-12	260	7	the	the	DET
bptjm-12	260	8	revival	revival	NOUN
bptjm-12	260	9	of	of	ADP
bptjm-12	260	10	neuron	neuron	NOUN
bptjm-12	260	11	activity	activity	NOUN
bptjm-12	260	12	,	,	PUNCT
bptjm-12	260	13	restoration	restoration	NOUN
bptjm-12	260	14	of	of	ADP
bptjm-12	260	15	the	the	DET
bptjm-12	260	16	cholinergic	cholinergic	ADJ
bptjm-12	260	17	signaling	signal	VERB
bptjm-12	260	18	system	system	NOUN
bptjm-12	260	19	alleviates	alleviate	VERB
bptjm-12	260	20	and	and	CCONJ
bptjm-12	260	21	e	e	NOUN
bptjm-12	260	22	�	�	NOUN
bptjm-12	260	23	ects	ect	NOUN
bptjm-12	260	24	(	(	PUNCT
bptjm-12	260	25	thompson	thompson	PROPN
bptjm-12	260	26	et	et	PROPN
bptjm-12	260	27	al	al	PROPN
bptjm-12	260	28	.	.	PROPN
bptjm-12	260	29	,	,	PUNCT
bptjm-12	260	30	2020	2020	NUM
bptjm-12	260	31	)	)	PUNCT
bptjm-12	260	32	.	.	PUNCT
bptjm-12	261	1	while	while	SCONJ
bptjm-12	261	2	commonly	commonly	ADV
bptjm-12	261	3	used	use	VERB
bptjm-12	261	4	as	as	ADP
bptjm-12	261	5	a	a	DET
bptjm-12	261	6	relief	relief	NOUN
bptjm-12	261	7	drug	drug	NOUN
bptjm-12	261	8	,	,	PUNCT
bptjm-12	261	9	natural	natural	ADJ
bptjm-12	261	10	cannabinoids	cannabinoid	NOUN
bptjm-12	261	11	thc	thc	NOUN
bptjm-12	261	12	and	and	CCONJ
bptjm-12	261	13	cbd	cbd	NOUN
bptjm-12	261	14	derived	derive	VERB
bptjm-12	261	15	from	from	ADP
bptjm-12	261	16	the	the	DET
bptjm-12	261	17	cannabis	cannabis	NOUN
bptjm-12	261	18	plant	plant	NOUN
bptjm-12	261	19	are	be	AUX
bptjm-12	261	20	used	use	VERB
bptjm-12	261	21	in	in	ADP
bptjm-12	261	22	tandem	tandem	NOUN
bptjm-12	261	23	to	to	PART
bptjm-12	261	24	manage	manage	VERB
bptjm-12	261	25	cognitive	cognitive	ADJ
bptjm-12	261	26	de	de	PROPN
bptjm-12	261	27	�	�	PROPN
bptjm-12	261	28	cits	cit	NOUN
bptjm-12	261	29	(	(	PUNCT
bptjm-12	261	30	giacoppo	giacoppo	PROPN
bptjm-12	261	31	et	et	PROPN
bptjm-12	261	32	al	al	PROPN
bptjm-12	261	33	.	.	PROPN
bptjm-12	261	34	,	,	PUNCT
bptjm-12	261	35	2014	2014	NUM
bptjm-12	261	36	)	)	PUNCT
bptjm-12	261	37	.	.	PUNCT
bptjm-12	262	1	cbd	cbd	NOUN
bptjm-12	262	2	acts	act	VERB
bptjm-12	262	3	as	as	ADP
bptjm-12	262	4	a	a	DET
bptjm-12	262	5	modulator	modulator	NOUN
bptjm-12	262	6	to	to	ADP
bptjm-12	262	7	thc	thc	NOUN
bptjm-12	262	8	intoxication	intoxication	NOUN
bptjm-12	262	9	and	and	CCONJ
bptjm-12	262	10	together	together	ADV
bptjm-12	262	11	e	e	PRON
bptjm-12	262	12	�	�	NOUN
bptjm-12	262	13	ectively	ectively	ADV
bptjm-12	262	14	reduces	reduce	VERB
bptjm-12	262	15	oxidative	oxidative	ADJ
bptjm-12	262	16	stress	stress	NOUN
bptjm-12	262	17	and	and	CCONJ
bptjm-12	262	18	in	in	ADP
bptjm-12	262	19	�	�	PROPN
bptjm-12	262	20	ammation	ammation	NOUN
bptjm-12	262	21	associated	associate	VERB
bptjm-12	262	22	with	with	ADP
bptjm-12	262	23	ad	ad	NOUN
bptjm-12	262	24	(	(	PUNCT
bptjm-12	262	25	giacoppo	giacoppo	PROPN
bptjm-12	262	26	etal	etal	PROPN
bptjm-12	262	27	.	.	PUNCT
bptjm-12	262	28	,	,	PUNCT
bptjm-12	262	29	2014	2014	NUM
bptjm-12	262	30	)	)	PUNCT
bptjm-12	262	31	.	.	PUNCT
bptjm-12	263	1	while	while	SCONJ
bptjm-12	263	2	more	more	ADJ
bptjm-12	263	3	studies	study	NOUN
bptjm-12	263	4	and	and	CCONJ
bptjm-12	263	5	clinical	clinical	ADJ
bptjm-12	263	6	trials	trial	NOUN
bptjm-12	263	7	are	be	AUX
bptjm-12	263	8	required	require	VERB
bptjm-12	263	9	before	before	ADP
bptjm-12	263	10	making	make	VERB
bptjm-12	263	11	any	any	DET
bptjm-12	263	12	de	de	X
bptjm-12	263	13	�	�	NOUN
bptjm-12	263	14	nitive	nitive	ADJ
bptjm-12	263	15	statements	statement	NOUN
bptjm-12	263	16	,	,	PUNCT
bptjm-12	263	17	the	the	DET
bptjm-12	263	18	associations	association	NOUN
bptjm-12	263	19	discovered	discover	VERB
bptjm-12	263	20	thus	thus	ADV
bptjm-12	263	21	far	far	ADV
bptjm-12	263	22	indicate	indicate	VERB
bptjm-12	263	23	necessary	necessary	ADJ
bptjm-12	263	24	future	future	ADJ
bptjm-12	263	25	research	research	NOUN
bptjm-12	263	26	and	and	CCONJ
bptjm-12	263	27	possible	possible	ADJ
bptjm-12	263	28	implementations	implementation	NOUN
bptjm-12	263	29	of	of	ADP
bptjm-12	263	30	this	this	DET
bptjm-12	263	31	form	form	NOUN
bptjm-12	263	32	of	of	ADP
bptjm-12	263	33	therapy	therapy	NOUN
bptjm-12	263	34	.	.	PUNCT
bptjm-12	264	1	berkeley	berkeley	PROPN
bptjm-12	264	2	pharma	pharma	PROPN
bptjm-12	264	3	tech	tech	PROPN
bptjm-12	264	4	journal	journal	NOUN
bptjm-12	264	5	of	of	ADP
bptjm-12	264	6	medicine	medicine	NOUN
bptjm-12	264	7	|	|	ADV
bptjm-12	264	8	20	20	NUM
bptjm-12	264	9	references	reference	NOUN
bptjm-12	264	10	1	1	NUM
bptjm-12	264	11	.	.	PUNCT
bptjm-12	265	1	aguirre	aguirre	PROPN
bptjm-12	265	2	-	-	PUNCT
bptjm-12	265	3	rueda	rueda	PROPN
bptjm-12	265	4	,	,	PUNCT
bptjm-12	265	5	d.	d.	PROPN
bptjm-12	265	6	,	,	PUNCT
bptjm-12	265	7	guerra	guerra	PROPN
bptjm-12	265	8	-	-	PUNCT
bptjm-12	265	9	ojeda	ojeda	PROPN
bptjm-12	265	10	,	,	PUNCT
bptjm-12	265	11	s.	s.	PROPN
bptjm-12	265	12	,	,	PUNCT
bptjm-12	265	13	aldasoro	aldasoro	PROPN
bptjm-12	265	14	,	,	PUNCT
bptjm-12	265	15	m.	m.	NOUN
bptjm-12	265	16	,	,	PUNCT
bptjm-12	265	17	iradi	iradi	NOUN
bptjm-12	265	18	,	,	PUNCT
bptjm-12	265	19	a.	a.	PROPN
bptjm-12	265	20	,	,	PUNCT
bptjm-12	265	21	obrador	obrador	PROPN
bptjm-12	265	22	,	,	PUNCT
bptjm-12	265	23	e.	e.	PROPN
bptjm-12	265	24	,	,	PUNCT
bptjm-12	265	25	mauricio	mauricio	PROPN
bptjm-12	265	26	,	,	PUNCT
bptjm-12	265	27	m.d	m.d	PROPN
bptjm-12	265	28	.	.	PROPN
bptjm-12	265	29	,	,	PUNCT
bptjm-12	265	30	vila	vila	PROPN
bptjm-12	265	31	,	,	PUNCT
bptjm-12	265	32	j.	j.	PROPN
bptjm-12	265	33	m.	m.	PROPN
bptjm-12	265	34	,	,	PUNCT
bptjm-12	265	35	marchio	marchio	PROPN
bptjm-12	265	36	,	,	PUNCT
bptjm-12	265	37	p.	p.	NOUN
bptjm-12	265	38	,	,	PUNCT
bptjm-12	265	39	&	&	CCONJ
bptjm-12	265	40	valles	valle	NOUN
bptjm-12	265	41	,	,	PUNCT
bptjm-12	265	42	s.	s.	PROPN
bptjm-12	265	43	l.	l.	PROPN
bptjm-12	265	44	(	(	PUNCT
bptjm-12	265	45	2015	2015	NUM
bptjm-12	265	46	)	)	PUNCT
bptjm-12	265	47	.	.	PUNCT
bptjm-12	266	1	win	win	VERB
bptjm-12	266	2	55,212	55,212	NUM
bptjm-12	266	3	-	-	SYM
bptjm-12	266	4	2	2	NUM
bptjm-12	266	5	,	,	PUNCT
bptjm-12	266	6	agonist	agonist	NOUN
bptjm-12	266	7	of	of	ADP
bptjm-12	266	8	cannabinoid	cannabinoid	NOUN
bptjm-12	266	9	receptors	receptor	NOUN
bptjm-12	266	10	,	,	PUNCT
bptjm-12	266	11	prevents	prevent	VERB
bptjm-12	266	12	amyloid	amyloid	NOUN
bptjm-12	266	13	β1	β1	PROPN
bptjm-12	266	14	-	-	PUNCT
bptjm-12	266	15	42	42	NUM
bptjm-12	266	16	e	e	NOUN
bptjm-12	266	17	�	�	NOUN
bptjm-12	266	18	ects	ect	VERB
bptjm-12	266	19	on	on	ADP
bptjm-12	266	20	astrocytes	astrocyte	NOUN
bptjm-12	266	21	in	in	ADP
bptjm-12	266	22	primary	primary	ADJ
bptjm-12	266	23	culture	culture	NOUN
bptjm-12	266	24	.	.	PUNCT
bptjm-12	267	1	plos	plos	PROPN
bptjm-12	267	2	one	one	NUM
bptjm-12	267	3	,	,	PUNCT
bptjm-12	267	4	10(4	10(4	NUM
bptjm-12	267	5	)	)	PUNCT
bptjm-12	267	6	,	,	PUNCT
bptjm-12	267	7	e0122843	e0122843	NOUN
bptjm-12	267	8	.	.	PUNCT
bptjm-12	268	1	2	2	NUM
bptjm-12	268	2	.	.	X
bptjm-12	268	3	ahmad	ahmad	PROPN
bptjm-12	268	4	,	,	PUNCT
bptjm-12	268	5	r.	r.	PROPN
bptjm-12	268	6	,	,	PUNCT
bptjm-12	268	7	go	go	VERB
bptjm-12	268	8	�	�	PROPN
bptjm-12	268	9	n	n	CCONJ
bptjm-12	268	10	,	,	PUNCT
bptjm-12	268	11	k.	k.	PROPN
bptjm-12	268	12	,	,	PUNCT
bptjm-12	268	13	van	van	PROPN
bptjm-12	268	14	den	den	PROPN
bptjm-12	268	15	stock	stock	NOUN
bptjm-12	268	16	,	,	PUNCT
bptjm-12	268	17	j.	j.	PROPN
bptjm-12	268	18	,	,	PUNCT
bptjm-12	268	19	de	de	PROPN
bptjm-12	268	20	winter	winter	PROPN
bptjm-12	268	21	,	,	PUNCT
bptjm-12	268	22	f.	f.	PROPN
bptjm-12	268	23	l.	l.	PROPN
bptjm-12	268	24	,	,	PUNCT
bptjm-12	268	25	cleeren	cleeren	PROPN
bptjm-12	268	26	,	,	PUNCT
bptjm-12	268	27	e.	e.	PROPN
bptjm-12	268	28	,	,	PUNCT
bptjm-12	268	29	bormans	bormans	PROPN
bptjm-12	268	30	,	,	PUNCT
bptjm-12	268	31	g.	g.	PROPN
bptjm-12	268	32	,	,	PUNCT
bptjm-12	268	33	tournoy	tournoy	X
bptjm-12	268	34	,	,	PUNCT
bptjm-12	268	35	j.	j.	PROPN
bptjm-12	268	36	,	,	PUNCT
bptjm-12	268	37	persoons	persoon	NOUN
bptjm-12	268	38	,	,	PUNCT
bptjm-12	268	39	p.	p.	NOUN
bptjm-12	268	40	,	,	PUNCT
bptjm-12	268	41	van	van	PROPN
bptjm-12	268	42	laere	laere	ADV
bptjm-12	268	43	,	,	PUNCT
bptjm-12	268	44	k.	k.	PROPN
bptjm-12	268	45	,	,	PUNCT
bptjm-12	268	46	&	&	CCONJ
bptjm-12	268	47	vandenbulcke	vandenbulcke	PROPN
bptjm-12	268	48	,	,	PUNCT
bptjm-12	268	49	m.	m.	NOUN
bptjm-12	268	50	(	(	PUNCT
bptjm-12	268	51	2014	2014	NUM
bptjm-12	268	52	)	)	PUNCT
bptjm-12	268	53	.	.	PUNCT
bptjm-12	269	1	in	in	ADP
bptjm-12	269	2	vivo	vivo	ADJ
bptjm-12	269	3	type	type	NOUN
bptjm-12	269	4	1	1	NUM
bptjm-12	269	5	cannabinoid	cannabinoid	NOUN
bptjm-12	269	6	receptor	receptor	NOUN
bptjm-12	269	7	availability	availability	NOUN
bptjm-12	269	8	in	in	ADP
bptjm-12	269	9	alzheimer	alzheimer	PROPN
bptjm-12	269	10	's	's	PART
bptjm-12	269	11	disease	disease	NOUN
bptjm-12	269	12	.	.	PUNCT
bptjm-12	270	1	european	european	PROPN
bptjm-12	270	2	neuropsychopharmacology	neuropsychopharmacology	PROPN
bptjm-12	270	3	:	:	PUNCT
bptjm-12	270	4	the	the	DET
bptjm-12	270	5	journal	journal	NOUN
bptjm-12	270	6	of	of	ADP
bptjm-12	270	7	the	the	DET
bptjm-12	270	8	european	european	PROPN
bptjm-12	270	9	college	college	PROPN
bptjm-12	270	10	of	of	ADP
bptjm-12	270	11	neuropsychopharmacology	neuropsychopharmacology	PROPN
bptjm-12	270	12	,	,	PUNCT
bptjm-12	270	13	24(2	24(2	NUM
bptjm-12	270	14	)	)	PUNCT
bptjm-12	270	15	,	,	PUNCT
bptjm-12	270	16	242–250.https://doi.org/10.1016	242–250.https://doi.org/10.1016	NUM
bptjm-12	270	17	/	/	SYM
bptjm-12	270	18	j.euroneuro	j.euroneuro	NOUN
bptjm-12	270	19	.	.	PUNCT
bptjm-12	271	1	2013.10.002	2013.10.002	NOUN
bptjm-12	271	2	3	3	NUM
bptjm-12	271	3	.	.	PUNCT
bptjm-12	272	1	ahmad	ahmad	PROPN
bptjm-12	272	2	,	,	PUNCT
bptjm-12	272	3	r.	r.	PROPN
bptjm-12	272	4	,	,	PUNCT
bptjm-12	272	5	postnov	postnov	NOUN
bptjm-12	272	6	,	,	PUNCT
bptjm-12	272	7	a.	a.	NOUN
bptjm-12	272	8	,	,	PUNCT
bptjm-12	272	9	bormans	borman	NOUN
bptjm-12	272	10	,	,	PUNCT
bptjm-12	272	11	g.	g.	PROPN
bptjm-12	272	12	,	,	PUNCT
bptjm-12	272	13	versijpt	versijpt	PROPN
bptjm-12	272	14	,	,	PUNCT
bptjm-12	272	15	j.	j.	PROPN
bptjm-12	272	16	,	,	PUNCT
bptjm-12	272	17	vandenbulcke	vandenbulcke	PROPN
bptjm-12	272	18	,	,	PUNCT
bptjm-12	272	19	m.	m.	NOUN
bptjm-12	272	20	,	,	PUNCT
bptjm-12	272	21	&	&	CCONJ
bptjm-12	272	22	van	van	PROPN
bptjm-12	272	23	laere	laere	ADV
bptjm-12	272	24	,	,	PUNCT
bptjm-12	272	25	k.	k.	PROPN
bptjm-12	272	26	(	(	PUNCT
bptjm-12	272	27	2016).decreased	2016).decrease	VERB
bptjm-12	272	28	in	in	ADP
bptjm-12	272	29	vivo	vivo	ADJ
bptjm-12	272	30	availability	availability	NOUN
bptjm-12	272	31	of	of	ADP
bptjm-12	272	32	the	the	DET
bptjm-12	272	33	cannabinoid	cannabinoid	NOUN
bptjm-12	272	34	type	type	NOUN
bptjm-12	272	35	2	2	NUM
bptjm-12	272	36	receptor	receptor	NOUN
bptjm-12	272	37	in	in	ADP
bptjm-12	272	38	alzheimer	alzheimer	PROPN
bptjm-12	272	39	's	's	PART
bptjm-12	272	40	disease	disease	NOUN
bptjm-12	272	41	.	.	PUNCT
bptjm-12	273	1	european	european	PROPN
bptjm-12	273	2	journal	journal	PROPN
bptjm-12	273	3	of	of	ADP
bptjm-12	273	4	nuclear	nuclear	ADJ
bptjm-12	273	5	medicine	medicine	NOUN
bptjm-12	273	6	and	and	CCONJ
bptjm-12	273	7	molecular	molecular	ADJ
bptjm-12	273	8	imaging	imaging	NOUN
bptjm-12	273	9	,	,	PUNCT
bptjm-12	273	10	43(12	43(12	NUM
bptjm-12	273	11	)	)	PUNCT
bptjm-12	273	12	,	,	PUNCT
bptjm-12	273	13	2219–2227.https://doi.org/10.1007	2219–2227.https://doi.org/10.1007	NUM
bptjm-12	273	14	/	/	SYM
bptjm-12	273	15	s00259	s00259	NOUN
bptjm-12	273	16	-	-	PUNCT
bptjm-12	273	17	016	016	NUM
bptjm-12	273	18	-3457	-3457	NOUN
bptjm-12	273	19	-	-	PUNCT
bptjm-12	273	20	7	7	NUM
bptjm-12	273	21	4	4	NUM
bptjm-12	273	22	.	.	PUNCT
bptjm-12	274	1	aso	aso	PROPN
bptjm-12	274	2	,	,	PUNCT
bptjm-12	274	3	e.	e.	PROPN
bptjm-12	274	4	,	,	PUNCT
bptjm-12	274	5	&	&	CCONJ
bptjm-12	274	6	ferrer	ferrer	PROPN
bptjm-12	274	7	,	,	PUNCT
bptjm-12	274	8	i.	i.	PROPN
bptjm-12	274	9	(	(	PUNCT
bptjm-12	274	10	2016	2016	NUM
bptjm-12	274	11	)	)	PUNCT
bptjm-12	274	12	.	.	PUNCT
bptjm-12	275	1	cb2	cb2	PROPN
bptjm-12	275	2	cannabinoid	cannabinoid	PROPN
bptjm-12	275	3	receptor	receptor	NOUN
bptjm-12	275	4	as	as	ADP
bptjm-12	275	5	potential	potential	ADJ
bptjm-12	275	6	target	target	NOUN
bptjm-12	275	7	against	against	ADP
bptjm-12	275	8	alzheimer	alzheimer	PROPN
bptjm-12	275	9	's	's	PART
bptjm-12	275	10	disease	disease	NOUN
bptjm-12	275	11	.	.	PUNCT
bptjm-12	276	1	frontiers	frontier	NOUN
bptjm-12	276	2	in	in	ADP
bptjm-12	276	3	neuroscience	neuroscience	NOUN
bptjm-12	276	4	,	,	PUNCT
bptjm-12	276	5	10	10	NUM
bptjm-12	276	6	,	,	PUNCT
bptjm-12	276	7	243	243	NUM
bptjm-12	276	8	.	.	NOUN
bptjm-12	276	9	5	5	NUM
bptjm-12	276	10	.	.	NUM
bptjm-12	276	11	atakan	atakan	PROPN
bptjm-12	276	12	z.	z.	PROPN
bptjm-12	276	13	(	(	PUNCT
bptjm-12	276	14	2012	2012	NUM
bptjm-12	276	15	)	)	PUNCT
bptjm-12	276	16	.	.	PUNCT
bptjm-12	277	1	cannabis	cannabis	PROPN
bptjm-12	277	2	,	,	PUNCT
bptjm-12	277	3	a	a	DET
bptjm-12	277	4	complex	complex	ADJ
bptjm-12	277	5	plant	plant	NOUN
bptjm-12	277	6	:	:	PUNCT
bptjm-12	277	7	di	di	NOUN
bptjm-12	277	8	�	�	PROPN
bptjm-12	277	9	erent	erent	NOUN
bptjm-12	277	10	compounds	compound	NOUN
bptjm-12	277	11	and	and	CCONJ
bptjm-12	277	12	di	di	NOUN
bptjm-12	277	13	�	�	PROPN
bptjm-12	277	14	erent	erent	NOUN
bptjm-12	277	15	e	e	NOUN
bptjm-12	277	16	�	�	NOUN
bptjm-12	277	17	ects	ect	VERB
bptjm-12	277	18	on	on	ADP
bptjm-12	277	19	individuals	individual	NOUN
bptjm-12	277	20	.	.	PUNCT
bptjm-12	278	1	therapeutic	therapeutic	ADJ
bptjm-12	278	2	advances	advance	NOUN
bptjm-12	278	3	in	in	ADP
bptjm-12	278	4	psychopharmacology	psychopharmacology	NOUN
bptjm-12	278	5	,	,	PUNCT
bptjm-12	278	6	2(6	2(6	NUM
bptjm-12	278	7	)	)	PUNCT
bptjm-12	278	8	,	,	PUNCT
bptjm-12	278	9	241–254	241–254	NUM
bptjm-12	278	10	.	.	PUNCT
bptjm-12	279	1	https://doi.org/10.1177/2045125312457586	https://doi.org/10.1177/2045125312457586	ADJ
bptjm-12	279	2	6	6	NUM
bptjm-12	279	3	.	.	PUNCT
bptjm-12	279	4	bonnet	bonnet	NOUN
bptjm-12	279	5	,	,	PUNCT
bptjm-12	279	6	a.	a.	PROPN
bptjm-12	279	7	e.	e.	PROPN
bptjm-12	279	8	,	,	PUNCT
bptjm-12	279	9	&	&	CCONJ
bptjm-12	279	10	marchalant	marchalant	PROPN
bptjm-12	279	11	,	,	PUNCT
bptjm-12	279	12	y.	y.	PROPN
bptjm-12	279	13	(	(	PUNCT
bptjm-12	279	14	2015	2015	NUM
bptjm-12	279	15	)	)	PUNCT
bptjm-12	279	16	.	.	PUNCT
bptjm-12	280	1	potential	potential	ADJ
bptjm-12	280	2	therapeutical	therapeutical	ADJ
bptjm-12	280	3	contributions	contribution	NOUN
bptjm-12	280	4	of	of	ADP
bptjm-12	280	5	the	the	DET
bptjm-12	280	6	endocannabinoid	endocannabinoid	NOUN
bptjm-12	280	7	system	system	NOUN
bptjm-12	280	8	towards	towards	ADP
bptjm-12	280	9	aging	aging	NOUN
bptjm-12	280	10	and	and	CCONJ
bptjm-12	280	11	alzheimer	alzheimer	NOUN
bptjm-12	280	12	's	's	PART
bptjm-12	280	13	disease	disease	NOUN
bptjm-12	280	14	.	.	PUNCT
bptjm-12	281	1	aging	aging	NOUN
bptjm-12	281	2	and	and	CCONJ
bptjm-12	281	3	disease	disease	NOUN
bptjm-12	281	4	,	,	PUNCT
bptjm-12	281	5	6(5	6(5	NUM
bptjm-12	281	6	)	)	PUNCT
bptjm-12	281	7	,	,	PUNCT
bptjm-12	281	8	400–405	400–405	NUM
bptjm-12	281	9	.	.	PUNCT
bptjm-12	282	1	https://doi.org/10.14336/ad.2015.0617	https://doi.org/10.14336/ad.2015.0617	ADJ
bptjm-12	282	2	7	7	NUM
bptjm-12	282	3	.	.	PUNCT
bptjm-12	282	4	basavarajappa	basavarajappa	PROPN
bptjm-12	282	5	,	,	PUNCT
bptjm-12	282	6	b.	b.	PROPN
bptjm-12	282	7	s.	s.	PROPN
bptjm-12	282	8	,	,	PUNCT
bptjm-12	282	9	nagre	nagre	NOUN
bptjm-12	282	10	,	,	PUNCT
bptjm-12	282	11	n.	n.	PROPN
bptjm-12	282	12	n.	n.	PROPN
bptjm-12	282	13	,	,	PUNCT
bptjm-12	282	14	xie	xie	PROPN
bptjm-12	282	15	,	,	PUNCT
bptjm-12	282	16	s.	s.	PROPN
bptjm-12	282	17	,	,	PUNCT
bptjm-12	282	18	&	&	CCONJ
bptjm-12	282	19	subbanna	subbanna	PROPN
bptjm-12	282	20	,	,	PUNCT
bptjm-12	282	21	s.	s.	PROPN
bptjm-12	282	22	(	(	PUNCT
bptjm-12	282	23	2014	2014	NUM
bptjm-12	282	24	)	)	PUNCT
bptjm-12	282	25	.	.	PUNCT
bptjm-12	283	1	elevation	elevation	NOUN
bptjm-12	283	2	of	of	ADP
bptjm-12	283	3	endogenous	endogenous	ADJ
bptjm-12	283	4	anandamide	anandamide	NOUN
bptjm-12	283	5	impairs	impair	VERB
bptjm-12	283	6	ltp	ltp	PROPN
bptjm-12	283	7	,	,	PUNCT
bptjm-12	283	8	learning	learning	NOUN
bptjm-12	283	9	,	,	PUNCT
bptjm-12	283	10	and	and	CCONJ
bptjm-12	283	11	memory	memory	NOUN
bptjm-12	283	12	through	through	ADP
bptjm-12	283	13	cb1	cb1	NOUN
bptjm-12	283	14	receptor	receptor	NOUN
bptjm-12	283	15	signaling	signal	VERB
bptjm-12	283	16	in	in	ADP
bptjm-12	283	17	mice	mouse	NOUN
bptjm-12	283	18	.	.	PUNCT
bptjm-12	284	1	hippocampus	hippocampus	NOUN
bptjm-12	284	2	,	,	PUNCT
bptjm-12	284	3	24(7	24(7	NUM
bptjm-12	284	4	)	)	PUNCT
bptjm-12	284	5	,	,	PUNCT
bptjm-12	284	6	808–818	808–818	NUM
bptjm-12	284	7	.	.	NOUN
bptjm-12	284	8	8	8	NUM
bptjm-12	284	9	.	.	X
bptjm-12	284	10	bonini	bonini	PROPN
bptjm-12	284	11	,	,	PUNCT
bptjm-12	284	12	s.	s.	PROPN
bptjm-12	284	13	a.	a.	PROPN
bptjm-12	284	14	,	,	PUNCT
bptjm-12	284	15	premoli	premoli	NOUN
bptjm-12	284	16	,	,	PUNCT
bptjm-12	284	17	m.	m.	NOUN
bptjm-12	284	18	,	,	PUNCT
bptjm-12	284	19	tambaro	tambaro	NOUN
bptjm-12	284	20	,	,	PUNCT
bptjm-12	284	21	s.	s.	PROPN
bptjm-12	284	22	,	,	PUNCT
bptjm-12	284	23	kumar	kumar	PROPN
bptjm-12	284	24	,	,	PUNCT
bptjm-12	284	25	a.	a.	PROPN
bptjm-12	284	26	,	,	PUNCT
bptjm-12	284	27	maccarinelli	maccarinelli	PROPN
bptjm-12	284	28	,	,	PUNCT
bptjm-12	284	29	g.	g.	PROPN
bptjm-12	284	30	,	,	PUNCT
bptjm-12	284	31	memo	memo	NOUN
bptjm-12	284	32	,	,	PUNCT
bptjm-12	284	33	m.	m.	NOUN
bptjm-12	284	34	,	,	PUNCT
bptjm-12	284	35	&	&	CCONJ
bptjm-12	284	36	mastinu	mastinu	PROPN
bptjm-12	284	37	,	,	PUNCT
bptjm-12	284	38	a.	a.	NOUN
bptjm-12	284	39	(	(	PUNCT
bptjm-12	284	40	2018	2018	NUM
bptjm-12	284	41	)	)	PUNCT
bptjm-12	284	42	.	.	PUNCT
bptjm-12	285	1	cannabis	cannabis	NOUN
bptjm-12	285	2	sativa	sativa	PROPN
bptjm-12	285	3	:	:	PUNCT
bptjm-12	285	4	a	a	DET
bptjm-12	285	5	comprehensive	comprehensive	ADJ
bptjm-12	285	6	ethnopharmacological	ethnopharmacological	ADJ
bptjm-12	285	7	review	review	NOUN
bptjm-12	285	8	of	of	ADP
bptjm-12	285	9	a	a	DET
bptjm-12	285	10	medicinal	medicinal	ADJ
bptjm-12	285	11	plant	plant	NOUN
bptjm-12	285	12	with	with	ADP
bptjm-12	285	13	a	a	DET
bptjm-12	285	14	long	long	ADJ
bptjm-12	285	15	history	history	NOUN
bptjm-12	285	16	.	.	PUNCT
bptjm-12	286	1	journal	journal	NOUN
bptjm-12	286	2	of	of	ADP
bptjm-12	286	3	ethnopharmacology	ethnopharmacology	NOUN
bptjm-12	286	4	,	,	PUNCT
bptjm-12	286	5	227	227	NUM
bptjm-12	286	6	,	,	PUNCT
bptjm-12	286	7	300–315	300–315	NUM
bptjm-12	286	8	.	.	PUNCT
bptjm-12	287	1	https://doi.org/10.1016/j.jep.2018.09.004	https://doi.org/10.1016/j.jep.2018.09.004	VERB
bptjm-12	287	2	9	9	NUM
bptjm-12	287	3	.	.	PUNCT
bptjm-12	288	1	çakır	çakır	PROPN
bptjm-12	288	2	,	,	PUNCT
bptjm-12	288	3	m.	m.	NOUN
bptjm-12	288	4	,	,	PUNCT
bptjm-12	288	5	tekin	tekin	PROPN
bptjm-12	288	6	,	,	PUNCT
bptjm-12	288	7	s.	s.	PROPN
bptjm-12	288	8	,	,	PUNCT
bptjm-12	288	9	doğanyiğit	doğanyiğit	PROPN
bptjm-12	288	10	,	,	PUNCT
bptjm-12	288	11	z.	z.	PROPN
bptjm-12	288	12	,	,	PUNCT
bptjm-12	288	13	erden	erden	ADV
bptjm-12	288	14	,	,	PUNCT
bptjm-12	288	15	y.	y.	PROPN
bptjm-12	288	16	,	,	PUNCT
bptjm-12	288	17	soytürk	soytürk	PROPN
bptjm-12	288	18	,	,	PUNCT
bptjm-12	288	19	m.	m.	NOUN
bptjm-12	288	20	,	,	PUNCT
bptjm-12	288	21	çiğremiş	çiğremiş	PROPN
bptjm-12	288	22	,	,	PUNCT
bptjm-12	288	23	y.	y.	PROPN
bptjm-12	288	24	,	,	PUNCT
bptjm-12	288	25	&	&	CCONJ
bptjm-12	288	26	sandal	sandal	NOUN
bptjm-12	288	27	,	,	PUNCT
bptjm-12	288	28	s.	s.	PROPN
bptjm-12	288	29	(	(	PUNCT
bptjm-12	288	30	2019	2019	NUM
bptjm-12	288	31	)	)	PUNCT
bptjm-12	288	32	.	.	PUNCT
bptjm-12	289	1	cannabinoid	cannabinoid	PROPN
bptjm-12	289	2	type	type	NOUN
bptjm-12	289	3	2	2	NUM
bptjm-12	289	4	receptor	receptor	NOUN
bptjm-12	289	5	agonist	agonist	NOUN
bptjm-12	289	6	jwh-133	jwh-133	NOUN
bptjm-12	289	7	,	,	PUNCT
bptjm-12	289	8	attenuates	attenuate	VERB
bptjm-12	289	9	okadaic	okadaic	ADJ
bptjm-12	289	10	acid	acid	PROPN
bptjm-12	289	11	induced	induce	VERB
bptjm-12	289	12	spatial	spatial	ADJ
bptjm-12	289	13	memory	memory	NOUN
bptjm-12	289	14	impairment	impairment	NOUN
bptjm-12	289	15	and	and	CCONJ
bptjm-12	289	16	neurodegeneration	neurodegeneration	NOUN
bptjm-12	289	17	in	in	ADP
bptjm-12	289	18	rats	rat	NOUN
bptjm-12	289	19	.	.	PUNCT
bptjm-12	290	1	life	life	NOUN
bptjm-12	290	2	sciences	science	NOUN
bptjm-12	290	3	,	,	PUNCT
bptjm-12	290	4	217	217	NUM
bptjm-12	290	5	,	,	PUNCT
bptjm-12	290	6	25–33	25–33	NUM
bptjm-12	290	7	.	.	PUNCT
bptjm-12	291	1	https://doi.org/10.1016/j.lfs.2018.11.058	https://doi.org/10.1016/j.lfs.2018.11.058	PROPN
bptjm-12	291	2	10	10	NUM
bptjm-12	291	3	.	.	PUNCT
bptjm-12	292	1	campbell	campbell	PROPN
bptjm-12	292	2	,	,	PUNCT
bptjm-12	292	3	v.	v.	PROPN
bptjm-12	292	4	a.	a.	PROPN
bptjm-12	292	5	,	,	PUNCT
bptjm-12	292	6	&	&	CCONJ
bptjm-12	292	7	gowran	gowran	NOUN
bptjm-12	292	8	,	,	PUNCT
bptjm-12	292	9	a.	a.	NOUN
bptjm-12	292	10	(	(	PUNCT
bptjm-12	292	11	2007	2007	NUM
bptjm-12	292	12	)	)	PUNCT
bptjm-12	292	13	.	.	PUNCT
bptjm-12	293	1	alzheimer	alzheimer	PROPN
bptjm-12	293	2	’s	’s	PART
bptjm-12	293	3	disease	disease	NOUN
bptjm-12	293	4	;	;	PUNCT
bptjm-12	293	5	taking	take	VERB
bptjm-12	293	6	the	the	DET
bptjm-12	293	7	edge	edge	NOUN
bptjm-12	293	8	o	o	NOUN
bptjm-12	293	9	�	�	NOUN
bptjm-12	293	10	with	with	ADP
bptjm-12	293	11	cannabinoids	cannabinoid	NOUN
bptjm-12	293	12	?	?	PUNCT
bptjm-12	294	1	british	british	ADJ
bptjm-12	294	2	journal	journal	PROPN
bptjm-12	294	3	of	of	ADP
bptjm-12	294	4	pharmacology	pharmacology	NOUN
bptjm-12	294	5	,	,	PUNCT
bptjm-12	294	6	152(5	152(5	NUM
bptjm-12	294	7	)	)	PUNCT
bptjm-12	294	8	,	,	PUNCT
bptjm-12	294	9	655–662	655–662	NUM
bptjm-12	294	10	.	.	PUNCT
bptjm-12	295	1	11	11	NUM
bptjm-12	295	2	.	.	X
bptjm-12	296	1	cubinkova	cubinkova	PROPN
bptjm-12	296	2	,	,	PUNCT
bptjm-12	296	3	v.	v.	ADV
bptjm-12	296	4	,	,	PUNCT
bptjm-12	296	5	valachova	valachova	X
bptjm-12	296	6	,	,	PUNCT
bptjm-12	296	7	b.	b.	PROPN
bptjm-12	296	8	,	,	PUNCT
bptjm-12	296	9	uhrinova	uhrinova	PROPN
bptjm-12	296	10	,	,	PUNCT
bptjm-12	296	11	i.	i.	PROPN
bptjm-12	296	12	,	,	PUNCT
bptjm-12	296	13	brezovakova	brezovakova	ADJ
bptjm-12	296	14	,	,	PUNCT
bptjm-12	296	15	v.	v.	ADV
bptjm-12	296	16	,	,	PUNCT
bptjm-12	296	17	smolek	smolek	NOUN
bptjm-12	296	18	,	,	PUNCT
bptjm-12	296	19	t.	t.	PROPN
bptjm-12	296	20	,	,	PUNCT
bptjm-12	296	21	jadhav	jadhav	PROPN
bptjm-12	296	22	,	,	PUNCT
bptjm-12	296	23	s.	s.	PROPN
bptjm-12	296	24	,	,	PUNCT
bptjm-12	296	25	&	&	CCONJ
bptjm-12	296	26	zilka	zilka	NOUN
bptjm-12	296	27	,	,	PUNCT
bptjm-12	296	28	n.	n.	NOUN
bptjm-12	296	29	(	(	PUNCT
bptjm-12	296	30	2018	2018	NUM
bptjm-12	296	31	)	)	PUNCT
bptjm-12	296	32	.	.	PUNCT
bptjm-12	297	1	alternative	alternative	ADJ
bptjm-12	297	2	hypotheses	hypothesis	NOUN
bptjm-12	297	3	related	relate	VERB
bptjm-12	297	4	to	to	ADP
bptjm-12	297	5	alzheimer	alzheimer	PROPN
bptjm-12	297	6	's	's	PART
bptjm-12	297	7	disease	disease	NOUN
bptjm-12	297	8	.	.	PUNCT
bptjm-12	298	1	bratislavske	bratislavske	PROPN
bptjm-12	298	2	lekarske	lekarske	PROPN
bptjm-12	298	3	listy	listy	PROPN
bptjm-12	298	4	,	,	PUNCT
bptjm-12	298	5	119(4	119(4	NUM
bptjm-12	298	6	)	)	PUNCT
bptjm-12	298	7	,	,	PUNCT
bptjm-12	298	8	210–216	210–216	NUM
bptjm-12	298	9	.	.	NOUN
bptjm-12	298	10	12	12	NUM
bptjm-12	298	11	.	.	PUNCT
bptjm-12	299	1	defrancesco	defrancesco	PROPN
bptjm-12	299	2	,	,	PUNCT
bptjm-12	299	3	m.	m.	NOUN
bptjm-12	299	4	,	,	PUNCT
bptjm-12	299	5	&	&	CCONJ
bptjm-12	299	6	hofer	hofer	PROPN
bptjm-12	299	7	,	,	PUNCT
bptjm-12	299	8	a.	a.	NOUN
bptjm-12	299	9	(	(	PUNCT
bptjm-12	299	10	2020	2020	NUM
bptjm-12	299	11	)	)	PUNCT
bptjm-12	299	12	.	.	PUNCT
bptjm-12	300	1	cannabinoid	cannabinoid	PROPN
bptjm-12	300	2	as	as	ADP
bptjm-12	300	3	bene	bene	PROPN
bptjm-12	300	4	�	�	PROPN
bptjm-12	300	5	cial	cial	ADJ
bptjm-12	300	6	replacement	replacement	NOUN
bptjm-12	300	7	therapy	therapy	NOUN
bptjm-12	300	8	for	for	ADP
bptjm-12	300	9	psychotropics	psychotropic	NOUN
bptjm-12	300	10	to	to	PART
bptjm-12	300	11	treat	treat	VERB
bptjm-12	300	12	berkeley	berkeley	PROPN
bptjm-12	300	13	pharma	pharma	PROPN
bptjm-12	300	14	tech	tech	NOUN
bptjm-12	300	15	journal	journal	NOUN
bptjm-12	300	16	of	of	ADP
bptjm-12	300	17	medicine	medicine	NOUN
bptjm-12	300	18	|	|	ADV
bptjm-12	300	19	21	21	NUM
bptjm-12	300	20	neuropsychiatric	neuropsychiatric	ADJ
bptjm-12	300	21	symptoms	symptom	NOUN
bptjm-12	300	22	in	in	ADP
bptjm-12	300	23	severe	severe	ADJ
bptjm-12	300	24	alzheimer	alzheimer	PROPN
bptjm-12	300	25	's	's	PART
bptjm-12	300	26	dementia	dementia	NOUN
bptjm-12	300	27	:	:	PUNCT
bptjm-12	300	28	a	a	DET
bptjm-12	300	29	clinical	clinical	ADJ
bptjm-12	300	30	case	case	NOUN
bptjm-12	300	31	report	report	NOUN
bptjm-12	300	32	.	.	PUNCT
bptjm-12	301	1	frontiers	frontier	NOUN
bptjm-12	301	2	in	in	ADP
bptjm-12	301	3	psychiatry	psychiatry	NOUN
bptjm-12	301	4	,	,	PUNCT
bptjm-12	301	5	11	11	NUM
bptjm-12	301	6	,	,	PUNCT
bptjm-12	301	7	413	413	NUM
bptjm-12	301	8	.	.	NOUN
bptjm-12	301	9	13	13	NUM
bptjm-12	301	10	.	.	X
bptjm-12	301	11	di	di	NOUN
bptjm-12	301	12	marzo	marzo	PROPN
bptjm-12	301	13	,	,	PUNCT
bptjm-12	301	14	v.	v.	ADV
bptjm-12	301	15	,	,	PUNCT
bptjm-12	301	16	stella	stella	PROPN
bptjm-12	301	17	,	,	PUNCT
bptjm-12	301	18	n.	n.	NOUN
bptjm-12	301	19	,	,	PUNCT
bptjm-12	301	20	&	&	CCONJ
bptjm-12	301	21	zimmer	zimmer	PROPN
bptjm-12	301	22	,	,	PUNCT
bptjm-12	301	23	a.	a.	PROPN
bptjm-12	301	24	(	(	PUNCT
bptjm-12	301	25	2015	2015	NUM
bptjm-12	301	26	)	)	PUNCT
bptjm-12	301	27	.	.	PUNCT
bptjm-12	302	1	endocannabinoid	endocannabinoid	NOUN
bptjm-12	302	2	signalling	signal	VERB
bptjm-12	302	3	and	and	CCONJ
bptjm-12	302	4	the	the	DET
bptjm-12	302	5	deteriorating	deteriorate	VERB
bptjm-12	302	6	brain	brain	NOUN
bptjm-12	302	7	.	.	PUNCT
bptjm-12	303	1	nature	nature	NOUN
bptjm-12	303	2	reviews	review	NOUN
bptjm-12	303	3	.	.	PUNCT
bptjm-12	304	1	neuroscience	neuroscience	NOUN
bptjm-12	304	2	,	,	PUNCT
bptjm-12	304	3	16(1	16(1	NUM
bptjm-12	304	4	)	)	PUNCT
bptjm-12	304	5	,	,	PUNCT
bptjm-12	304	6	30–42	30–42	NUM
bptjm-12	304	7	.	.	PUNCT
bptjm-12	305	1	https://doi.org/10.1038/nrn3876	https://doi.org/10.1038/nrn3876	VERB
bptjm-12	305	2	14	14	NUM
bptjm-12	305	3	.	.	PUNCT
bptjm-12	306	1	ehrhart	ehrhart	PROPN
bptjm-12	306	2	,	,	PUNCT
bptjm-12	306	3	j.	j.	PROPN
bptjm-12	306	4	,	,	PUNCT
bptjm-12	306	5	obregon	obregon	PROPN
bptjm-12	306	6	,	,	PUNCT
bptjm-12	306	7	d.	d.	PROPN
bptjm-12	306	8	,	,	PUNCT
bptjm-12	306	9	mori	mori	PROPN
bptjm-12	306	10	,	,	PUNCT
bptjm-12	306	11	t.	t.	PROPN
bptjm-12	306	12	et	et	PROPN
bptjm-12	306	13	al	al	PROPN
bptjm-12	306	14	.	.	PROPN
bptjm-12	306	15	stimulation	stimulation	NOUN
bptjm-12	306	16	of	of	ADP
bptjm-12	306	17	cannabinoid	cannabinoid	NOUN
bptjm-12	306	18	receptor	receptor	NOUN
bptjm-12	306	19	2	2	NUM
bptjm-12	306	20	(	(	PUNCT
bptjm-12	306	21	cb2	cb2	NOUN
bptjm-12	306	22	)	)	PUNCT
bptjm-12	306	23	suppresses	suppress	VERB
bptjm-12	306	24	microglial	microglial	ADJ
bptjm-12	306	25	activation	activation	NOUN
bptjm-12	306	26	.	.	PUNCT
bptjm-12	307	1	j	j	PROPN
bptjm-12	307	2	neuroinflammation	neuroinflammation	PROPN
bptjm-12	307	3	2,29	2,29	PROPN
bptjm-12	307	4	(	(	PUNCT
bptjm-12	307	5	2005	2005	NUM
bptjm-12	307	6	)	)	PUNCT
bptjm-12	307	7	.	.	PUNCT
bptjm-12	308	1	15	15	NUM
bptjm-12	308	2	.	.	PUNCT
bptjm-12	308	3	esposito	esposito	PROPN
bptjm-12	308	4	,	,	PUNCT
bptjm-12	308	5	g.	g.	PROPN
bptjm-12	308	6	,	,	PUNCT
bptjm-12	308	7	de	de	X
bptjm-12	308	8	filippis	filippis	PROPN
bptjm-12	308	9	,	,	PUNCT
bptjm-12	308	10	d.	d.	PROPN
bptjm-12	308	11	,	,	PUNCT
bptjm-12	308	12	carnuccio	carnuccio	PROPN
bptjm-12	308	13	,	,	PUNCT
bptjm-12	308	14	r.	r.	PROPN
bptjm-12	308	15	,	,	PUNCT
bptjm-12	308	16	izzo	izzo	PROPN
bptjm-12	308	17	,	,	PUNCT
bptjm-12	308	18	a.	a.	NOUN
bptjm-12	308	19	a.	a.	PROPN
bptjm-12	308	20	,	,	PUNCT
bptjm-12	308	21	&	&	CCONJ
bptjm-12	308	22	iuvone	iuvone	NOUN
bptjm-12	308	23	,	,	PUNCT
bptjm-12	308	24	t.	t.	PROPN
bptjm-12	308	25	(	(	PUNCT
bptjm-12	308	26	2006	2006	NUM
bptjm-12	308	27	)	)	PUNCT
bptjm-12	308	28	.	.	PUNCT
bptjm-12	309	1	the	the	DET
bptjm-12	309	2	marijuana	marijuana	PROPN
bptjm-12	309	3	component	component	NOUN
bptjm-12	309	4	cannabidiol	cannabidiol	PROPN
bptjm-12	309	5	inhibits	inhibit	VERB
bptjm-12	309	6	beta	beta	NOUN
bptjm-12	309	7	-	-	PUNCT
bptjm-12	309	8	amyloid	amyloid	NOUN
bptjm-12	309	9	-	-	PUNCT
bptjm-12	309	10	induced	induce	VERB
bptjm-12	309	11	tau	tau	NOUN
bptjm-12	309	12	protein	protein	NOUN
bptjm-12	309	13	hyperphosphorylation	hyperphosphorylation	NOUN
bptjm-12	309	14	through	through	ADP
bptjm-12	309	15	wnt	wnt	PROPN
bptjm-12	309	16	/	/	SYM
bptjm-12	309	17	beta	beta	NOUN
bptjm-12	309	18	-	-	PUNCT
bptjm-12	309	19	catenin	catenin	NOUN
bptjm-12	309	20	pathway	pathway	NOUN
bptjm-12	309	21	rescue	rescue	NOUN
bptjm-12	309	22	in	in	ADP
bptjm-12	309	23	pc12	pc12	PROPN
bptjm-12	309	24	cells	cell	NOUN
bptjm-12	309	25	.	.	PUNCT
bptjm-12	310	1	journal	journal	NOUN
bptjm-12	310	2	of	of	ADP
bptjm-12	310	3	molecular	molecular	ADJ
bptjm-12	310	4	medicine	medicine	NOUN
bptjm-12	310	5	(	(	PUNCT
bptjm-12	310	6	berlin	berlin	PROPN
bptjm-12	310	7	,	,	PUNCT
bptjm-12	310	8	germany	germany	PROPN
bptjm-12	310	9	)	)	PUNCT
bptjm-12	310	10	,	,	PUNCT
bptjm-12	310	11	84(3	84(3	NUM
bptjm-12	310	12	)	)	PUNCT
bptjm-12	310	13	,	,	PUNCT
bptjm-12	310	14	253–258	253–258	NUM
bptjm-12	310	15	.	.	PUNCT
bptjm-12	311	1	16	16	NUM
bptjm-12	311	2	.	.	PUNCT
bptjm-12	311	3	aso	aso	PROPN
bptjm-12	311	4	,	,	PUNCT
bptjm-12	311	5	e.	e.	PROPN
bptjm-12	311	6	,	,	PUNCT
bptjm-12	311	7	&	&	CCONJ
bptjm-12	311	8	ferrer	ferrer	PROPN
bptjm-12	311	9	,	,	PUNCT
bptjm-12	311	10	i.	i.	PROPN
bptjm-12	311	11	(	(	PUNCT
bptjm-12	311	12	2014	2014	NUM
bptjm-12	311	13	)	)	PUNCT
bptjm-12	311	14	.	.	PUNCT
bptjm-12	312	1	cannabinoids	cannabinoid	NOUN
bptjm-12	312	2	for	for	ADP
bptjm-12	312	3	treatment	treatment	NOUN
bptjm-12	312	4	of	of	ADP
bptjm-12	312	5	alzheimer	alzheimer	PROPN
bptjm-12	312	6	's	's	PART
bptjm-12	312	7	disease	disease	NOUN
bptjm-12	312	8	:	:	PUNCT
bptjm-12	312	9	moving	move	VERB
bptjm-12	312	10	toward	toward	ADP
bptjm-12	312	11	the	the	DET
bptjm-12	312	12	clinic	clinic	NOUN
bptjm-12	312	13	.	.	PUNCT
bptjm-12	313	1	frontiers	frontier	NOUN
bptjm-12	313	2	in	in	ADP
bptjm-12	313	3	pharmacology	pharmacology	NOUN
bptjm-12	313	4	,	,	PUNCT
bptjm-12	313	5	5	5	NUM
bptjm-12	313	6	,	,	PUNCT
bptjm-12	313	7	37	37	NUM
bptjm-12	313	8	.	.	PUNCT
bptjm-12	314	1	https://doi.org/10.3389/fphar.2014.00037	https://doi.org/10.3389/fphar.2014.00037	PROPN
bptjm-12	314	2	17	17	NUM
bptjm-12	314	3	.	.	PUNCT
bptjm-12	314	4	eubanks	eubanks	PROPN
bptjm-12	314	5	,	,	PUNCT
bptjm-12	314	6	l.	l.	PROPN
bptjm-12	314	7	m.	m.	PROPN
bptjm-12	314	8	,	,	PUNCT
bptjm-12	314	9	rogers	rogers	PROPN
bptjm-12	314	10	,	,	PUNCT
bptjm-12	314	11	c.	c.	PROPN
bptjm-12	314	12	j.	j.	PROPN
bptjm-12	314	13	,	,	PUNCT
bptjm-12	314	14	beuscher	beuscher	PROPN
bptjm-12	314	15	,	,	PUNCT
bptjm-12	314	16	koob	koob	PROPN
bptjm-12	314	17	,	,	PUNCT
bptjm-12	314	18	g.	g.	PROPN
bptjm-12	314	19	f.	f.	PROPN
bptjm-12	314	20	,	,	PUNCT
bptjm-12	314	21	olson	olson	PROPN
bptjm-12	314	22	,	,	PUNCT
bptjm-12	314	23	a.	a.	PROPN
bptjm-12	314	24	j.	j.	PROPN
bptjm-12	314	25	,	,	PUNCT
bptjm-12	314	26	dickerson	dickerson	PROPN
bptjm-12	314	27	,	,	PUNCT
bptjm-12	314	28	t.	t.	PROPN
bptjm-12	314	29	j.	j.	PROPN
bptjm-12	314	30	,	,	PUNCT
bptjm-12	314	31	&	&	CCONJ
bptjm-12	314	32	janda	janda	PROPN
bptjm-12	314	33	,	,	PUNCT
bptjm-12	314	34	k.d	k.d	PROPN
bptjm-12	314	35	.	.	PROPN
bptjm-12	314	36	(	(	PUNCT
bptjm-12	314	37	2006	2006	NUM
bptjm-12	314	38	)	)	PUNCT
bptjm-12	314	39	.	.	PUNCT
bptjm-12	315	1	a	a	DET
bptjm-12	315	2	molecular	molecular	ADJ
bptjm-12	315	3	link	link	NOUN
bptjm-12	315	4	between	between	ADP
bptjm-12	315	5	the	the	DET
bptjm-12	315	6	active	active	ADJ
bptjm-12	315	7	component	component	NOUN
bptjm-12	315	8	of	of	ADP
bptjm-12	315	9	marijuana	marijuana	PROPN
bptjm-12	315	10	and	and	CCONJ
bptjm-12	315	11	alzheimer	alzheimer	PROPN
bptjm-12	315	12	’s	’s	PART
bptjm-12	315	13	disease	disease	NOUN
bptjm-12	315	14	pathology	pathology	NOUN
bptjm-12	315	15	.	.	PUNCT
bptjm-12	316	1	molecular	molecular	ADJ
bptjm-12	316	2	pharmaceutics	pharmaceutic	NOUN
bptjm-12	316	3	,	,	PUNCT
bptjm-12	316	4	3(6	3(6	NUM
bptjm-12	316	5	)	)	PUNCT
bptjm-12	316	6	,	,	PUNCT
bptjm-12	316	7	773–777	773–777	NUM
bptjm-12	316	8	.	.	PUNCT
bptjm-12	317	1	18	18	NUM
bptjm-12	317	2	.	.	PUNCT
bptjm-12	317	3	fagan	fagan	PROPN
bptjm-12	317	4	,	,	PUNCT
bptjm-12	317	5	s.	s.	PROPN
bptjm-12	317	6	g.	g.	PROPN
bptjm-12	317	7	,	,	PUNCT
bptjm-12	317	8	&	&	CCONJ
bptjm-12	317	9	campbell	campbell	PROPN
bptjm-12	317	10	,	,	PUNCT
bptjm-12	317	11	v.	v.	ADP
bptjm-12	317	12	a.	a.	NOUN
bptjm-12	317	13	(	(	PUNCT
bptjm-12	317	14	2014	2014	NUM
bptjm-12	317	15	)	)	PUNCT
bptjm-12	317	16	.	.	PUNCT
bptjm-12	318	1	the	the	PRON
bptjm-12	318	2	in	in	ADP
bptjm-12	318	3	�	�	PROPN
bptjm-12	318	4	uence	uence	NOUN
bptjm-12	318	5	of	of	ADP
bptjm-12	318	6	cannabinoids	cannabinoid	NOUN
bptjm-12	318	7	on	on	ADP
bptjm-12	318	8	generic	generic	ADJ
bptjm-12	318	9	traits	trait	NOUN
bptjm-12	318	10	of	of	ADP
bptjm-12	318	11	neurodegeneration	neurodegeneration	NOUN
bptjm-12	318	12	.	.	PUNCT
bptjm-12	319	1	british	british	ADJ
bptjm-12	319	2	journal	journal	PROPN
bptjm-12	319	3	of	of	ADP
bptjm-12	319	4	pharmacology	pharmacology	NOUN
bptjm-12	319	5	,	,	PUNCT
bptjm-12	319	6	171(6	171(6	NUM
bptjm-12	319	7	)	)	PUNCT
bptjm-12	319	8	,	,	PUNCT
bptjm-12	319	9	1347–1360	1347–1360	NUM
bptjm-12	319	10	.	.	PUNCT
bptjm-12	320	1	19	19	NUM
bptjm-12	320	2	.	.	X
bptjm-12	320	3	farkhondeh	farkhondeh	PROPN
bptjm-12	320	4	,	,	PUNCT
bptjm-12	320	5	t.	t.	PROPN
bptjm-12	320	6	,	,	PUNCT
bptjm-12	320	7	khan	khan	PROPN
bptjm-12	320	8	,	,	PUNCT
bptjm-12	320	9	h.	h.	PROPN
bptjm-12	320	10	,	,	PUNCT
bptjm-12	320	11	aschner	aschner	NOUN
bptjm-12	320	12	,	,	PUNCT
bptjm-12	320	13	m.	m.	NOUN
bptjm-12	320	14	,	,	PUNCT
bptjm-12	320	15	samini	samini	PROPN
bptjm-12	320	16	,	,	PUNCT
bptjm-12	320	17	f.	f.	PROPN
bptjm-12	320	18	,	,	PUNCT
bptjm-12	320	19	pourbagher	pourbagher	NOUN
bptjm-12	320	20	-	-	PUNCT
bptjm-12	320	21	shahri	shahri	PROPN
bptjm-12	320	22	,	,	PUNCT
bptjm-12	320	23	a.	a.	NOUN
bptjm-12	320	24	m.	m.	NOUN
bptjm-12	320	25	,	,	PUNCT
bptjm-12	320	26	aramjoo	aramjoo	ADV
bptjm-12	320	27	,	,	PUNCT
bptjm-12	320	28	h.	h.	PROPN
bptjm-12	320	29	,	,	PUNCT
bptjm-12	320	30	roshanravan	roshanravan	PROPN
bptjm-12	320	31	,	,	PUNCT
bptjm-12	320	32	b.	b.	PROPN
bptjm-12	320	33	,	,	PUNCT
bptjm-12	320	34	hoyte	hoyte	PROPN
bptjm-12	320	35	,	,	PUNCT
bptjm-12	320	36	c.	c.	PROPN
bptjm-12	320	37	,	,	PUNCT
bptjm-12	320	38	mehrpour	mehrpour	PROPN
bptjm-12	320	39	,	,	PUNCT
bptjm-12	320	40	o.	o.	PROPN
bptjm-12	320	41	,	,	PUNCT
bptjm-12	320	42	&	&	CCONJ
bptjm-12	320	43	samarghandian	samarghandian	PROPN
bptjm-12	320	44	,	,	PUNCT
bptjm-12	320	45	s.	s.	PROPN
bptjm-12	320	46	(	(	PUNCT
bptjm-12	320	47	2020	2020	NUM
bptjm-12	320	48	)	)	PUNCT
bptjm-12	320	49	.	.	PUNCT
bptjm-12	321	1	impact	impact	NOUN
bptjm-12	321	2	of	of	ADP
bptjm-12	321	3	cannabis	cannabis	NOUN
bptjm-12	321	4	-	-	PUNCT
bptjm-12	321	5	based	base	VERB
bptjm-12	321	6	medicine	medicine	NOUN
bptjm-12	321	7	on	on	ADP
bptjm-12	321	8	alzheimer	alzheimer	PROPN
bptjm-12	321	9	's	's	PART
bptjm-12	321	10	disease	disease	NOUN
bptjm-12	321	11	by	by	ADP
bptjm-12	321	12	focusing	focus	VERB
bptjm-12	321	13	on	on	ADP
bptjm-12	321	14	the	the	DET
bptjm-12	321	15	amyloid	amyloid	NOUN
bptjm-12	321	16	β	β	X
bptjm-12	321	17	-	-	PUNCT
bptjm-12	321	18	modi	modi	PROPN
bptjm-12	321	19	�	�	NOUN
bptjm-12	321	20	cations	cation	NOUN
bptjm-12	321	21	:	:	PUNCT
bptjm-12	321	22	a	a	DET
bptjm-12	321	23	systematic	systematic	ADJ
bptjm-12	321	24	study	study	NOUN
bptjm-12	321	25	.	.	PUNCT
bptjm-12	322	1	cns	cns	PROPN
bptjm-12	322	2	&	&	CCONJ
bptjm-12	322	3	neurological	neurological	ADJ
bptjm-12	322	4	disorders	disorder	NOUN
bptjm-12	322	5	drug	drug	NOUN
bptjm-12	322	6	targets	target	NOUN
bptjm-12	322	7	,	,	PUNCT
bptjm-12	322	8	19(5	19(5	NUM
bptjm-12	322	9	)	)	PUNCT
bptjm-12	322	10	,	,	PUNCT
bptjm-12	322	11	334–343	334–343	NUM
bptjm-12	322	12	.	.	PUNCT
bptjm-12	322	13	https://doi.org/10.2174/18715273196662007081	https://doi.org/10.2174/18715273196662007081	PROPN
bptjm-12	322	14	30745	30745	NUM
bptjm-12	322	15	20	20	NUM
bptjm-12	322	16	.	.	PUNCT
bptjm-12	323	1	fernández	fernández	PROPN
bptjm-12	323	2	-	-	PUNCT
bptjm-12	323	3	ruiz	ruiz	PROPN
bptjm-12	323	4	,	,	PUNCT
bptjm-12	323	5	j.	j.	PROPN
bptjm-12	323	6	,	,	PUNCT
bptjm-12	323	7	moro	moro	PROPN
bptjm-12	323	8	,	,	PUNCT
bptjm-12	323	9	m.	m.	NOUN
bptjm-12	323	10	a.	a.	PROPN
bptjm-12	323	11	,	,	PUNCT
bptjm-12	323	12	&	&	CCONJ
bptjm-12	323	13	martínez	martínez	PROPN
bptjm-12	323	14	-	-	PUNCT
bptjm-12	323	15	orgado	orgado	PROPN
bptjm-12	323	16	,	,	PUNCT
bptjm-12	323	17	j.	j.	PROPN
bptjm-12	323	18	(	(	PUNCT
bptjm-12	323	19	2015	2015	NUM
bptjm-12	323	20	)	)	PUNCT
bptjm-12	323	21	.	.	PUNCT
bptjm-12	324	1	cannabinoids	cannabinoid	NOUN
bptjm-12	324	2	in	in	ADP
bptjm-12	324	3	neurodegenerative	neurodegenerative	ADJ
bptjm-12	324	4	disorders	disorder	NOUN
bptjm-12	324	5	and	and	CCONJ
bptjm-12	324	6	stroke	stroke	NOUN
bptjm-12	324	7	/	/	SYM
bptjm-12	324	8	brain	brain	NOUN
bptjm-12	324	9	trauma	trauma	NOUN
bptjm-12	324	10	:	:	PUNCT
bptjm-12	324	11	from	from	ADP
bptjm-12	324	12	preclinical	preclinical	ADJ
bptjm-12	324	13	models	model	NOUN
bptjm-12	324	14	to	to	ADP
bptjm-12	324	15	clinical	clinical	ADJ
bptjm-12	324	16	applications	application	NOUN
bptjm-12	324	17	.	.	PUNCT
bptjm-12	325	1	neurotherapeutics	neurotherapeutic	NOUN
bptjm-12	325	2	:	:	PUNCT
bptjm-12	325	3	the	the	DET
bptjm-12	325	4	journal	journal	NOUN
bptjm-12	325	5	of	of	ADP
bptjm-12	325	6	the	the	DET
bptjm-12	325	7	american	american	ADJ
bptjm-12	325	8	society	society	NOUN
bptjm-12	325	9	for	for	ADP
bptjm-12	325	10	experimental	experimental	ADJ
bptjm-12	325	11	neurotherapeutics	neurotherapeutic	NOUN
bptjm-12	325	12	,	,	PUNCT
bptjm-12	325	13	12(4	12(4	NUM
bptjm-12	325	14	)	)	PUNCT
bptjm-12	325	15	,	,	PUNCT
bptjm-12	325	16	793–806	793–806	NUM
bptjm-12	325	17	.	.	PUNCT
bptjm-12	326	1	https://doi.org/10.1007/s13311-015-0381-7	https://doi.org/10.1007/s13311-015-0381-7	PRON
bptjm-12	326	2	21	21	NUM
bptjm-12	326	3	.	.	PUNCT
bptjm-12	327	1	giacoppo	giacoppo	PROPN
bptjm-12	327	2	,	,	PUNCT
bptjm-12	327	3	s.	s.	PROPN
bptjm-12	327	4	,	,	PUNCT
bptjm-12	327	5	mandolino	mandolino	PROPN
bptjm-12	327	6	,	,	PUNCT
bptjm-12	327	7	g.	g.	NOUN
bptjm-12	327	8	,	,	PUNCT
bptjm-12	327	9	galuppo	galuppo	NOUN
bptjm-12	327	10	,	,	PUNCT
bptjm-12	327	11	m.	m.	NOUN
bptjm-12	327	12	,	,	PUNCT
bptjm-12	327	13	bramanti	bramanti	NOUN
bptjm-12	327	14	,	,	PUNCT
bptjm-12	327	15	p.	p.	NOUN
bptjm-12	327	16	,	,	PUNCT
bptjm-12	327	17	&	&	CCONJ
bptjm-12	327	18	mazzon	mazzon	PROPN
bptjm-12	327	19	,	,	PUNCT
bptjm-12	327	20	e.	e.	PROPN
bptjm-12	327	21	(	(	PUNCT
bptjm-12	327	22	2014	2014	NUM
bptjm-12	327	23	)	)	PUNCT
bptjm-12	327	24	.	.	PUNCT
bptjm-12	328	1	cannabinoids	cannabinoid	NOUN
bptjm-12	328	2	:	:	PUNCT
bptjm-12	328	3	new	new	ADJ
bptjm-12	328	4	promising	promising	ADJ
bptjm-12	328	5	agents	agent	NOUN
bptjm-12	328	6	in	in	ADP
bptjm-12	328	7	the	the	DET
bptjm-12	328	8	treatment	treatment	NOUN
bptjm-12	328	9	of	of	ADP
bptjm-12	328	10	neurological	neurological	ADJ
bptjm-12	328	11	diseases	disease	NOUN
bptjm-12	328	12	.	.	PUNCT
bptjm-12	329	1	molecules	molecule	NOUN
bptjm-12	329	2	(	(	PUNCT
bptjm-12	329	3	basel	basel	PROPN
bptjm-12	329	4	,	,	PUNCT
bptjm-12	329	5	switzerland	switzerland	PROPN
bptjm-12	329	6	)	)	PUNCT
bptjm-12	329	7	,	,	PUNCT
bptjm-12	329	8	19(11	19(11	NUM
bptjm-12	329	9	)	)	PUNCT
bptjm-12	329	10	,	,	PUNCT
bptjm-12	329	11	18781–18816	18781–18816	NUM
bptjm-12	329	12	.	.	PUNCT
bptjm-12	330	1	https://doi.org/10.3390/molecules191118781	https://doi.org/10.3390/molecules191118781	PROPN
bptjm-12	330	2	.	.	PUNCT
bptjm-12	331	1	22	22	NUM
bptjm-12	331	2	.	.	PUNCT
bptjm-12	331	3	hall	hall	PROPN
bptjm-12	331	4	,	,	PUNCT
bptjm-12	331	5	g.	g.	PROPN
bptjm-12	331	6	f.	f.	PROPN
bptjm-12	331	7	,	,	PUNCT
bptjm-12	331	8	lee	lee	PROPN
bptjm-12	331	9	,	,	PUNCT
bptjm-12	331	10	v.	v.	ADP
bptjm-12	331	11	m.	m.	PROPN
bptjm-12	331	12	,	,	PUNCT
bptjm-12	331	13	lee	lee	PROPN
bptjm-12	331	14	,	,	PUNCT
bptjm-12	331	15	g.	g.	PROPN
bptjm-12	331	16	,	,	PUNCT
bptjm-12	331	17	&	&	CCONJ
bptjm-12	331	18	yao	yao	PROPN
bptjm-12	331	19	,	,	PUNCT
bptjm-12	331	20	j.	j.	PROPN
bptjm-12	331	21	(	(	PUNCT
bptjm-12	331	22	2001	2001	NUM
bptjm-12	331	23	)	)	PUNCT
bptjm-12	331	24	.	.	PUNCT
bptjm-12	332	1	staging	staging	NOUN
bptjm-12	332	2	of	of	ADP
bptjm-12	332	3	neuro	neuro	PROPN
bptjm-12	332	4	�	�	PROPN
bptjm-12	332	5	brillary	brillary	ADJ
bptjm-12	332	6	degeneration	degeneration	NOUN
bptjm-12	332	7	caused	cause	VERB
bptjm-12	332	8	by	by	ADP
bptjm-12	332	9	human	human	ADJ
bptjm-12	332	10	tau	tau	PROPN
bptjm-12	332	11	overexpression	overexpression	NOUN
bptjm-12	332	12	in	in	ADP
bptjm-12	332	13	a	a	DET
bptjm-12	332	14	unique	unique	ADJ
bptjm-12	332	15	cellular	cellular	ADJ
bptjm-12	332	16	model	model	NOUN
bptjm-12	332	17	of	of	ADP
bptjm-12	332	18	human	human	ADJ
bptjm-12	332	19	tauopathy	tauopathy	NOUN
bptjm-12	332	20	.	.	PUNCT
bptjm-12	333	1	the	the	DET
bptjm-12	333	2	americanjournal	americanjournal	NOUN
bptjm-12	333	3	of	of	ADP
bptjm-12	333	4	pathology	pathology	NOUN
bptjm-12	333	5	,	,	PUNCT
bptjm-12	333	6	158(1	158(1	NUM
bptjm-12	333	7	)	)	PUNCT
bptjm-12	333	8	,	,	PUNCT
bptjm-12	333	9	235–246	235–246	NUM
bptjm-12	333	10	.	.	PUNCT
bptjm-12	333	11	https://doi.org/10.1016/s0002-9440(10)63962-4	https://doi.org/10.1016/s0002-9440(10)63962-4	VERB
bptjm-12	333	12	23	23	NUM
bptjm-12	333	13	.	.	PUNCT
bptjm-12	334	1	hughes	hughes	PROPN
bptjm-12	334	2	,	,	PUNCT
bptjm-12	334	3	b.	b.	PROPN
bptjm-12	334	4	,	,	PUNCT
bptjm-12	334	5	&	&	CCONJ
bptjm-12	334	6	herron	herron	PROPN
bptjm-12	334	7	,	,	PUNCT
bptjm-12	334	8	c.	c.	PROPN
bptjm-12	334	9	e.	e.	PROPN
bptjm-12	334	10	(	(	PUNCT
bptjm-12	334	11	2019	2019	NUM
bptjm-12	334	12	)	)	PUNCT
bptjm-12	334	13	.	.	PUNCT
bptjm-12	335	1	cannabidiol	cannabidiol	PROPN
bptjm-12	335	2	reverses	reverse	VERB
bptjm-12	335	3	de	de	PROPN
bptjm-12	335	4	�	�	PROPN
bptjm-12	335	5	cits	cit	NOUN
bptjm-12	335	6	in	in	ADP
bptjm-12	335	7	hippocampal	hippocampal	ADJ
bptjm-12	335	8	ltp	ltp	PROPN
bptjm-12	335	9	in	in	ADP
bptjm-12	335	10	amodel	amodel	PROPN
bptjm-12	335	11	of	of	ADP
bptjm-12	335	12	alzheimer	alzheimer	PROPN
bptjm-12	335	13	’s	’s	PART
bptjm-12	335	14	disease	disease	NOUN
bptjm-12	335	15	.	.	PUNCT
bptjm-12	336	1	neurochemical	neurochemical	ADJ
bptjm-12	336	2	research	research	NOUN
bptjm-12	336	3	,	,	PUNCT
bptjm-12	336	4	44(3	44(3	NOUN
bptjm-12	336	5	)	)	PUNCT
bptjm-12	336	6	,	,	PUNCT
bptjm-12	336	7	703–713	703–713	NUM
bptjm-12	336	8	.	.	PUNCT
bptjm-12	337	1	24	24	NUM
bptjm-12	337	2	.	.	PUNCT
bptjm-12	338	1	karl	karl	PROPN
bptjm-12	338	2	,	,	PUNCT
bptjm-12	338	3	t.	t.	PROPN
bptjm-12	338	4	,	,	PUNCT
bptjm-12	338	5	garner	garner	PROPN
bptjm-12	338	6	,	,	PUNCT
bptjm-12	338	7	b.	b.	PROPN
bptjm-12	338	8	,	,	PUNCT
bptjm-12	338	9	&	&	CCONJ
bptjm-12	338	10	cheng	cheng	PROPN
bptjm-12	338	11	,	,	PUNCT
bptjm-12	338	12	d.	d.	PROPN
bptjm-12	338	13	(	(	PUNCT
bptjm-12	338	14	2017	2017	NUM
bptjm-12	338	15	)	)	PUNCT
bptjm-12	338	16	.	.	PUNCT
bptjm-12	339	1	the	the	DET
bptjm-12	339	2	therapeutic	therapeutic	ADJ
bptjm-12	339	3	potential	potential	NOUN
bptjm-12	339	4	of	of	ADP
bptjm-12	339	5	the	the	DET
bptjm-12	339	6	phytocannabinoid	phytocannabinoid	NOUN
bptjm-12	339	7	cannabidiol	cannabidiol	NOUN
bptjm-12	339	8	for	for	ADP
bptjm-12	339	9	alzheimer	alzheimer	PROPN
bptjm-12	339	10	’s	’s	PART
bptjm-12	339	11	disease	disease	NOUN
bptjm-12	339	12	.	.	PUNCT
bptjm-12	340	1	behavioural	behavioural	ADJ
bptjm-12	340	2	pharmacology	pharmacology	NOUN
bptjm-12	340	3	,	,	PUNCT
bptjm-12	340	4	28	28	NUM
bptjm-12	340	5	,	,	PUNCT
bptjm-12	340	6	berkeley	berkeley	PROPN
bptjm-12	340	7	pharma	pharma	PROPN
bptjm-12	340	8	tech	tech	NOUN
bptjm-12	340	9	journal	journal	NOUN
bptjm-12	340	10	of	of	ADP
bptjm-12	340	11	medicine	medicine	NOUN
bptjm-12	340	12	|	|	ADV
bptjm-12	340	13	22	22	NUM
bptjm-12	340	14	142–160.https://doi.org/10.1097	142–160.https://doi.org/10.1097	NUM
bptjm-12	340	15	/	/	SYM
bptjm-12	340	16	fbp.0000000	fbp.0000000	NUM
bptjm-12	340	17	000000247	000000247	NUM
bptjm-12	340	18	25	25	NUM
bptjm-12	340	19	.	.	PUNCT
bptjm-12	341	1	li	li	PROPN
bptjm-12	341	2	,	,	PUNCT
bptjm-12	341	3	h.	h.	PROPN
bptjm-12	341	4	,	,	PUNCT
bptjm-12	341	5	liu	liu	PROPN
bptjm-12	341	6	,	,	PUNCT
bptjm-12	341	7	y.	y.	PROPN
bptjm-12	341	8	,	,	PUNCT
bptjm-12	341	9	tian	tian	PROPN
bptjm-12	341	10	,	,	PUNCT
bptjm-12	341	11	d.	d.	PROPN
bptjm-12	341	12	,	,	PUNCT
bptjm-12	341	13	tian	tian	PROPN
bptjm-12	341	14	,	,	PUNCT
bptjm-12	341	15	l.	l.	PROPN
bptjm-12	341	16	,	,	PUNCT
bptjm-12	341	17	ju	ju	PROPN
bptjm-12	341	18	,	,	PUNCT
bptjm-12	341	19	x.	x.	PROPN
bptjm-12	341	20	,	,	PUNCT
bptjm-12	341	21	qi	qi	PROPN
bptjm-12	341	22	,	,	PUNCT
bptjm-12	341	23	l.	l.	PROPN
bptjm-12	341	24	,	,	PUNCT
bptjm-12	341	25	wang	wang	PROPN
bptjm-12	341	26	,	,	PUNCT
bptjm-12	341	27	y.	y.	PROPN
bptjm-12	341	28	,	,	PUNCT
bptjm-12	341	29	&	&	CCONJ
bptjm-12	341	30	liang	liang	PROPN
bptjm-12	341	31	,	,	PUNCT
bptjm-12	341	32	c.	c.	PROPN
bptjm-12	341	33	(	(	PUNCT
bptjm-12	341	34	2020	2020	NUM
bptjm-12	341	35	)	)	PUNCT
bptjm-12	341	36	.	.	PUNCT
bptjm-12	342	1	overview	overview	NOUN
bptjm-12	342	2	of	of	ADP
bptjm-12	342	3	cannabidiol	cannabidiol	NOUN
bptjm-12	342	4	(	(	PUNCT
bptjm-12	342	5	cbd	cbd	NOUN
bptjm-12	342	6	)	)	PUNCT
bptjm-12	342	7	and	and	CCONJ
bptjm-12	342	8	its	its	PRON
bptjm-12	342	9	analogues	analogue	NOUN
bptjm-12	342	10	:	:	PUNCT
bptjm-12	342	11	structures	structure	NOUN
bptjm-12	342	12	,	,	PUNCT
bptjm-12	342	13	biological	biological	ADJ
bptjm-12	342	14	activities	activity	NOUN
bptjm-12	342	15	,	,	PUNCT
bptjm-12	342	16	and	and	CCONJ
bptjm-12	342	17	neuroprotective	neuroprotective	ADJ
bptjm-12	342	18	mechanisms	mechanism	NOUN
bptjm-12	342	19	in	in	ADP
bptjm-12	342	20	epilepsy	epilepsy	NOUN
bptjm-12	342	21	and	and	CCONJ
bptjm-12	342	22	alzheimer	alzheimer	PROPN
bptjm-12	342	23	's	's	PART
bptjm-12	342	24	disease	disease	NOUN
bptjm-12	342	25	.	.	PUNCT
bptjm-12	343	1	european	european	PROPN
bptjm-12	343	2	journal	journal	PROPN
bptjm-12	343	3	of	of	ADP
bptjm-12	343	4	medicinal	medicinal	ADJ
bptjm-12	343	5	chemistry	chemistry	NOUN
bptjm-12	343	6	,	,	PUNCT
bptjm-12	343	7	192	192	NUM
bptjm-12	343	8	,	,	PUNCT
bptjm-12	343	9	112163	112163	NUM
bptjm-12	343	10	.	.	PUNCT
bptjm-12	344	1	26	26	NUM
bptjm-12	344	2	.	.	PUNCT
bptjm-12	345	1	libro	libro	PROPN
bptjm-12	345	2	,	,	PUNCT
bptjm-12	345	3	r.	r.	PROPN
bptjm-12	345	4	,	,	PUNCT
bptjm-12	345	5	diomede	diomede	PROPN
bptjm-12	345	6	,	,	PUNCT
bptjm-12	345	7	f.	f.	PROPN
bptjm-12	345	8	,	,	PUNCT
bptjm-12	345	9	scionti	scionti	PROPN
bptjm-12	345	10	,	,	PUNCT
bptjm-12	345	11	d.	d.	PROPN
bptjm-12	345	12	,	,	PUNCT
bptjm-12	345	13	piattelli	piattelli	PROPN
bptjm-12	345	14	,	,	PUNCT
bptjm-12	345	15	a.	a.	PROPN
bptjm-12	345	16	,	,	PUNCT
bptjm-12	345	17	grassi	grassi	PROPN
bptjm-12	345	18	,	,	PUNCT
bptjm-12	345	19	g.	g.	PROPN
bptjm-12	345	20	,	,	PUNCT
bptjm-12	345	21	pollastro	pollastro	PROPN
bptjm-12	345	22	,	,	PUNCT
bptjm-12	345	23	f.	f.	PROPN
bptjm-12	345	24	,	,	PUNCT
bptjm-12	345	25	bramanti	bramanti	VERB
bptjm-12	345	26	,	,	PUNCT
bptjm-12	345	27	p.	p.	NOUN
bptjm-12	345	28	,	,	PUNCT
bptjm-12	345	29	mazzon	mazzon	PROPN
bptjm-12	345	30	,	,	PUNCT
bptjm-12	345	31	e.	e.	PROPN
bptjm-12	345	32	,	,	PUNCT
bptjm-12	345	33	&	&	CCONJ
bptjm-12	345	34	trubiani	trubiani	NOUN
bptjm-12	345	35	,	,	PUNCT
bptjm-12	345	36	o.	o.	NOUN
bptjm-12	345	37	(	(	PUNCT
bptjm-12	345	38	2016	2016	NUM
bptjm-12	345	39	)	)	PUNCT
bptjm-12	345	40	.	.	PUNCT
bptjm-12	346	1	cannabidiol	cannabidiol	PROPN
bptjm-12	346	2	modulates	modulate	VERB
bptjm-12	346	3	the	the	DET
bptjm-12	346	4	expression	expression	NOUN
bptjm-12	346	5	of	of	ADP
bptjm-12	346	6	alzheimer	alzheimer	PROPN
bptjm-12	346	7	's	's	PART
bptjm-12	346	8	disease	disease	NOUN
bptjm-12	346	9	-	-	PUNCT
bptjm-12	346	10	related	relate	VERB
bptjm-12	346	11	genes	gene	NOUN
bptjm-12	346	12	in	in	ADP
bptjm-12	346	13	mesenchymal	mesenchymal	ADJ
bptjm-12	346	14	stem	stem	NOUN
bptjm-12	346	15	cells	cell	NOUN
bptjm-12	346	16	.	.	PUNCT
bptjm-12	347	1	international	international	ADJ
bptjm-12	347	2	journal	journal	NOUN
bptjm-12	347	3	of	of	ADP
bptjm-12	347	4	molecular	molecular	ADJ
bptjm-12	347	5	sciences	science	NOUN
bptjm-12	347	6	,	,	PUNCT
bptjm-12	347	7	18(1	18(1	NUM
bptjm-12	347	8	)	)	PUNCT
bptjm-12	347	9	,	,	PUNCT
bptjm-12	347	10	26	26	NUM
bptjm-12	347	11	.	.	PUNCT
bptjm-12	348	1	https://doi.org/10.3390/ijms18010026	https://doi.org/10.3390/ijms18010026	PROPN
bptjm-12	348	2	27	27	NUM
bptjm-12	348	3	.	.	PUNCT
bptjm-12	349	1	eubanks	eubanks	PROPN
bptjm-12	349	2	,	,	PUNCT
bptjm-12	349	3	l.	l.	PROPN
bptjm-12	349	4	m.	m.	PROPN
bptjm-12	349	5	,	,	PUNCT
bptjm-12	349	6	rogers	rogers	PROPN
bptjm-12	349	7	,	,	PUNCT
bptjm-12	349	8	c.	c.	PROPN
bptjm-12	349	9	j.	j.	PROPN
bptjm-12	349	10	,	,	PUNCT
bptjm-12	349	11	beuscher	beuscher	PROPN
bptjm-12	349	12	,	,	PUNCT
bptjm-12	349	13	a.	a.	PROPN
bptjm-12	349	14	e.	e.	PROPN
bptjm-12	349	15	,	,	PUNCT
bptjm-12	349	16	4th	4th	ADJ
bptjm-12	349	17	,	,	PUNCT
bptjm-12	349	18	koob	koob	PROPN
bptjm-12	349	19	,	,	PUNCT
bptjm-12	349	20	g.	g.	PROPN
bptjm-12	349	21	f.	f.	PROPN
bptjm-12	349	22	,	,	PUNCT
bptjm-12	349	23	olson	olson	PROPN
bptjm-12	349	24	,	,	PUNCT
bptjm-12	349	25	a.	a.	PROPN
bptjm-12	349	26	j.	j.	PROPN
bptjm-12	349	27	,	,	PUNCT
bptjm-12	349	28	dickerson	dickerson	PROPN
bptjm-12	349	29	,	,	PUNCT
bptjm-12	349	30	t.	t.	PROPN
bptjm-12	349	31	j.	j.	PROPN
bptjm-12	349	32	,	,	PUNCT
bptjm-12	349	33	&	&	CCONJ
bptjm-12	349	34	janda	janda	PROPN
bptjm-12	349	35	,	,	PUNCT
bptjm-12	349	36	k.	k.	PROPN
bptjm-12	349	37	d.	d.	PROPN
bptjm-12	349	38	(	(	PUNCT
bptjm-12	349	39	2006	2006	NUM
bptjm-12	349	40	)	)	PUNCT
bptjm-12	349	41	.	.	PUNCT
bptjm-12	350	1	a	a	DET
bptjm-12	350	2	molecular	molecular	ADJ
bptjm-12	350	3	link	link	NOUN
bptjm-12	350	4	between	between	ADP
bptjm-12	350	5	the	the	DET
bptjm-12	350	6	active	active	ADJ
bptjm-12	350	7	component	component	NOUN
bptjm-12	350	8	of	of	ADP
bptjm-12	350	9	marijuana	marijuana	PROPN
bptjm-12	350	10	and	and	CCONJ
bptjm-12	350	11	alzheimer	alzheimer	PROPN
bptjm-12	350	12	's	's	PART
bptjm-12	350	13	disease	disease	NOUN
bptjm-12	350	14	pathology	pathology	NOUN
bptjm-12	350	15	.	.	PUNCT
bptjm-12	351	1	molecular	molecular	ADJ
bptjm-12	351	2	pharmaceutics	pharmaceutic	NOUN
bptjm-12	351	3	,	,	PUNCT
bptjm-12	351	4	3(6	3(6	NUM
bptjm-12	351	5	)	)	PUNCT
bptjm-12	351	6	,	,	PUNCT
bptjm-12	351	7	773–777	773–777	NUM
bptjm-12	351	8	.	.	PUNCT
bptjm-12	352	1	https://doi.org/10.1021/mp060066	https://doi.org/10.1021/mp060066	PROPN
bptjm-12	352	2	m	m	VERB
bptjm-12	352	3	28	28	NUM
bptjm-12	352	4	.	.	PUNCT
bptjm-12	353	1	liu	liu	PROPN
bptjm-12	353	2	,	,	PUNCT
bptjm-12	353	3	c.	c.	PROPN
bptjm-12	353	4	s.	s.	PROPN
bptjm-12	353	5	,	,	PUNCT
bptjm-12	353	6	chau	chau	PROPN
bptjm-12	353	7	,	,	PUNCT
bptjm-12	353	8	s.	s.	PROPN
bptjm-12	353	9	a.	a.	PROPN
bptjm-12	353	10	,	,	PUNCT
bptjm-12	353	11	ruthirakuhan	ruthirakuhan	PROPN
bptjm-12	353	12	,	,	PUNCT
bptjm-12	353	13	m.	m.	NOUN
bptjm-12	353	14	,	,	PUNCT
bptjm-12	353	15	lanctôt	lanctôt	PROPN
bptjm-12	353	16	,	,	PUNCT
bptjm-12	353	17	k.	k.	PROPN
bptjm-12	353	18	l.	l.	PROPN
bptjm-12	353	19	,	,	PUNCT
bptjm-12	353	20	&	&	CCONJ
bptjm-12	353	21	herrmann	herrmann	PROPN
bptjm-12	353	22	,	,	PUNCT
bptjm-12	353	23	n.	n.	PROPN
bptjm-12	353	24	(	(	PUNCT
bptjm-12	353	25	2015	2015	NUM
bptjm-12	353	26	)	)	PUNCT
bptjm-12	353	27	.	.	PUNCT
bptjm-12	354	1	cannabinoids	cannabinoid	NOUN
bptjm-12	354	2	for	for	ADP
bptjm-12	354	3	the	the	DET
bptjm-12	354	4	treatment	treatment	NOUN
bptjm-12	354	5	of	of	ADP
bptjm-12	354	6	agitation	agitation	NOUN
bptjm-12	354	7	and	and	CCONJ
bptjm-12	354	8	aggression	aggression	NOUN
bptjm-12	354	9	in	in	ADP
bptjm-12	354	10	alzheimer	alzheimer	PROPN
bptjm-12	354	11	’s	’s	PART
bptjm-12	354	12	disease	disease	NOUN
bptjm-12	354	13	.	.	PUNCT
bptjm-12	355	1	cns	cns	NOUN
bptjm-12	355	2	drugs	drug	NOUN
bptjm-12	355	3	,	,	PUNCT
bptjm-12	355	4	29(8	29(8	NOUN
bptjm-12	355	5	)	)	PUNCT
bptjm-12	355	6	,	,	PUNCT
bptjm-12	355	7	615–623	615–623	NUM
bptjm-12	355	8	.	.	PUNCT
bptjm-12	356	1	29	29	NUM
bptjm-12	356	2	.	.	X
bptjm-12	356	3	martín	martín	NOUN
bptjm-12	356	4	-	-	PUNCT
bptjm-12	356	5	moreno	moreno	PROPN
bptjm-12	356	6	,	,	PUNCT
bptjm-12	356	7	a.	a.	NOUN
bptjm-12	356	8	m.	m.	NOUN
bptjm-12	356	9	,	,	PUNCT
bptjm-12	356	10	reigada	reigada	PROPN
bptjm-12	356	11	,	,	PUNCT
bptjm-12	356	12	d.	d.	PROPN
bptjm-12	356	13	,	,	PUNCT
bptjm-12	356	14	ramírez	ramírez	NOUN
bptjm-12	356	15	,	,	PUNCT
bptjm-12	356	16	b.	b.	PROPN
bptjm-12	356	17	g.	g.	PROPN
bptjm-12	356	18	,	,	PUNCT
bptjm-12	356	19	mechoulam	mechoulam	PROPN
bptjm-12	356	20	,	,	PUNCT
bptjm-12	356	21	r.	r.	PROPN
bptjm-12	356	22	,	,	PUNCT
bptjm-12	356	23	innamorato	innamorato	PROPN
bptjm-12	356	24	,	,	PUNCT
bptjm-12	356	25	n.	n.	NOUN
bptjm-12	356	26	,	,	PUNCT
bptjm-12	356	27	cuadrado	cuadrado	PROPN
bptjm-12	356	28	,	,	PUNCT
bptjm-12	356	29	a.	a.	PROPN
bptjm-12	356	30	,	,	PUNCT
bptjm-12	356	31	&	&	CCONJ
bptjm-12	356	32	de	de	X
bptjm-12	356	33	ceballos	ceballos	PROPN
bptjm-12	356	34	,	,	PUNCT
bptjm-12	356	35	m.	m.	NOUN
bptjm-12	356	36	l.	l.	PROPN
bptjm-12	356	37	(	(	PUNCT
bptjm-12	356	38	2011	2011	NUM
bptjm-12	356	39	)	)	PUNCT
bptjm-12	356	40	.	.	PUNCT
bptjm-12	357	1	cannabidiol	cannabidiol	PROPN
bptjm-12	357	2	and	and	CCONJ
bptjm-12	357	3	other	other	ADJ
bptjm-12	357	4	cannabinoids	cannabinoid	NOUN
bptjm-12	357	5	reduce	reduce	VERB
bptjm-12	357	6	microglial	microglial	ADJ
bptjm-12	357	7	activation	activation	NOUN
bptjm-12	357	8	in	in	ADP
bptjm-12	357	9	vitro	vitro	X
bptjm-12	357	10	and	and	CCONJ
bptjm-12	357	11	in	in	ADP
bptjm-12	357	12	vivo	vivo	NOUN
bptjm-12	357	13	:	:	PUNCT
bptjm-12	357	14	relevance	relevance	NOUN
bptjm-12	357	15	to	to	ADP
bptjm-12	357	16	alzheimer	alzheimer	PROPN
bptjm-12	357	17	's	's	PART
bptjm-12	357	18	disease	disease	NOUN
bptjm-12	357	19	.	.	PUNCT
bptjm-12	358	1	molecular	molecular	ADJ
bptjm-12	358	2	pharmacology	pharmacology	NOUN
bptjm-12	358	3	,	,	PUNCT
bptjm-12	358	4	79(6	79(6	NUM
bptjm-12	358	5	)	)	PUNCT
bptjm-12	358	6	,	,	PUNCT
bptjm-12	358	7	964–973	964–973	NUM
bptjm-12	358	8	.	.	PUNCT
bptjm-12	359	1	https://doi.org/10.1124/mol.111.071290	https://doi.org/10.1124/mol.111.071290	PROPN
bptjm-12	359	2	30	30	NUM
bptjm-12	359	3	.	.	PUNCT
bptjm-12	360	1	mcpartland	mcpartland	PROPN
bptjm-12	360	2	,	,	PUNCT
bptjm-12	360	3	j.	j.	PROPN
bptjm-12	360	4	m.	m.	PROPN
bptjm-12	360	5	,	,	PUNCT
bptjm-12	360	6	glass	glass	NOUN
bptjm-12	360	7	,	,	PUNCT
bptjm-12	360	8	m.	m.	NOUN
bptjm-12	360	9	,	,	PUNCT
bptjm-12	360	10	&	&	CCONJ
bptjm-12	360	11	pertwee	pertwee	PROPN
bptjm-12	360	12	,	,	PUNCT
bptjm-12	360	13	r.	r.	PROPN
bptjm-12	360	14	g.	g.	PROPN
bptjm-12	360	15	(	(	PUNCT
bptjm-12	360	16	2007	2007	NUM
bptjm-12	360	17	)	)	PUNCT
bptjm-12	360	18	.	.	PUNCT
bptjm-12	361	1	meta	meta	ADJ
bptjm-12	361	2	-	-	PUNCT
bptjm-12	361	3	analysis	analysis	NOUN
bptjm-12	361	4	of	of	ADP
bptjm-12	361	5	cannabinoid	cannabinoid	PROPN
bptjm-12	361	6	ligand	ligand	NOUN
bptjm-12	361	7	binding	bind	VERB
bptjm-12	361	8	a	a	DET
bptjm-12	361	9	�	�	NOUN
bptjm-12	361	10	nity	nity	NOUN
bptjm-12	361	11	and	and	CCONJ
bptjm-12	361	12	receptor	receptor	NOUN
bptjm-12	361	13	distribution	distribution	NOUN
bptjm-12	361	14	:	:	PUNCT
bptjm-12	361	15	interspecies	interspecie	NOUN
bptjm-12	361	16	di	di	PROPN
bptjm-12	361	17	�	�	PROPN
bptjm-12	361	18	erences	erence	NOUN
bptjm-12	361	19	.	.	PUNCT
bptjm-12	362	1	british	british	ADJ
bptjm-12	362	2	journal	journal	PROPN
bptjm-12	362	3	of	of	ADP
bptjm-12	362	4	pharmacology	pharmacology	NOUN
bptjm-12	362	5	,	,	PUNCT
bptjm-12	362	6	152(5	152(5	NUM
bptjm-12	362	7	)	)	PUNCT
bptjm-12	362	8	,	,	PUNCT
bptjm-12	362	9	583–593	583–593	NUM
bptjm-12	362	10	.	.	PUNCT
bptjm-12	363	1	https://doi.org/10.1038/sj.bjp.0707399	https://doi.org/10.1038/sj.bjp.0707399	NOUN
bptjm-12	363	2	31	31	NUM
bptjm-12	363	3	.	.	PUNCT
bptjm-12	364	1	nelson	nelson	PROPN
bptjm-12	364	2	,	,	PUNCT
bptjm-12	364	3	p.	p.	PROPN
bptjm-12	364	4	t.	t.	PROPN
bptjm-12	364	5	,	,	PUNCT
bptjm-12	364	6	alafuzo	alafuzo	PROPN
bptjm-12	364	7	�	�	PROPN
bptjm-12	364	8	,	,	PUNCT
bptjm-12	364	9	i.	i.	PROPN
bptjm-12	364	10	,	,	PUNCT
bptjm-12	364	11	bigio	bigio	NOUN
bptjm-12	364	12	,	,	PUNCT
bptjm-12	364	13	e.	e.	PROPN
bptjm-12	364	14	h.	h.	PROPN
bptjm-12	364	15	,	,	PUNCT
bptjm-12	364	16	bouras	bouras	PROPN
bptjm-12	364	17	,	,	PUNCT
bptjm-12	364	18	c.	c.	NOUN
bptjm-12	364	19	,	,	PUNCT
bptjm-12	364	20	braak	braak	PROPN
bptjm-12	364	21	,	,	PUNCT
bptjm-12	364	22	h.	h.	PROPN
bptjm-12	364	23	,	,	PUNCT
bptjm-12	364	24	cairns	cairns	PROPN
bptjm-12	364	25	,	,	PUNCT
bptjm-12	364	26	n.	n.	PROPN
bptjm-12	364	27	j.	j.	PROPN
bptjm-12	364	28	,	,	PUNCT
bptjm-12	364	29	castellani	castellani	PROPN
bptjm-12	364	30	,	,	PUNCT
bptjm-12	364	31	r.	r.	PROPN
bptjm-12	364	32	j.	j.	PROPN
bptjm-12	364	33	,crain	,crain	PROPN
bptjm-12	364	34	,	,	PUNCT
bptjm-12	364	35	b.	b.	PROPN
bptjm-12	364	36	j.	j.	PROPN
bptjm-12	364	37	,	,	PUNCT
bptjm-12	364	38	davies	davy	NOUN
bptjm-12	364	39	,	,	PUNCT
bptjm-12	364	40	p.	p.	NOUN
bptjm-12	364	41	,	,	PUNCT
bptjm-12	364	42	del	del	PROPN
bptjm-12	364	43	tredici	tredici	PROPN
bptjm-12	364	44	,	,	PUNCT
bptjm-12	364	45	k.	k.	PROPN
bptjm-12	364	46	,	,	PUNCT
bptjm-12	364	47	duyckaerts	duyckaert	NOUN
bptjm-12	364	48	,	,	PUNCT
bptjm-12	364	49	c.	c.	PROPN
bptjm-12	364	50	,	,	PUNCT
bptjm-12	364	51	frosch	frosch	PROPN
bptjm-12	364	52	,	,	PUNCT
bptjm-12	364	53	m.	m.	NOUN
bptjm-12	364	54	p.	p.	PROPN
bptjm-12	364	55	,	,	PUNCT
bptjm-12	364	56	haroutunian	haroutunian	PROPN
bptjm-12	364	57	,	,	PUNCT
bptjm-12	364	58	v.	v.	PROPN
bptjm-12	364	59	,	,	PUNCT
bptjm-12	364	60	hof	hof	PROPN
bptjm-12	364	61	,	,	PUNCT
bptjm-12	364	62	p.r	p.r	PROPN
bptjm-12	364	63	.	.	PROPN
bptjm-12	364	64	,	,	PUNCT
bptjm-12	364	65	hulette	hulette	PROPN
bptjm-12	364	66	,	,	PUNCT
bptjm-12	364	67	c.	c.	PROPN
bptjm-12	364	68	m.	m.	PROPN
bptjm-12	364	69	,	,	PUNCT
bptjm-12	364	70	hyman	hyman	PROPN
bptjm-12	364	71	,	,	PUNCT
bptjm-12	364	72	b.	b.	PROPN
bptjm-12	364	73	t.	t.	PROPN
bptjm-12	364	74	,	,	PUNCT
bptjm-12	364	75	iwatsubo	iwatsubo	ADJ
bptjm-12	364	76	,	,	PUNCT
bptjm-12	364	77	t.	t.	PROPN
bptjm-12	364	78	,	,	PUNCT
bptjm-12	364	79	jellinger	jellinger	PROPN
bptjm-12	364	80	,	,	PUNCT
bptjm-12	364	81	k.	k.	PROPN
bptjm-12	364	82	a.	a.	PROPN
bptjm-12	364	83	,	,	PUNCT
bptjm-12	364	84	jicha	jicha	PROPN
bptjm-12	364	85	,	,	PUNCT
bptjm-12	364	86	g.	g.	PROPN
bptjm-12	364	87	a.	a.	PROPN
bptjm-12	364	88	,	,	PUNCT
bptjm-12	364	89	kövari	kövari	PROPN
bptjm-12	364	90	,	,	PUNCT
bptjm-12	364	91	e.	e.	PROPN
bptjm-12	364	92	,	,	PUNCT
bptjm-12	364	93	...	...	PUNCT
bptjm-12	364	94	beach	beach	NOUN
bptjm-12	364	95	,	,	PUNCT
bptjm-12	364	96	t.	t.	PROPN
bptjm-12	364	97	g.	g.	PROPN
bptjm-12	364	98	(	(	PUNCT
bptjm-12	364	99	2012	2012	NUM
bptjm-12	364	100	)	)	PUNCT
bptjm-12	364	101	.	.	PUNCT
bptjm-12	365	1	correlation	correlation	NOUN
bptjm-12	365	2	of	of	ADP
bptjm-12	365	3	alzheimer	alzheimer	PROPN
bptjm-12	365	4	disease	disease	PROPN
bptjm-12	365	5	neuropathologic	neuropathologic	NOUN
bptjm-12	365	6	changes	change	NOUN
bptjm-12	365	7	with	with	ADP
bptjm-12	365	8	cognitive	cognitive	ADJ
bptjm-12	365	9	status	status	NOUN
bptjm-12	365	10	:	:	PUNCT
bptjm-12	365	11	a	a	DET
bptjm-12	365	12	review	review	NOUN
bptjm-12	365	13	of	of	ADP
bptjm-12	365	14	the	the	DET
bptjm-12	365	15	literature	literature	NOUN
bptjm-12	365	16	.	.	PUNCT
bptjm-12	366	1	journal	journal	PROPN
bptjm-12	366	2	of	of	ADP
bptjm-12	366	3	neuropathology	neuropathology	NOUN
bptjm-12	366	4	and	and	CCONJ
bptjm-12	366	5	experimental	experimental	ADJ
bptjm-12	366	6	neurology	neurology	NOUN
bptjm-12	366	7	,	,	PUNCT
bptjm-12	366	8	71(5	71(5	NUM
bptjm-12	366	9	)	)	PUNCT
bptjm-12	366	10	,	,	PUNCT
bptjm-12	366	11	362–381	362–381	NUM
bptjm-12	366	12	.	.	PUNCT
bptjm-12	367	1	https://doi.org/10.1097/nen.0b013e318250	https://doi.org/10.1097/nen.0b013e318250	PROPN
bptjm-12	367	2	18f7	18f7	NUM
bptjm-12	367	3	.	.	PUNCT
bptjm-12	368	1	32	32	NUM
bptjm-12	368	2	.	.	PUNCT
bptjm-12	369	1	nuñez	nuñez	NOUN
bptjm-12	369	2	-	-	PUNCT
bptjm-12	369	3	borque	borque	PROPN
bptjm-12	369	4	,	,	PUNCT
bptjm-12	369	5	e.	e.	PROPN
bptjm-12	369	6	,	,	PUNCT
bptjm-12	369	7	gonzález	gonzález	PROPN
bptjm-12	369	8	-	-	PUNCT
bptjm-12	369	9	naranjo	naranjo	PROPN
bptjm-12	369	10	,	,	PUNCT
bptjm-12	369	11	p.	p.	NOUN
bptjm-12	369	12	,	,	PUNCT
bptjm-12	369	13	bartolomé	bartolomé	PROPN
bptjm-12	369	14	,	,	PUNCT
bptjm-12	369	15	f.	f.	PROPN
bptjm-12	369	16	,	,	PUNCT
bptjm-12	369	17	alquézar	alquézar	NOUN
bptjm-12	369	18	,	,	PUNCT
bptjm-12	369	19	c.	c.	PROPN
bptjm-12	369	20	,	,	PUNCT
bptjm-12	369	21	reinares	reinare	VERB
bptjm-12	369	22	-	-	PUNCT
bptjm-12	369	23	sebastián	sebastián	ADJ
bptjm-12	369	24	,	,	PUNCT
bptjm-12	369	25	a.	a.	NOUN
bptjm-12	369	26	,pérez	,pérez	PUNCT
bptjm-12	369	27	,	,	PUNCT
bptjm-12	369	28	c.	c.	PROPN
bptjm-12	369	29	,	,	PUNCT
bptjm-12	369	30	ceballos	ceballos	PROPN
bptjm-12	369	31	,	,	PUNCT
bptjm-12	369	32	m.	m.	NOUN
bptjm-12	369	33	l.	l.	PROPN
bptjm-12	369	34	,	,	PUNCT
bptjm-12	369	35	páez	páez	PROPN
bptjm-12	369	36	,	,	PUNCT
bptjm-12	369	37	j.	j.	PROPN
bptjm-12	369	38	a.	a.	PROPN
bptjm-12	369	39	,	,	PUNCT
bptjm-12	369	40	campillo	campillo	PROPN
bptjm-12	369	41	,	,	PUNCT
bptjm-12	369	42	n.	n.	PROPN
bptjm-12	369	43	e.	e.	PROPN
bptjm-12	369	44	,	,	PUNCT
bptjm-12	369	45	&	&	CCONJ
bptjm-12	369	46	martín	martín	NOUN
bptjm-12	369	47	-	-	PUNCT
bptjm-12	369	48	requero	requero	NOUN
bptjm-12	369	49	,	,	PUNCT
bptjm-12	369	50	á	á	X
bptjm-12	369	51	.	.	PUNCT
bptjm-12	370	1	(	(	PUNCT
bptjm-12	370	2	2020	2020	NUM
bptjm-12	370	3	)	)	PUNCT
bptjm-12	370	4	.	.	PUNCT
bptjm-12	371	1	targeting	target	VERB
bptjm-12	371	2	cannabinoid	cannabinoid	NOUN
bptjm-12	371	3	receptor	receptor	NOUN
bptjm-12	371	4	activation	activation	NOUN
bptjm-12	371	5	and	and	CCONJ
bptjm-12	371	6	bace-1	bace-1	NUM
bptjm-12	371	7	activity	activity	NOUN
bptjm-12	371	8	counteracts	counteract	VERB
bptjm-12	371	9	tgapp	tgapp	VERB
bptjm-12	371	10	mice	mouse	NOUN
bptjm-12	371	11	memory	memory	NOUN
bptjm-12	371	12	impairment	impairment	NOUN
bptjm-12	371	13	and	and	CCONJ
bptjm-12	371	14	alzheimer	alzheimer	PROPN
bptjm-12	371	15	's	's	PART
bptjm-12	371	16	disease	disease	NOUN
bptjm-12	371	17	lymphoblast	lymphoblast	VERB
bptjm-12	371	18	alterations	alteration	NOUN
bptjm-12	371	19	.	.	PUNCT
bptjm-12	372	1	molecular	molecular	ADJ
bptjm-12	372	2	neurobiology	neurobiology	NOUN
bptjm-12	372	3	,	,	PUNCT
bptjm-12	372	4	57(4	57(4	NUM
bptjm-12	372	5	)	)	PUNCT
bptjm-12	372	6	,	,	PUNCT
bptjm-12	372	7	1938–1951	1938–1951	NUM
bptjm-12	372	8	.	.	PUNCT
bptjm-12	373	1	https://doi.org/10.1007/s11064-018-2513-z	https://doi.org/10.1007/s11064-018-2513-z	PROPN
bptjm-12	373	2	33	33	NUM
bptjm-12	373	3	.	.	PUNCT
bptjm-12	374	1	paloczi	paloczi	PROPN
bptjm-12	374	2	,	,	PUNCT
bptjm-12	374	3	j.	j.	PROPN
bptjm-12	374	4	,	,	PUNCT
bptjm-12	374	5	varga	varga	PROPN
bptjm-12	374	6	,	,	PUNCT
bptjm-12	374	7	z.	z.	PROPN
bptjm-12	375	1	v.	v.	PROPN
bptjm-12	375	2	,	,	PUNCT
bptjm-12	375	3	hasko	hasko	PROPN
bptjm-12	375	4	,	,	PUNCT
bptjm-12	375	5	g.	g.	PROPN
bptjm-12	375	6	,	,	PUNCT
bptjm-12	375	7	&	&	CCONJ
bptjm-12	375	8	pacher	pacher	PROPN
bptjm-12	375	9	,	,	PUNCT
bptjm-12	375	10	p.	p.	NOUN
bptjm-12	375	11	(	(	PUNCT
bptjm-12	375	12	2018	2018	NUM
bptjm-12	375	13	)	)	PUNCT
bptjm-12	375	14	.	.	PUNCT
bptjm-12	376	1	neuroprotection	neuroprotection	NOUN
bptjm-12	376	2	in	in	ADP
bptjm-12	376	3	oxidative	oxidative	ADJ
bptjm-12	376	4	stress	stress	NOUN
bptjm-12	376	5	-	-	PUNCT
bptjm-12	376	6	related	relate	VERB
bptjm-12	376	7	neurodegenerative	neurodegenerative	ADJ
bptjm-12	376	8	diseases	disease	NOUN
bptjm-12	376	9	:	:	PUNCT
bptjm-12	376	10	role	role	NOUN
bptjm-12	376	11	of	of	ADP
bptjm-12	376	12	endocannabinoid	endocannabinoid	NOUN
bptjm-12	376	13	system	system	NOUN
bptjm-12	376	14	modulation	modulation	NOUN
bptjm-12	376	15	.	.	PUNCT
bptjm-12	377	1	antioxidants	antioxidant	NOUN
bptjm-12	377	2	&	&	CCONJ
bptjm-12	377	3	redox	redox	PROPN
bptjm-12	377	4	signaling	signal	VERB
bptjm-12	377	5	,	,	PUNCT
bptjm-12	377	6	29(1	29(1	NUM
bptjm-12	377	7	)	)	PUNCT
bptjm-12	377	8	,	,	PUNCT
bptjm-12	377	9	75–108	75–108	PROPN
bptjm-12	377	10	.	.	PUNCT
bptjm-12	377	11	34	34	NUM
bptjm-12	377	12	.	.	PUNCT
bptjm-12	378	1	plotnikov	plotnikov	PROPN
bptjm-12	378	2	,	,	PUNCT
bptjm-12	378	3	a.	a.	NOUN
bptjm-12	378	4	,	,	PUNCT
bptjm-12	378	5	zehorai	zehorai	PROPN
bptjm-12	378	6	,	,	PUNCT
bptjm-12	378	7	e.	e.	PROPN
bptjm-12	378	8	,	,	PUNCT
bptjm-12	378	9	procaccia	procaccia	PROPN
bptjm-12	378	10	,	,	PUNCT
bptjm-12	378	11	s.	s.	PROPN
bptjm-12	378	12	,	,	PUNCT
bptjm-12	378	13	&	&	CCONJ
bptjm-12	378	14	seger	seger	PROPN
bptjm-12	378	15	,	,	PUNCT
bptjm-12	378	16	r.	r.	PROPN
bptjm-12	378	17	(	(	PUNCT
bptjm-12	378	18	2011	2011	NUM
bptjm-12	378	19	)	)	PUNCT
bptjm-12	378	20	.	.	PUNCT
bptjm-12	379	1	the	the	DET
bptjm-12	379	2	mapk	mapk	NOUN
bptjm-12	379	3	cascades	cascade	VERB
bptjm-12	379	4	:	:	PUNCT
bptjm-12	379	5	signaling	signal	VERB
bptjm-12	379	6	components	component	NOUN
bptjm-12	379	7	,	,	PUNCT
bptjm-12	379	8	nuclear	nuclear	ADJ
bptjm-12	379	9	roles	role	NOUN
bptjm-12	379	10	and	and	CCONJ
bptjm-12	379	11	mechanisms	mechanism	NOUN
bptjm-12	379	12	of	of	ADP
bptjm-12	379	13	nuclear	nuclear	ADJ
bptjm-12	379	14	translocation	translocation	NOUN
bptjm-12	379	15	.	.	PUNCT
bptjm-12	380	1	berkeley	berkeley	PROPN
bptjm-12	380	2	pharma	pharma	PROPN
bptjm-12	380	3	tech	tech	PROPN
bptjm-12	380	4	journal	journal	NOUN
bptjm-12	380	5	of	of	ADP
bptjm-12	380	6	medicine	medicine	NOUN
bptjm-12	380	7	|	|	ADV
bptjm-12	380	8	23	23	NUM
bptjm-12	380	9	biochimica	biochimica	PROPN
bptjm-12	380	10	et	et	PROPN
bptjm-12	380	11	biophysica	biophysica	PROPN
bptjm-12	380	12	acta	acta	PROPN
bptjm-12	380	13	,	,	PUNCT
bptjm-12	380	14	1813(9	1813(9	NUM
bptjm-12	380	15	)	)	PUNCT
bptjm-12	380	16	,	,	PUNCT
bptjm-12	380	17	1619–1633	1619–1633	NUM
bptjm-12	380	18	.	.	PUNCT
bptjm-12	381	1	https://doi.org/10.1016/j.bbamcr.2010.12.012	https://doi.org/10.1016/j.bbamcr.2010.12.012	PROPN
bptjm-12	381	2	35	35	NUM
bptjm-12	381	3	.	.	PUNCT
bptjm-12	382	1	ramírez	ramírez	PROPN
bptjm-12	382	2	,	,	PUNCT
bptjm-12	382	3	b.	b.	PROPN
bptjm-12	382	4	g.	g.	PROPN
bptjm-12	382	5	,	,	PUNCT
bptjm-12	382	6	blázquez	blázquez	NOUN
bptjm-12	382	7	,	,	PUNCT
bptjm-12	382	8	c.	c.	NOUN
bptjm-12	382	9	,	,	PUNCT
bptjm-12	382	10	pulgar	pulgar	NOUN
bptjm-12	382	11	,	,	PUNCT
bptjm-12	382	12	t.	t.	PROPN
bptjm-12	382	13	g.	g.	PROPN
bptjm-12	382	14	del	del	PROPN
bptjm-12	382	15	,	,	PUNCT
bptjm-12	382	16	guzmán	guzmán	NOUN
bptjm-12	382	17	,	,	PUNCT
bptjm-12	382	18	m.	m.	NOUN
bptjm-12	382	19	,	,	PUNCT
bptjm-12	382	20	&	&	CCONJ
bptjm-12	382	21	ceballos	ceballos	PROPN
bptjm-12	382	22	,	,	PUNCT
bptjm-12	382	23	m.	m.	PROPN
bptjm-12	382	24	l.	l.	PROPN
bptjm-12	382	25	de	de	PROPN
bptjm-12	382	26	.	.	PROPN
bptjm-12	383	1	(	(	PUNCT
bptjm-12	383	2	2005).prevention	2005).prevention	NUM
bptjm-12	383	3	of	of	ADP
bptjm-12	383	4	alzheimer	alzheimer	PROPN
bptjm-12	383	5	’s	’s	PART
bptjm-12	383	6	disease	disease	NOUN
bptjm-12	383	7	pathology	pathology	NOUN
bptjm-12	383	8	by	by	ADP
bptjm-12	383	9	cannabinoids	cannabinoid	NOUN
bptjm-12	383	10	:	:	PUNCT
bptjm-12	383	11	neuroprotection	neuroprotection	NOUN
bptjm-12	383	12	mediated	mediate	VERB
bptjm-12	383	13	byblockade	byblockade	NOUN
bptjm-12	383	14	of	of	ADP
bptjm-12	383	15	microglial	microglial	ADJ
bptjm-12	383	16	activation	activation	NOUN
bptjm-12	383	17	.	.	PUNCT
bptjm-12	384	1	journal	journal	NOUN
bptjm-12	384	2	of	of	ADP
bptjm-12	384	3	neuroscience	neuroscience	NOUN
bptjm-12	384	4	,	,	PUNCT
bptjm-12	384	5	25(8	25(8	NUM
bptjm-12	384	6	)	)	PUNCT
bptjm-12	384	7	,	,	PUNCT
bptjm-12	384	8	1904–1913	1904–1913	NUM
bptjm-12	384	9	.	.	PUNCT
bptjm-12	385	1	36	36	NUM
bptjm-12	385	2	.	.	PUNCT
bptjm-12	385	3	rodrigues	rodrigues	PROPN
bptjm-12	385	4	,	,	PUNCT
bptjm-12	385	5	r.	r.	PROPN
bptjm-12	385	6	s.	s.	PROPN
bptjm-12	385	7	,	,	PUNCT
bptjm-12	385	8	lourenço	lourenço	PROPN
bptjm-12	385	9	,	,	PUNCT
bptjm-12	385	10	d.	d.	PROPN
bptjm-12	385	11	m.	m.	PROPN
bptjm-12	385	12	,	,	PUNCT
bptjm-12	385	13	paulo	paulo	PROPN
bptjm-12	385	14	,	,	PUNCT
bptjm-12	385	15	s.	s.	PROPN
bptjm-12	385	16	l.	l.	PROPN
bptjm-12	385	17	,	,	PUNCT
bptjm-12	385	18	mateus	mateus	PROPN
bptjm-12	385	19	,	,	PUNCT
bptjm-12	385	20	j.	j.	PROPN
bptjm-12	385	21	m.	m.	PROPN
bptjm-12	385	22	,	,	PUNCT
bptjm-12	385	23	ferreira	ferreira	PROPN
bptjm-12	385	24	,	,	PUNCT
bptjm-12	385	25	m.	m.	PROPN
bptjm-12	385	26	f.	f.	PROPN
bptjm-12	385	27	,	,	PUNCT
bptjm-12	385	28	mouro	mouro	PROPN
bptjm-12	385	29	,	,	PUNCT
bptjm-12	385	30	f.	f.	PROPN
bptjm-12	385	31	m.	m.	PROPN
bptjm-12	385	32	,moreira	,moreira	PROPN
bptjm-12	385	33	,	,	PUNCT
bptjm-12	385	34	j.	j.	PROPN
bptjm-12	385	35	b.	b.	PROPN
bptjm-12	385	36	,	,	PUNCT
bptjm-12	385	37	ribeiro	ribeiro	PROPN
bptjm-12	385	38	,	,	PUNCT
bptjm-12	385	39	f.	f.	PROPN
bptjm-12	385	40	f.	f.	PROPN
bptjm-12	385	41	,	,	PUNCT
bptjm-12	385	42	sebastião	sebastião	PROPN
bptjm-12	385	43	,	,	PUNCT
bptjm-12	385	44	a.	a.	NOUN
bptjm-12	385	45	m.	m.	NOUN
bptjm-12	385	46	,	,	PUNCT
bptjm-12	385	47	&	&	CCONJ
bptjm-12	385	48	xapelli	xapelli	PROPN
bptjm-12	385	49	,	,	PUNCT
bptjm-12	385	50	s.	s.	PROPN
bptjm-12	385	51	(	(	PUNCT
bptjm-12	385	52	2019	2019	NUM
bptjm-12	385	53	)	)	PUNCT
bptjm-12	385	54	.	.	PUNCT
bptjm-12	386	1	cannabinoid	cannabinoid	PROPN
bptjm-12	386	2	actions	action	NOUN
bptjm-12	386	3	onneural	onneural	ADJ
bptjm-12	386	4	stem	stem	NOUN
bptjm-12	386	5	cells	cell	NOUN
bptjm-12	386	6	:	:	PUNCT
bptjm-12	386	7	implications	implication	NOUN
bptjm-12	386	8	for	for	ADP
bptjm-12	386	9	pathophysiology	pathophysiology	NOUN
bptjm-12	386	10	.	.	PUNCT
bptjm-12	387	1	molecules	molecule	NOUN
bptjm-12	387	2	(	(	PUNCT
bptjm-12	387	3	basel	basel	PROPN
bptjm-12	387	4	,	,	PUNCT
bptjm-12	387	5	switzerland	switzerland	PROPN
bptjm-12	387	6	)	)	PUNCT
bptjm-12	387	7	,	,	PUNCT
bptjm-12	387	8	24(7),1350	24(7),1350	NUM
bptjm-12	387	9	.	.	PUNCT
bptjm-12	388	1	37	37	NUM
bptjm-12	388	2	.	.	PUNCT
bptjm-12	389	1	ruthirakuhan	ruthirakuhan	PROPN
bptjm-12	389	2	,	,	PUNCT
bptjm-12	389	3	m.	m.	NOUN
bptjm-12	389	4	,	,	PUNCT
bptjm-12	389	5	lanctôt	lanctôt	PROPN
bptjm-12	389	6	,	,	PUNCT
bptjm-12	389	7	k.	k.	PROPN
bptjm-12	389	8	l.	l.	PROPN
bptjm-12	389	9	,	,	PUNCT
bptjm-12	389	10	vieira	vieira	PROPN
bptjm-12	389	11	,	,	PUNCT
bptjm-12	389	12	d.	d.	PROPN
bptjm-12	389	13	,	,	PUNCT
bptjm-12	389	14	&	&	CCONJ
bptjm-12	389	15	herrmann	herrmann	PROPN
bptjm-12	389	16	,	,	PUNCT
bptjm-12	389	17	n.	n.	PROPN
bptjm-12	389	18	(	(	PUNCT
bptjm-12	389	19	2019	2019	NUM
bptjm-12	389	20	)	)	PUNCT
bptjm-12	389	21	.	.	PUNCT
bptjm-12	390	1	natural	natural	ADJ
bptjm-12	390	2	and	and	CCONJ
bptjm-12	390	3	synthetic	synthetic	ADJ
bptjm-12	390	4	cannabinoids	cannabinoid	NOUN
bptjm-12	390	5	for	for	ADP
bptjm-12	390	6	agitation	agitation	NOUN
bptjm-12	390	7	and	and	CCONJ
bptjm-12	390	8	aggression	aggression	NOUN
bptjm-12	390	9	in	in	ADP
bptjm-12	390	10	alzheimer	alzheimer	PROPN
bptjm-12	390	11	's	's	PART
bptjm-12	390	12	disease	disease	NOUN
bptjm-12	390	13	:	:	PUNCT
bptjm-12	390	14	a	a	DET
bptjm-12	390	15	meta	meta	ADJ
bptjm-12	390	16	-	-	PUNCT
bptjm-12	390	17	analysis	analysis	NOUN
bptjm-12	390	18	.	.	PUNCT
bptjm-12	391	1	the	the	DET
bptjm-12	391	2	journal	journal	NOUN
bptjm-12	391	3	of	of	ADP
bptjm-12	391	4	clinical	clinical	ADJ
bptjm-12	391	5	psychiatry	psychiatry	NOUN
bptjm-12	391	6	,	,	PUNCT
bptjm-12	391	7	80(2	80(2	NUM
bptjm-12	391	8	)	)	PUNCT
bptjm-12	391	9	,	,	PUNCT
bptjm-12	391	10	18r12617	18r12617	NUM
bptjm-12	391	11	.	.	PUNCT
bptjm-12	391	12	https://doi.org/10.4088/jcp.18r12617	https://doi.org/10.4088/jcp.18r12617	PROPN
bptjm-12	391	13	38	38	NUM
bptjm-12	391	14	.	.	PUNCT
bptjm-12	392	1	schubert	schubert	PROPN
bptjm-12	392	2	,	,	PUNCT
bptjm-12	392	3	d.	d.	PROPN
bptjm-12	392	4	,	,	PUNCT
bptjm-12	392	5	kepchia	kepchia	PROPN
bptjm-12	392	6	,	,	PUNCT
bptjm-12	392	7	d.	d.	PROPN
bptjm-12	392	8	,	,	PUNCT
bptjm-12	392	9	liang	liang	PROPN
bptjm-12	392	10	,	,	PUNCT
bptjm-12	392	11	z.	z.	PROPN
bptjm-12	392	12	,	,	PUNCT
bptjm-12	392	13	dargusch	dargusch	PROPN
bptjm-12	392	14	,	,	PUNCT
bptjm-12	392	15	r.	r.	PROPN
bptjm-12	392	16	,	,	PUNCT
bptjm-12	392	17	goldberg	goldberg	PROPN
bptjm-12	392	18	,	,	PUNCT
bptjm-12	392	19	j.	j.	PROPN
bptjm-12	392	20	,	,	PUNCT
bptjm-12	392	21	&	&	CCONJ
bptjm-12	392	22	maher	maher	PROPN
bptjm-12	392	23	,	,	PUNCT
bptjm-12	392	24	p.	p.	NOUN
bptjm-12	392	25	(	(	PUNCT
bptjm-12	392	26	2019	2019	NUM
bptjm-12	392	27	)	)	PUNCT
bptjm-12	392	28	.	.	PUNCT
bptjm-12	393	1	e	e	X
bptjm-12	393	2	�	�	PROPN
bptjm-12	393	3	cacyof	cacyof	ADJ
bptjm-12	393	4	cannabinoids	cannabinoid	NOUN
bptjm-12	393	5	in	in	ADP
bptjm-12	393	6	a	a	DET
bptjm-12	393	7	pre	pre	ADJ
bptjm-12	393	8	-	-	ADJ
bptjm-12	393	9	clinical	clinical	ADJ
bptjm-12	393	10	drug	drug	NOUN
bptjm-12	393	11	-	-	PUNCT
bptjm-12	393	12	screening	screen	VERB
bptjm-12	393	13	platform	platform	NOUN
bptjm-12	393	14	for	for	ADP
bptjm-12	393	15	alzheimer	alzheimer	PROPN
bptjm-12	393	16	’s	’s	PART
bptjm-12	393	17	disease	disease	NOUN
bptjm-12	393	18	.	.	PUNCT
bptjm-12	394	1	molecular	molecular	ADJ
bptjm-12	394	2	neurobiology	neurobiology	NOUN
bptjm-12	394	3	,	,	PUNCT
bptjm-12	394	4	56(11	56(11	NUM
bptjm-12	394	5	)	)	PUNCT
bptjm-12	394	6	,	,	PUNCT
bptjm-12	394	7	7719–7730	7719–7730	NUM
bptjm-12	394	8	.	.	PUNCT
bptjm-12	394	9	https://doi.org/10.1007/s12035-019-1637-8	https://doi.org/10.1007/s12035-019-1637-8	NUM
bptjm-12	394	10	.	.	PUNCT
bptjm-12	395	1	39	39	NUM
bptjm-12	395	2	.	.	PUNCT
bptjm-12	396	1	scuderi	scuderi	PROPN
bptjm-12	396	2	,	,	PUNCT
bptjm-12	396	3	c.	c.	PROPN
bptjm-12	396	4	,	,	PUNCT
bptjm-12	396	5	steardo	steardo	PROPN
bptjm-12	396	6	,	,	PUNCT
bptjm-12	396	7	l.	l.	PROPN
bptjm-12	396	8	,	,	PUNCT
bptjm-12	396	9	&	&	CCONJ
bptjm-12	396	10	esposito	esposito	PROPN
bptjm-12	396	11	,	,	PUNCT
bptjm-12	396	12	g.	g.	PROPN
bptjm-12	396	13	(	(	PUNCT
bptjm-12	396	14	2014	2014	NUM
bptjm-12	396	15	)	)	PUNCT
bptjm-12	396	16	.	.	PUNCT
bptjm-12	397	1	cannabidiol	cannabidiol	PROPN
bptjm-12	397	2	promotes	promote	VERB
bptjm-12	397	3	amyloid	amyloid	NOUN
bptjm-12	397	4	precursor	precursor	NOUN
bptjm-12	397	5	protein	protein	NOUN
bptjm-12	397	6	ubiquitination	ubiquitination	NOUN
bptjm-12	397	7	and	and	CCONJ
bptjm-12	397	8	reduction	reduction	NOUN
bptjm-12	397	9	of	of	ADP
bptjm-12	397	10	beta	beta	ADJ
bptjm-12	397	11	amyloid	amyloid	NOUN
bptjm-12	397	12	expression	expression	NOUN
bptjm-12	397	13	in	in	ADP
bptjm-12	397	14	shsy5yapp+	shsy5yapp+	PROPN
bptjm-12	397	15	cells	cell	NOUN
bptjm-12	397	16	through	through	ADP
bptjm-12	397	17	pparγ	pparγ	ADJ
bptjm-12	397	18	involvement	involvement	NOUN
bptjm-12	397	19	.	.	PUNCT
bptjm-12	398	1	phytotherapy	phytotherapy	NOUN
bptjm-12	398	2	research	research	NOUN
bptjm-12	398	3	:	:	PUNCT
bptjm-12	398	4	ptr	ptr	PROPN
bptjm-12	398	5	,	,	PUNCT
bptjm-12	398	6	28(7	28(7	NUM
bptjm-12	398	7	)	)	PUNCT
bptjm-12	398	8	,	,	PUNCT
bptjm-12	398	9	1007–1013	1007–1013	NUM
bptjm-12	398	10	.	.	PUNCT
bptjm-12	399	1	https://doi.org/10.1002/ptr.5095	https://doi.org/10.1002/ptr.5095	NOUN
bptjm-12	399	2	.	.	PUNCT
bptjm-12	400	1	40	40	NUM
bptjm-12	400	2	.	.	PUNCT
bptjm-12	401	1	shankar	shankar	PROPN
bptjm-12	401	2	,	,	PUNCT
bptjm-12	401	3	g.	g.	PROPN
bptjm-12	401	4	m.	m.	PROPN
bptjm-12	401	5	,	,	PUNCT
bptjm-12	401	6	li	li	PROPN
bptjm-12	401	7	,	,	PUNCT
bptjm-12	401	8	s.	s.	PROPN
bptjm-12	401	9	,	,	PUNCT
bptjm-12	401	10	mehta	mehta	PROPN
bptjm-12	401	11	,	,	PUNCT
bptjm-12	401	12	t.	t.	PROPN
bptjm-12	401	13	h.	h.	PROPN
bptjm-12	401	14	,	,	PUNCT
bptjm-12	401	15	garcia	garcia	PROPN
bptjm-12	401	16	-	-	PUNCT
bptjm-12	401	17	munoz	munoz	PROPN
bptjm-12	401	18	,	,	PUNCT
bptjm-12	401	19	a.	a.	PROPN
bptjm-12	401	20	,	,	PUNCT
bptjm-12	401	21	shepardson	shepardson	PROPN
bptjm-12	401	22	,	,	PUNCT
bptjm-12	401	23	n.	n.	PROPN
bptjm-12	401	24	e.	e.	PROPN
bptjm-12	401	25	,	,	PUNCT
bptjm-12	401	26	smith	smith	PROPN
bptjm-12	401	27	,	,	PUNCT
bptjm-12	401	28	i.	i.	PROPN
bptjm-12	401	29	,	,	PUNCT
bptjm-12	401	30	brett	brett	PROPN
bptjm-12	401	31	,	,	PUNCT
bptjm-12	401	32	f.	f.	PROPN
bptjm-12	401	33	m.	m.	PROPN
bptjm-12	401	34	,	,	PUNCT
bptjm-12	401	35	farrell	farrell	PROPN
bptjm-12	401	36	,	,	PUNCT
bptjm-12	401	37	m.	m.	NOUN
bptjm-12	401	38	a.	a.	PROPN
bptjm-12	401	39	,	,	PUNCT
bptjm-12	401	40	rowan	rowan	PROPN
bptjm-12	401	41	,	,	PUNCT
bptjm-12	401	42	m.	m.	PROPN
bptjm-12	401	43	j.	j.	PROPN
bptjm-12	401	44	,	,	PUNCT
bptjm-12	401	45	lemere	lemere	PROPN
bptjm-12	401	46	,	,	PUNCT
bptjm-12	401	47	c.	c.	PROPN
bptjm-12	401	48	a.	a.	PROPN
bptjm-12	401	49	,	,	PUNCT
bptjm-12	401	50	regan	regan	NOUN
bptjm-12	401	51	,	,	PUNCT
bptjm-12	401	52	c.	c.	PROPN
bptjm-12	401	53	m.	m.	PROPN
bptjm-12	401	54	,	,	PUNCT
bptjm-12	401	55	walsh	walsh	PROPN
bptjm-12	401	56	,	,	PUNCT
bptjm-12	401	57	d.	d.	PROPN
bptjm-12	401	58	m.	m.	PROPN
bptjm-12	401	59	,	,	PUNCT
bptjm-12	401	60	sabatini	sabatini	PROPN
bptjm-12	401	61	,	,	PUNCT
bptjm-12	401	62	b.	b.	PROPN
bptjm-12	401	63	l.	l.	PROPN
bptjm-12	401	64	,	,	PUNCT
bptjm-12	401	65	&	&	CCONJ
bptjm-12	401	66	selkoe	selkoe	PROPN
bptjm-12	401	67	,	,	PUNCT
bptjm-12	401	68	d.	d.	PROPN
bptjm-12	401	69	j.	j.	PROPN
bptjm-12	401	70	(	(	PUNCT
bptjm-12	401	71	2008	2008	NUM
bptjm-12	401	72	)	)	PUNCT
bptjm-12	401	73	.	.	PUNCT
bptjm-12	402	1	amyloid	amyloid	NOUN
bptjm-12	402	2	-	-	PUNCT
bptjm-12	402	3	beta	beta	NOUN
bptjm-12	402	4	protein	protein	NOUN
bptjm-12	402	5	dimers	dimer	NOUN
bptjm-12	402	6	isolated	isolate	VERB
bptjm-12	402	7	directly	directly	ADV
bptjm-12	402	8	from	from	ADP
bptjm-12	402	9	alzheimer	alzheimer	PROPN
bptjm-12	402	10	's	's	PART
bptjm-12	402	11	brains	brain	NOUN
bptjm-12	402	12	impair	impair	VERB
bptjm-12	402	13	synaptic	synaptic	ADJ
bptjm-12	402	14	plasticity	plasticity	NOUN
bptjm-12	402	15	and	and	CCONJ
bptjm-12	402	16	memory	memory	NOUN
bptjm-12	402	17	.	.	PUNCT
bptjm-12	403	1	nature	nature	NOUN
bptjm-12	403	2	medicine	medicine	NOUN
bptjm-12	403	3	,	,	PUNCT
bptjm-12	403	4	14(8	14(8	NUM
bptjm-12	403	5	)	)	PUNCT
bptjm-12	403	6	,	,	PUNCT
bptjm-12	403	7	837–842	837–842	NUM
bptjm-12	403	8	.	.	PUNCT
bptjm-12	404	1	https://doi.org/10.1038/nm1782	https://doi.org/10.1038/nm1782	PROPN
bptjm-12	404	2	41	41	NUM
bptjm-12	404	3	.	.	PUNCT
bptjm-12	405	1	sofroniew	sofroniew	NOUN
bptjm-12	405	2	,	,	PUNCT
bptjm-12	405	3	m.	m.	NOUN
bptjm-12	405	4	v.	v.	PROPN
bptjm-12	405	5	,	,	PUNCT
bptjm-12	405	6	&	&	CCONJ
bptjm-12	405	7	vinters	vinter	NOUN
bptjm-12	405	8	,	,	PUNCT
bptjm-12	405	9	h.	h.	PROPN
bptjm-12	405	10	v.	v.	PROPN
bptjm-12	405	11	(	(	PUNCT
bptjm-12	405	12	2010	2010	NUM
bptjm-12	405	13	)	)	PUNCT
bptjm-12	405	14	.	.	PUNCT
bptjm-12	406	1	astrocytes	astrocyte	NOUN
bptjm-12	406	2	:	:	PUNCT
bptjm-12	406	3	biology	biology	NOUN
bptjm-12	406	4	and	and	CCONJ
bptjm-12	406	5	pathology	pathology	NOUN
bptjm-12	406	6	.	.	PUNCT
bptjm-12	407	1	acta	acta	PROPN
bptjm-12	407	2	neuropathologica	neuropathologica	PROPN
bptjm-12	407	3	,	,	PUNCT
bptjm-12	407	4	119(1	119(1	NUM
bptjm-12	407	5	)	)	PUNCT
bptjm-12	407	6	,	,	PUNCT
bptjm-12	407	7	7–35.suryadevara	7–35.suryadevara	NUM
bptjm-12	407	8	,	,	PUNCT
bptjm-12	407	9	u.	u.	PROPN
bptjm-12	407	10	,	,	PUNCT
bptjm-12	407	11	bruijnzeel	bruijnzeel	NOUN
bptjm-12	407	12	,	,	PUNCT
bptjm-12	407	13	d.	d.	PROPN
bptjm-12	407	14	m.	m.	PROPN
bptjm-12	407	15	,	,	PUNCT
bptjm-12	407	16	nuthi	nuthi	PROPN
bptjm-12	407	17	,	,	PUNCT
bptjm-12	407	18	m.	m.	NOUN
bptjm-12	407	19	,	,	PUNCT
bptjm-12	407	20	jagnarine	jagnarine	NOUN
bptjm-12	407	21	,	,	PUNCT
bptjm-12	407	22	d.	d.	PROPN
bptjm-12	407	23	a.	a.	PROPN
bptjm-12	407	24	,	,	PUNCT
bptjm-12	407	25	tandon	tandon	PROPN
bptjm-12	407	26	,	,	PUNCT
bptjm-12	407	27	r.	r.	PROPN
bptjm-12	407	28	,	,	PUNCT
bptjm-12	407	29	&	&	CCONJ
bptjm-12	407	30	bruijnzeel	bruijnzeel	PROPN
bptjm-12	407	31	,	,	PUNCT
bptjm-12	407	32	a.w	a.w	PROPN
bptjm-12	407	33	.	.	PROPN
bptjm-12	407	34	(	(	PUNCT
bptjm-12	407	35	2017	2017	NUM
bptjm-12	407	36	)	)	PUNCT
bptjm-12	407	37	.	.	PUNCT
bptjm-12	408	1	pros	pro	NOUN
bptjm-12	408	2	and	and	CCONJ
bptjm-12	408	3	cons	con	NOUN
bptjm-12	408	4	of	of	ADP
bptjm-12	408	5	medical	medical	ADJ
bptjm-12	408	6	cannabis	cannabis	NOUN
bptjm-12	408	7	use	use	NOUN
bptjm-12	408	8	by	by	ADP
bptjm-12	408	9	people	people	NOUN
bptjm-12	408	10	with	with	ADP
bptjm-12	408	11	chronic	chronic	ADJ
bptjm-12	408	12	brain	brain	NOUN
bptjm-12	408	13	disorders	disorder	NOUN
bptjm-12	408	14	.	.	PUNCT
bptjm-12	409	1	current	current	ADJ
bptjm-12	409	2	neuropharmacology	neuropharmacology	NOUN
bptjm-12	409	3	,	,	PUNCT
bptjm-12	409	4	15(6	15(6	NUM
bptjm-12	409	5	)	)	PUNCT
bptjm-12	409	6	,	,	PUNCT
bptjm-12	409	7	800–814.https://doi.org/10.2174/1570159x1	800–814.https://doi.org/10.2174/1570159x1	NUM
bptjm-12	409	8	4666161101095325	4666161101095325	NUM
bptjm-12	409	9	.	.	PUNCT
bptjm-12	410	1	42	42	NUM
bptjm-12	410	2	.	.	PUNCT
bptjm-12	411	1	suryadevara	suryadevara	NOUN
bptjm-12	411	2	,	,	PUNCT
bptjm-12	411	3	u.	u.	PROPN
bptjm-12	411	4	,	,	PUNCT
bptjm-12	411	5	bruijnzeel	bruijnzeel	NOUN
bptjm-12	411	6	,	,	PUNCT
bptjm-12	411	7	d.	d.	PROPN
bptjm-12	411	8	m.	m.	PROPN
bptjm-12	411	9	,	,	PUNCT
bptjm-12	411	10	nuthi	nuthi	PROPN
bptjm-12	411	11	,	,	PUNCT
bptjm-12	411	12	m.	m.	NOUN
bptjm-12	411	13	,	,	PUNCT
bptjm-12	411	14	jagnarine	jagnarine	NOUN
bptjm-12	411	15	,	,	PUNCT
bptjm-12	411	16	d.	d.	PROPN
bptjm-12	411	17	a.	a.	PROPN
bptjm-12	411	18	,	,	PUNCT
bptjm-12	411	19	tandon	tandon	PROPN
bptjm-12	411	20	,	,	PUNCT
bptjm-12	411	21	r.	r.	PROPN
bptjm-12	411	22	,	,	PUNCT
bptjm-12	411	23	&	&	CCONJ
bptjm-12	411	24	bruijnzeel	bruijnzeel	PROPN
bptjm-12	411	25	,	,	PUNCT
bptjm-12	411	26	a.w	a.w	PROPN
bptjm-12	411	27	.	.	PROPN
bptjm-12	411	28	(	(	PUNCT
bptjm-12	411	29	2017	2017	NUM
bptjm-12	411	30	)	)	PUNCT
bptjm-12	411	31	.	.	PUNCT
bptjm-12	412	1	pros	pro	NOUN
bptjm-12	412	2	and	and	CCONJ
bptjm-12	412	3	cons	con	NOUN
bptjm-12	412	4	of	of	ADP
bptjm-12	412	5	medical	medical	ADJ
bptjm-12	412	6	cannabis	cannabis	NOUN
bptjm-12	412	7	use	use	NOUN
bptjm-12	412	8	by	by	ADP
bptjm-12	412	9	people	people	NOUN
bptjm-12	412	10	with	with	ADP
bptjm-12	412	11	chronic	chronic	ADJ
bptjm-12	412	12	brain	brain	NOUN
bptjm-12	412	13	disorders	disorder	NOUN
bptjm-12	412	14	.	.	PUNCT
bptjm-12	413	1	current	current	ADJ
bptjm-12	413	2	neuropharmacology	neuropharmacology	NOUN
bptjm-12	413	3	,	,	PUNCT
bptjm-12	413	4	15(6	15(6	NUM
bptjm-12	413	5	)	)	PUNCT
bptjm-12	413	6	,	,	PUNCT
bptjm-12	413	7	800–814.https://doi.org/10.2174/1570159x1	800–814.https://doi.org/10.2174/1570159x1	NUM
bptjm-12	413	8	4666161101095325	4666161101095325	NUM
bptjm-12	413	9	.	.	PUNCT
bptjm-12	414	1	43	43	NUM
bptjm-12	414	2	.	.	PUNCT
bptjm-12	414	3	talarico	talarico	PROPN
bptjm-12	414	4	,	,	PUNCT
bptjm-12	414	5	g.	g.	PROPN
bptjm-12	414	6	,	,	PUNCT
bptjm-12	414	7	trebbastoni	trebbastoni	PROPN
bptjm-12	414	8	,	,	PUNCT
bptjm-12	414	9	a.	a.	PROPN
bptjm-12	414	10	,	,	PUNCT
bptjm-12	414	11	bruno	bruno	PROPN
bptjm-12	414	12	,	,	PUNCT
bptjm-12	414	13	g.	g.	PROPN
bptjm-12	414	14	,	,	PUNCT
bptjm-12	414	15	&	&	CCONJ
bptjm-12	414	16	de	de	PROPN
bptjm-12	414	17	lena	lena	PROPN
bptjm-12	414	18	,	,	PUNCT
bptjm-12	414	19	c.	c.	NOUN
bptjm-12	414	20	(	(	PUNCT
bptjm-12	414	21	2019	2019	NUM
bptjm-12	414	22	)	)	PUNCT
bptjm-12	414	23	.	.	PUNCT
bptjm-12	415	1	modulation	modulation	NOUN
bptjm-12	415	2	of	of	ADP
bptjm-12	415	3	the	the	DET
bptjm-12	415	4	cannabinoidsystem	cannabinoidsystem	NOUN
bptjm-12	415	5	:	:	PUNCT
bptjm-12	415	6	a	a	DET
bptjm-12	415	7	new	new	ADJ
bptjm-12	415	8	perspective	perspective	NOUN
bptjm-12	415	9	for	for	ADP
bptjm-12	415	10	the	the	DET
bptjm-12	415	11	treatment	treatment	NOUN
bptjm-12	415	12	of	of	ADP
bptjm-12	415	13	the	the	DET
bptjm-12	415	14	alzheimer	alzheimer	PROPN
bptjm-12	415	15	’s	’s	PART
bptjm-12	415	16	disease	disease	NOUN
bptjm-12	415	17	.	.	PUNCT
bptjm-12	416	1	current	current	ADJ
bptjm-12	416	2	neuropharmacology	neuropharmacology	NOUN
bptjm-12	416	3	,	,	PUNCT
bptjm-12	416	4	17(2	17(2	NUM
bptjm-12	416	5	)	)	PUNCT
bptjm-12	416	6	,	,	PUNCT
bptjm-12	416	7	176–183	176–183	NUM
bptjm-12	416	8	.	.	PUNCT
bptjm-12	417	1	https://doi.org/10.2174/1570159x166661807021	https://doi.org/10.2174/1570159x166661807021	PROPN
bptjm-12	417	2	44644	44644	NUM
bptjm-12	417	3	.	.	PUNCT
bptjm-12	418	1	44	44	NUM
bptjm-12	418	2	.	.	PUNCT
bptjm-12	419	1	karl	karl	PROPN
bptjm-12	419	2	,	,	PUNCT
bptjm-12	419	3	t.	t.	PROPN
bptjm-12	419	4	,	,	PUNCT
bptjm-12	419	5	cheng	cheng	PROPN
bptjm-12	419	6	,	,	PUNCT
bptjm-12	419	7	d.	d.	PROPN
bptjm-12	419	8	,	,	PUNCT
bptjm-12	419	9	garner	garner	PROPN
bptjm-12	419	10	,	,	PUNCT
bptjm-12	419	11	b.	b.	PROPN
bptjm-12	419	12	,	,	PUNCT
bptjm-12	419	13	&	&	CCONJ
bptjm-12	419	14	arnold	arnold	PROPN
bptjm-12	419	15	,	,	PUNCT
bptjm-12	419	16	j.	j.	PROPN
bptjm-12	419	17	c.	c.	PROPN
bptjm-12	419	18	(	(	PUNCT
bptjm-12	419	19	2012	2012	NUM
bptjm-12	419	20	)	)	PUNCT
bptjm-12	419	21	.	.	PUNCT
bptjm-12	420	1	the	the	DET
bptjm-12	420	2	therapeutic	therapeutic	ADJ
bptjm-12	420	3	potential	potential	NOUN
bptjm-12	420	4	of	of	ADP
bptjm-12	420	5	the	the	DET
bptjm-12	420	6	endocannabinoid	endocannabinoid	NOUN
bptjm-12	420	7	system	system	NOUN
bptjm-12	420	8	for	for	ADP
bptjm-12	420	9	alzheimer	alzheimer	PROPN
bptjm-12	420	10	's	's	PART
bptjm-12	420	11	disease	disease	NOUN
bptjm-12	420	12	.	.	PUNCT
bptjm-12	421	1	berkeley	berkeley	PROPN
bptjm-12	421	2	pharma	pharma	PROPN
bptjm-12	421	3	tech	tech	PROPN
bptjm-12	421	4	journal	journal	NOUN
bptjm-12	421	5	of	of	ADP
bptjm-12	421	6	medicine	medicine	NOUN
bptjm-12	421	7	|	|	ADV
bptjm-12	421	8	24	24	NUM
bptjm-12	421	9	expert	expert	NOUN
bptjm-12	421	10	opinion	opinion	NOUN
bptjm-12	421	11	on	on	ADP
bptjm-12	421	12	therapeutic	therapeutic	ADJ
bptjm-12	421	13	targets	target	NOUN
bptjm-12	421	14	,	,	PUNCT
bptjm-12	421	15	16(4	16(4	NUM
bptjm-12	421	16	)	)	PUNCT
bptjm-12	421	17	,	,	PUNCT
bptjm-12	421	18	407–420	407–420	NUM
bptjm-12	421	19	.	.	PUNCT
bptjm-12	422	1	https://doi.org/10.1517/14728222.2012.671812	https://doi.org/10.1517/14728222.2012.671812	PROPN
bptjm-12	422	2	45	45	NUM
bptjm-12	422	3	.	.	PUNCT
bptjm-12	423	1	thomas	thomas	PROPN
bptjm-12	423	2	,	,	PUNCT
bptjm-12	423	3	a.	a.	PROPN
bptjm-12	423	4	,	,	PUNCT
bptjm-12	423	5	baillie	baillie	PROPN
bptjm-12	423	6	,	,	PUNCT
bptjm-12	423	7	g.	g.	PROPN
bptjm-12	423	8	l.	l.	PROPN
bptjm-12	423	9	,	,	PUNCT
bptjm-12	423	10	phillips	phillips	PROPN
bptjm-12	423	11	,	,	PUNCT
bptjm-12	423	12	a.	a.	NOUN
bptjm-12	423	13	m.	m.	NOUN
bptjm-12	423	14	,	,	PUNCT
bptjm-12	423	15	razdan	razdan	PROPN
bptjm-12	423	16	,	,	PUNCT
bptjm-12	423	17	r.	r.	PROPN
bptjm-12	423	18	k.	k.	PROPN
bptjm-12	423	19	,	,	PUNCT
bptjm-12	423	20	ross	ross	PROPN
bptjm-12	423	21	,	,	PUNCT
bptjm-12	423	22	r.	r.	PROPN
bptjm-12	423	23	a.	a.	PROPN
bptjm-12	423	24	,	,	PUNCT
bptjm-12	423	25	&	&	CCONJ
bptjm-12	423	26	pertwee	pertwee	PROPN
bptjm-12	423	27	,	,	PUNCT
bptjm-12	423	28	r.	r.	PROPN
bptjm-12	423	29	g.	g.	PROPN
bptjm-12	423	30	(	(	PUNCT
bptjm-12	423	31	2007	2007	NUM
bptjm-12	423	32	)	)	PUNCT
bptjm-12	423	33	.	.	PUNCT
bptjm-12	424	1	cannabidiol	cannabidiol	PROPN
bptjm-12	424	2	displays	display	VERB
bptjm-12	424	3	unexpectedly	unexpectedly	ADV
bptjm-12	424	4	high	high	ADJ
bptjm-12	424	5	potency	potency	NOUN
bptjm-12	424	6	as	as	ADP
bptjm-12	424	7	an	an	DET
bptjm-12	424	8	antagonist	antagonist	NOUN
bptjm-12	424	9	of	of	ADP
bptjm-12	424	10	cb1	cb1	PROPN
bptjm-12	424	11	and	and	CCONJ
bptjm-12	424	12	cb2	cb2	PROPN
bptjm-12	424	13	receptor	receptor	NOUN
bptjm-12	424	14	agonists	agonist	NOUN
bptjm-12	424	15	in	in	ADP
bptjm-12	424	16	vitro	vitro	X
bptjm-12	424	17	.	.	PUNCT
bptjm-12	425	1	british	british	ADJ
bptjm-12	425	2	journal	journal	PROPN
bptjm-12	425	3	of	of	ADP
bptjm-12	425	4	pharmacology	pharmacology	NOUN
bptjm-12	425	5	,	,	PUNCT
bptjm-12	425	6	150(5	150(5	NUM
bptjm-12	425	7	)	)	PUNCT
bptjm-12	425	8	,	,	PUNCT
bptjm-12	425	9	613–623	613–623	NUM
bptjm-12	425	10	.	.	PUNCT
bptjm-12	426	1	https://doi.org/10.1038/sj.bjp.0707133	https://doi.org/10.1038/sj.bjp.0707133	VERB
bptjm-12	426	2	46	46	NUM
bptjm-12	426	3	.	.	PUNCT
bptjm-12	427	1	thompson	thompson	PROPN
bptjm-12	427	2	,	,	PUNCT
bptjm-12	427	3	k.	k.	PROPN
bptjm-12	427	4	j.	j.	PROPN
bptjm-12	427	5	,	,	PUNCT
bptjm-12	427	6	&	&	CCONJ
bptjm-12	427	7	tobin	tobin	PROPN
bptjm-12	427	8	,	,	PUNCT
bptjm-12	427	9	a.	a.	PROPN
bptjm-12	427	10	b.	b.	PROPN
bptjm-12	427	11	(	(	PUNCT
bptjm-12	427	12	2020	2020	NUM
bptjm-12	427	13	)	)	PUNCT
bptjm-12	427	14	.	.	PUNCT
bptjm-12	428	1	crosstalk	crosstalk	VERB
bptjm-12	428	2	between	between	ADP
bptjm-12	428	3	the	the	DET
bptjm-12	428	4	m1	m1	PROPN
bptjm-12	428	5	muscarinic	muscarinic	ADJ
bptjm-12	428	6	acetylcholine	acetylcholine	NOUN
bptjm-12	428	7	receptor	receptor	NOUN
bptjm-12	428	8	and	and	CCONJ
bptjm-12	428	9	the	the	DET
bptjm-12	428	10	endocannabinoid	endocannabinoid	NOUN
bptjm-12	428	11	system	system	NOUN
bptjm-12	428	12	:	:	PUNCT
bptjm-12	428	13	a	a	DET
bptjm-12	428	14	relevance	relevance	NOUN
bptjm-12	428	15	for	for	ADP
bptjm-12	428	16	alzheimer	alzheimer	PROPN
bptjm-12	428	17	’s	’s	PART
bptjm-12	428	18	disease	disease	NOUN
bptjm-12	428	19	?	?	PUNCT
bptjm-12	429	1	cellular	cellular	ADJ
bptjm-12	429	2	signalling	signalling	NOUN
bptjm-12	429	3	,	,	PUNCT
bptjm-12	429	4	70	70	NUM
bptjm-12	429	5	,	,	PUNCT
bptjm-12	429	6	109545	109545	NUM
bptjm-12	429	7	.	.	PUNCT
bptjm-12	430	1	47	47	NUM
bptjm-12	430	2	.	.	PUNCT
bptjm-12	430	3	tolón	tolón	PROPN
bptjm-12	430	4	,	,	PUNCT
bptjm-12	430	5	r.	r.	PROPN
bptjm-12	430	6	m.	m.	PROPN
bptjm-12	430	7	,	,	PUNCT
bptjm-12	430	8	núñez	núñez	PROPN
bptjm-12	430	9	,	,	PUNCT
bptjm-12	430	10	e.	e.	PROPN
bptjm-12	430	11	,	,	PUNCT
bptjm-12	430	12	pazos	pazos	PROPN
bptjm-12	430	13	,	,	PUNCT
bptjm-12	430	14	m.	m.	PROPN
bptjm-12	430	15	r.	r.	PROPN
bptjm-12	430	16	,	,	PUNCT
bptjm-12	430	17	benito	benito	PROPN
bptjm-12	430	18	,	,	PUNCT
bptjm-12	430	19	c.	c.	PROPN
bptjm-12	430	20	,	,	PUNCT
bptjm-12	430	21	castillo	castillo	PROPN
bptjm-12	430	22	,	,	PUNCT
bptjm-12	430	23	a.	a.	NOUN
bptjm-12	430	24	i.	i.	PROPN
bptjm-12	430	25	,	,	PUNCT
bptjm-12	430	26	martínez	martínez	NOUN
bptjm-12	430	27	-	-	PUNCT
bptjm-12	430	28	orgado	orgado	PROPN
bptjm-12	430	29	,	,	PUNCT
bptjm-12	430	30	j.	j.	PROPN
bptjm-12	430	31	a.	a.	PROPN
bptjm-12	430	32	,	,	PUNCT
bptjm-12	430	33	&	&	CCONJ
bptjm-12	430	34	romero	romero	PROPN
bptjm-12	430	35	,	,	PUNCT
bptjm-12	430	36	j.	j.	PROPN
bptjm-12	430	37	(	(	PUNCT
bptjm-12	430	38	2009	2009	NUM
bptjm-12	430	39	)	)	PUNCT
bptjm-12	430	40	.	.	PUNCT
bptjm-12	431	1	the	the	DET
bptjm-12	431	2	activation	activation	NOUN
bptjm-12	431	3	of	of	ADP
bptjm-12	431	4	cannabinoid	cannabinoid	NOUN
bptjm-12	431	5	cb2	cb2	PROPN
bptjm-12	431	6	receptors	receptor	NOUN
bptjm-12	431	7	stimulates	stimulate	VERB
bptjm-12	431	8	in	in	ADP
bptjm-12	431	9	situ	situ	NOUN
bptjm-12	431	10	and	and	CCONJ
bptjm-12	431	11	in	in	ADP
bptjm-12	431	12	vitrobeta	vitrobeta	ADJ
bptjm-12	431	13	-	-	PUNCT
bptjm-12	431	14	amyloid	amyloid	NOUN
bptjm-12	431	15	removal	removal	NOUN
bptjm-12	431	16	by	by	ADP
bptjm-12	431	17	human	human	ADJ
bptjm-12	431	18	macrophages	macrophage	NOUN
bptjm-12	431	19	.	.	PUNCT
bptjm-12	432	1	brain	brain	NOUN
bptjm-12	432	2	research	research	NOUN
bptjm-12	432	3	,	,	PUNCT
bptjm-12	432	4	1283	1283	NUM
bptjm-12	432	5	,	,	PUNCT
bptjm-12	432	6	148–154	148–154	NUM
bptjm-12	432	7	.	.	PUNCT
bptjm-12	433	1	48	48	NUM
bptjm-12	433	2	.	.	PUNCT
bptjm-12	434	1	uddin	uddin	PROPN
bptjm-12	434	2	,	,	PUNCT
bptjm-12	434	3	m.	m.	NOUN
bptjm-12	434	4	s.	s.	PROPN
bptjm-12	434	5	,	,	PUNCT
bptjm-12	434	6	mamun	mamun	PROPN
bptjm-12	434	7	,	,	PUNCT
bptjm-12	434	8	a.	a.	NOUN
bptjm-12	434	9	a.	a.	PROPN
bptjm-12	434	10	,	,	PUNCT
bptjm-12	434	11	sumsuzzman	sumsuzzman	NOUN
bptjm-12	434	12	,	,	PUNCT
bptjm-12	434	13	d.	d.	PROPN
bptjm-12	434	14	m.	m.	PROPN
bptjm-12	434	15	,	,	PUNCT
bptjm-12	434	16	ashraf	ashraf	PROPN
bptjm-12	434	17	,	,	PUNCT
bptjm-12	434	18	g.	g.	PROPN
bptjm-12	434	19	m.	m.	PROPN
bptjm-12	434	20	,	,	PUNCT
bptjm-12	434	21	perveen	perveen	PROPN
bptjm-12	434	22	,	,	PUNCT
bptjm-12	434	23	a.	a.	NOUN
bptjm-12	434	24	,	,	PUNCT
bptjm-12	434	25	bungau	bungau	NOUN
bptjm-12	434	26	,	,	PUNCT
bptjm-12	434	27	s.	s.	PROPN
bptjm-12	434	28	g.	g.	PROPN
bptjm-12	434	29	,mousa	,mousa	PROPN
bptjm-12	434	30	,	,	PUNCT
bptjm-12	434	31	s.	s.	PROPN
bptjm-12	434	32	a.	a.	PROPN
bptjm-12	434	33	,	,	PUNCT
bptjm-12	434	34	el	el	PROPN
bptjm-12	434	35	-	-	PUNCT
bptjm-12	434	36	seedi	seedi	PROPN
bptjm-12	434	37	,	,	PUNCT
bptjm-12	434	38	h.	h.	PROPN
bptjm-12	434	39	r.	r.	PROPN
bptjm-12	434	40	,	,	PUNCT
bptjm-12	434	41	bin	bin	PROPN
bptjm-12	434	42	-	-	PUNCT
bptjm-12	434	43	jumah	jumah	PROPN
bptjm-12	434	44	,	,	PUNCT
bptjm-12	434	45	m.	m.	NOUN
bptjm-12	434	46	n.	n.	PROPN
bptjm-12	434	47	,	,	PUNCT
bptjm-12	434	48	&	&	CCONJ
bptjm-12	434	49	abdel	abdel	PROPN
bptjm-12	434	50	-	-	PUNCT
bptjm-12	434	51	daim	daim	PROPN
bptjm-12	434	52	,	,	PUNCT
bptjm-12	434	53	m.	m.	NOUN
bptjm-12	434	54	m.	m.	NOUN
bptjm-12	434	55	(	(	PUNCT
bptjm-12	434	56	2020	2020	NUM
bptjm-12	434	57	)	)	PUNCT
bptjm-12	434	58	.	.	PUNCT
bptjm-12	435	1	emergingpromise	emergingpromise	NOUN
bptjm-12	435	2	of	of	ADP
bptjm-12	435	3	cannabinoids	cannabinoid	NOUN
bptjm-12	435	4	for	for	ADP
bptjm-12	435	5	the	the	DET
bptjm-12	435	6	management	management	NOUN
bptjm-12	435	7	of	of	ADP
bptjm-12	435	8	pain	pain	NOUN
bptjm-12	435	9	and	and	CCONJ
bptjm-12	435	10	associated	associated	ADJ
bptjm-12	435	11	neuropathologicalalterations	neuropathologicalalteration	NOUN
bptjm-12	435	12	in	in	ADP
bptjm-12	435	13	alzheimer	alzheimer	PROPN
bptjm-12	435	14	's	's	PART
bptjm-12	435	15	disease	disease	NOUN
bptjm-12	435	16	.	.	PUNCT
bptjm-12	436	1	frontiers	frontier	NOUN
bptjm-12	436	2	in	in	ADP
bptjm-12	436	3	pharmacology	pharmacology	NOUN
bptjm-12	436	4	,	,	PUNCT
bptjm-12	436	5	11	11	NUM
bptjm-12	436	6	,	,	PUNCT
bptjm-12	436	7	1097.https://doi.org/10.3389/fphar.2020.01097	1097.https://doi.org/10.3389/fphar.2020.01097	NUM
bptjm-12	436	8	49	49	NUM
bptjm-12	436	9	.	.	PUNCT
bptjm-12	437	1	vallée	vallée	NOUN
bptjm-12	437	2	,	,	PUNCT
bptjm-12	437	3	a.	a.	NOUN
bptjm-12	437	4	,	,	PUNCT
bptjm-12	437	5	lecarpentier	lecarpentier	NOUN
bptjm-12	437	6	,	,	PUNCT
bptjm-12	437	7	y.	y.	PROPN
bptjm-12	437	8	,	,	PUNCT
bptjm-12	437	9	guillevin	guillevin	PROPN
bptjm-12	437	10	,	,	PUNCT
bptjm-12	437	11	r.	r.	PROPN
bptjm-12	437	12	,	,	PUNCT
bptjm-12	437	13	&	&	CCONJ
bptjm-12	437	14	vallée	vallée	NOUN
bptjm-12	437	15	,	,	PUNCT
bptjm-12	437	16	j.	j.	PROPN
bptjm-12	437	17	n.	n.	PROPN
bptjm-12	437	18	(	(	PUNCT
bptjm-12	437	19	2017	2017	NUM
bptjm-12	437	20	)	)	PUNCT
bptjm-12	437	21	.	.	PUNCT
bptjm-12	438	1	e	e	X
bptjm-12	438	2	�	�	NOUN
bptjm-12	438	3	ects	ect	NOUN
bptjm-12	438	4	of	of	ADP
bptjm-12	438	5	cannabidiol	cannabidiol	NOUN
bptjm-12	438	6	interactions	interaction	NOUN
bptjm-12	438	7	with	with	ADP
bptjm-12	438	8	wnt	wnt	PROPN
bptjm-12	438	9	/	/	SYM
bptjm-12	438	10	β	β	NOUN
bptjm-12	438	11	-	-	ADJ
bptjm-12	438	12	catenin	catenin	ADJ
bptjm-12	438	13	pathway	pathway	NOUN
bptjm-12	438	14	and	and	CCONJ
bptjm-12	438	15	pparγ	pparγ	ADJ
bptjm-12	438	16	on	on	ADP
bptjm-12	438	17	oxidative	oxidative	ADJ
bptjm-12	438	18	stress	stress	NOUN
bptjm-12	438	19	and	and	CCONJ
bptjm-12	438	20	neuroin	neuroin	NOUN
bptjm-12	438	21	�	�	PROPN
bptjm-12	438	22	ammation	ammation	NOUN
bptjm-12	438	23	in	in	ADP
bptjm-12	438	24	alzheimer	alzheimer	PROPN
bptjm-12	438	25	's	's	PART
bptjm-12	438	26	disease	disease	NOUN
bptjm-12	438	27	.	.	PUNCT
bptjm-12	439	1	acta	acta	PROPN
bptjm-12	439	2	biochimica	biochimica	PROPN
bptjm-12	439	3	et	et	PROPN
bptjm-12	439	4	biophysica	biophysica	PROPN
bptjm-12	439	5	sinica	sinica	PROPN
bptjm-12	439	6	,	,	PUNCT
bptjm-12	439	7	49(10	49(10	PROPN
bptjm-12	439	8	)	)	PUNCT
bptjm-12	439	9	,	,	PUNCT
bptjm-12	439	10	853–866	853–866	NUM
bptjm-12	439	11	.	.	PUNCT
bptjm-12	440	1	https://doi.org/10.1093/abbs/gmx073	https://doi.org/10.1093/abbs/gmx073	NOUN
bptjm-12	440	2	50	50	NUM
bptjm-12	440	3	.	.	PUNCT
bptjm-12	441	1	velikova	velikova	PROPN
bptjm-12	441	2	,	,	PUNCT
bptjm-12	441	3	m.	m.	NOUN
bptjm-12	441	4	,	,	PUNCT
bptjm-12	441	5	doncheva	doncheva	PROPN
bptjm-12	441	6	,	,	PUNCT
bptjm-12	441	7	d.	d.	PROPN
bptjm-12	441	8	,	,	PUNCT
bptjm-12	441	9	&	&	CCONJ
bptjm-12	441	10	tashev	tashev	PROPN
bptjm-12	441	11	,	,	PUNCT
bptjm-12	441	12	r.	r.	PROPN
bptjm-12	441	13	(	(	PUNCT
bptjm-12	441	14	2020	2020	NUM
bptjm-12	441	15	)	)	PUNCT
bptjm-12	441	16	.	.	PUNCT
bptjm-12	442	1	subchronic	subchronic	PROPN
bptjm-12	442	2	e	e	SYM
bptjm-12	442	3	�	�	PROPN
bptjm-12	442	4	ects	ect	NOUN
bptjm-12	442	5	of	of	ADP
bptjm-12	442	6	ligands	ligand	NOUN
bptjm-12	442	7	of	of	ADP
bptjm-12	442	8	cannabinoid	cannabinoid	NOUN
bptjm-12	442	9	receptors	receptor	NOUN
bptjm-12	442	10	on	on	ADP
bptjm-12	442	11	learning	learning	NOUN
bptjm-12	442	12	and	and	CCONJ
bptjm-12	442	13	memory	memory	NOUN
bptjm-12	442	14	processes	process	NOUN
bptjm-12	442	15	of	of	ADP
bptjm-12	442	16	olfactory	olfactory	ADJ
bptjm-12	442	17	bulbectomized	bulbectomize	VERB
bptjm-12	442	18	rats	rat	NOUN
bptjm-12	442	19	.	.	PUNCT
bptjm-12	443	1	acta	acta	PROPN
bptjm-12	443	2	neurobiologiae	neurobiologiae	PROPN
bptjm-12	443	3	experimentalis	experimentali	NOUN
bptjm-12	443	4	,	,	PUNCT
bptjm-12	443	5	80(3	80(3	NUM
bptjm-12	443	6	)	)	PUNCT
bptjm-12	443	7	,	,	PUNCT
bptjm-12	443	8	286–296	286–296	NUM
bptjm-12	443	9	.	.	PUNCT
bptjm-12	444	1	51	51	NUM
bptjm-12	444	2	.	.	PUNCT
bptjm-12	444	3	watt	watt	NOUN
bptjm-12	444	4	,	,	PUNCT
bptjm-12	444	5	g.	g.	PROPN
bptjm-12	444	6	,	,	PUNCT
bptjm-12	444	7	&	&	CCONJ
bptjm-12	444	8	karl	karl	PROPN
bptjm-12	444	9	,	,	PUNCT
bptjm-12	444	10	t.	t.	PROPN
bptjm-12	444	11	(	(	PUNCT
bptjm-12	444	12	2017	2017	NUM
bptjm-12	444	13	)	)	PUNCT
bptjm-12	444	14	.	.	PUNCT
bptjm-12	445	1	in	in	ADP
bptjm-12	445	2	vivo	vivo	ADJ
bptjm-12	445	3	evidence	evidence	NOUN
bptjm-12	445	4	for	for	ADP
bptjm-12	445	5	therapeutic	therapeutic	ADJ
bptjm-12	445	6	properties	property	NOUN
bptjm-12	445	7	of	of	ADP
bptjm-12	445	8	cannabidiol	cannabidiol	NOUN
bptjm-12	445	9	(	(	PUNCT
bptjm-12	445	10	cbd)for	cbd)for	PROPN
bptjm-12	445	11	alzheimer	alzheimer	PROPN
bptjm-12	445	12	’s	’s	PART
bptjm-12	445	13	disease	disease	NOUN
bptjm-12	445	14	.	.	PUNCT
bptjm-12	446	1	frontiers	frontier	NOUN
bptjm-12	446	2	in	in	ADP
bptjm-12	446	3	pharmacology	pharmacology	NOUN
bptjm-12	446	4	,	,	PUNCT
bptjm-12	446	5	8	8	NUM
bptjm-12	446	6	.	.	NOUN
bptjm-12	446	7	52	52	NUM
bptjm-12	446	8	.	.	PUNCT
bptjm-12	447	1	wu	wu	PROPN
bptjm-12	447	2	,	,	PUNCT
bptjm-12	447	3	j.	j.	PROPN
bptjm-12	447	4	,	,	PUNCT
bptjm-12	447	5	bie	bie	PROPN
bptjm-12	447	6	,	,	PUNCT
bptjm-12	447	7	b.	b.	PROPN
bptjm-12	447	8	,	,	PUNCT
bptjm-12	447	9	yang	yang	PROPN
bptjm-12	447	10	,	,	PUNCT
bptjm-12	447	11	h.	h.	PROPN
bptjm-12	447	12	,	,	PUNCT
bptjm-12	447	13	xu	xu	PROPN
bptjm-12	447	14	,	,	PUNCT
bptjm-12	447	15	j.	j.	PROPN
bptjm-12	447	16	j.	j.	PROPN
bptjm-12	447	17	,	,	PUNCT
bptjm-12	447	18	brown	brown	PROPN
bptjm-12	447	19	,	,	PUNCT
bptjm-12	447	20	d.	d.	PROPN
bptjm-12	447	21	l.	l.	PROPN
bptjm-12	447	22	,	,	PUNCT
bptjm-12	447	23	&	&	CCONJ
bptjm-12	447	24	naguib	naguib	PROPN
bptjm-12	447	25	,	,	PUNCT
bptjm-12	447	26	m.	m.	NOUN
bptjm-12	447	27	(	(	PUNCT
bptjm-12	447	28	2013	2013	NUM
bptjm-12	447	29	)	)	PUNCT
bptjm-12	447	30	.	.	PUNCT
bptjm-12	448	1	suppression	suppression	NOUN
bptjm-12	448	2	of	of	ADP
bptjm-12	448	3	central	central	ADJ
bptjm-12	448	4	chemokine	chemokine	ADJ
bptjm-12	448	5	fractalkine	fractalkine	NOUN
bptjm-12	448	6	receptor	receptor	NOUN
bptjm-12	448	7	signaling	signal	VERB
bptjm-12	448	8	alleviates	alleviate	VERB
bptjm-12	448	9	amyloid	amyloid	NOUN
bptjm-12	448	10	-	-	PUNCT
bptjm-12	448	11	induced	induce	VERB
bptjm-12	448	12	memory	memory	NOUN
bptjm-12	448	13	de	de	NOUN
bptjm-12	448	14	�	�	NOUN
bptjm-12	448	15	ciency	ciency	NOUN
bptjm-12	448	16	.	.	PUNCT
bptjm-12	449	1	neurobiology	neurobiology	NOUN
bptjm-12	449	2	of	of	ADP
bptjm-12	449	3	aging	aging	NOUN
bptjm-12	449	4	,	,	PUNCT
bptjm-12	449	5	34(12	34(12	NUM
bptjm-12	449	6	)	)	PUNCT
bptjm-12	449	7	,	,	PUNCT
bptjm-12	449	8	2843–2852	2843–2852	NUM
bptjm-12	449	9	.	.	PUNCT
bptjm-12	450	1	https://doi.org/10.1016/j.neurobiolaging.2013.0	https://doi.org/10.1016/j.neurobiolaging.2013.0	NUM
bptjm-12	450	2	6.003	6.003	NUM
bptjm-12	450	3	berkeley	berkeley	PROPN
bptjm-12	450	4	pharma	pharma	PROPN
bptjm-12	450	5	tech	tech	NOUN
bptjm-12	450	6	journal	journal	NOUN
bptjm-12	450	7	of	of	ADP
bptjm-12	450	8	medicine	medicine	NOUN
bptjm-12	450	9	|	|	ADV
bptjm-12	450	10	25	25	NUM
bptjm-12	450	11	article	article	NOUN
bptjm-12	450	12	1_the	1_the	NUM
bptjm-12	450	13	therapeutic	therapeutic	ADJ
bptjm-12	450	14	potential	potential	NOUN
bptjm-12	450	15	of	of	ADP
bptjm-12	450	16	synthetic	synthetic	ADJ
bptjm-12	450	17	and	and	CCONJ
bptjm-12	450	18	natural	natural	ADJ
bptjm-12	450	19	cannabinoids	cannabinoid	NOUN
bptjm-12	450	20	in	in	ADP
bptjm-12	450	21	treating	treat	VERB
bptjm-12	450	22	alzheimer	alzheimer	PROPN
bptjm-12	450	23	’s	’s	PART
bptjm-12	450	24	disease_publish.pdf	disease_publish.pdf	NOUN
bptjm-12	450	25	2	2	NUM
bptjm-12	450	26	.	.	PUNCT
bptjm-12	450	27	front	front	ADJ
bptjm-12	450	28	page	page	NOUN
bptjm-12	450	29	the	the	DET
bptjm-12	450	30	therapeutic	therapeutic	ADJ
bptjm-12	450	31	potential	potential	NOUN
bptjm-12	450	32	of	of	ADP
bptjm-12	450	33	synthetic	synthetic	ADJ
bptjm-12	450	34	and	and	CCONJ
bptjm-12	450	35	natural	natural	ADJ
bptjm-12	450	36	cannabinoids	cannabinoid	NOUN
bptjm-12	450	37	in	in	ADP
bptjm-12	450	38	treating	treat	VERB
bptjm-12	450	39	alzheimer	alzheimer	PROPN
bptjm-12	450	40	’s	’s	PART
bptjm-12	450	41	disease	disease	NOUN
bptjm-12	450	42	(	(	PUNCT
bptjm-12	450	43	1).pdf	1).pdf	NUM
bptjm-12	450	44	3	3	X
bptjm-12	450	45	.	.	PUNCT
bptjm-12	450	46	body	body	NOUN
bptjm-12	450	47	document	document	NOUN
bptjm-12	450	48	the	the	DET
bptjm-12	450	49	therapeutic	therapeutic	ADJ
bptjm-12	450	50	potential	potential	NOUN
bptjm-12	450	51	of	of	ADP
bptjm-12	450	52	synthetic	synthetic	ADJ
bptjm-12	450	53	and	and	CCONJ
bptjm-12	450	54	natural	natural	ADJ
bptjm-12	450	55	cannabinoids	cannabinoid	NOUN
bptjm-12	450	56	in	in	ADP
bptjm-12	450	57	treating	treat	VERB
bptjm-12	450	58	alzheimer	alzheimer	PROPN
bptjm-12	450	59	’s	’s	PART
bptjm-12	450	60	disease.pdf	disease.pdf	PRON
bptjm-12	450	61	cannabinoids	cannabinoid	NOUN
bptjm-12	450	62	paper	paper	NOUN
bptjm-12	450	63	reference	reference	NOUN
bptjm-12	450	64	page	page	NOUN
bptjm-12	450	65	(	(	PUNCT
bptjm-12	450	66	3).pdf	3).pdf	NUM